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Abstract
Objectives: To investigate the effects of a 24-week programme of upper- and lower- 
limb aerobic exercise training on walking performance and quality of life in patients 
with symptomatic peripheral arterial disease (PAD) and to study the mechanisms, which 
could influence symptomatic improvement.
Methods: Following approval from the North Sheffield Local Research Ethics 
Committee, 104 patients (median age 69 y, range 50-85 y) with stable PAD were 
randomised into an upper- or lower-limb aerobic exercise training group, or to a non­
exercise training control group. Training was performed twice weekly for 24-weeks at 
equivalent relative exercise intensities. An incremental arm- and leg-crank test (ACT 
and LCT, respectively) to maximum exercise tolerance was performed before and at 6-, 
12-, 18- and 24-weeks of the intervention to determine peak oxygen consumption 
(VO2 ). Walking performance, defined as the claudication and maximum walking 
distance (CD and MWD respectively) achieved before intolerable claudication pain, 
was assessed at the same time-points using a shuttle-walk protocol. Peak blood lactate 
concentration, ratings of perceived exertion (Borg RPE) and pain (Borg CR-10) were 
recorded during all assessments. Physical activity status, community-based walking 
ability and quality of life were assessed throughout the intervention period. Assessments 
were repeated 6-, 12-, 24- and 48-weeks following the intervention period.
Results: Both CD and MWD increased over time (.P <0.01) in both training groups.
At 24-weeks, CD had improved by 56% and 65% and MWD had improved by 30% and 
35% (P <0.01) in the upper-limb and lower-limb exercise groups, respectively. These 
changes were associated with improvements in community-based walking distance, 
speed and stair-climbing ability (P < 0.01). All patients assigned to exercise training 
exhibited an increase in LCT peak VO2 at the 24-week time-point in relation to baseline 
measures (P <0.01) and control patients (P < 0.01), whereas ACT peak VO2 at the 24- 
week time-point was only improved in the upper-limb exercise training group (P <
0.05). An increase in peak blood lactate concentration (1.95 ± 0.14 vs. 2.40 ±0.17 mM, 
mean ± SEM; P < 0.05) and amount of pain experienced at MWD (P < 0.05) was only 
observed in the upper-limb exercise training group. This suggests that an alteration in 
exercise pain tolerance accounted, at least in part, for the improvement in MWD in this 
group. Upon completing the intervention period the general health status of both 
exercise training groups was improved in relation to the control group (P < 0.05). 
However, improvements in physical functioning and bodily pain in relation to baseline 
(P < 0.05) and energy and vitality in relation to control patients (P < 0.05) were only 
observed in the upper-limb training group. At 48-weeks follow-up, CD remained 
improved by 39% and 48% (P < 0.05) and MWD remained improved by 18% and 26%
(P < 0.05) in the upper-limb and lower-limb exercise groups, respectively, compared to 
baseline measures. A retained improvement in walking confidence (P <0.01) and 
community-based walking distance (P < 0.05) was also observed, however global 
physical activity status in both exercise trained patient groups, returned to baseline. 
Conclusions: Both upper- and lower-limb aerobic exercise training can be useful 
exercise training modalities for improving cardiovascular function, walking 
performance, exercise pain tolerance and quality of life in patients with symptomatic 
PAD. This study suggests that a combination of physiological adaptations and altered 
exercise pain tolerance might account for the improvement in walking performance 
achieved through upper-limb aerobic exercise training in patients with PAD. This study 
also indicates that although walking performance remained improved in both exercise 
trained patients at 48-weeks follow-up, as compared to baseline measures, a progressive 
dwindling of improvement was observed over this time period. Reluctance for the 
continuation of exercise in the home-setting was observed.
Chapter 1 - Introduction
1.1 Background information
Peripheral arterial disease (PAD) is a clinical manifestation of atherosclerosis that is 
prevalent in industrialised societies (Mohler III et al. 2003). Epidemiological studies 
illustrate that PAD is very common when screening is performed in older adults 
(Newman, 2000). Intermittent claudication is the most common symptomatic 
manifestation of mild to moderate PAD (Regensteiner et al. 1997a), typically occurring 
in one out of every 20 people over the age of 65 years in the general population (Beebe, 
2001). The condition usually results from atherosclerotic narrowing of the lower-limb 
arteries (Santilli et al. 1996) and it is generally characterised by lesions within the 
aorto-iliac and/or superficial femoral arteries, popliteal arteries or femoropopliteal 
arterial segments.
In the presence of slowly progressive arterial stenosis, blood flow through collateral 
channels is usually sufficient to maintain normal metabolic function at rest, but is 
inadequate to meet an increased metabolic demand during exercise (McCombs and 
Subramanian, 2002). During ambulation, when the arterial oxygen supply is insufficient 
to meet the metabolic requirements of the exercising leg muscles (Beebe, 2001; 
Regensteiner and Hiatt, 1995), the environment for substrate metabolism becomes 
relatively anaerobic, thereby resulting in the local accumulation of lactic acid and 
metabolic by-products; this accounts for the development of muscle pain and tightness 
(claudication) (McCombs and Subramanian, 2002).
The term ‘claudication’ is derived from the Latin word claudicare, meaning to “limp”, 
after the Roman Emperor Claudius who limped - limping is the typical gait pattern 
observed in patients with claudication (Hiatt and Nehler, 2001). Patients typically walk 
at a slower pace and exhibit a decreased step length and cadence compared with age- 
matched healthy individuals and these abnormal gait parameters impair walking ability 
(Scherer et al. 1998). The pain is often described as cramp-like (Beebe, 2001), and 
although this most commonly affects the calf muscles (Hiatt and Nehler, 2001), it can 
also affect the thigh and buttock regions in one or both legs during walking (Santilli et 
al. 1996). The pain usually subsides within ten minutes of rest (McDermott et al.
2002b) in patients with mild to moderate disease.
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Compared with healthy individuals of a similar age, the peak treadmill walking 
performance of patients with claudication is reduced by 50% to 60% (Hiatt and Nehler, 
2001). Furthermore, on the basis of peak oxygen uptake (FO2) measurements, these 
patients exhibit an approximately 50% reduction in peak aerobic exercise capacity 
compared to healthy age-matched control patients (Hiatt et a l 1987; Hiatt et al. 1988)
- the clinical condition of these patients is therefore of a similar severity as class III 
heart failure patients (Hiatt, 1999). The condition is also associated with an increased 
risk of cardiovascular morbidity and mortality (Regensteiner and Hiatt, 2002b).
Intermittent claudication is a relatively common condition (Beebe, 2001), with males 
developing claudication about twice as frequently as females (McCombs and 
Subramanian, 2002). Approximately 2% of men aged 45-69 years and 1% of women 
aged 50-69 years are affected (Hughson et al 1978). The Framingham study estimated 
the incidence of claudication at 26.6 per 1000 males and 13.3 per 1000 females less than 
65 years of age (Kannel and McGee, 1985). The prevalence of claudication increases 
with age, with up to 1 in 5 patients over the age of 75 years being affected (Spronk et al 
2003). When questioned, many older patients consider increased difficulty in walking to 
be a normal consequence of ageing (Boccalon, 1999) and thus, do not report symptoms 
to a physician (Beebe, 2001). This might account for the fact that, despite its prevalence, 
PAD often remains undiagnosed and the risk of cardiovascular ischaemic events, 
disease progression, functional disability, amputation and death are therefore increased 
(Treat-Jacobson and Walsh, 2003). An under-representation of the condition might also 
account for the observed gender differences in its incidence.
1.1.1 Natural history o f intermittent claudication
Despite the functional impairment caused by intermittent claudication, its natural 
history, in terms of the risk of disease progression with respect to disability and eventual 
limb loss (McCombs and Subramanian, 2002) in the affected limb is relatively benign 
(Nehler and Hiatt, 1999b). Patients with PAD can often remain at the same level of 
walking impairment for years if not offered specific treatments (Regensteiner and Hiatt,
1995). Intermittent claudication can, however, progress in five different ways; i) 
improvement, ii) stabilisation, iii) worsening of the disease, but with no 
revascularisation required, iv) worsening of the disease with revascularisation required, 
and v) a requirement for amputation, usually after disease progression (Aquino et a l 
2001). A large proportion of claudicants (approximately 75%) improve spontaneously
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or remain stable (Gardner et a l 2004b), particularly those who stop smoking and 
persevere with walking (Whyman and Ruckley, 1998). If patients with claudication 
ignore the symptoms, a gradual process of decline usually occurs (Beebe, 2001). It has 
been estimated that 30% to 40% of patients will experience a symptomatic and/or 
objective deterioration over time, as measured by the ankle to brachial pressure index 
(ABPI) (Aquino et al. 2001), with approximately 25% of patients experiencing a 
deterioration in symptoms over five years (Bloor, 1961; Jelnes et al 1986).
Rest pain is indicative of critical limb ischaemia (Creager, 2001), and further 
deterioration could result in limb loss (Hiatt and Nehler, 2001). The cumulative 10-year 
risk of developing ischaemic rest pain and ischaemic ulceration is reported to be 23% 
and 30%, respectively (Aquino et a l 2001). Studies during the last 40 years suggest 
that only about a quarter of patients with intermittent claudication will develop critical 
limb ischaemia, and this deterioration typically occurs during the first year after 
diagnosis (Aquino et a l 2001). The yearly incidence of amputation is low and reported 
to be between 1.4% (McCombs and Subramanian, 2002) and 5% (McDaniel and 
Cronenwett, 1989).
1.1.2 Associated diseases and mortality
Patients with PAD are more likely to report exertional leg symptoms, and 
musculoskeletal disease than non-PAD patients (McDermott et a l 2002a). Population 
studies of PAD confirm that older adults with PAD are disabled (Newman, 2000). 
Interestingly, despite the major impact on physical exercise performance, the emotional 
state and mental health of patients with intermittent claudication has been reported to be 
relatively normal compared with age-matched healthy controls (Regensteiner et al
1996). However, some patients can feel very negative about their health and their future, 
and this can lead to unemployment, social isolation and depression (Binnie et al 1999).
Although the prognosis for the claudicating limb is reasonably good (Tisi and 
Shearman, 1998; Stewart and Lamont, 2001), PAD can be thought of as a marker of 
advanced systemic atherosclerosis (Beebe, 2001; Newman, 2000), since its 
identification increases the likelihood of there being co-existent coronary heart (CHD) 
and cerebrovascular disease (Eberhardt and Coffman, 2004). The prognosis of patients 
with these risk factors is poor as they are at greater risk of suffering from myocardial 
infarction (MI), stroke, and cardiovascular death (Creager, 2001). Indeed, patients are
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classed as being at a high risk of sustaining such a systemic ischaemic event (Hiatt and 
Nehler, 2001) and compared with aged-matched controls, patients with intermittent 
claudication exhibit excess cardiovascular morbidity and mortality rates (Tisi and 
Shearman, 1998; Stewart and Lamont, 2001).
Population studies confirm that patients with PAD have a high risk of total mortality 
(Newman, 2000). Epidemiological studies have shown there to be a two to three fold 
increase in cardiovascular disease (CVD) morbidity and mortality in patients with PAD 
(Newman, 2000). Mortality has been reported to be 60% over 10 years (Hiatt, 1997a), 
with most of these deaths resulting from MI, stroke (Regensteiner and Hiatt, 2002b) and 
other cardiovascular events (Creager, 2001). A four-fold increase in the overall 
mortality rate among patients with large vessel PAD, as diagnosed by non-invasive 
testing, and a 15-fold increase in rates of mortality due to CVD and CHD among 
patients with large-vessel PAD which was both severe and symptomatic has been 
reported (Criqui et a l 1992). The risk of CVD and mortality in patients with PAD is 
similar to those with a history of MI or stroke, therefore it has been suggested that 
patients with PAD should be subjected to the same measures as those recommended for 
secondary prevention in MI and stroke survivors (Newman, 2000).
Intermittent claudication is therefore an important clinical predictor of increased 
cardiovascular mortality (Boccalon, 1999). Lower ABPI, older age, stroke, and 
diabetes-requiring medication have been reported to be the four key predictive risk 
factors for mortality in claudicants (Aquino et a l 2001). Cardiovascular mortality 
correlates inversely with ABPI, and the risk of death is greatest in those patients with 
most severe PAD (Creager, 2001). Prompt diagnosis and management of the condition 
are crucial (Olin, 2002), and it is recommended that patients with PAD receive anti­
platelet therapy in order to prevent ischaemic events (Regensteiner and Hiatt, 2002b).
1.1.3 Diagnosis o f  intermittent claudication
PAD is probably the most under-diagnosed and least aggressively managed 
atherosclerotic disease (Mohler, 2003). Although leg pain which is associated with 
exercise and relieved by rest is suggestive of intermittent claudication, other conditions 
such as major venous outflow obstruction, chronic compartment syndrome, nerve root 
compression, and arthritis can cause similar, confusing symptoms (Beebe, 2001). 
Claudication pain is associated with the location of the occlusive lesion, hence aorto-
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iliac occlusive arteriosclerosis produces pain in the hip, buttocks or thigh, whereas pain 
associated with more distal femoropopliteal occlusive lesions typically occurs in the 
muscles of the calf (Beebe, 2001). Non-invasive approaches to locate lesions include 
magnetic resonance angiography, duplex scanning and haemodynamic localisation (Gey 
et al. 2004).
The diagnosis of intermittent claudication is based on patient history and physical 
examination. Although these are extremely important, they may prove to be of limited 
value due to the lack of consistent sensitivity and specificity (Mohler, 2003). The 
arterial physical examination includes pulse evaluation and careful inspection of the leg. 
The most important predictor of clinical outcome has been reported to be the severity of 
objectively determined arterial occlusive disease on initial evaluation (Aquino et al. 
2001).
Diagnosis is usually confirmed by assessing the ABPI (Santilli et al. 1996). In addition, 
occlusive lesions can be further localised by taking pressure measurements in the upper 
and lower thigh and calf (Doppler segmental limb pressures) (Hiatt and Nehler, 2001). 
Thigh pressures are decreased in patients with iliac occlusive disease, whereas patients 
with disease more distal in the leg may exhibit a normal thigh pressure, but decreased 
calf and ankle pressures (Hiatt and Nehler, 2001).
1.1.3.1 Ankle to Brachial Pressure Index (ABPI)
The ABPI provides important information regarding the diagnosis and prognosis of 
PAD (Hiatt and Nehler, 2001). Serial measurements of Doppler ankle pressures have 
been used extensively to quantify haemodynamic improvements produced by arterial 
reconstruction and exercise rehabilitation, and to determine the progression of occlusive 
disease (Baker and Dix, 1981). Screening based on ABPI using Doppler 
ultrasonography may be more useful than physical examination alone (Gey et al. 2004). 
An ABPI should be performed in all patients suspected of having PAD, including 
patients at risk by age criteria (older than 70 years) or in younger patients with risk 
factors. This includes patients between 50 and 69 years of age who smoke or have 
diabetes (Hiatt and Nehler, 2001). Patients with exertional leg symptoms should also be 
evaluated with an ABPI (Hiatt and Nehler, 2001).
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ABPI is a simple, non-invasive and reliable approach for the measurement of impaired 
lower-extremity perfusion (McDermott et al. 2002b). The ABPI is the ratio of ankle 
(dorsalis pedis and posterior tibial arteries) to upper arm (brachial artery) systolic blood 
pressure, and it is determined using a standard blood pressure cuff and a simple, 
continuous wave Doppler ultrasound instrument (Beebe, 2001). The resting ABPI in 
most patients who experience intermittent claudication is reduced (Amirhamzeh et al.
1997). An ABPI of less than 0.90 is 95% sensitive and 99% specific for PAD (Olin,
1998) and supports the diagnosis of peripheral arterial insufficiency (Amirhamzeh et al.
1997). However, multiple baseline determinations should be obtained on patients 
studied longitudinally (Baker and Dix, 1981).
ABPI is calculated by dividing the ankle systolic pressure in each lower extremity by 
the brachial systolic pressure (McDermott et al. 1998b). Conflicting arguments exist 
regarding the use of dorsalis pedis or posterior tibial artery pressures. It is important to 
note that the dorsalis pedis artery may not be palpable in 5% of normal individuals 
(Beebe, 2001). Previously the highest arm pressure (Baker and Dix, 1981) and the 
higher of either the posterior tibial or dorsalis pedis systolic pressures in the more 
severely diseased leg (Izquierdo-Porrera et al. 2000) have been recommended for 
calculation of ABPI.
More recently the association between ABPI and lower-extremity function has been 
found to be strongest when ABPI is calculated by averaging the values from the dorsalis 
pedis and posterior tibial arteries (McDermott et al. 2000). The brachial arterial 
pressures in each arm should also be averaged to obtain the upper extremity pressure 
(McDermott et al. 1998b). The higher of the two brachial pressures should only be used 
if the two brachial pressures differ by more than 10 mm Hg, in which case subclavian 
stenosis should be suspected (McDermott et al. 1998b; McDermott et al. 2002a). The 
lowest ABPI obtained from the right and left legs should be used in all calculations 
(McDermott et al. 2002a).
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1.1.3.2 ABPI interpretation
Table 1. ABPI interpretation (Treat-Jacobson and Walsh, 2003).
ABPI Diagnosis
Above 0.90 Normal
0.71-0.90 Mild Obstruction
0.41-0.70 Moderate Obstruction
0.00-0.40 Severe Obstruction
ABPI values between 0.41 and 0.90 represent mild to moderate PAD, and values of 
0.40 or less are consistent with critical leg ischaemia (Hiatt and Nehler, 2001). On the 
basis of long-term follow-up of 1,244 patients with intermittent claudication having a 
mean ABPI of 0.78, the average yearly decline in ABPI is 0.014 (Aquino et al 2001).
ABPI has been reported to be highly correlated with lower-extremity functional 
measures (McDermott et al. 2002b). The ankle systolic pressure correlates closely with 
direct intra-arterial pressure recordings, except at extremes of very high (0.8) or very 
low (< 0.4) ABPI (Beebe, 2001). It is well correlated with disease severity and can be 
used to assess disease progression and predict cardiovascular and cerebrovascular 
mortality (Mohler, 2003). However, ABPI has not shown a good correlation with 
walking performance in some studies (Beebe, 2001; Leder et a l 2002).
An accurate ankle pressure may not always be obtained (Hiatt and Nehler, 2001), 
especially in patients with long standing diabetes (Beebe, 2001). Patients with diabetes 
mellitus or end-stage renal disease might have calcified tibial vessels (Hiatt and Nehler, 
2001). With incompressible vessels (Blackburn and Peterson-Kennedy, 1994), pressures 
can be artificially increased (McDermott et al 2002b) and the clinical status 
consequently appears to be better than it really is (Beebe, 2001). The pressure in these 
calcified arteries is much greater than in the arm (> 200-250 mm Hg), leading to an 
ABPI value of greater than 1.30 (Hiatt and Nehler, 2001). However, other reports have 
found that mean ABPI is similar in PAD patients with and without diabetes (Dolan et 
al 2002).
Approximately 5% of patients with PAD have a normal ABPI (McDermott et al 
2002b). These patients should be referred to a non-invasive laboratory for Doppler
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waveform evaluation of the lower-extremity arteries and an exercise test on a treadmill 
to evaluate post-exercise ABPI (McDermott et a l 2002b). A significant decrease in 
post-exercise ABPI confirms the diagnosis of PAD (Hiatt and Nehler, 2001). With 
exercise testing it must change by at least 0.15 before it can be considered significant 
(Baker and Dix, 1981).
1.2 Assessment of functional status
1.2.1 Introduction
Improving walking ability is the primary goal of treating intermittent claudication. The 
condition is associated with a significant deterioration in functional capacity on exertion 
(Askew et a l 2002). The limitation in exercise capacity reduces a patient’s level of 
everyday physical activity (Barletta et a l 1996). Determination of peak VO2 is 
considered to be important for assessing a patient’s functional capacity (Womack et al
1998) and is a common physiological variable measured during exercise testing, since 
its measurement helps to further define the extent of exercise intolerance and sheds light 
on the underlying causes (Askew et al 2002).
The assessment of both walking ability (Regensteiner et a l 1990) and functional status 
in patients with intermittent claudication in the laboratory and community settings are 
important, so that the relative efficacies of the various treatments can be judged 
(Regensteiner, 1997). Quality of life should also be assessed, in order to ascertain the 
benefit of a given treatment for patients with PAD (Regensteiner, 2004). Treadmill 
protocols and questionnaire assessments are typically used (Regensteiner et al 1997a), 
since both provide a high degree of precision and accuracy, and are practical and 
reproducible (Regensteiner and Hiatt, 1995).
1.2.2 Objective assessment o f  walking performance
1.2.2.1 Claudication and maximum walking distance
The primary measure of disability in patients with intermittent claudication is walking 
distance (Watson and Collin, 1998). The arterial insufficiency to the extremities due to 
the condition results in a mismatch of oxygen supply and demand to the working 
muscles, causing ischaemic pain (Askew et al. 2002). Both claudication distance (CD, 
distance at which claudication pain first occurs) and maximum walking distance 
(MWD, maximum distance terminated by intolerable claudication pain) are considered 
to be clinically relevant parameters (Labs et al. 1999a). Any therapy designed to
improve the symptomatic status of patients with claudication will typically result in an 
increase in CD as well as MWD (Hiatt and Nehler, 2001). Determination of both CD 
and MWD is part of a routine programme in the angiological examination of patients 
with PAD (Muller-Buhl et al. 1999).
A prerequisite for any test that is used to quantify walking capacity in this patient group 
is that it displays acceptable test-retest reliability (Labs et al. 1998), as defined in terms 
of the coefficient of variation and intraclass and Pearson product moment correlation 
coefficients of repeated tests, and that there is no significant difference in the readings 
obtained from repeated tests. Most treadmill studies have reported coefficients of 
variation for CD and MWD in the range of 15 - 40% (Cachovan et al. 1999; Gardner et 
al. 1991; Labs et al. 1999b; Labs et al. 1998; Perakyla et al. 1998). The variability of 
test-retest reliability coefficients reported from treadmill studies can probably be 
explained by differences in the testing protocols used and/or the way in which the test 
was administered, as well as the level of prior patient familiarisation and characteristics 
of the sample population (Zwierska et al. 2004).
The quantification of CD is the main outcome measure for clinical trials (Labs et al.
1998), since the daily activities of patients with PAD are typically governed by the 
onset of symptoms and not maximally tolerated discomfort (Mohler III et al. 2003). It 
has therefore been suggested that CD should receive greater attention than MWD in 
everyday clinical practice (Muller-Buhl et al. 1999). However, MWD has been found 
to correlate in a better way than CD with the objective and subjective assessment 
criteria of PAD (Muller-Buhl et al. 1999), since patients’ own estimations of their CD 
are very subjective and in many cases unreliable (Nasr et al. 2002). MWD rather than 
the CD therefore appears to be the most reliable (Chaudhry et al. 1997) and important 
criteria by which to assess these patients (Muller-Buhl et al. 1999). The assessment of 
walking ability is not only an objective measure of the effectiveness of therapy, but it is 
also a valuable tool for motivating and providing feedback to the patient (Binnie et al.
1999).
1.2.2.2 Treadmill tests o f walking performance
Walking is the most common mode of assessment of intermittent claudication (Askew 
et al. 2002). Treadmill testing provides an objective measure of walking capacity in 
PAD (Hiatt and Nehler, 2001). Patients have a reduced treadmill exercise performance
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that is associated with severe limitations in physical functioning and ambulatory activity 
in the community (Regensteiner et a l 1996). It is widely believed that treadmill testing 
is the gold standard means of assessment, since exercise performance can be 
characterised and changes due to an intervention assessed (Regensteiner et a l 1990). A 
change in treadmill performance in response to therapy is the most commonly used 
endpoint in clinical claudication trials (Nasr et al 2002). Typically, a 25% to 50% 
increase in treadmill performance is considered to be of clinical significance (Hiatt et al 
1995a; Hiatt, 1999).
There are two internationally accepted treadmill protocols, namely the constant- 
workload protocol, which uses a constant speed and grade (mostly 2mph or S^km.h'1 
and 12% grade) and the graded (incremental) test, in which the speed is kept constant, 
but the gradient is varied. This test begins on the horizontal, after which the incline 
increases in pre-defined increments (e.g. 2%) at pre-defined intervals (e.g. 2 minutes) 
(Labs et a l 1999a).
The time or distance to the onset of claudication pain and maximal walking time or 
distance are recorded during an assessment (Nehler and Hiatt, 1999b). ABPI, blood 
pressure and heart rate can also be determined immediately after treadmill testing, while 
patients rest in the supine position on an examination table in close proximity to the 
treadmill (Montgomery and Gardner, 1998). The constant-load treadmill test and the 
graded-exercise treadmill tests show similar reproducibility (Cachovan, 1997). 
Constant-pace tests are generally easier to administer and do not require a 
programmable treadmill. In addition, there is a larger historical database derived from 
constant-pace tests, as many of the earlier published studies have used such protocols.
However, incremental (graded) protocols have the advantage that they can be used to 
assess walking performance in more heterogeneous patient populations with wide- 
ranging walking abilities (Hiatt et al., 1995; Regensteiner and Hiatt 1995). In addition, 
incremental protocols are likely to be more useful for re-assessing patients after a 
treatment intervention (in which an improvement is expected), as they do not exhibit the 
‘ceiling’ or ‘placebo’ effects which are more characteristic of constant-pace protocols 
(Regensteiner and Hiatt, 1995). Incremental treadmill protocols are also generally 
considered to have higher test-retest reproducibility for MWD than constant-pace 
treadmill protocols (Hiatt et al., 1995; Labs et al., 1999; Regensteiner and Hiatt 1995).
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However, there is some evidence that constant-pace tests exhibit superior 
reproducibility for those patients with MWD in the range 50 - 150 m (Cachovan, 1997).
1.2.2.3 Alternative testing modalities
There are well documented limitations associated with treadmill testing, in that CD 
measured during a maximal graded exercise test may not accurately reflect the effect of 
claudication on everyday physical activities (Montgomery and Gardner, 1998). 
Furthermore, treadmill testing does not measure the effects of an intervention on the 
patient’s perceived ability to walk or carry out activities in the community setting 
(Regensteiner et al. 1996). The test is costly and time-consuming (Montgomery and 
Gardner, 1998), since treadmills are expensive and require the presence of trained 
personnel (Cameron et al. 1997). Treadmill testing might not be available, practical or 
feasible in all clinical and rehabilitation settings e.g. vascular screening clinics, nursing 
homes, and retirement communities (Montgomery and Gardner, 1998). As a 
consequence, treadmill testing can be impractical in large epidemiologic studies or 
primary care settings (Regensteiner et al. 1990). Some elderly patients might also find 
treadmill assessments stressful (Amirhamzeh et al. 1997) or impossible to perform due 
to restricting factors other than claudication pain (Perakyla et al. 1999).
In addition to these potential problems, patients with claudication rarely need to walk at 
the intensity attained during a maximal, graded treadmill test (Gardner et al. 2001). 
Therefore, walking capacity assessed via incline treadmill testing might not accurately 
reflect the influence of claudication on everyday functional ability (Montgomery and 
Gardner, 1998; Coughlin et al. 2001), particularly walking ability on level ground in 
the non-laboratory setting (Regensteiner et al. 1990). Neither does treadmill testing 
directly assess a patient’s perception of functional impairment, nor whether therapy has 
resulted in benefit (Nasr et al. 2002; Regensteiner et al. 1996).
One alternative to treadmill testing is a protocol in which patients walk up and down a 
100-foot hallway for 6 minutes (the 6-minute walk protocol), during which they are 
encouraged to complete as many laps as possible (Guyatt et al. 1985). The test is 
clinically useful because it is less time consuming and exhausting than a treadmill 
graded exercise test and is less anxiety producing than other tests (Montgomery and 
Gardner, 1998). When compared to the graded treadmill protocol, the 6-minute walk 
test yields highly reliable measurements, which are related to the functional and
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haemodynamic severity of PAD in patients with intermittent claudication, when 
compared with a graded treadmill protocol (Montgomery and Gardner, 1998).
Some studies have shown walking performance to improve significantly between the 
first and second test during the six-minute walk test, but not between the second and 
third test (Bauman and Arthur, 1997). These findings indicate that, as with treadmill 
testing, familiarisation is essential prior to data collection during this type of testing. 
However, in contrast, other studies (Montgomery and Gardner, 1998) have found no 
significant change between the first and second test, suggesting that accurate results can 
be obtained in patients with intermittent claudication following only one 6-minute walk 
test. Compared with the standard graded exercise test, the 6-minute walk test is easy to 
administer, requires less time, is less expensive, is better tolerated by patients and 
provides a better approximation of walking ability typically encountered during 
activities of daily living (Montgomery and Gardner, 1998). However, the 6-minute walk 
test does have a few disadvantages, in that a walking test that is performed in a 100-foot 
corridor logistically prevents immediate post-exercise measurements from being 
obtained because patients are far from an examination table upon test completion 
(Montgomery and Gardner, 1998). Personnel who administer the test must be trained to 
provide the same instructions to all patients (Montgomery and Gardner, 1998). 
Furthermore, the 6-minute walk test may not be as accurate in evaluating ambulatory 
function in patients who have asymptomatic PAD (Fontaine Stage I), because of a 
ceiling effect, and in patients with rest pain (Fontaine Stage III) or tissue loss (Fontaine 
Stage IV), because of a floor effect (Montgomery and Gardner, 1998).
Other alternatives to treadmill testing include cycling. However, currently cycling has 
little place in the assessment of intermittent claudication or prescription of exercise, 
which might in some respect be due to the lack of data on the physiological responses to 
cycling in intermittent claudication that are required to help determine or predict its 
effectiveness, relative to walking as a mode of exercise assessment or prescription 
(Askew et al. 2002).
An alternative exercise testing modality to treadmill walking for assessing the effect of 
the disease or treatment intervention on the functional capacity of a patient is a shuttle- 
walk test such as that developed by Singh et al for patients with chronic airways 
obstruction (Singh et al. 1992). In a shuttle-walk test, patients walk back and forth
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between two cones placed a set distance apart on flat ground at a pace which is 
controlled by audio-tape bleeps. Walking speed is increased incrementally - this 
gradually stresses the cardio-respiratory system to a symptom-limited maximum (Singh 
et al. 1992) and potentially makes it safer for patients with cardiac and respiratory 
conditions.
Figure 1. Patient undertaking a shuttle-walk test
The shuttle-walk test has recently been evaluated in patients with intermittent 
claudication, with respect to test-retest reliability, cardiovascular responses and patient 
preferences (Zwierska et al. 2004). The test exhibited similar test-retest reliability as an 
internationally accepted treadmill protocol (Labs et al. 1999a), but evoked lower levels 
of cardiovascular stress. Furthermore, compared to the graded treadmill protocol, the 
incremental shuttle-walk test was the preferred method of assessing walking ability by a 
large proportion of patients who expressed a definite opinion (Zwierska et al. 2004).
1.2.3 Questionnaires used to evaluate functional status
1.2.3.1 Introduction
Initial patient evaluation should consist of a clinical assessment of their disability, 
including a walking test to maximal claudication pain (Nehler and Hiatt, 1999b). 
However, in order to comprehensively evaluate functional status, it is important not 
only to consider laboratory-based measures such as treadmill tests, but also to examine 
community-based functional status such as can be obtained from questionnaires
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(Regensteiner and Hiatt, 1995). Certain well-established questionnaires assess walking 
capacity (Nehler and Hiatt, 1999b) and provide patient-based information on 
claudication severity and response to therapy (Hiatt, 1997b). Questionnaires that 
evaluate functional status may play an important role in describing the benefits of 
interventions in patients with PAD (Regensteiner et a l 1996; Regensteiner and Hiatt, 
1995). To evaluate their validity, questionnaire responses have been correlated to 
objective measures of walking performance and have been shown to have a high degree 
of precision and accuracy, and to be practical and reproducible (Regensteiner and Hiatt, 
1995).
It is important that a questionnaire is easy to administer and evaluate (Regensteiner and 
Hiatt, 1995) and in the case of patients with intermittent claudication the most important 
criterion for the quality of life is functional disability (Muller-Buhl et a l 2003). The 
condition impairs patient’s general health, and patients exhibit low scores for physical, 
social and emotional function (Barletta et a l 1996). The expected gain in quality of life 
should therefore be a crucial factor in the choice of treatment for patients with 
intermittent claudication (de Vries et al 2002). Three such questionnaires that are used 
to evaluate disease-specific functional status/quality of life, generic health related 
quality of life and physical activity status are the Walking Impairment Questionnaire 
(WIQ), the Medical Outcomes Study SF-36 questionnaire and the PAD-Physical 
Activity Recall (PAD-PAR) questionnaire, respectively (Regensteiner et a l 1997a). 
These questionnaires have been used to quantify improvements in a patient’s ability to 
walk distances and speeds, in the amount of habitual physical activity and in physical 
functioning after treatment interventions (Regensteiner et a l 1997a). The overall 
impact of a treatment intervention on health status (Hiatt, 1997b) and the overall impact 
on claudication can be described (Hiatt, 1999). Activity monitors that evaluate 
functional status can be used in conjunction with questionnaires to more fully describe 
the benefits of interventions in patients with PAD (Regensteiner et a l 1996). The 
information derived from such questionnaires thus provides a valuable adjunct to 
laboratory-based measures (Regensteiner and Hiatt, 1995).
1.2.3.2 Walking Impairment Questionnaire (WIQ)
The Walking Impairment Questionnaire (WIQ, Appendix 15) was developed and 
validated specifically for patients with intermittent claudication by Regensteiner et al. 
(Regensteiner et al. 1990). The WIQ is a disease-specific questionnaire (Hiatt et al.
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1995a) which quantifies patients’ self-reported claudication severity, the ability to walk 
defined distances, speeds and climb stairs (Regensteiner and Hiatt, 1995). It also 
characterises the symptoms that limit walking ability in patients with PAD 
(Regensteiner et al. 1990; Regensteiner et al. 1996) through a series of questions (Hiatt 
et al. 1995a).
The WIQ is simple to administer (Hiatt, 1999) and has been validated for detecting 
changes in walking impairment due to interventions in patients with intermittent 
claudication (Regensteiner et al. 1990). A treadmill test cannot fully evaluate whether 
an intervention alters a patient’s perceived ability to walk in the community or non­
laboratory setting, and might not therefore characterise a patients functional ability 
(Regensteiner et al. 1990). In the WIQ, patients rank their ability to walk specific 
distances on a 0-4 Likert scale.
The WIQ responses are stable when repeated over time in control patients (Hiatt et al. 
1995b). The WIQ has been validated by comparison with treadmill walking, peripheral 
bypass and angioplasty in patients with PAD (Regensteiner et al. 1990; Regensteiner et 
al. 1993a). Changes in walking ability with exercise training have also been evaluated 
(Hiatt et al. 1990; Regensteiner et al. 1990). Modest correlations (r = 0.68) between 
the WIQ questionnaire and peak treadmill walking time have previously been reported 
(Regensteiner et al. 1990). Following a 3-month randomised controlled trial of exercise 
conditioning or post-surgery, the WIQ has identified improvements in the walking 
distance and speed domains, which were corroborated by treadmill performance 
(Regensteiner et al. 1990). An advantage of this questionnaire is that it can be 
administered and scored in 6-8 minutes (Regensteiner and Hiatt, 1995).
1.2.3.3 Physical activity recall (PAD-PAR) questionnaire
Physical activity status is an important variable to measure in PAD, given the link 
between inactivity and cardiovascular disease morbidity and mortality (Sieminski et al. 
1997). The PAD-Physical Activity Recall (PAD-PAR; Appendix 18) has been 
developed and recommended (Regensteiner et al. 1997a; Regensteiner et al. 1996) for 
quantifying the weekly physical activity level of patients with intermittent claudication 
(Otis et al. 2000). The questionnaire has been modified from the original physical 
activity recall questionnaire developed by Sallis et al. (Sallis et al. 1985) to be more 
appropriate for patients with intermittent claudication (Hiatt et al. 1995b), since the
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condition limits the number and amount of activities of daily living that can be 
performed by patients (Sieminski et al. 1997).
The PAD-PAR provides a global measure of habitual physical activity levels. Patients 
evaluate time spent over the previous week performing work activities, household 
tasks/yard work and leisure activities (Otis et al. 2000; Hiatt et a l 1995b; Sallis et al 
1985), classified as heavy, moderate, light and very light on the basis of metabolic 
equivalents (METs). One MET is equivalent to a resting VOi of 3.5ml.kg'1.min'1. 
Global physical activity status is obtained by estimating the total energy expenditure by 
summing the number of hours of physical activity per week in each of the four 
categories, which is recorded in MET hours per week (MET-h.wk'1: hours per week 
multiplied by the MET value of the activity). Although the PAD-PAR must be 
administered by an interviewer, typically it can be administered and scored in less than 
12 min (Regensteiner and Hiatt, 1995).
1.2.3.4 Quality o f life assessment - the Medical Outcomes Study SF-36 v2 
Intermittent claudication has detrimental effects on quality of life (Oka et al. 2003; 
Treat-Jacobson and Walsh, 2003). Patients are limited in their capacity to exercise and 
this consequently reduces their level of everyday physical activity (Barletta et al. 1996) 
and functioning (Taft et al. 2001). The Medical Outcomes Short Form-36 (MOS SF-36 
v2; Appendix 13) (Ware and Sherboume, 1992) is a self-administered health-related 
quality of life questionnaire that is easy to score (Regensteiner and Hiatt, 1995). The 
SF-36 assesses multiple aspects of normal life function (Hiatt et al. 1995b). It is a non­
disease specific questionnaire (Hiatt and Nehler, 2001) and is a reliable and valid 
generic instrument which includes multi-item scales that assess two components of 
health, namely physical and mental (Gardner et al. 2001). More precisely, physical 
function and general health and well-being perceptions, as well as limitations due to 
mental health, social function and vitality (Ware and Sherboume, 1992; McHomey et 
al. 1993; Regensteiner et al. 1997a; Regensteiner, 1997; Tarlov et al. 1989; Gardner 
et al. 2001; Stewart et al. 1989). Each domain of the SF-36 is scored from 0 (poorest 
health) to 100 (optimal health; Table 2).
This questionnaire has been used in population studies to evaluate functional status in a 
number of disease states and healthy persons (Tarlov et al. 1989; Stewart et al. 1989). 
It is well-validated and has been widely implemented in PAD studies. Patients with
16
PAD report profound limitations in all domains of quality of life which are related to 
their reduced physical health (Dumville et a l 2004). The scores from these domains are 
generally worse than those given by patients with chronic pulmonary disease and 
moderate to severe heart failure (Oka et al 2003). Patients frequently report a 
significant impairment in their general health and lower scores for physical function 
(Barletta et a l 1996; Bauman and Arthur, 1997).
The effect of intermittent claudication on social and emotional function is questionable, 
since some studies have reported an impairment in these domains (Barletta et a l 1996), 
whereas others have not (Dumville et al 2004). Furthermore, conflicting evidence 
exists regarding the correlation between a patient’s quality of life impairment and their 
exercise capacity as assessed using the treadmill test. Some studies have reported poor 
correlations (Barletta et a l 1996), whereas others have reported correlations with 
physical domains, but not mental domains (Bauman and Arthur, 1997). The 
questionnaire is therefore particularly sensitive to detecting treatment effects in the 
physical functioning realm (Hiatt and Nehler, 2001). Such measurements provide a 
comprehensive insight into the degree of disability experienced by the patient as a result 
of the disease (Hiatt et a l 1995b).
Intermittent claudication has a greater impact on SF-36 scores in women than on men, 
which might result from a higher prevalence of mood disturbances and decreased 
physical functioning and more bodily pain in women compared to men (Oka et al 
2003). Training and invasive therapy have been shown to have a similar impact on 
health related quality of life dimensions (Taft et a l 2001), whereas unsupervised 
exercise programmes are unlikely to significantly improve a patient’s quality of life 
(Currie et a l 1995). Ultimately, the success of any treatment or intervention must be 
judged against a patient’s own assessments of change in various aspects of everyday life 
affected by the illness (Taft et a l 2001). For this reason, the SF-36 questionnaire is a 
useful measure of quality of life. It can be used with other health status questionnaires, 
such as the European Quality of Life (EuroQol) EQ-5D questionnaire (Appendix 14). 
The EuroQol has been used in previous studies (de Vries et a l 2002), since this 
questionnaire was best for discriminating among patients with different symptom 
severity.
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1.3 Current management of intermittent claudication
1.3.1 Treatment o f  intermittent claudication
The primary objectives of treatment for intermittent claudication are to improve walking 
ability (Hiatt, 1997a) and to reduce cardiovascular morbidity and mortality by treating 
the systemic atherosclerosis via the modification of risk factors and the use of anti­
platelet drugs (Hiatt and Nehler, 2001). It is mandatory for clinicians to treat both PAD- 
specific symptoms (to decrease functional impairment and thereby improve quality of 
life, as well as to decrease rates of amputation) and the underlying systemic 
atherosclerosis (and thereby reduce cardiovascular ischaemic events, especially MI and 
stroke) (Hirsch and Reich, 2001).
Some patients with claudication are chronically disabled and in these patients the 
treatment goals are to relieve symptoms and to improve exercise performance and daily 
functional abilities (Hiatt and Nehler, 2001), predominately walking ability (Hiatt, 
1997a). Treatment must be individualised, in that it must be based on the degree of 
lifestyle-limiting symptoms that are experienced by each patient (Beebe, 2001).
Given the relatively stable natural history of claudication, but severe limitation 
associated with the condition (Nehler and Hiatt, 1999b), vascular specialists typically 
recommend complete smoking cessation and home-based physical exercise as a primary 
treatment modality (Nehler and Hiatt, 1999b), coupled with vigorous risk factor 
modification (Santilli et al. 1996). Conservative management is advocated as the 
treatment of choice (Tan et al. 2000b), however compliance to these recommendations 
and ultimate benefit from these lifestyle modifications have not been well documented 
(Nehler and Hiatt, 1999b).
Further treatment to relieve claudication may include other pharmacological therapies 
and, occasionally, endovascular or other procedures (Santilli et al. 1996). Controversy 
exists concerning the relative effectiveness of conservative management and invasive 
therapy (Taft et al. 2001). Although many therapies for claudication have been 
thoroughly investigated, research continues on new treatments (Regensteiner and Hiatt, 
2002b).
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1.3.2 Intervention therapies
The decision to proceed with interventional surgery in patients with intermittent 
claudication requires an understanding of the natural history of the disease and an 
assessment of the patient’s quality of life impairment as a result of walking difficulty 
(Hiatt and Nehler, 2001). Angiography precedes invasive treatment, however currently 
angiography is often replaced by non-invasive imaging modalities such as magnetic 
resonance angiography and duplex ultrasonography (de Vries et a l 2002). These 
modalities involve lower costs and risks compared to angiography, however they can 
lead to false test results (de Vries et al. 2002). Catheter-based endovascular treatments 
which are used in PAD include balloon angioplasty, endoluminal stents, and mechanical 
atherectomy devices (Beebe, 2001).
A large proportion of balloon angioplasties are technically successful and these improve 
the resting and post-exercise ankle pressures (Whyman and Ruckley, 1998). Invasive 
therapy might be more effective than supervised exercise training in alleviating illness- 
specific symptoms and improving certain aspects of physical functioning (Taft et al.
2001). However, many patients with intermittent claudication of relatively short 
duration can experience an improvement in their ischaemic symptoms without 
interventional treatment (McCombs and Subramanian, 2002). The choice between 
exercise training and angioplasty in the treatment of claudication with regards to the 
functional benefits and quality of life improvements achieved, thus remains 
controversial (Nehler and Hiatt, 1999b; Lewis et al. 1999).
The hazards of percutaneous transluminal angioplasty must also not be overlooked. 
Despite the reported low incidence of major complications, the occasional patient 
requires surgical intervention for bleeding, false aneurysm or acute ischaemia (Whyman 
and Ruckley, 1998). Blood flow may be restored and functional status improved, 
however for a symptom that has a relatively stable natural history, the associated cost of 
morbidity and mortality is high (Regensteiner and Hiatt, 1995).
A vascular bypass graft is a further option as this improves the exercise tolerance of 
claudicants by increasing blood flow to the lower-limbs (Tan et al. 2000a). Surgery 
generally involves two operations, the aortofemoral bypass which has the greatest utility 
in claudication and involves a single surgical procedure which bypasses diffusely 
diseased iliac arteries, and the femoral above-knee popliteal bypass (Hiatt and Nehler,
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2001). Surgical revascularisation is undertaken on patients with severe aortoiliac disease 
in whom long-term patency is likely to be achieved (e.g. aorto-bifemoral or femoral- 
femoral bypass) and in patients who have a low cardiovascular peri-operative ischaemic 
risk (Hirsch and Reich, 2001). Endovascular revascularisation currently serves as an 
effective therapy for patients with high grade stenosis of the proximal limb arterial 
segments (e.g. distal aorta, common iliac artery, or external iliac artery, and 
occasionally the proximal common femoral artery) (Hirsch and Reich, 2001). In patients 
primarily considered for surgical treatment, anti-platelet and anticoagulant drug therapy 
can be used as a means of promoting graft patency, and beta-adrenergic blockers can be 
used as a means of reducing the perioperative risks associated with vascular surgery 
(Hiatt, 2002).
Patients with symptoms that limit their lifestyle may benefit from elective invasive 
revascularisation (Mohler III, 1999). While peripheral bypass surgery is feasible in the 
majority of patients with claudication, most vascular surgeons wish to delay this option 
as long as possible (Nehler and Hiatt, 1999b). Revascularisation procedures are 
therefore generally postponed until initial conservative management fails (de Vries et al
2002). Symptoms consistent with limb-threatening ischaemia (such as rest pain) or a 
foot ulcer that does not heal (especially in a patient with diabetes) require immediate 
attention and possibly revascularisation (Mohler III, 1999). Surgery is also reserved for 
patients with severe, incapacitating claudication (Beebe, 2001; Regensteiner, 2004), 
those who develop ischaemic pain at rest or limb threatening ischaemia (Tsai et al 
2002; Gardner et a l 2001), and for those in whom all other therapies have failed 
(Nehler and Hiatt, 1999b).
All invasive interventions have a finite duration of success (Hiatt and Nehler, 2001) and 
may be inappropriate or unsuccessful, leaving patients with a significant handicap 
(Binnie et a l 1999). With bypass surgery, problems with graft failure, particularly with 
femoral above-knee popliteal bypass may arise (Hiatt and Nehler, 2001). This has the 
potential to convert a patient with claudication into a patient with more severe leg 
ischaemia, requiring further bypass surgery to avoid limb loss (Nehler and Hiatt,
1999b). The overly liberal use of catheter-based intervention or surgery, without 
vigorous attempts at risk-factor reduction, and exercise and medical therapy, is 
misguided and carries the needless potential risk of converting a non-limb-threatening 
condition into a worse situation should complications occur (Beebe, 2001).
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Following failure of angioplasty or bypass surgery, the resultant limb circulation is 
frequently worse than that encountered before the intervention (Hiatt and Nehler, 2001). 
This occurs because of division or thrombosis of the collateral circulation at the time of 
the intervention, or the failure of thrombus propagation or embolisation at the time of 
reconstruction, or both (Hiatt and Nehler, 2001). These events are more likely to occur 
in vascular bypass procedures than angioplasty (Hiatt and Nehler, 2001).
Angioplasty performed whenever feasible has been shown to be more effective than 
exercise alone (de Vries et a l 2002). However, invasive treatments can carry economic 
implications, since percutaneous transluminal angioplasty is expensive both in terms of 
consumables and staff costs (Whyman and Ruckley, 1998). Considering the limited 
health care budget, consideration needs to be made regarding whether the gain in 
quality-adjusted life expectancy justifies the cost involved (de Vries et a l 2002). The 
expected gain in effectiveness achieved with bypass surgery for intermittent 
claudication is considered to be small compared with the cost involved (de Vries et al
2002), and as such it is recognised as an expensive treatment which is of unproven 
benefit for claudication (Whyman and Ruckley, 1998).
1.3.3 Pharmacological therapies
Although pharmacological therapies have been developed, the role of drugs in the 
overall management of the disease needs further study (Regensteiner and Hiatt, 1995). 
Various classes of drugs have been suggested as possible treatment options for 
intermittent claudication. In patients with PAD evidence supports the use of statin drugs 
for lipid management and angiotensin-converting enzyme-1 inhibitors for blood 
pressure control (Hiatt, 2002). Atorvastatin improves pain-free walking distance and 
community-based physical activity in patients with intermittent claudication (Mohler III 
et a l 2003). Recently, the Heart Protection Study confirmed that statin treatment 
reduces the risk of death and adverse cardiovascular events in patients with coronary 
and non-coronary atherosclerosis, including patients with PAD who had not had a prior 
cardiovascular event (MRC/BHF Heart Protection Study, 2002).
One possible mechanism of action of how modification of the lipid profile with a statin 
drug improves symptoms of claudication, might be the reduction in plaque size, thereby 
improving the blood flow in the large arteries of the lower extremities (Mohler III et al
2003). Another possible mechanism is statin-induced improvement of vasomotor
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regulation of blood flow, particularly in the micro circulation or it might affect new 
blood vessel formation (Mohler III et a l 2003). It has been suggested that the timing of 
clinical improvement for atorvastatin appears to be longer compared with cilostazol, and 
thus patients with claudication symptoms should not expect symptomatic improvement 
in pain-free walking time after weeks, but more likely after months of treatment 
(Mohler III et al. 2003).
Furthermore, specific anti-platelet agents (aspirin and clopidogrel), anti-claudicants 
(cilostazol and pentoxifylline) (Olin, 2002), carnitine (Hiatt, 1997a), vasodilators, 
anticoagulants, prostaglandins and prostaglandin derivatives, have been recommended, 
all of which have variable and generally disappointing results (Beebe, 2001). Aspirin 
should be considered in all patients with PAD, with clopidogrel an alternate (and 
potentially more effective) agent (Hiatt and Nehler, 2001). Aspirin, is considered 
valuable because of its impact on vascular events at other sites (Verstraete, 1994), 
possibly promoting the patency of surgical and angioplasty procedures (Hiatt and 
Nehler, 2001). It has also been indicated to reduce morbidity and mortality in PAD 
(Bradberry, 2004). Anti-platelet agents such as clopidogrel and ticlopidine act by 
blocking adenosine diphosphate (ADP) receptors on the platelet (Hiatt and Nehler, 
2001). Clopidogrel reduces the risk of atherothrombotic events such as MI and stroke in 
these patients (Bradberry, 2004) and may be beneficial in the long-term management of 
atherosclerotic disorders (Beebe, 2001). Angiotensin-converting enzyme (ACE) 
inhibitors may confer an additional benefit in terms of reducing the risk of fatal and 
non-fatal ischaemic events (Hiatt and Nehler, 2001).
Although no studies have shown that these drugs are capable of improving the 
symptoms of claudication (Beebe, 2001), substantial reductions in cardiovascular 
morbidity and mortality can be achieved (Creager, 2001). Nevertheless, risk factor 
modification in conjunction with anti-platelet treatment does decrease the incidence of 
heart attack, stroke and peripheral vascular events in PAD (Mohler III, 2004) and 
should be considered in all patients with intermittent claudication (Hiatt, 1997a).
Other drugs such as pentoxifylline, a xanthine derivative, has been shown to reduce 
blood viscosity (Beebe, 2001). Pentoxifylline exhibits a modest (Hiatt, 1997a) to 
marginal efficacy in improved treadmill exercise performance (Nehler and Hiatt, 1999b; 
Girolami et al. 1999) and is the only drug approved for the treatment of claudication in
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the USA. It has been reported to improve MWD by approximately 20 - 25% (Creager, 
2001). However, adverse effects including headache, diarrhoea, abnormal stools and 
palpitations have been reported with the drug (Chapman and Goa, 2003).
Cilostazol, a phosphodiesterase type 3 inhibitor, approved for the treatment of PAD in 
1999 (Jaff, 2002) is currently the most effective drug for claudication (Hiatt and Nehler, 
2001). It is significantly more effective than pentoxifylline in improving both pain-free 
and MWD (Beebe, 2001). Randomised, double-blind, placebo controlled trials in 
patients with moderate to severe intermittent claudication have demonstrated that 
cilostazol significantly increases walking distances and improves quality of life 
compared with placebo (Chapman and Goa, 2003). In clinical trials, MWD has been 
reported to improve by approximately 40 - 60% (Creager, 2001).
It acts by inhibiting platelet aggregation and increasing vasodilation (Beebe, 2001). It 
also exhibits anti-proliferative effects on smooth muscle cells and has beneficial effects 
on high density lipoprotein-cholesterol and triglyceride levels (Chapman and Goa,
2003). Although the drug has been shown to have a good safety and tolerability profile 
(Collinson and Donnelly, 2004), it does have side effects including headache, transient 
diarrhoea, abnormal stools, peripheral edema (Chapman and Goa, 2003), palpitations 
and dizziness. It should not be given to patients with claudication who also have heart 
failure (Hiatt and Nehler, 2001) and severe hepatic or renal impairment (Chapman and 
Goa, 2003). In the UK, USA and Japan, cilostazol administered at lOOmg twice daily is 
licensed for symptom relief in patients with stable, moderate-to-severe intermittent 
claudication and as an adjunct to non-pharmacological approaches such as exercise 
(Collinson and Donnelly, 2004).
Several other anti-platelet agents, angiogenic growth factors such as vascular 
endothelial growth factor, basic fibroblast growth factor, propionyl-l-camitine, 
vasodilator prostaglandins, L-arginine and lipid-lowering drugs are also being evaluated 
for the treatment of claudication (Hiatt, 1997a; Creager, 2001). Angiogenic growth 
factors have shown preliminary success in patients with rest pain and ischaemic ulcers 
and are being investigated for use in patients with intermittent claudication (Schainfeld, 
2001). Drugs such as oxpentifylline and naftidrofuryl may also improve the walking 
distance in some patients, however they have not been shown to be of long-term value 
and are infrequently prescribed by vascular surgeons (Whyman and Ruckley, 1998).
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Although new pharmacologic therapies are emerging, supervised exercise rehabilitation 
remains the most effective approach for increasing pain-free walking for patients with 
intermittent claudication (Mohler III, 1999).
1.3.4 Lifestyle management
Although the treatment of claudication symptoms is important, an improved lifestyle 
and treatment of risk factors will prolong life (Mohler III, 2004). Hence, 
epidemiological evidence has led most clinicians in both primary and hospital care to 
manage intermittent claudication conservatively (Stewart and Lamont, 2001); by 
advising claudicants of the benefits of taking regular exercise, giving up smoking and 
when necessary, losing some weight (Binnie et a l 1999). The main treatment strategy 
for symptomatic relief for patients with mild to moderate intermittent claudication in the 
UK is exercise advice (Cheetham et a l 2004). Indeed, the general advice given in the 
hospital setting is to “stop smoking and keep walking” (Housley, 1988).
The goal of patient education is to increase awareness about the causative relationship 
between risk factors and poor lifestyle choices and the disease (Beebe, 2001). Simple 
advice given to walk further, regardless of cessation of smoking and correction of other 
risk factors, can improve walking ability remarkably and the improvements can be 
sustained at two years, possibly even in the presence of a worsening disease profile 
(Whyman and Ruckley, 1998). Unfortunately, a major problem for clinicians is 
motivating targeted individuals to begin and adhere to an exercise regimen and to stop 
smoking (Christman et a l 2001), since many patients find it difficult to translate this 
general advice into specific practical strategies for achieving, and sustaining, 
appropriate changes in behaviour (Binnie et a l 1999). Furthermore, patients are 
reluctant to understand that various interventions, including limb bypass and 
angioplasty, do not cure PAD (Beebe, 2001).
Nursing intervention can improve the functional ability and the general well-being of 
many patients (Binnie et a l 1999). In the hospital setting vascular nurses practicing in a 
multitude of inpatient and outpatient settings can play an important role during exercise 
therapy, by developing and providing a personalised home-based exercise programme, 
and the nurses can care and motivate patients during follow-up periods (Spronk et al
2003). Vascular nurses can also assist patients with risk factor modifications (Treat- 
Jacobson and Walsh, 2003). Substantial data exists proving the benefit of life-style
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modification in improving mortality and reducing cardiovascular events in patients with 
PAD (Khan et a l 2005). There exists compelling evidence to support smoking 
cessation, to increase exercise capacity and improve diet in these patients (Khan et al 
2005). Counselling sessions about nutrition, exercise, risk factors for atherosclerosis, 
and potential complications of cardiovascular disease have been administered in 
conjunction with supervised exercise therapy (Menard et a l 2004). Smoking cessation, 
blood pressure control, lipid modification and strict control of diabetes mellitus will 
reduce the risk of both macro- and micro vascular disease progression (Mohler III, 2004) 
and this should be the first choice approach for the treatment for PAD (Beebe, 2001).
A combination of health education and exercise for claudicants with high cholesterol, 
could lower the total cholesterol, possibly reducing the need for additional treatment 
(Tan et a l 2000a). However, deficiencies in physician knowledge and attitudes 
regarding atherosclerotic risk factor reduction in PAD contribute to lower rates of risk 
factor reduction in these patients (McDermott et a l 2002c). Maintaining glycaemic 
control, and ensuring the initiation of lifelong anti-platelet therapy and participation in 
exercise rehabilitation programmes, will all promote positive outcomes for patients with 
intermittent claudication (Treat-Jacobson and Walsh, 2003).
1.3,5 Risk factor modification
The risk factors that contribute to PAD are similar to those associated with systemic 
atherosclerosis, namely, cigarette smoking and diabetes mellitus (both of which pose the 
greatest risk for disease progression) (Aquino et a l 2001; Creager, 2001), 
hypertension, hypercholesterolemia, hyperhomocysteinemia (Creager, 2001), 
dyslipidaemia and age (Treat-Jacobson and Walsh, 2003). Elevated levels of plasma 
homocysteine are an independent risk factor for PAD, although to date no clinical trials 
have demonstrated a clinical benefit in reducing homocysteine levels through vitamin 
supplements (Hiatt and Nehler, 2001). PAD may progress if these atherosclerotic risk 
factors remain uncontrolled (Mohler III, 2004).
Current treatment strategies for patients with symptomatic PAD include aggressive 
modification of risk factors for cardiovascular disease, such as cessation of smoking, 
treatment of hypertension and diabetes, normalisation of low-density lipoprotein 
cholesterol (Regensteiner and Hiatt, 2002b) and exercise (Beebe, 2001). The focus on 
improving functional impairment as well as on aggressive risk factor modification is
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important (Regensteiner et al. 1997a). In many patients, a significant reduction of 
symptoms and prevention of disease progression (Beebe, 2001) can be achieved by 
correction of associated risk factors and supervised exercise training (e.g. walking) 
(Duprez et al. 1999), which can also improve the functional status of patients (Beebe, 
2001).
Although cardiovascular and cerebrovascular complications are more prevalent in 
patients with severe PAD, patients with asymptomatic disease are still at significant 
risk, therefore the focus on the management of PAD should be on early diagnosis and 
efforts to reduce the risk of adverse events including risk factor modification and anti­
platelet therapy (Eberhardt and Coffman, 2004). Attempts to reduce atherosclerotic risk 
factors in patients with PAD are less common than in patients with coronary artery 
disease (CAD) (McDermott et al 1997), and such ‘under treatment’ may contribute to 
the high rates of cardiovascular disease morbidity and mortality in PAD (McDermott et 
al. 2002c).
Even after adjustment for risk factors, PAD appears to increase the risk for ischaemic 
events in other vascular territories with an approximate two-fold increase in myocardial 
infarctions and perhaps stroke (Eberhardt and Coffman, 2004). The reasons for the 
under-treatment of atherosclerotic risk factors in PAD are unknown, however one 
possible explanation is that physicians are less aware of the high rate of cardiovascular 
morbidity and mortality or the importance of risk factor reduction in PAD (McDermott 
et a l 2002c).
1.3.6 Key modifiable risk factors in PAD
1.3.6.1 Smoking
Cigarette smoking has both long-term and short-term affects on arterial blood flow in 
the lower extremities in patients with PAD (Gardner et al. 2004a). Smoking is the 
single most important modifiable risk factor for patients with PAD and has a synergistic 
effect on other risk factors associated with intermittent claudication, including 
hypertension, hypercholesterolemia, and diabetes (Beebe, 2001). Cigarette smoking 
causes lingering impairments in peripheral blood flow and oxygen delivery to the 
lower-extremity musculature following acute exposure to smoking (Yataco and 
Gardner, 1999; Ricci et al. 1993).
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Cigarette smokers with PAD have more severe claudication, reduced peripheral 
circulation, lower exercise capacity and poorer cardiopulmonary measurements at peak 
exercise than ex-smoking claudicants (Gardner, 1996), possibly because they are less 
physically active than non-smokers (Gardner et a l 1997). Evidence suggests that 
smokers engage in activities of similar intensity, but for a shorter duration of time than 
ex-smoking claudicants (Gardner et a l 1999b), resulting in reduced exercise capacity. 
This places patients who smoke at a greater risk of dependency than patients who do not 
smoke (Gardner, 1996).
Non-smokers can walk further than current or former smokers and they have a higher 
ABPI than patients who currently smoke (Cahan et a l 1999). The more rapid 
development of claudication pain in current smokers has been associated with lower 
peak VO2 compared to former smokers or patients with PAD who have never smoked 
(Gardner et a l 2004a; Gardner, 1996; Gardner et a l 1999a). In one study, smoking 
cessation alone was associated with a 40% improvement in MWD (Quick and Cotton 
1982). Cigarette smoking has been suggested to result in peripheral vasoconstriction in 
the lower extremities (Ricci et al 1993). The greater impairment in perfusion of the 
calf musculature in patients who smoke is a potential explanation for their lower CD 
and overall physical function than in the non-smoking patient with PAD (Gardner et al 
1997; Gardner et a l 1999b).
Consequently, patients with PAD who smoke are on the lower end of the physical 
function spectrum and may be prime candidates to regain lost functional independence 
through a program of exercise rehabilitation (Gardner et a l 2004a). Furthermore 
smoking may affect patient’s health-related quality of life (Gardner et a l 2004a). 
Although a 6-month exercise rehabilitation programme has reported similar 
improvements in claudication pain distances, ambulatory function, physical activity, 
peripheral circulation and health-related quality of life in smoking and non-smoking 
patients with PAD (Gardner et a l 2004a), smoking cessation is important (Girolami et 
al 1999) as it is associated with improved postoperative graft patency rates and a 
reduction in the complications of PAD (Radack and Wyderski, 1990). All available 
strategies to help patients stop smoking such as counselling and nicotine replacement 
should be used (Gey et a l 2004).
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1.3.6.2 Diabetes
Type 2 diabetes is common in both men and women with PAD. Diabetic patients with 
PAD are younger, have a higher BMI, a poorer neuropathy score, a higher prevalence of 
hypertension and a greater number of cardiovascular co-morbidities (predominantly 
cardiovascular) compared with non-diabetic patients with PAD (Dolan et al. 2002). 
Differences in physical activity levels exist between PAD patients that have and do not 
have diabetes. Patients with diabetes have a shorter mean 6-minute walking distance 
and a slower fast-pace 4-metre walk velocity compared with those without diabetes. 
Patients with diet-controlled diabetes perform better than those on diabetes medication 
(Dolan et al. 2002). In diabetic patients with PAD, the disease tends to follow a more 
aggressive course, with early large vessel involvement coupled with microangiopathy 
(Aquino et al. 2001). Thus, aggressive lifestyle modification for diabetes prevention 
should be offered in patients with PAD at high risk of developing the disease (Dolan et 
al. 2002). Monitoring for diabetes generally occurs on a regular basis once a patient is 
diagnosed with PAD (Dolan et al. 2002). Diabetic patients with PAD should be 
evaluated for the presence of associated co-morbidities that could contribute to further 
disability (Dolan et al. 2002). Intensive blood glucose control and aggressive risk factor 
modification (Hiatt and Nehler, 2001) should be implemented. However, although 
intensive blood glucose control may have favourable effects on the risk of 
cardiovascular events, it does not improve the risks associated with PAD (Hiatt and 
Nehler, 2001).
Diabetic patients with PAD are less likely to report classical intermittent claudication 
(i.e. the onset of a cramp-like pain during walking) than those without diabetes, and 
more likely to report leg pain on both exertion and rest, which might be explained by 
the altered foot architecture in these patients (Dolan et al. 2002). Compared with non­
diabetic patients, diabetic patients with claudication have a 2.9-fold increased risk for 
development of ischaemic ulceration and a 1.7-fold increased risk for development of 
ischaemic rest pain (Aquino et al. 2001). Death in patients suffering with PAD and 
diabetes has been reported to be 2.2 times that for PAD alone (Leibson et al. 2004). 
Diabetes is a risk factor for both PAD and PAD-associated mortality, emphasising the 
need to detect and monitor PAD in diabetic patients (Leibson et al. 2004).
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1.3.6.3 Hypertension and hyperlipidaemia
Hypertensive patients with PAD should be aggressively managed (Hiatt and Nehler, 
2001). Normalisation of blood pressure (less than 130/90 mm Hg) should be the goal to 
decrease the rates of cardiovascular ischaemic events in all patients with PAD, unless 
otherwise contraindicated (Hirsch and Reich, 2001). All classes of anti-hypertensive 
agents can safely be administered to patients with PAD (Hiatt and Nehler, 2001).
For primary prevention of CHD the British Heart Foundation recommends a total 
cholesterol level of less than 5.2 mM for normal adults (Tan et al. 2000a) and low- 
density lipoprotein (LDL) cholesterol should be less than 3.4 mM (American College of 
Sports Medicine, 2000; Hirsch and Reich, 2001). Niacin, is regarded as an important 
treatment agent in patients with PAD for lowering triglyceride levels and increasing 
high-density lipoprotein (HDL) cholesterol (Hiatt and Nehler, 2001).
1.3.7 Physical activity
1.3.7.1 Introduction
Over the past 15 years or so, the medical community has become increasingly aware of 
the important role which physical inactivity plays in the development of many chronic 
degenerative diseases (Fletcher et al. 1992; Pate et al. 1995; Bouchard, 2001). Physical 
inactivity itself is an independent risk factor for atherosclerosis (Stewart and Lamont,
2001). Patients with PAD who have impaired lower extremity performance are less 
physically active than non-PAD patients and this might contribute to subsequent 
disability (McDermott et al. 2002a; Regensteiner et al. 1994).
Low performance scores on a test battery, which combine walking velocity and time for 
five repeated chair rises and standing balance (which measures leg strength and 
balance), have been found in more sedentary patients, and it is possible that their lower 
level of physical activity could form part of the causal pathway linking reduced lower 
extremity performance to functional decline and mortality (McDermott et al. 2002a). 
These reductions in daily activity are similar to those of patients with severe heart 
failure and thus indicate a profound limitation in physical performance (Hiatt, 1999).
1.3.7.2 Exercise rehabilitation
A substantial number of patients referred to vascular clinics with intermittent 
claudication cannot be helped by conventional treatments, for example those with
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lesions unsuitable for angioplasty, or those in whom angioplasties have failed, and those 
whose symptoms are not sufficiently disabling to justify the risks of reconstructive 
surgery (Binnie et a l 1999). For these patients conservative therapy programmes, such 
as exercise rehabilitation in conjunction with risk factor management are a possibility 
(Binnie et a l 1999). In the general elderly population regular exercise can often slow or 
reverse the decreased mobility that contributes to disease and disability (Buckwalter, 
1997). However, it is important to note that individual responses to exercise might vary 
considerably (de Vries et a l 2002). Exercise is a good alternative to reconstructive 
surgery in patients with intermittent claudication (Ekroth et al 1978), since it is non- 
invasive, effective (Treesak et al 2004), inexpensive and deemed to be of low risk 
(Leng et al 2000). Indeed, it has been suggested that for the treatment of intermittent 
claudication the success rate of exercise therapy compares favourably with percutaneous 
transluminal angioplasty and some infrainguinal bypass studies, with very low threat to 
limb viability and without the risk of surgical complications (Menard et a l 2004). By 
improving functional exercise capacity, physical abilities may also improve (Bauman 
and Arthur, 1997).
Formal exercise programmes to treat claudication have been evaluated for over 30 years 
and exercise has been shown to be efficacious in terms of improving walking 
performance, quality of life, functional capacity (Nehler and Hiatt, 1999b) and 
community-based functional status (Regensteiner et a l 1997a; Hiatt, 1991). Exercise is 
also generally well tolerated by patients (Regensteiner and Hiatt, 1995). Increases in 
walking ability following supervised exercise are independent of the location of the 
atherosclerotic lesion or the presence of diabetes (Ekroth et al 1978). There is no age 
limit to the benefit of exercise (Buckwalter, 1997). In older individuals, leisure-time 
physical activity enhances health and function (Tager et a l 1998). This is increasingly 
important in intermittent claudication, since compared with aged-matched healthy 
individuals, claudicants exhibit lower levels of physical activity and the severity of PAD 
increases as patients become progressively more sedentary (Sieminski and Gardner, 
1997).
All published studies of exercise conditioning in patients with PAD, whether 
randomised, controlled trials or not, have reported an increase in treadmill exercise 
performance and a lessening of claudication pain severity during exercise (Regensteiner 
and Hiatt, 1995). Exercise as a treatment for intermittent claudication is not new, with
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improvements in walking having been described from as early as 1898 (Stewart and 
Lamont, 2001). It has become the mainstay of non-pharmacologic therapy (Beebe,
2001) and can also be used in conjunction with medications specifically indicated to 
improve symptoms (Treat-Jacobson and Walsh, 2003). Certainly, in the last 50 years, 
exercise training in some form has been recommended as a means to help patients with 
symptomatic PAD improve their walking ability (Regensteiner and Hiatt, 1995).
Exercise increases walking distances to the onset of pain and to MWD, and improves 
walking economy (i.e. efficiency) (Hiatt et al. 1995b; Wolmack et a l 1997), and 
function (Katzel et a l 2000), thereby conferring greater improvements than angioplasty 
(Perkins et a l 1996). Furthermore, exercise does not interfere with the option for 
surgery should this become necessary in the immediate or latter course of the disease 
(Ekroth et a l 1978). Exercise rehabilitation provides benefit, and in addition to the low 
associated morbidity, should be recommended as an important treatment option for 
patients with intermittent claudication (Regensteiner et a l 1997a; Regensteiner and 
Hiatt, 1995).
1.3.7.3 Possible contraindications to exercise in diabetic patients with PAD 
Although physical activity is a major therapeutic modality for type 2 diabetes (Allbright 
et al 2000), patients with PAD and diabetes have a poorer lower extremity function 
compared to patients with only PAD, which might be explained by diabetes-associated 
neuropathy, differences in exertional leg symptoms, and greater cardiovascular disease 
in patients with diabetes (Dolan et al. 2002). Both neuropathy and foot ulceration in 
these patients are associated with an increased risk of gangrene and lower extremity 
amputation (Nathan, 1993). Furthermore, the development of autonomic neuropathy in 
patients with diabetes affects the heart rate response to exercise, and as a result ratings 
of perceived exertion rather than heart rate may need to be used to moderate the 
intensity of physical activity in these patients (Allbright et al. 2000). Type 3 diabetic 
patients with PAD generally have a low level of fitness ( VOi max) compared to non­
diabetic patients, and as a consequence, exercise intensity should be at a comfortable 
level (RPE 10-12) in the initial periods of training and should proceed cautiously as 
tolerance for physical activity improves (Allbright et al. 2000).
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1.3.7.4 Mechanisms associated with improved walking ability
The mechanism by which exercise rehabilitation produces improved walking ability in 
intermittent claudication is not completely understood (McCombs and Subramanian,
2002). It is believed that exercise training improves walking distance via a combination 
of mechanisms, including an adaptation or redistribution of the peripheral blood flow 
(collateral development), metabolic adaptations within the exercise-trained skeletal 
muscle, an inhibition of atherosclerotic disease progression (Remijnse-Tamerius et al. 
1999), improved circulatory dynamics (McCombs and Subramanian, 2002), improved 
cardiac status, reduced oxygen cost of exercise or reduction of lactate load (Tan et al. 
2000a). Such physiological adaptations frequently improve both the patient’s physical 
aspect and quality of life (Tan et al. 2000b).
1.3.7.5 Central and peripheral circulatory adaptations
Normal individuals can increase the quantity and velocity of blood flow to an exercising 
extremity via a combination of physiological responses, including an increase in cardiac 
output and reduction in the peripheral resistance of arterioles supplying the exercising 
muscles, thereby achieving a modest increase of lower extremity blood flow in response 
to physical training (McCombs and Subramanian, 2002). There is evidence that central 
cardiac pumping capacity can be improved with aerobic exercise training in patients 
with symptomatic PAD (Walker et al. 2000). With improved central cardiac pumping 
capacity, a decrease in resting and exercising heart rate is achieved (Tan et al. 2000a). 
Following a short period of structured upper-and lower-limb aerobic exercise training 
(Walker et al. 2000) and walking exercise rehabilitation (Tan et al. 2000a) in patients 
with symptomatic PAD, at equivalent submaximal intensities the heart rate response to 
exercise intensities has been shown to be reduced. These studies suggest that an 
improvement in central cardiac pumping capacity can have a significant impact on 
exercise tolerance (Tan et al. 2000a).
Vascular bypass grafts improve the exercise tolerance of patients with intermittent 
claudication by directly increasing blood flow to the lower-limbs (Tan et al. 2000a). 
This is an uncommon finding following exercise training (Tan et al. 2000b; Nehler and 
Hiatt, 1999b), which suggests the involvement of mechanisms other than an increase in 
absolute blood flow (Tan et al. 2000a). In previous studies, changes in flow have not 
been correlated with changes in exercise performance (Nehler and Hiatt, 1999b; 
Regensteiner and Hiatt, 1995). Indeed, improvements in walking occur largely
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independently of ankle pressures, thereby suggesting that the adaptation is not purely a 
flow phenomenon (Johnson et al. 1989; Carter et a l 1989). However, it is possible that 
there might be a better redistribution of flow to exercising muscles (Nehler and Hiatt, 
1999b; Regensteiner and Hiatt, 1995) without an increase in the absolute flow rate (Tan 
et a l 2000a). Collateral blood flow is believed to be the most important determinant of 
functional parameters, such as exercise tolerance and intensity of symptoms (McCombs 
and Subramanian, 2002). A decrease in blood viscosity (Ernst and Matrai, 1987) or an 
increase in capillary density and surface area, as well as haemorheological changes may 
also alter the exchange of oxygen and substrate at the capillary/muscle fiber interface 
(Regensteiner and Hiatt, 1995).
Patients with PAD exhibit a high incidence of abnormal blood rheology 
(Pararajasingam et a l 1998). In one study, almost half of the patients had a plasma 
viscosity in excess of the upper limit of normal (1.72 cP) (Tan et a l 2000a). In PAD, 
blood viscosity plays a major role in residual micro vascular perfusion, indeed during 
acute leg ischaemia factors influencing microvascular blood viscosity include the 
plasma fibrinogen concentration, red and white blood cell rheology, as well as platelet 
aggregation and activation (Ciuffetti et al 2003). In normal individuals, exercise 
training reduces plasma viscosity (Ernst, 1987; Chien et a l 1966) and decreases packed 
cell volume (PCV) (Fellmann, 1992). This decrease in PCV can consequently lead to 
improved blood flow (Tan et al 2000a).
A significant improvement in blood rheology in patients with intermittent claudication 
has been found following a supervised training programme in some studies (Ernst and 
Matrai, 1987), but not in others (Tan et a l 2000a). Furthermore, endothelial function, 
which is a measure of vascular health, is also impaired in patients with PAD. Exercise 
rehabilitation which improves ambulatory function can also improve endothelial- 
dependent vasodilation in older patients with intermittent claudication (Brendle et al 
2001).
1.3.7.6 Local metabolic adaptations in skeletal muscle
An additional mechanism which has been proposed is an increase in muscle enzyme 
activity (Nehler and Hiatt, 1999b). Increases in the activity of cytochrome oxidase, 
citrate synthetase and 3-hydroxyacyl-CoA dehydrogenase, and changes in blood 
rheology and improved blood oxygen extraction have all been suggested (Whyman and
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Ruckley, 1998). Metabolic adaptations may occur in the ischaemic muscle in response 
to exercise, via an up-regulation of glucose and fatty acid metabolism under reduced 
oxygen tensions (McCombs and Subramanian, 2002).
In normal individuals, exercise training leads to an improvement in the oxidative 
metabolism of skeletal muscle and these changes are associated with an improvement in 
the extraction of oxygen and substrate during exercise (Regensteiner and Hiatt, 1995).
In patients with intermittent claudication, regular exercise is also believed to be 
effective in altering skeletal muscle metabolism (Sidoti, 1992), thereby preserving 
aerobic glycolysis and preventing the accumulation of lactate and pyruvate (McCombs 
and Subramanian, 2002). Skeletal muscle mitochondrial ATP production rate has been 
shown to be significantly higher in trained patients compared with controls (Hou et al.
2002). This, and citrate synthase activity have been shown to be highly correlated with 
walking performance in patients with PAD, suggesting that muscle mitochondrial 
capacity to oxidise carbohydrate is positively related to walking performance in patients 
with PAD (Hou et al. 2002).
The determination of peak VO2 is considered important for assessing functional capacity 
and exercise prescription (Womack et al. 1998). Associated metabolic dysfunction of 
the skeletal muscles is rectified by exercise, resulting in a change in oxidative capacity 
of the skeletal muscle and greater utilisation of oxygen (Tan et al. 2000b). A period of 
supervised treadmill walking (12 weeks) can increase peak VO2 by 30%, with no 
change in control patients (Hiatt et al. 1990). Part of the metabolic adaptation that 
occurs with training in normal individuals is an increase in the oxidative capacity, and a 
fall in the RER (Holloszy and Coyle, 1984). A fall in RER in claudicants has also been 
shown following supervised exercise training (Hiatt et al. 1990).
A further metabolic adaptation relates to changes in carnitine metabolism with exercise 
training (Regensteiner and Hiatt, 1995). Under normal metabolic conditions, carnitine is 
required for the transportation of long-chain fatty acyl groups into the mitochondria 
(Regensteiner and Hiatt, 1995). Under abnormal metabolic conditions, such as muscle 
ischaemia, carnitine interacts with the cellular acyl-CoA pool to form acylcamitines 
thereby removing a variety of acyl groups from acyl-CoA intermediates (Bieber et a l 
1982). Patients with claudication accumulate acylcamitines in their skeletal muscle 
(Nehler and Hiatt, 1999b).
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Elevated levels of plasma concentration of acylcamitines are associated with functional 
impairment of PAD and reflect the metabolic state of ischaemic skeletal muscle (Hiatt 
et al. 1990). Exercise training clears these acylcamitine compounds and the degree of 
removal from skeletal muscle is directly correlated with improved exercise 
performance, suggesting some metabolic improvement as a result of training (Nehler 
and Hiatt, 1999b; Hiatt et a l 1990). Indeed, a 12-week supervised treadmill walking 
programme has been shown to result in a 26% decrease in resting plasma short-chain 
acylcamitine concentration, which was correlated with improved maximum walking 
time (Hiatt et a l 1990). Furthermore, a decrease in venous lactate levels after exercise 
has also been found through training, supporting the concept of the reduction in 
anaerobic metabolism (Tan et a l 2000a), which has been associated with increased 
MWD (Tan et a l 2000a).
It has been suggested that the presence of a chronic state of arterial insufficiency might 
lead to changes in the metabolic state of muscle (Jansson et al 1988), and that the main 
mechanism of improvement in exercise performance appears to involve peripheral 
adaptations in skeletal muscle metabolism rather than increases in cardiac output or 
peripheral blood flow (Hiatt, 1991).
1.3.7.7 Other adaptations
A further possible mechanism for the improved walking ability following exercise 
training could be a change in gait (Regensteiner and Hiatt, 1995). Patients with 
claudication compared to aged matched controls demonstrate abnormal gait parameters, 
and it has been suggested that further studies should evaluate whether the abnormal gait 
significantly curtails walking ability (Scherer et al. 1998). It is likely that patients with 
intermittent claudication perform minimal exercise, and subsequently develop features 
of disuse atrophy. Exercise training might help to overcome some of the inefficiencies 
of walking associated with such gait disturbances (Tan et al. 2000a).
Improvements in the biomechanics of walking through exercise training in patients with 
PAD have also been associated with improved walking ability (Tan et al. 2000a), and 
hence an improved walking efficiency and decreased energy expenditure for a given 
work load (Regensteiner and Hiatt, 1995). In this respect, exercise training results in a 
decreased VO2 at sub-maximal workloads (Hiatt et al. 1990). This suggests an 
improvement in walking efficiency (Nehler and Hiatt, 1999b) and the biomechanics of
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walking (Womack et al. 1997). If the onset of claudication is due to a mismatch of 
oxygen delivery to oxygen demand, then the lower VOi per workload may be associated 
with the ability to walk longer after exercise training (Regensteiner and Hiatt, 1995).
Changes in the psychological approach to exercise (Whyman and Ruckley, 1998), 
adjustments in gait, pain threshold (Regensteiner and Hiatt, 1995) and pain perception 
(Remijnse-Tamerius et al. 1999) could all account for the improved walking efficiency 
(Nehler and Hiatt, 1999b), as well as a possible improved tolerance to exercise.
1.4 Exercise training
1.4.1 Supervised vs. non-supervised exercise training
Supervision is a well-documented key factor in the success of exercise programmes for 
intermittent claudication (Beebe, 2001). It is regarded as the preferred gold standard 
among conservative treatment options (Degischer et al. 2002) to improve walking 
capacity (Brevetti et a l 2002). Supervised exercise programmes are superior to 
unsupervised exercise (Gardner and Poehlman, 1995), for improving treadmill exercise 
performance (Whyman and Ruckley, 1998) and functional status (Regensteiner et al. 
1997b), however they are still very rarely employed (Carlon et al. 2003). Perhaps due 
to elevated indirect costs (Brevetti et a l 2002).
Structured dynamic exercise programmes increase pain-free walking distance (Radack 
and Wyderski, 1990), relieve pain and promote optimal wellness (Ciaccia, 1993). 
Significant improvement in walking speed and distance with the WIQ and in the 
physical function and vitality domain of the SF-36 have also been reported following 
supervised training (Nehler and Hiatt, 1999b). There is overwhelming evidence that 
supervised exercise is of symptomatic benefit for intermittent claudication and little 
evidence that exercise advice alone is an effective treatment (Stewart and Lamont,
2001). Primarily this results from the fact that simple advice from a healthcare provider 
is insufficient to induce patients with PAD to exercise to maximum benefit (Beebe, 
2001). Although a home-based exercise programme, incorporating weekly lectures 
relating to PAD and weekly exercise instruction can improve walking performance and 
health perception, this is attributable to the high degree of interaction between patients 
and healthcare providers (Patterson et a l 1997). Without such personalised and direct 
supervision, some individuals would lack sufficient motivation to continue on their own 
(Beebe, 2001).
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A typical supervised exercise programme lasts approximately 60 minutes, and is 
conducted for a period of 3 to 6 months, and is monitored by a skilled nurse or 
technician (Nehler and Hiatt, 1999b). Patients should be reassessed clinically, on a 
regular basis, as they are able to walk further and further at their chosen workload, 
which necessitates an increase in speed or grade, or both, to allow patients to 
successfully work at harder and harder workloads, in order to induce a training benefit 
(Nehler and Hiatt, 1999b).
It is perceived that patient-specific exercise programmes and risk factor modification 
are standard interventions in patients with intermittent claudication (Beebe, 2001). A 
survey of consultant surgeons conducted in the UK and Ireland with an interest in 
vascular disease showed that supervised exercise programmes were only available to 
27% of consultants (Stewart and Lamont, 2001). Most programmes consisted of only 
once weekly exercise classes (44.6%), 3.6% comprised of three or more sessions a 
week, and most (58.9%) lasting two or three months (Stewart and Lamont, 2001). In 
patients with PAD considerable effects on functional capacity and certain dimensions of 
quality of life can be achieved by a short exercise and education programme 
(Gartenmann et al. 2002). Weekly supervised exercise and motivation classes for a 6- 
month period provide a significant improvement in patients symptoms, quality of life 
and distance walked compared with advice alone and this improvement has been shown 
to continue after attendance at the classes has ceased (Cheetham et al. 2004).
Given the dramatic increase in walking distance produced by an effective, supervised 
exercise programme, and the poor results of simply giving advice, it remains surprising 
that supervised programmes are not more widely available (Stewart and Lamont, 2001), 
particularly in light of the Chief Medical Officers recommendation that for “people with 
peripheral vascular disease, exercise rehabilitation can improve walking ability and the 
ability to perform everyday tasks” (Chief Medical Officer, 2004). The costs of 
physiotherapy supervision are low, at less than £5,000 a year for two classes a week, 
and there may be further morbidity and health related cost benefit through encouraging 
a healthier and more active lifestyle in this high risk group (Stewart and Lamont, 2001). 
However, patient compliance to exercise programmes is often disappointing (Beebe, 
2001). Compliance can be greatly improved through a good understanding of patients’ 
limitations, and development of a so-called “rapport with the patient” at the initial 
consultation session, which should not be underestimated.
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1.4.2 Importance o f  initial consultation sessions
At the initial appointment, patients often reveal quite negative attitudes, many are 
sceptical about the value of exercise, while others are disappointed or angry that they 
have not been offered a “high-tech” treatment to cure their problem (Binnie et al.
1999). There are drawbacks with undertaking an exercise training programme in that 
patients must spend a considerable amount of time participating in such a training 
programme to derive a benefit (Regensteiner and Hiatt, 1995). This is in contrast to an 
interventional procedure in which the patient, outside of consenting to a procedure is a 
more passive participant, and to pharmacological therapy, in which the patient’s 
involvement is limited to taking a medication (Regensteiner and Hiatt, 1995). 
Acknowledging and accepting these attitudes is essential to providing an honest basis 
for beginning therapeutic work (Binnie et al. 1999).
Allowing a generous amount of time for consultations is crucial, usually an hour for the 
initial appointment and half an hour for follow-up sessions (Binnie et a l 1999). During 
this period, strategies for exercise or other behavioural change can be considered in the 
context of each patient’s daily life, their other health problems and their particular 
perceptions and concerns. A great deal of patient listening and careful exploration of 
sensitive issues can be required to identify the right motivational triggers or to expose 
the real stumbling blocks (Binnie et al. 1999).
The continuity of patients seeing the same nurse in the hospital setting allows for the 
development of a relationship in which the personal dimension of each patient’s 
disability can be explored and in which the details of their efforts to deal with it can be 
followed and supported (Binnie et a l 1999). Investing time, skill and energy in 
establishing a relationship which is comfortable and appropriate for each patient is seen 
as the central element of the conservative therapy programme, and it is the medium 
through which practical strategies for behavioural change are negotiated and supported 
(Binnie et a l 1999). Such a strategy can increase patient compliance and adherence to 
lengthy exercise programmes.
1.4.3 Time o f  day preferences to undertake exercise
The time of day when exercise is performed can influence performance. The optimal 
time of day for exercise is a complex issue and is determined not just by endogenous 
rhythms (rhythms, which are body clock driven), but by the nature and intensity of
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exercise, the population concerned, environmental conditions and individual phase 
types (Reilly, 1990). Circadian phase types have been referred to as larks (morning 
types) and owls (evening types) indicating a preference for morning or evening activity. 
When considering exercise programmes, patient preferences should be considered, and 
this should remain consistent throughout a study to eliminate bias. Patients’ rating of 
perceived exertion can also be affected by the time of day. The time of day when 
exercise is undertaken should be consistent throughout a study. The administration of a 
simple questionnaire (Home and Ostberg, 1976) “lark/owl questionnaire” (Appendix 
10) can classify individuals accordingly.
1.4.4 Limitations and long-term efficacy o f  structured exercise programmes
Though exercise rehabilitation (e.g. walking exercise) has been shown to improve 
walking performance, it is important to note that at the end of an intervention period, 
patients might still be impaired due to claudication (Izquierdo-Porrera et al. 2000). 
Furthermore, doubts exist regarding the long-term efficacy of exercise therapy and few 
trials report medium to long term effectiveness (Stewart and Lamont, 2001). Continued 
physical activity following a structured exercise programme is important to sustain 
improvements in walking performance. A 12-month period of less frequent exercise, 
preceded by a six-month exercise rehabilitation programme can sustain improvements 
in claudication distance, walking economy, 6-minute walk distance, peripheral 
circulation and increase daily physical activity levels by 31% in intermittent 
claudication (Gardner et al. 2002).
1.4.5 Adverse effects with exercise
The expectation is that improved walking confers cardiovascular benefits as well as 
giving a better quality of life (Whyman and Ruckley, 1998). However, evidence 
suggests that walking until the onset of calf pain (ischaemia) followed by rest 
(reperfusion) can result in the generation of oxygen-derived free radicals, neutrophil 
activation and a generalised increase in vascular permeability, and thus a low grade 
inflammatory response (Tisi and Shearman, 1998). Furthermore, baseline levels of 
chronic inflammatory markers such as acute-phase proteins are elevated in claudicants 
compared with controls, suggesting that the transient acute inflammatory response has 
longer-term consequences (Tisi and Shearman, 1998).
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It has been hypothesised that this so called ischaemia/reperfusion injury may give rise to 
systemic vascular endothelial damage (Khaira et a l 1995a; Khaira et al 1995b), and 
the cumulative effects of these individual events could have an adverse effect on the 
progression of atherosclerosis (Tisi and Shearman, 1998). In these patients the 
administration of vitamin C has been shown to prevent the acute systemic impairment in 
endothelial function induced by maximal exercise (Silvestro et a l 2002). Therapeutic 
exercise training appears to lead to an attenuation of these inflammatory markers (Tisi 
and Shearman, 1998), however researchers have concluded that the concerns about 
exercise training potentiating the vascular inflammatory response appear to be 
unjustified, and that exercise should be considered as an important treatment option for 
claudication (Tisi and Shearman, 1998).
1.4.6 Cardiovascular demand and safety during exercise
The potential for an adverse event exists in any exercise programme, especially in one 
in which an elderly group of patients with cardiovascular disease is involved in 
(Regensteiner and Hiatt, 1995). Patients with PAD frequently have concomitant- 
cardiovascular problems during exercise, such as hypertension (Gardner et al 1995), 
due mainly to the high prevalence of systemic cardiovascular disease as well as PAD in 
these patients (Regensteiner and Hiatt, 1995). For testing and rehabilitation purposes, 
exercise which elicits a lower heart rate and blood pressure at a given metabolic 
intensity should be preferred over a more demanding task (Gardner et a l 1995).
The sudden release of catecholamines coupled with local ischaemia during exercise may 
accelerate the pre-existing pro-thrombotic potential of the atherosclerotic vessel wall 
(Mustonen et a l 1998). Indeed, sudden extreme physical stress has been associated 
with an increase in the risk of myocardial infarction especially in individuals with pre­
existing atherosclerosis (Mustonen et a l 1998). Adverse effects with supervised 
exercise programmes have included angina and dyspnoea on a treadmill (Larsen and 
Lassen, 1966).
1.4.7 Effects o f  exercise rehabilitation on cardiovascular risk factors
Dynamic, relatively intense physical training, performed at least 3 times per week for 30 
minutes for 1 to 8 months, has been shown to reduce blood pressure, particularly in 
hypertensive patients (Fagard, 1994). Exercise rehabilitation can also potentially 
improve glucose tolerance. Control of such factors is an integral part in the management
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of PAD (Izquierdo-Porrera et a l 2000), since it can reduce cardiovascular risk (Stewart 
and Lamont, 2001). However, previous reports have been unable to find a correlation 
between changes in functional performance and changes in cardiovascular risk factors, 
suggesting that exercise acts through different mechanisms in order to achieve 
improvements in these parameters (Izquierdo-Porrera et a l 2000).
Exercise has a beneficial effect on the risk factors that contribute to the development of 
PAD and the rate of atherosclerosis progression, including lowering total cholesterol 
and low-density lipoprotein cholesterol (LDL-C) (Izquierdo-Porrera et a l 2000), which 
might reduce the risks of coronary events (Tan et a l 2000a). Although, it has been 
argued that despite the large functional gains following exercise rehabilitation, the 
absolute amount of exercise in this debilitated population might be insufficient to elicit 
favourable alterations in cardiovascular risk factors (Izquierdo-Porrera et a l 2000).
1.4.8 Optimum exercise programme and prescription
Exercise training programmes have a clinically important impact on functional capacity 
in patients in whom spontaneous recovery of symptomatic PAD does not occur 
(Regensteiner and Hiatt, 1995). Important details about aerobic exercise include the 
physiological responses to an acute bout of exercise, chronic adaptations to training, 
prescription of training programmes, and health benefits (Wilmore, 2003). The ability to 
improve the cardiovascular, musculoskeletal, and respiratory response to aerobic 
exercise is directly related to the frequency, intensity and duration of the programme 
(Evans et a l 1994) and mode of exercise (Wilmore, 2003).
Of the exercise prescription factors, the most important is intensity. With older and high 
risk individuals, intensity must be monitored carefully to ascertain that they are training 
at levels that will not only provide a training stimulus, but also be safe (Wilmore, 2003). 
The patients’ initial fitness level, age, personal goals, and methods for monitoring the 
intensity of exercise are also important considerations (Wilmore, 2003). Activities 
commonly used by older adults to improve these responses include walking, jogging, 
cycling and swimming (Evans et a l 1994). The American College of Sports Medicine 
recommends that the mode of activity should use large muscle groups, maintain a 
continuous pace and be rhythmical and aerobic in nature (American College of Sports 
Medicine Position Stand: 1998). However, there is no consensus about the indication of 
exercises for patients with intermittent claudication of the lower extremity and the
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characteristics of an exercise programme to improve waking distance (Brandsma et al 
1998). Many studies have shown that exercise training is beneficial for patients with 
PAD, however there is little research comparing various modes of training (Jones et al 
1996). Exercise principles that have been shown to be effective in increasing walking 
distance in claudicants include exercising to near maximal pain during training for more 
than 30 minutes, for at least three times per week, in a programme lasting at least six 
months in duration and which includes walking as the mode of exercise (Gardner and 
Poehlman, 1995). However, interventions designed to encourage adoption of an 
exercise regimen must be responsive to the individual’s current stage of readiness and 
focus efforts on moving the individual through the various “stages of change” (Allbright 
et a l 2000). Differences in both CD and MWD observed between studies can be 
interpreted due to differences in exercise intensity and duration, which can have a 
bearing on improvement (Table 3).
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1.4.9 Cost implications
It emerges that PAD places a great burden on health systems and on society as a whole 
(Brevetti and Chiariello, 2004). Some of these costs, including indirect and intangible 
costs (i.e. those related to productivity, and reduced quality of life, respectively) could 
be reduced if the condition were to be recognised and correctly treated at an early stage 
(Brevetti and Chiariello, 2004). Furthermore complications associated with PAD, for 
instance during invasive therapy, can take a great toll in terms of treatment costs 
(Brevetti and Chiariello, 2004).
Physical inactivity is a major health concern today (Wilmore, 2003). Cost effectiveness 
and the economic implication of exercise needs careful consideration, since the national 
implication of physical inactivity might have immense future implications for PAD 
care. Maintaining an active lifestyle throughout life appears to be critical to maintaining 
independence and health (Wilmore, 2003). Low levels of physical activity have already 
become a major public health problem in most Western societies, with the cost of 
physical inactivity in England estimated to be at least £8.2 billion a year (Chief Medical 
Officer, 2004).
A test that is used in clinical trials should address patient-focused clinical outcomes, 
including functional status, walking ability and quality of life (Regensteiner and Hiatt,
1995). The potential benefits of sustained exercise programmes for intermittent 
claudication not only include improvements in effective exercise performance, walking 
distance and increases in levels of physical functioning, but also cost-effectiveness 
(Beebe, 2001). A 6-month programme of exercise rehabilitation has been found to be 
more effective and cost less than percutaneous transluminal angiolplasty, and has been 
suggested to be cost-saving (Treesak et al. 2004), even in the form of supervised 
classes, since many patients can be treated at the same time (Whyman and Ruckley, 
1998). However it is important to take into consideration that patients must invest time 
before reaping any health reward, therefore exercise may not be as inexpensive as it 
seems when this perspective is considered, since the cost of the time spent exercising 
must be taken into account (de Vries et al. 2002). Furthermore non-medical costs 
including transportation costs should also be considered (de Vries et a l 2002).
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1.5 Comparison of various modes of exercise training
1.5.1 Walking exercise
Walking is not only rhythmic and dynamic, but it is the most natural aerobic weight­
bearing activity of large skeletal muscles, and in the general population it confers 
various benefits with minimal adverse effects (Morris and Hardman, 1997). It is 
associated with an increase in bone related strength in individuals of all ages (Morris 
and Hardman, 1997). In intermittent claudication, exercise in the form of walking is 
effective in reducing pain and improving walking distance (Bartelink et a l 2004). At 
the very least, walking prevents a deterioration in symptoms in the majority of patients, 
and the greatest effect is generally noted within the first three months of commencing a 
walking programme (Whyman and Ruckley, 1998).
Early descriptions of exercise therapy for patients with PAD consisted of general advice 
to take daily walks (Regensteiner and Hiatt, 1995). This was to be done at an intensity 
below the threshold of claudication pain, and exercise was to cease at the onset of pain 
(Foley and Wright, 1953). More recently, it has been suggested that patients should be 
encouraged to walk primarily on a treadmill, because this most closely reproduces 
walking in a community setting (Hiatt and Nehler, 2001). The benefits of a supervised 
walking exercise programme have been considered and therefore exercise rehabilitation 
constitutes an important form of therapy for these patients (Regensteiner, 2004), since 
walking distance (Brandsma et al. 1998) and exercise performance are improved 
(Regensteiner et al. 1996).
It has been suggested that the initial workload should be set to a speed that brings on 
claudication pain within three to five minutes, and that patients should walk at this 
intensity until they achieve claudication of moderate severity (Nehler and Hiatt, 1999b). 
Patients should then rest until the claudication abates, and then resume further exercise 
(Nehler and Hiatt, 1999b). Supervised physical training beyond the claudication 
threshold significantly improves both walking time and the quality of life of patients 
with intermittent claudication (Carlon et al. 2003).
To date, the most utilised and effective mode of exercise therapy for PAD has been 
treadmill walking exercise in a hospital-based setting (Regensteiner and Hiatt, 1995). 
Supervised treadmill training programmes can improve functional status during daily 
activities, with 24-weeks of training being more effective than 12-weeks (Regensteiner
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et al. 1996). Treadmill training alone has been demonstrated to be more effective in 
improving functional status in patients with intermittent claudication than strength 
training or combinations of the training modalities (Regensteiner et a l 1996). As such, 
a 24-week treadmill training programme for patients with disabling claudication has 
been recommended (Regensteiner et al. 1996). Such programmes are associated with 
well-established changes in treadmill exercise performance and community-based 
walking ability in patients with intermittent claudication (Hiatt et al. 1990;
Regensteiner and Hiatt, 2002a). Improvements in walking distance have been reported 
to be in the region of 44 - 300 % and 25 - 442 %, for pain-free and MWD, respectively 
(Regensteiner et al. 1997a).
1.5.2 Potential problems with walking exercise rehabilitation programmes
Incentives associated with starting and continuing walking have included advice from a 
doctor, relief of complaints and achievement of a better general condition (Bartelink et 
al. 2004). However, walking exercise programmes do have several disadvantages. 
Firstly, patients with intermittent claudication are limited in their ability to walk (Hiatt 
et al. 1988) and the physical discomfort encountered by performing lower-limb weight­
bearing exercise is undoubtedly a major reason why this strategy has failed to achieve 
widespread popularity (Walker et al. 2000).
Walking exercise requires patients to be well motivated and not to have severe co- 
morbid conditions such as disabling angina, dyspnoea or arthritis, which might render 
exercise to be impossible (Whyman and Ruckley, 1998). Exercising patients over the 
pain threshold might also be dangerous (Carlon et a l 2003). Further disadvantages with 
community-based walking programmes include the deterrents of road traffic accidents, 
heavily polluted air and the smell of traffic (Morris and Hardman, 1997). Cracked or 
uneven pavements may present additional hazards.
Patients frequently complain that the prospect of walking up a hill terrifies them and 
generally they plan their route to minimise any hill walking, due to the excruciating pain 
that they experience as a consequence of their intermittent claudication. Resistance and 
anxieties, may have to be overcome before patients adopt walking exercise (Table 4) 
(Binnie et a l 1999). In addition, a lack of specific advice and supervision, and the 
presence of co-morbidity have all been found to be important barriers to taking up 
walking exercise (Bartelink et al 2004).
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Table 4. Patients anxieties associated with walking exercise (Binnie et a l 1999).
1. Fear of the pain (i.e. that walking with pain will do some damage)
2. A perception that going for a walk is not possible because of the pain
3. A fear of not being able to get home, or of legs ‘giving way’
4. Feeling foolish when having to stop (‘people wonder what you are doing, just 
standing there’)
5. A perception of not having time to go for regular walks
6. A dislike of walking without a purpose
7. Fear or dislike of going out alone
8. Confusing ‘stop-start’ activities (e.g. ‘pottering about’; ‘I’m on my feet all day’; 
wandering around the shops’) with the sustained effort of a purposeful walk
Walking may also be regarded as a convenient low-impact mode for diabetics, but some 
patients, because of peripheral neuropathy and/ or foot problems, may need to do non- 
weight-bearing activities (Allbright et al 2000).
1.5.3 Alternative training modalities
The effects of other modes of exercise training on functional status in the PAD patient 
population have not been fully assessed (Regensteiner et al 1996). Although many 
studies have shown that exercise training is beneficial for patients with PAD, there is 
little research comparing various modes of training. In previous studies, VO2 during 
walking and stair climbing has been found to be similar (Gardner et a l 1995). Indeed, 
one study involving exercise tests performed on a StairMaster apparatus has produced 
improvements in exercise capacity that are similar to those elicited by treadmill tests, 
and it has been suggested that this type of apparatus should be incorporated as part of 
the exercise prescription for the treatment of patients with PAD (Jones et a l 1996).
Other studies have utilised pneumatic foot compressions to improve walking distance in 
these patients. Intermittent pneumatic foot compression augments arterial leg inflow, 
and following 4.5 months of prolonged use of impulse leg compressions at home, CD 
and resting ABPI and post ABPI after exercise and arterial calf inflow have been shown 
to improve, suggesting an improved collateral circulation (Konstantinos et a l 2000). A 
24-week programme of progressive resistance training can also improve pain-free 
walking distance in these patients (McGuigan et a l 2001). A 12-week programme of
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strength training with treadmill training has also been compared (Regensteiner et al. 
1996). Strength training of the lower leg muscles was evaluated because of the 
observation that patients with PAD have leg muscle weakness (Regensteiner et al 
1993b). In addition, it has previously been observed that strength training may augment 
the response to an aerobic training programme in normal subjects (Hickson et al 
1988). However, the study found that strength training does not improve peak exercise 
performance or peak VOi, whereas treadmill training does (Hiatt et a l 1996). 
Treadmill training alone is thus more effective in improving functional status, when 
compared with strength training or a combination of treadmill and strength training 
modalities (Regensteiner et al 1996).
Cycling as a testing modality in the treatment of intermittent claudication has also been 
compared with graded walking (Askew et a l 2002). Maximal exercise times in the two 
modalities, although different, were highly correlated, suggesting that the level of 
exercise intolerance established using a cycle test is similar to that determined from a 
treadmill test (Askew et al 2002). Peak VOi measured during the cycle test was similar 
to that observed during treadmill walking, and the two sets of peak VOi were highly 
correlated with each other (Askew et al 2002), suggesting that cycle testing elicits a 
peak VO2 comparable with that observed during a treadmill test. It has thus been 
suggested that tests that reduce the risk of falling and are not weight bearing (i.e. cycle 
test) may be of considerable benefit in the assessment of frail and very de-conditioned 
individuals (Askew et a l 2002). In many clinical settings a Monark leg ergomater is 
used (Kang et a l 1999). However, the need for an optimal rehabilitation programme 
has been stressed (Robeer et al 1998), since exercising the lower-limbs can be painful, 
and this can limit the training intensity. During walking, calf pain is the primary 
limiting symptom, whereas the symptoms during cycling are more varied and include 
thigh pain, calf pain and dyspnoea (Askew et a l 2002).
The efficacy of walking using modified ski poles (pole striding exercise), which uses 
the muscles of the upper and lower body in a continuous movement similar to cross­
country skiing, has shown to improve exercise tolerance of patients with intermittent 
claudication (Collins et a l 2003) following a 24-week training period (Langbein et al 
2002).
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A further alternative training modality is upper-limb exercise training. Such exercise is 
often performed on a mechanically braked ergometer, which permits accurate 
measurement of power output (Astrand, 1977). The Monark (Varberg, Sweden) arm 
ergometer is one such device that is widely used (Kang et a l 1999). Stationary arm- 
cranking is a mode of exercise commonly used for fitness testing and aerobic 
conditioning in individuals with lower extremity and spinal cord injuries (Balady, 1993; 
Graves and Pollock, 1993).
The potential advantages of such an exercise regimen in patients with intermittent 
claudication are two-fold. Firstly, patients do not experience the ischaemic pain which 
is associated with leg exercise, Secondly, upper-limb exercise might not induce the 
systemic inflammatory response associated with relative ischaemia-reperfusion and 
neutrophil activation that is associated with lower-limb exercise, thereby allowing 
patients to exercise to a greater intensity (Nawaz et al. 1999). Thus, preliminary 
evidence suggests that carefully prescribed upper-limb exercise training can be used as 
an alternative exercise strategy for evoking symptomatic improvement in patients with 
intermittent claudication (Walker et al. 2000). This type of exercise strategy might 
therefore have a role to play in exercise rehabilitation, as it might be a more acceptable 
mode of training by these patients, whilst simultaneously evoking positive 
cardiovascular adaptations.
A 6-week programme of upper-limb cardiovascular training has reported to produce an 
improvement in pain-free walking distance, which was comparable to that achieved 
using lower-limb training in a parallel group of patients (Walker et a l 2000). This 
suggests that exercise-induced central adaptations influence improvements in walking 
distance after training as well as local adaptations in leg skeletal muscle (Walker et al
2000).
1.5.4 Physiology o f  upper- and lower-limb exercise
Questions arise as to whether upper-body exercise on an arm ergometer and leg 
ergometer will elicit different physiological and perceptual responses even though the 
exercise is performed at a similar power output (Kang et a l 1999). Upper-body 
exercise on an arm ergometer has been shown to elicit greater cardiorespiratory, 
metabolic and perceptual responses compared with a modified leg ergometer at the 
same sub-maximal power outputs, as manifested by higher VOi, heart rate, respiratory
50
exchange ratio, pulmonary ventilation and perceived exertion (Kang et al 1999). Such 
cardiorespiratory differences between upper- and lower-limb exercise have previously 
been reported in healthy (Aminoff et al 1998; Kang et a l 1999), and ischaemic heart 
disease patients (Lazarus et a l 1981), but not in patients with intermittent claudication.
Peak aerobic exercise capacity for arm-crank exercise in healthy individuals is in the 
region of 60 - 80% of comparable lower-limb exercise capacity (Cummins and Gladden, 
1983; Reybrouck et a l 1975; Vokac et a l 1975; Astrand et a l 1961). Suspected 
physiological mechanisms to account for these differences in VOi are outlined in Table
5.
Table 5. Physiological mechanism(s) suspected to be responsible for the lower peak 
VOi values during arm-exercise compared to leg-exercise (Sawka, 1986).
Reduced potential to generate muscular tension
smaller total skeletal muscle mass 
smaller cross-sectional area of muscle 
Reduced oxidative capacity
smaller skeletal muscle mass 
differences in muscle fibre composition 
differences in motor unit recruitment patterns 
Reduced blood perfusion of skeletal muscle
smaller total capillary cross-sectional area (maximal vasodilation) 
vascular capillary bed differences (fibre type) 
intramuscular pressures exceeding perfusion pressure
During arm-crank exercise, the smaller amount of active skeletal muscle might account 
for the lower peak aerobic exercise capacity in healthy individuals, however this does 
not appear to be the case for patients with symptomatic PAD. Fardy et al (1977) 
reported the case of a patient with PAD whose maximum physical work capacity for 
arm-cranking exercise was equivalent to that for treadmill walking exercise (6 METs) 
due to the ischaemic pain encountered during walking (Fardy et al 1977). This case 
suggests that arm-cranking could be an equivalent exercise stimulus to weight-bearing 
walking exercise for evoking positive cardiovascular adaptations in this patient group.
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Thus, an improved insight into the factors that influence exercise tolerance with 
alternative muscle groups could lead to better exercise prescriptions for these patients 
with intermittent claudication.
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1.6 Study aims
The aim of this study was to determine the relative efficacy of a 24-week programme of 
twice weekly upper-limb and lower-limb exercise training on both pain-free and MWD 
in patients with stable intermittent claudication and its impact on community-based 
walking ability and quality of life, by assessing patients at 6-weekly intervals 
throughout the intervention period.
This study was also designed to provide an insight into the possible mechanism(s) 
underlying the exercise-induced symptomatic improvements in these patients, such as 
central cardiovascular, localised metabolic adaptations or psychological factors, such as 
improved confidence in walking or pain tolerance. The relative importance of these 
factors and possible cross-over effects were determined over the duration of the 24- 
week training programme. Patients’ actual and perceived walking ability, functional 
capacity, physical activity and quality of life were also observed at 6-, 12-, 24- and 48- 
weeks following the end of the intervention period. These time-points were selected, in 
order to consider both the short to medium, and longer-term effects following a 
programme of exercise rehabilitation in patients with intermittent claudication.
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Chapter 2 - Methodology
2.1 Research design
This was a randomised controlled trial (RCT), with patients randomised into one of 
three groups: - upper-limb exercise training, lower-limb exercise training or to a non­
exercise training control group. The study was designed to include an intervention 
period of 24-weeks in duration, followed by a 48-week follow-up period.
2.2 Patient selection and accustomisation to test procedures
2.2.1 Selection and recruitment
Ethical approval was obtained from the North Sheffield Local Research Ethics 
Committee. Clinically diagnosed patients with stable intermittent claudication were 
selected and recruited from clinical notes, from the Sheffield Vascular Institute, at the 
Northern General Hospital, Sheffield, U.K. Selection was based on patient's medical 
history, previous physical examination and on the inclusion and exclusion criteria 
dictated by this study (Appendix 1). In accordance with previous suggestions, nursing 
home residents, wheelchair bound patients, and patients with foot or leg amputations 
were excluded, because their function was uniquely impaired (McDermott et al 
2002a). Vascular consultants also referred suitable patients onto this study.
Patients satisfying the study criteria were sent a letter (Appendix 2), with an attached 
patient information sheet (Appendix 3) and a leaflet describing the facilities and 
directions to the Centre for Sport and Exercise Science. The letter clearly stated that 
there was no obligation or pressure to participate in this study. If patients did not wish to 
participate, their future medical care would not be jeopardised. Patients declining to be 
contacted were requested to leave an answer-phone message by a specified date.
Patients, who had not left an answer-phone message declining to take part, were 
presumed to have a possible interest in study participation. These patients were 
contacted via telephone, and vetted to ascertain that they still fulfilled the study criteria. 
All initial patients’ questions were answered. Patients satisfying the study criteria were 
invited to the Centre for Sport and Exercise Science for an initial consultation session to 
view the facilities and to thoroughly discuss all aspects of the study.
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The composition of the three study groups, the randomisation procedure, potential 
benefits of both training programmes, the required commitment to the training sessions 
and the measurements that were to be taken during the assessment sessions were all 
discussed, as were the requirements from patients if randomised to the control group. 
Suitability was re-assessed on the basis of previous history, in accordance with the 
study inclusion and exclusion criteria.
Based on the guidelines of the American College of Sports Medicine (American 
College of Sports Medicine., 1991) and Regensteiner et al (Regensteiner et a l 1996) 
patients with any of the following criteria were excluded from the study: Fontaine stage 
I PAD (ambulation not limited by claudication); Fontaine stage III PAD (pain at rest); 
exercise tolerance limited by factors other than claudication (e.g. severe CAD, poorly 
controlled hypertension, pulmonary disease, severe arthritis or orthopaedic conditions); 
poorly controlled diabetes mellitus; or other active major medical problems including 
cancer, renal or liver disease, anaemia, substance abuse or dementia (Gardner et al
2001).
Patients with unstable hypertension were excluded as blood pressure rises considerably 
when hypertensive patients perform dynamic exercise (Fagard, 1994). Patients with 
diabetes were included in this study. Previous studies have excluded these patients on 
the grounds that authors wished to avoid the confounding effects possibly resulting 
from complications common to diabetes (i.e. neuropathy, autonomic dysfunction) that 
can interfere with the ability to benefit from a training programme (Regensteiner et al
1996).
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2.2.2 Inclusion criteria
Patients were included in the study on the basis of:-
• Clinical symptoms and signs of PAD supported by the presence of usual risk 
factors
• Symptoms of stable intermittent claudication of 12 months or more duration
• An ABPI of less than 0.9
• No interventional procedures within the last 12 months (i.e. angioplasty etc)
• Ability to undertake exercise
• No exercise-limiting angina
• No shortness of breath
• No severe arthritis
2.2.3 Exclusion criteria
Patients were excluded on the basis of:-
• Symptoms of intermittent claudication present for less than 12 months
• Significant change in walking ability within the last 12 months (denoting 
unstable claudication)
• Exhibiting features of critical limb ischaemia
• A re-vascularisation procedure, or other surgical intervention to the lower-limbs 
within the last 12 months
• If initial assessment established that the patient suffered from
- severe arthritis
- or unstable cardio-respiratory conditions, such as
- shortness of breath
- or exercise-limiting angina
Upon providing verbal agreement to study participation, informed consent (Appendix 4) 
was obtained and a Physical Activity Readiness Questionnaire (PAR-Q; Appendix 5) 
form was completed. Patients fulfilling the study criteria were thoroughly familiarised 
with all test protocols and equipment. Smoking status was confirmed by a smokerlyzer 
test (Bedfont, UK), which measured and verified carbon monoxide (CO) levels.
56
2.2.4 Power calculations fo r  determination o f  sample size
The primary outcome variable for the calculation of sample size was MWD due to 
intolerable claudication pain, since CD is recognised as a less reliable walking 
performance measure compared to MWD in incremental walking assessments (Gardner 
et al., 1991; Hiatt et al., 1988; Hiatt et al., 1995; Labs et al., 1999). In a preliminary 
study, MWD increased from a baseline level (± SD) of 289 ± 127 to 427 ± 219 m 
following a 6-week period of upper-limb aerobic exercise (Walker et al. 2000). A 
similar improvement in MWD was observed following lower-limb aerobic exercise 
training. An improvement in MWD of this magnitude is considered to be clinically 
important in patients with PAD. On the basis of these data, and taking into account an 
expected patient drop-out of 30% over a 6-month intervention period, recruitment of 35 
patients for each group yielded an 80% power to detect an increase in MWD of this 
magnitude at the alpha level of 0.05.
2.2.5 Accustomisation ofpatients to the test procedures
2.2.5.1 Accustomisation to Borg (RPE and CR-10) scales
All patients received instructions regarding the definition of perceived exertion and the 
use of the exertion (Borg 15-graded RPE) and pain (Borg CR-10) rating scales 
(Appendix 6, 7, 8 and 9; (Borg, 1998)). Six points were followed in accordance with 
these instructions set out by Noble and Robertson (1996) (Noble and Robertson, 1996), 
regarding their administration namely:-
1. Defining perceived exertion and perceived pain
2. Anchoring the perceptual range
3. Explaining the nature and use of the scales
4. Explaining differentiated ratings
5. Correctness of perceptual responses
6. Answering participant’s questions
Both the Borg 15-graded RPE scale (Appendix 6) and Borg CR-10 pain scale 
(Appendix 7) were shown and remained on view whilst the scale instructions were 
subsequently read out to the patient (Appendix 8 and 9, for RPE and pain scale 
instructions, respectively). The instructions emphasised that the perceptual ratings of 
perceived exertion should reflect sensations of exertion, stress, and/or discomfort in the 
limbs and respiratory system (Kang et al. 1999). Any questions were answered.
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2.2.5.2 Leg and arm-cranking accustomisation
The first step in the pre-participation evaluation was to assess for contraindications to 
exercise testing and training and to identify any risks or limitations relevant to the 
exercise prescription (Kligman et al 1999). Prior to undertaking any exercise, systolic 
(SBP) and diastolic blood pressure (DBP) was measured (manual sphygmomanometer). 
Heart rate (HR) was continuously monitored using a short-range radio-telemetry 
monitor (Polar Sport Tester, Kempele, Finland), which was slightly moistened and 
applied to the lower thorax. Patients were asked to exercise on a standard friction 
braked arm ergometer (Monark 88IE, Varberg, Sweden).
In accordance with previous suggestions, prior to undertaking exercise the height of the 
ergometer crank sprocket was adjusted so that the crank axle was at shoulder level and 
the elbow was extended, but not locked when the handgrip was farthest from the body 
(Kang et a l 1999). Patients exercised at 50 revs.min'1, for 2 min at 7.5 W. A 
metronome was used to keep pace when required. HR was ascertained during the last 15 
seconds of the 2-min exercise bout. Patients were asked to evaluate without 
overestimating or underestimating both their feelings of exertion and perceived pain 
using the Borg 15-graded RPE and pain scales (Borg CR-10), respectively.
Following a 2-min rest interval, patients continued to exercise in bouts of 2 min of 
exercise, followed by 2 min of rest. Each time the exercise intensity was increased by
7.5 W until exertion was perceived to be 13 {somewhat hard) on the Borg RPE scale, or 
pain was of a moderate intensity (number 3 on the Borg CR-10 scale), whichever was 
experienced first. This cycle of events incorporated both the lower and higher anchors 
of the scale, thereby acquainting patients with the feelings of exertion that they should 
experience at each of those anchors. Following an adequate rest interval, patients 
repeated the procedure on a standard stationary cycle ergometer (Monark 824E,
Varberg, Sweden) with the exercise intensity increased by 15 W each increment due to 
the larger skeletal muscle mass involved.
Patients were shown the gas analysis equipment used to measure and record breath-by- 
breath data. The correct use of the mouth piece and nose-clip was demonstrated to the 
patient, after which the patient was asked to insert a suitably sized mouth piece into 
their own mouth and instructed to breathe as normally as possible. The nose clip was 
applied in order to prevent inhalation and exhalation through the nasal passage. Patients
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were asked to breathe only through the mouth piece and were instructed that this 
process would be required during the assessment visits.
2.2.5.3 Incremental shuttle-walk accumstomisation
Walking ability was assessed using an incremental shuttle-walk test (Zwierska et al 
2004). The protocol was initially demonstrated to the patient. All patients were 
accustomised with the protocol, during which their CD and MWD were assessed.
2.2.6 Time o f  day preferences to undertake exercise
Patients were asked to consider their time of day preferences to perform exercise. 
Patients completed Horne and Ostberg’s (1976) Lark-Owl questionnaire (Appendix 10) 
which relates to individuals time of day preferences to perform physical activity (Home 
and Ostberg, 1976).
The questionnaire was scored accordingly
Table 6. Scoring of lark/owl questionnaire.
Score Type of Individual (i.e. morning (lark) or evening (owl) type)
70-86 Definitely a morning person
59-69 A moderate morning person
42-58 Neither a morning nor an evening person
31-41 A moderate evening person
16-30 Definitely an evening person
Scores were evaluated against a patient’s self perception of time of day preferences. 
Patients were advised that all training and assessment sessions would be conducted at 
similar times of the day, at their perceived optimum time of day to perform exercise in 
accordance with their expressed preference, as confirmed via the questionnaire.
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2.2.7 Medical examination
Prior to entering the study, all patients on a separate occasion underwent a thorough 
medical examination performed by Mr. Sohail Choksy, FRCS (Vascular Surgeon, 
Northern General Hospital, Sheffield, U.K.). During the peripheral vascular 
examination the diagnosis of intermittent claudication was further confirmed by the 
Doppler assessment of ABPI, in accordance with current U.K. medical practice. Some 
patients had previously undergone duplex ultrasonography and/or intra-vascular 
peripheral angiography assessments, and these results were made available during the 
examination. In two-thirds of the patients, claudication was due to superficial femoral 
artery disease as determined by angiogram, duplex scanning or examination of pulses. 
The remainder of patients had tibial vessel disease.
During the medical examination, details of surgical history, co-morbid conditions and 
risk factors such as smoking status were assessed (Appendix 11). Efficient screening 
highlights previous exercise programmes, present activity and existing chronic or acute 
disease (Kligman et al. 1999). The physical examination also includes vital signs and 
cardiorespiratory and musculoskeletal evaluation (Kligman et al. 1999). Current 
medication was also confirmed. Medical history needs to be taken and medication 
reviewed in order to determine any potential interaction with exercise testing or training 
(Kligman et al. 1999). Smoking status was assessed on the basis of history and further 
confirmed by CO analysis using a smoke meter (Bedfont, U.K.). Patients on long-term 
medication continued on their treatment. Blood pressure was taken (manual 
sphygmomanometer) and a resting 12-lead ECG (Seca, CT3000B, Switzerland) was 
performed with the patient in the supine position, in order to identify evidence of 
arrhythmias (the commonest being atrial fibrillation), previous myocardial infarction (Q 
waves) or ischaemia (ST segment depression).
Absolute contraindications to formal exercise testing include recent 
electrocardiographic changes or acute myocardial infarction, unstable angina, third- 
degree heart block, and acute congestive heart failure (Mahler and American College of 
Sports Medicine, 1995). Patients with abnormal resting ECG readings were excluded 
from participation in the study. Relative contraindications to exercise testing include 
elevated blood pressure, cardiomyopathies, valvular heart disease, complex ventricular 
ectopy and uncontrolled metabolic diseases (Kligman et a l 1999). The initial arm- 
cranking assessment to maximum exercise tolerance was undertaken in the presence of
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Mr. Sohail Choksy, FRCS. All other sessions were undertaken in the presence of 
personnel that had received training in advanced life support procedures. All patients 
GP's were notified in writing of study participation (Appendix 12).
2.2.8 Randomisation and frequency o f  attendance
2.2.8.1 Patient randomisation
Upon completing all baseline assessments, patients were randomised (random selection 
without replacement) into either the lower-limb exercise training, upper-limb exercise 
training or control group, using the fishbowl technique (Baumgartner and Strong, 1998). 
The fishbowl technique involved writing the names of recruited patients on a piece of 
paper. The pieces of paper were placed in a box and drawn. This approach ensures 
randomisation and an equal distribution of patients into each of the three study groups.
The randomisation procedure was conducted by a member of the research team not 
involved in the recruitment, familiarisation or assessment process. Patients were 
randomised into the groups regardless of gender, age, severity of symptoms, current 
medication or smoking status.
2.2.8.2 Frequency o f  assessment sessions
The initial leg-crank test (LCT), arm-crank test (ACT) and walking assessments were 
repeated every 6-weeks during the 24-week intervention period. During each 
assessment week, patients randomised to the training study did not perform any training 
sessions. During the intervention period patients performed five assessments in total.
All patients were also assessed 6-, 12-, 24- and 48-weeks after the end of the 
intervention period.
2.3 Assessment sessions
One hundred and four patients (median age 69 yr, range 50-85 yr) with stable 
intermittent claudication were recruited from the Sheffield Vascular Institute at the 
Northern General Hospital, Sheffield, U.K. Demographic data (sex, age, weight, height, 
body mass index, diabetic and smoking status) are shown in Table 8. In accordance with 
previous suggestions (Tan et al 2000a), patients were instructed not to perform any 
exercise for 24 hr prior to each assessment session. Patients were also advised to abstain 
from caffeinated beverages and nicotine intake for at least 2 hr prior to each test.
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2.3.1 Assessment o f  walking performance using the incremental shuttle-walk test 
Intermittent claudication was defined as exertional calf pain which never begins at rest 
and resolves within 10 min of rest. Walking performance was assessed using an 
incremental shuttle-walk test. This ascertained that the severity of claudication pain was 
the limiting symptom during daily activities and during walking assessment in the 
laboratory.
The shuttle-walk test was a modified version of the protocol developed by Singh et al 
(Singh et a l 1992) for use in patients with chronic airways obstruction. This test has 
recently been evaluated against an internationally accepted, standardised treadmill 
protocol (walking speed 3.2 km.h'1 at 12% gradient) (Labs et a l 1999a) in patients with 
intermittent claudication, with respect to test-retest reliability, cardiovascular responses 
and patient preferences (Zwierska et al 2004).
All patients were confirmed to be pain-free (using the Borg CR-10 scale) prior to 
commencing the shuttle-walk test. HR at rest was recorded using a short-range radio­
telemetry monitor (Polar Sport Tester, Kempele, Finland) and a small resting blood 
sample for lactate analysis (25 pi) was taken. The incremental shuttle-walk test required 
patients to walk back and forth between two cones placed 10 metres apart on a flat 
floor. Walking speed was controlled by bleeps recorded onto an audio-tape and the 
accuracy of the timed signal was ensured by the inclusion on the tape of a calibration 
period of 1 minute. Patients began walking on hearing the first bleep and aimed to reach 
the opposite cone by the next. If patients arrived before the bleep, they were required to 
wait for it before walking back. Patients arriving after the bleep were given verbal 
instructions to increase their walking speed so as to make it to the opposite cone before 
the next bleep. Patients achieved the correct walking pace within two or three 
repetitions (20-30 metres).
The initial walking speed was 3 km.h'1. At the end of each minute, the time interval 
between audible bleeps decreased, and this resulted in a step-increase in walking speed 
of 0.5 km.h'1. This incremental increase in walking speed gradually stresses the cardio­
respiratory system to a symptom-limited maximum, potentially making it safer for 
patients with cardiac and respiratory conditions (Singh et a l 1992).
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For each patient the time taken to reach the onset of claudication pain (claudication 
distance, CD) was recorded, at which point patients were encouraged to continue 
walking until they could no longer tolerate the claudication pain (maximum walking 
distance, MWD). The time taken to reach this point was noted, and the test was 
concluded. The time measurements were converted into distances walked (metres) using 
a macro-program, developed by Dr. Richard D. Walker. HR at CD and MWD was 
recorded using a short-range radio-telemetry monitor (Polar Sport Tester, Kempele, 
Finland). At CD patients were asked to consider their degree of claudication pain (Borg 
CR-10 scale) and at MWD their degree of claudication pain and RPE, using the Borg 
CR-10 and Borg RPE scales, respectively. A post-walking and a 5-min post-walking 
blood sample for lactate analysis (25 pi) was taken. After the walking assessment, 
patients were allowed to rest whilst being continuously monitored in order to ensure that 
BP and HR returned to resting levels.
The initial assessment of walking performance using the incremental shuttle-walk test 
was performed on a separate occasion, usually a few days after undertaking the ACT 
and following prior familiarisation with the shuttle-walk protocol. To minimise 
inconvenience to patients, all other 6-weekly re-assessments of walking performance 
were undertaken prior to, but on the same day as the ACT. A time period of at least 15 
min was allowed before undertaking the ACT and patients were asked to confirm that 
they were pain-free (Borg CR-10 scale) prior to undertaking the ACT.
2.3.2 Precautions during the shuttle-walk assessment
Previous reports have suggested that walking surface, incline walking, the type of 
footwear worn and environmental conditions can all influence walking ability. In order 
to prevent bias, all shuttle-walk tests were undertaken in the same laboratory under 
consistent and controlled environmental conditions. All walking was undertaken on the 
flat. Ladies in the past have stipulated that walking undertaken with footwear having a 
heel can alter their walking ability. For each assessment all patients were instructed to 
wear the same type of footwear.
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2.4 Outcome measures during walking performance
2.4.1 Heart rate, perceived pain and perceived exertion
HR and perceived pain responses (Borg CR-10 scale) at CD and perceived exertion 
(Borg RPE scale) at MWD were assessed during the shuttle-walk test to assess the 
consistency of effort and the degree of pain experienced during each walking 
assessment at the different time points throughout the intervention period.
2.4.2 Ankle-Brachial Pressure Index (ABPI)
ABPI was determined prior to, and immediately following the incremental shuttle-walk 
test, at each assessment time-point. For the baseline ABPI measurement, patients rested 
in a recumbent position for at least 5 min. SBP and DBP (manual sphygmomanometer) 
were measured using an appropriately sized blood pressure cuff in the left and right 
brachial artery above each malleolus (McDermott et a l 2002b). If one brachial arterial 
pressure was greater than the opposite brachial arterial pressure and the difference was 
at least 10 mm Hg, subclavian stenosis was suspected, and the pressure measurement 
from the arm with the highest SBP was used to calculate ABPI (McDermott et al 
2002b).
SBP was then measured in the posterior tibial and dorsalis pedis artery at the ankle in 
both the symptomatic and non-symptomatic leg using a Doppler ultrasound probe 
(Huntleigh Diagnostics, U.K.) and a standard-sized ankle BP cuff (10-cm width). Both 
arterial pressures were recorded. Resting ankle to brachial pressure index (ABPI), 
recommended for evaluating treatment outcome in claudicants (Hiatt et al 1995b), was 
determined by averaging the values from the dorsalis pedis and posterior tibial arteries 
(McDermott et a l 2000) and dividing this ankle SBP by the brachial SBP. Patients with 
an ABPI of 0.9 or less were classified as having PAD (McDermott et a l 2002b). For 
each patient, the measurement from the leg with the lower ABPI, denoted their 
symptomatic limb.
ABPI was re-assessed immediately following the walking test. The couch was 
positioned centrally at the side of the 10 m walk-way, so that the time taken to reach the 
couch for measurements was similar for all patients. To reduce variability a single 
investigator performed all shuttle-walk tests and ABPI measures.
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2.4.3 Blood lactate
The pain experienced during claudication is caused in part by elevated levels of lactate 
resulting from anaerobic metabolism. A small (25 pi) blood sample for lactate analysis 
(YSI 1500 Sport, Ohio, U.S.A) was taken from the finger tip immediately and 5-min 
after the cessation of walking. A change in end-exercise blood lactate levels could 
indicate a potential mechanism by which exercise training increases walking 
performance, since in young, healthy subjects training can increase tolerance to these 
lactate levels.
2.5 Assessment of functional capacity
2.5.1 Incremental arm- and leg-cranking assessments
Patients were weighed and had their height measured during each assessment visit, and 
prior to undertaking exercise. A calibrated electronically-braked cycle ergometer 
(Gould, Bilthoven, Holland) was used for the incremental LCT and was modified for 
the incremental ACT (Figure 2). Both the LCT and the ACT were performed on 
separate occasions, at similar times of the day, in accordance with patients previously 
expressed preferences (Home and Ostberg 1976, Appendix 10). There was typically a 
two day interval between the LCT and ACT, in order to eliminate fatigue. The LCT and 
ACT were performed in random order throughout the study period to prevent any 
learning, bias or order effect, since this could limit the ability of assessing the 
intervention (Regensteiner and Hiatt, 1995).
Prior to each assessment, resting blood pressure was measured using a manual 
sphygmomanometer. An appropriately sized arm cuff was chosen for each patient, and 
each time that blood pressure was measured the cuff was wrapped as carefully and as 
snugly as possible. Patients were subsequently connected to a 6-lead ECG (Marquette 
CaSE 15, Winconsin, U.S.A.), allowing the continuous monitoring of ECG traces and 
HR, which was recorded at rest. A small (25 pi) blood sample was taken from a finger­
tip for blood lactate (YSI 1500 Sport, Ohio, U.S.A) and haematocrit analysis 
(Microhematocrit Centrifuge, Hawksley & Sons Ltd, Sussex, England) using 
appropriate capillary tubes. Patients were confirmed to be leg or arm pain-free (Borg 
CR-10 scale), as appropriate. During each exercise increment, pulmonary gas exchange 
variables were measured directly, breath-by-breath, using on-line expired gas analysis 
system (CaSE EX670 PulmoLab, Kent, U.K.).
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For the LCT, the seat height was adjusted to allow slight knee flexion at bottom dead 
centre, and for the ACT, the mid-point of the sprocket was set at shoulder height. Both 
the LCT and ACT were discontinuous in nature, comprising 3-min bouts of constant 
exercise at a cranking rate of 50 revs.min'1 interpolated with 2-min rest intervals, to 
maximum exercise tolerance. During exercise, patients HR and ECG were continuously 
monitored to detect any exercise-induced dysrhythmias (Tsai et al. 2002). The initial 
intensity was 9 W for both tests. On the basis of previous pilot work (Walker et al. 
2000), power output was increased by 7 W and 14 W per increment in the LCT and 
ACT, respectively, due to the differences in muscle mass involved.
In the last 30 seconds of every 3-min bout of exercise, patients were asked to consider 
their RPE and degree of pain experienced as a result of the exercise, using the Borg 15- 
graded RPE scale and Borg CR-10 scale, respectively. These were on view at all times. 
In the last 10-15 seconds of every 3-min bout of exercise HR was recorded, in 
accordance with previous procedures (Kang et al. 1999). RPE and degree of pain were 
ascertained. SBP and DBP readings were measured (manual sphygmomanometer) 
immediately after each exercise increment and a finger tip blood sample for blood 
lactate analysis was collected. Following the 2-min rest interval, patients repeated the 
cycle of 3-min bouts of exercise followed by 2-min rest intervals until maximum 
exercise tolerance was reached. Each patient was verbally encouraged to continue 
exercising until maximum exercise tolerance.
If maximum exercise tolerance was reached during an incomplete 3-min bout of 
exercise, HR, blood pressure, blood lactate, RPE and pain were determined immediately 
upon cessation of exercise. After reaching maximum exercise tolerance, patients rested 
on a chair and were monitored at 5-min intervals until complete recovery. Cardio­
respiratory recovery following exercise is more rapid in trained individuals than in 
untrained subjects (McArdle et al. 1991), for this reason as well as the issue of safety, 
patients were monitored until complete recovery.
Exercise sessions were terminated if HR considered to be maximal for a patients age 
was reached or patients exhibited ST depression (1.0 mm or more correctly identifies a 
patient with CAD) (American College of Sports Medicine, 2000), abnormal ECG 
readings (as specified prior) or symptoms of exercise-induced angina during exercise. 
For safety reasons, these patients were excluded from study participation. In our study,
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no patient suffered any cardiovascular complication. Some patients reported an 
exacerbation of existing musculoskeletal problems (i.e. knee stiffness), however in the 
majority of cases, patients tolerated the assessment sessions well.
2.5.2 Standardisation o f  assessment sessions
The same members of the research team performed all of the upper- and lower-limb 
peak aerobic power assessments and shuttle-walk assessments. Prior to every 
assessment, all patients were informed of the necessity to walk to intolerable 
claudication pain (MWD) and to exercise on the arm- and leg-crank ergometers to 
maximum exercise tolerance. Breath by breath data were collected using the same 
equipment (CaSE EX670 PulmoLab, Kent, U.K.) throughout the study period, and this 
was appropriately calibrated prior to every assessment session.
For the upper- and lower-limb peak aerobic power assessments, RPE and CR-10 scales 
were on view at all times while the patients were exercising. All assessments were 
performed at a similar time of the day, in accordance with patients’ time of day 
preferences.
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2.6 Outcome measures during incremental exercise
2.6.1 Maximum achieved power
This was recorded as the maximum power output achieved during the incremental LCT 
and ACT. The maximum achieved power (MAP) in an incremental exercise test has 
previously been shown to increase after a 6-week training programme (Walker et al. 
2000) and is a useful indicator of individual exercise capacity. The training intensity 
prescribed for those patients randomised to the lower- and upper-limb training groups 
was based on their individual performance during the assessment sessions.
2.6.2 Pulmonary variables
Pulmonary variables included VO2 , which provides an indication of aerobic capacity, 
carbon dioxide production ( PCO2), respiratory exchange ratio (RER defined as PCO2 / 
PO2), pulmonary ventilation (PE ), ventilatory equivalent for oxygen (PE /PO2), tidal 
volume (Pt) and breath frequency (Bf). All variables were averaged from the last 30 
seconds of breath-by-breath data from each exercise increment.
The RER is used as an indicator of the general progress of an exercise test, with starting 
levels of around 0.8 expected, rising to greater than 1 under stress. Increases in maximal 
PO2 as a consequence of exercise training are indicative of improved cardio-respiratory 
fitness (Hiatt et a l 1994). At low to moderate exercise intensities the rate of tissue VO2 
is linearly related to work rate. However, at high work rates, further increases in 
exercise intensity produce no further increase in PO2 and the plateau is defined as the 
peak PO2 . At this point, high intensity exercise can only be accomplished by 
supplemental anaerobic metabolism, resulting in the accumulation of lactic acid.
The ratio between the amount of oxygen consumed by the tissues ( PO2) and the volume 
of air ventilated ( PE) in a given amount of time indicates breathing economy, and is 
referred to as the ventilatory equivalent for oxygen, or PE / PO2 . It is typically measured 
in litres of air breathed per litre of oxygen consumed per minute. PE /PO2 at rest can 
range from 23-28 L of air per litre of oxygen consumed, which can increase above 30 L 
of air per litre of oxygen consumed as work increases to near maximum.
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2.6.3 Cardiovascular variables
SBP and DBP were measured using a manual sphygmomanometer at rest and at the end 
of each 3-min bout of exercise, which were determined for both the LCT and ACT. The 
cuff was rapidly inflated to 20 mm Hg above the audible systolic pressure in each arm 
and deflated at a rate of 2 mm.s'1, and recorded as the pressure at which the first 
sustained systolic pressure was audible (McDermott et al. 2002b). Hypertension was 
defined as SBP higher than 140 mm Hg and/ or a DBP higher than 90 mm Hg, on two 
or more visits and/or with the use of blood pressure medication.
HR alone, or better still HR blood pressure products (rate pressure product, RPP) are 
satisfactory predictors of coronary blood flow and myocardial oxygen consumption in 
normal, young subjects over a wide range of upright exercise (Kitamura et a l 1972). 
HR was continuously monitored using a 6-Lead ECG (Marquette CaSE 15, Winconsin, 
U.S.A.). The RPP, an index of myocardial workload (Kitamura et a l 1972; Nelson et 
al 1974), was calculated for each work increment as the product of peak SBP and HR. 
From a diagnostic perspective, information on peak HR and RPP is also useful in 
assessing the likelihood that a test can detect coexisting cardiac disease (Askew et al
2002).
2.6.4 Blood lactate
Examination of the blood lactate profile during incremental exercise has previously 
been a useful tool for studying the relationship between aerobic and anaerobic 
metabolism. Assessment of the blood lactate profile in response to incremental exercise 
following upper- and lower-limb training can provide an insight as to whether training 
induced adaptations are primarily occurring at the local or the central level.
2.6.5 Perceived exertion and pain
Patients rating of perceived exertion (RPE) and perceived pain were obtained using the 
Borg 15-graded RPE scale and the Borg CR-10 scale, respectively (Borg, 1998). The 
15-graded RPE scale (Appendix 6), is a universally accepted perceptual scale (Noble 
and Robertson, 1996), commonly used in exercise testing, training and rehabilitation 
(Borg, 1998), in both research and clinical settings for its ease of use (Noble and 
Robertson, 1996). The Borg CR-10 scale (Appendix 7) is similar to the RPE scale. 
Although it has a wider applicability and can be used for most perceptual intensities, it 
is most commonly used to estimate pain (Borg, 1998).
70
2.6.6 Other variables o f  interest
2.6.6.1 Haematocrit
The haematocrit is the ratio of the formed elements in the blood (red and white cells, 
and platelets) to the total blood volume. The percentage of the total blood volume 
composed of cells or formed elements is referred to as haematocrit. Normally 
haematocrit constitutes about 40-50% of total blood volume. Training reduces the 
haematocrit (total blood volume and plasma volume increase, although slight increases 
in erythrocyte numbers are noted). The change in the ratio of plasma to cells, resulting 
from an increase in the fluid portion reduces blood viscosity. Reduced viscosity may 
facilitate blood movement through the blood vessels, particularly through the smallest 
vessels, such as the capillaries, and a lowering of blood viscosity enhances oxygen 
delivery to the active muscle mass (Wilmore and Costill, 1994).
2.6.6.2 Venepuncture
Venepuncture was performed at each assessment time point. With the patient semi- 
recumbent, the venepuncture procedure was explained, thus allaying any fears or 
anxieties. Subsequently, a tourniquet was applied to the upper arm at a pressure high 
enough to impede venous distension, without restricting arterial flow (Mallet & 
Dougherty 2000). A sterile alcohol swab (Isopropyl Alcohol 70% v/v, Seton Healthcare 
Group pic, Oldham, U.K.) was used to clean the puncture site and the area was allowed 
to dry. Blood sampling was facilitated by the insertion of either a 0.7 (x 38 mm) or 0.8 
(x 38 mm) Precision Glide needle (Becton Dickinson, Plymouth, U.K.) at an angle of 
approximately 30 degrees into the basilica vein at the elbow. Once the needle was in the 
correct position, blood was collected (one of serum (9.5 ml SST) and two of plasma (4.5 
ml K3E 15% 0.054 ml)). Blood was allowed to clot for 30 min, after which samples 
were centrifuged (Labofuge 400 R, Kendro Laboratory products, Germany) for 10 min 
at 1000-1300 g  at 25°C and aliquots stored at -80°C until analysis.
2.6.6.3 Body Mass Index (BMI)
The Body Mass Index (BMI) is a measure of the relationship of weight relative to 
height, defined in kg.m'2 (Kligman et al. 1999) and is regarded as a reliable indicator of 
total body fat and is related to the risk of premature death, cardiovascular disease, high 
blood pressure, osteoarthritis, diabetes and some cancers. Although generally useful, 
this index is of questionable value in older subjects, especially those who have
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decreased bone mineralization (Kligman et al. 1999). BMI was determined at all 
assessments (Table 7).
2.6.6.4 BMI score interpretation
Table 7. BMI score interpretation.
BM I Weight Status
Below 18.5 Underweight
18.5-24.9 Normal
25.0 - 29.9 Overweight
30.0 and above Obese
2.7 Calibration of equipment
2.7.1 Expired gas analysis (Mass Spectrometer)
Pulmonary gas exchange variables were directly measured, breath-by-breath, using an 
on-line expired gas analysis, mass spectrometer system (CaSE EX670 PulmoLab, Kent, 
U.K.). Prior to each test the system was calibrated by inputting the patient’s weight and 
height details, barometric pressure (Holtain, Crymych, U.K.), temperature and humidity 
(Oregon Scientific, U.S.). The turbine was calibrated based on a fixed volume, using a 
large (3L) syringe. The acceptable range was 2.97 to 3.03 L, thereby allowing an error 
of 0.1%. Calibration was achieved using known gases; nitrogen, oxygen, carbon dioxide 
and argon.
By the nature of the mass spectrometer, the measured gas concentrations are all fast- 
response and synchronous, however the output on screen occurs some hundreds of 
milliseconds after the event. The turbine produces a single signal for volume, which 
occurs within 10 ms of the event. A realignment of these two signals is achieved with a 
‘delay’ value. This ‘delays’ the volume by the intrinsic delay value of the gases. A 
breath is defined as a period containing an inspirate phase, followed by an expirate 
phase. The expirate is compared to the inspirate to determine gas exchange. During 
expirate the volume is measured and the expirate will contain rising CO2 and falling O2 
concentrations.
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2.7.2 Calibration o f  YSI sport
The YSI Sport (YSI 1500 Sport, Ohio, U.S.A) is a portable, battery powered blood 
lactate analyser. It is designed to provide a quick measurement of lactate in whole 
blood. The buffer reagent, reference and waste bottles hold the solutions needed for 
sample analysis.
The reagent solutions for the Sport were prepared manually (YSI Model 1504 Starter 
Kit). The buffer solution was prepared by filling a 500mL mixing bottle with reagent 
water. High quality deionised water was used, since the reagent water must be very 
pure. One package of buffer concentrate (YSI 2357) was added to the water and stirred, 
ensuring that the buffer chemicals had completely dissolved. Prior to every assessment 
the YSI SPORT was calibrated with a 5 mM standard (YSI 2327), using a capillary tube 
injector (YSI 1502 (25 pi)). The face of the probe, covered by a membrane, is situated 
in a buffer-filled sample chamber into which the sample was injected. The probe is 
fitted with a three-layer membrane containing immobilised lactate oxidase in the middle 
layer. The Sport automatically senses the injection device.
For initial calibration the 25 pi of calibration standard was dispensed into the chamber, 
which already contains approximately 500 pi of buffer. Some of the substrate diffuses 
through the membrane. The sensor response increases, until it reaches a plateau, this 
taking approximately 30 seconds. When it contacts the immobilised enzyme (lactate 
oxidase), it is rapidly oxidised producing hydrogen peroxide (H2O2). The H2O2 is in turn 
oxidised at the platinum anode, producing electrons. A dynamic equilibrium is achieved 
when the rate of H2O2 production and the rate at which H2O2 leaves the immobilised 
enzyme layer become constant. Equilibrium is indicated by a steady state response. The 
electron flow is linearly proportional to the steady state H2O2 concentration and 
therefore to the concentration of lactate.
The reference pump then flushes the chamber for approximately 33 seconds and the 
sensor response changes to a different value. At this point the instrument calculates the 
relationship of the known standard to the reference solution and stores this information 
until another calibration injection is performed. The buffer pump then flushes the 
chamber for approximately 33 seconds and the sensor response decreases to the normal 
baseline value. Once the analysis is complete, the result is displayed on screen. Each 
sample is stored in memory, identified by date and time.
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The calibration procedure is necessary to compare the relative concentration of the 
standard with the relative concentration of the unknown sample. During each 
subsequent sample cycle, the reference solution is again measured and then internally 
compared to the reference solution concentration measured during the initial calibration. 
If a variation exists, the calculation of the sample concentration will be compensated 
accordingly.
2.7.3 Calibration o f  cycle ergo meters and arm-crankers
Both the arm ergometer (Monark 88IE, Varberg, Sweden) and standard stationary cycle 
ergometer (Monark 824E, Varberg, Sweden) used in the exercise training sessions were 
calibrated at the Monark (Varberg, Sweden) works. Calibration of both pieces of 
equipment was routinely verified as per the manufacturer’s instructions. The 
electronically-braked cycle ergometer (Gould, Bilthoven, Holland) utilised during both 
the upper- and lower-limb assessment sessions was calibrated using an external 
calibrator (Lode Portable Calibratior 2000, Lode BV, Groningen, Netherlands). An 
actual value was compared against a display value, from which a calibration curve was 
drawn.
2.8 Questionnaires
In agreement with previous studies, the potential for bias in the self-evaluation of 
walking ability and functional status was minimised by administering the questionnaires 
before the walking test (Regensteiner et a l 1996). Thus questionnaire responses were 
not influenced by a patient’s shuttle-walk performance. In addition, the interviewer and 
patient were blinded to previous questionnaire scores. Functional status was assessed by 
questionnaires characterising walking ability (WIQ), habitual physical activity levels 
(PAD-PAR), and physical, social, and role functioning, well-being, and overall health 
(SF-36) (Regensteiner et al 1996).
2.8.1 Quality o f  Life. Medical Outcomes Study SF-36 v2 and the EuroQol EQ-5D
Quality of life assessments were made using the SF-36 v2 (Appendix 13) and the 
EuroQol EQ-5D (Appendix 14) questionnaires. Both questionnaires were administered 
to all patients at the start of the study, at 6-weeks into, and at the end of the intervention 
period, in order to assess both the short- and longer-term benefits of exercise training on 
quality of life, respectively. The questionnaires were also administered at all four time 
points of the follow-up period, namely 6-, 12-, 24- and 48-weeks to assess changes in
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perception of quality of life following the period of supervised exercise training. The 
questionnaires were administered to the control patients at identical time points. 
Questionnaire completeness was checked in the presence of the patient.
The SF-36 v2 questionnaire evaluates physical function and general health perceptions 
as well as limitations due to mental, social function and vitality (Regensteiner et al. 
1997a; Regensteiner, 1997). The questionnaire encompasses eight quality of life 
domains, four specifically relating to physical health namely;- general health, physical 
functioning, role limitation physical, bodily pain, and four relating to mental status, 
namely, mental health, energy and vitality, role limitation emotional and social 
functioning. With the SF-36 v2 each of the domains was scored separately on a scale of 
0 to 100% (Regensteiner et al. 1996). A typical range of responses for many diseases, 
although not PAD has been established for this questionnaire (Stewart et al. 1989).The 
SF-36 v2 is a self-administered questionnaire which is easy to score (Regensteiner and 
Hiatt, 1995).
The EuroQol EQ-5D questionnaire is a non-disease specific instrument, developed 
within the framework of a joint European project. The visual analogue scale is similar to 
that of a thermometer (Health Policy, 1990). It measures health and health-related 
quality of life in patients, and is designed for self-completion. It comprises five 
dimensions of health: mobility, self-care, degree of difficulty in performing usual 
activities, pain and discomfort, and anxiety and depression. The EuroQol instrument is 
specifically designed to complement other quality of life measures (Health Policy,
1990), such as the SF-36 v2. It has been utilised in previous studies comparing symptom 
severity and health values (De Vries et al. 1998).
2.8.2 Walking Impairment Questionnaire (WIQ)
The Walking Impairment Questionnaire (WIQ; Appendix 15) was investigator 
administered at every assessment session, prior to the assessment of walking ability 
(incremental shuttle-walk test). It is simple to administer (Hiatt, 1999) and is valid for 
characterising walking ability and detecting changes in walking impairment due to 
interventions in patients with intermittent claudication (Regensteiner et al. 1990).
The WIQ is a disease-specific questionnaire that asks a series of questions regarding 
patients self-reported claudication severity and ability to walk defined distances and
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speeds, and stair climbing ability (Hiatt et a l 1995a). Patients rank their ability to walk 
specific distances on a 0-4 Likert scale. The WIQ distance score is calculated by 
multiplying the Likert scale score with the corresponding distance, summing these 
products, and then dividing by the maximum score possible to get a percentage score 
(Regensteiner et al. 1996). Thereby, allowing outcome to be expressed as a percentage 
of full function (Menard et al. 2004). The distance summary score ranged from 0% 
(patient unable to walk 50 feet without claudication pain) to 100% (patient able to walk 
1,500 feet without claudication pain) (Regensteiner et al. 1996).
Walking speed is assessed by asking patients to rank their degree of difficulty in 
walking a block (300 feet) slowly, at average speed, quickly, and running or jogging on 
a 0-4 Likert scale (4=best). Patients’ responses on the Likert scale are multiplied by the 
approximate miles per hour represented by each walking speed. The resultant score is 
then divided by the maximum possible score to achieve a percentage score. The 
summary score for walking speed ranged from 0% (patient unable to walk 300 feet 
slowly without claudication pain) to 100% (patient able to jog 300 feet without 
difficulty) (Regensteiner et al. 1996).
Similarly, stair climbing ability and claudication severity are calculated for each patient. 
The stair climbing score was rated so that 0% indicated a patient could not climb one 
flight of stairs without claudication, while 100% indicated no difficulty in climbing 
three flights of stairs (Regensteiner et al. 1996). The claudication severity score was 
scaled so that 0% indicated that the patient had much claudication pain when walking, 
while 100% indicated no claudication with walking difficulty (Regensteiner et a l 
1996). The feasibility is good for this questionnaire, which can be administered and 
scored in 6-8 min (Regensteiner and Hiatt, 1995).
2.8.3 S elf perceived walking ability
At the end of the intervention period patients were asked regarding their self perceived 
walking ability (Appendix 16). Patients were asked whether they felt that their walking 
ability had improved, remained unchanged or deteriorated over the 24-week 
intervention period. Patients were asked to give one response only, by circling the 
appropriate response. Data were presented as the percentage of patients in each of the 
study groups giving each response.
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2.8.4 Confidence in walking
At the beginning and end of the intervention period, and at each follow-up time point, 
patients were asked regarding their general confidence in walking (Appendix 17). 
Patients were asked to circle the number on the scale (0-10 scale, 0 denoting no 
confidence and 10 denoting total confidence in walking). The median (range) value for 
each study group was calculated.
2.8.5 Physical activity recall
The PAD-Physical Activity Recall (PAD-PAR) questionnaire (Appendix 18) is specific 
for PAD patients, and provides a global measure of habitual physical activity levels by 
estimating the total energy expenditure of the patient at work, in the home, and during 
leisure/recreational time (Sallis et al. 1985; Hiatt et a l 1995a). The amount of energy 
expenditure for each activity is expressed as metabolic equivalent hours per week 
(METs). One MET equals 3.5 mL/kg per minute of oxygen consumption (Hiatt et al 
1995a). The PAD-PAR has been modified from the original version (Sallis et al 1985) 
to be more appropriate for patients with claudication who can perform only low levels 
of physical activity (Hiatt et al 1995a).
The PAD-PAR was administered every week throughout the intervention period to all 
patients regardless of group. For each category (work, household and leisure or 
recreational activities) the patient was asked to estimate the number of hours per week 
spent within the category during the preceding week. A card with a range of physical 
activities (Appendix 19) was used as a prompt for the patients, who were asked about 
specific activities within each intensity of exercise (heavy to very light). For each 
activity (heavy to very light), the number of hours spent in that activity was calculated 
(days per week times hours per week). Activities are classed according to the following 
scale: very light (0.9 to 2.0 METs), light (2.1 to 3.0 METs), moderate (3.1 to 5.0 
METs), and heavy (5.1 to 7.0 METs). For each category the hours per week were 
summed to determine the total hours per week.
Data are reported in MET hours per week (hours per week times the MET value of the 
activity) (Hiatt et a l 1995a). The PAD-PAR must be administered by an interviewer, 
but it was usually administered and scored in less than 12 min in accordance with 
previous studies (Regensteiner and Hiatt, 1995). It was also administered at all four time
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points of the follow-up period to assess patients’ physical activity levels, following the 
end of structured, supervised exercise training.
2.8.6 S elf perception o f  physical activity status
At the beginning and end of the intervention period and at each of the follow-up 
assessment time-points, patients were asked to rate their physical activity status using 
the physical activity ladder (0-10 scale; Appendix 20) (Biener and Abrams, 1991). The 
median (range) value for each study group was calculated.
2.8.7 Incentive to perform physical activity
At the end of the 24-week intervention period patients were asked whether they felt that 
the study had provided them with an incentive to perform physical activity (Appendix 
21). Patients were asked to circle the appropriate response, that being, incentive to 
perform physical activity or no incentive to perform physical activity. For each response 
the percentage of patients in each group was calculated.
2.9 Supervised Exercise Sessions
2.9.1 Structure o f  training sessions
Patients randomised to the lower-limb exercise training or upper-limb exercise training 
groups undertook a 24-week period of twice weekly supervised exercise sessions, 
organised into blocks of five weeks of training and exercise assessments in every sixth 
week. Patients thus performed 20-weeks worth of training, interpolated with 5-weeks of 
assessment sessions, during the intervention period.
Training was undertaken on a group basis (maximum of 8 patients), with the sessions 
equally balanced during the week. Classes were consistently organised on Mondays and 
Thursdays. This provided a structure and allowed patients to rest between sessions, 
thereby allowing recovery and the possible influence of fatigue to be minimised. 
Training sessions were organised in both the mornings and afternoons on both days, 
namely at 10am, 1 lam and 2.30pm, taking into account and excluding the lunch-time 
dip, which could possibly affect exercise performance. Patients attended the session in 
which they felt at their optimum time of day to perform exercise, as described earlier.
Those patients randomised to the upper-limb exercise training group performed exercise 
on a standard friction braked arm ergometer (Monark 88IE, Varberg, Sweden) and
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those to the lower-limb exercise training group on a standard stationary cycle ergometer 
(Monark 824E, Varberg, Sweden; Figure 3). A 2-min warm-up period preceded the 
exercise training session, designed to slowly increase HR. Patients were instructed to 
maintain the speed of 50 ± 2 revs.min'1, at all times. During each session, training was 
undertaken at the required intensity in cycles of 2-min of exercise, followed by 2-min 
rest intervals, for a total exercise time of 20-min in a 40-min session (Walker et al 
2000). These parameters were strictly adhered to.
This strategy enables a greater volume of higher intensity work to be performed in a 
given amount of time than can be achieved using continuous exercise of a similar 
nature, and therefore optimises the stimulus for cardiovascular adaptations (Astrand and 
Rodhal, 1986). All patients wore a short-range radio-telemetry monitor (Polar Sport 
Tester, Kempele, Finland), for continual HR monitoring. The RPE and CR-10 scales 
were on view at all times. HR, RPE and CR-10 were recorded for the first and last 2- 
min exercise bouts. A 2-min cool-down period followed the last 2-min bout of exercise, 
in order to return the HR to baseline and thus minimise risk of injury.
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Figure 3. Patient undertaking lower-limb exercise training (above) and upper-limb exercise (below)
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2.9.2 Exercise intensity during training sessions
Supervised exercise training was undertaken at equivalent limb-specific relative 
exercise intensities. For each patient, training intensity was individualised using the 
penultimate power output achieved in the respective LCT and ACT assessment. Use of 
penultimate power output enabled training intensity to be balanced at 85-90% of the 
limb-specific peak VO2 between the upper- and lower-limb exercise training groups, 
thus ensuring a similar cardiovascular stimulus. In addition to power output, training 
intensity was also balanced on the basis of HR, RPE and pain data from the penultimate 
power output achieved during the respective assessment session. This ensured that the 
correct training intensities were used in the supervised exercise sessions, with most 
patients exercising between the Borg RPE scale ratings of 13 (“somewhat hard”) to 16 
(“hard to very hard). In certain patients, the training intensity was increased to the 
maximal work rate achieved during the assessment session after 3-weeks of training in 
order to ensure that a sufficient training stimulus was maintained as fitness levels 
improved (Walker et al. 2000). For all patients, exercise training intensity was adjusted 
following each 6-week incremental assessment, as appropriate.
2.9.3 Precautions during the training sessions
Patients with PAD often have co-morbid medical problems that may interfere with their 
ability to safely participate in exercise rehabilitation programs (Katzel et al 2000). To 
promote safety, all patients during the training sessions were monitored using telemetry 
devices regardless of whether they had clinical evidence of co-morbid coronary disease. 
During the exercise sessions, HR and cardiac rhythm were continuously evaluated. 
Blood pressure was measured before and after the training sessions in those patients 
with a history of coronary problems. Some patients from the lower-limb training group 
in the initial stages of the exercise programme reported an exacerbation of existing 
musculoskeletal problems (i.e. knee stiffness). These were in the main relieved 
following the 2 day rest interval between training sessions. A similar long-term 
programme has also previously recommended that training sessions be separated by 48 
hr (McGuigan et al. 2001). In the majority of patients the exercise training sessions 
were well tolerated.
2.9.4 Monitoring o f  attendance
Attendance at the twice weekly training sessions was monitored. Any patient providing 
prior notice of their inability to attend their specified exercise session were allocated an
81
equivalent time of day session on another day, usually conducted on an individual basis, 
to maintain twice-weekly adherence and compliance. Patients who were absent from 
their specified session without prior notice (usually due to ill health or an unexpected 
commitment) were contacted by telephone, and a suitable arrangement was made, in 
order to maintain twice-weekly compliance.
2.9.5 Monitoring o f  control patients
Patients randomised to the control group were provided with an in-depth lifestyle advice 
consultation session. In accordance with current U.K. medical practice, all patients were 
advised to "stop smoking and keep walking “(Housley, 1988). This message was 
reinforced by telephone every week during the intervention period.
Patients were informed that their level of physical activity in accordance with the PAD- 
PAR questionnaire (Appendix 18) would be monitored on a weekly basis, stressing the 
importance that patients should be as honest as possible. Patients were thus contacted 
weekly by telephone, during which their level of physical activity was assessed via 
completion of a PAD-PAR questionnaire. Emotional support identical to that received 
by the patients randomised to the supervised exercise programme was provided when 
appropriate. Control patients undertook all re-assessments at identical time points as the 
training cohorts.
2.9.6 Medication
During the intervention period, patients on long-term medication continued with their 
treatment. These were stable and no major changes were introduced into the medication 
profile. Slight adjustments to drug dosages in some patients were made. Patients 
prescribed GTN did not need to use the medication during the assessment sessions, 
since it has been shown that walking distance can improve following GTN 
administration in patients with intermittent claudication (Heer et a l 2001).
2.10 Statistical analysis
Trials of healthcare interventions fall into two categories: explanatory and pragmatic. 
Explanatory trials usually measure treatment efficacy on the basis of intermediate 
outcomes, as a means to elucidating the time-course and biological bases of a positive 
response. It is felt that this study was an explanatory trial, investigating the efficacy of 
upper-limb exercise in relation to that of comparable lower-limb exercise, with the aim
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of attempting to identify possible underlying mechanisms. The efficacy of upper-limb 
exercise training for patients with PAD is still in the early stages of being examined, 
and following our earlier preliminary study (Walker et a l 2000), a larger-scale RCT 
was needed to prove that upper-limb exercise training can evoke positive health 
outcomes and to further understand the mechanisms of action. Such a robustly designed 
trial has never been performed previously.
Given these considerations, it was felt more appropriate to restrict analysis to those 
patients who completed the course of treatment at the intended intensity for the intended 
time interval. Missing data points were not therefore considered on an intention to treat 
basis. The rationale to this approach is that this was a scientific study aimed at 
evaluating the influence of upper- and lower-limb aerobic exercise training on the 
clinical status of these patients. This was not a pragmatic trial, designed to evaluate the 
effectiveness of a physical activity intervention programme. During the intervention and 
follow-up period, data analysis was performed on 94 and 76 patients, respectively (32, 
30 and 32; and 25, 25 and 26 patients from the lower- and upper-limb exercise training 
and control groups, respectively). Haematocrit and walking confidence data analysis 
were performed on fewer patients (n=65), since the decision to include these variables 
was made once the study had commenced, and this accounts for the difference in patient 
numbers.
Descriptive statistics were obtained for all baseline variables during the intervention and 
follow-up period. Dependent variables were first tested for normal distribution using the 
Shapiro-Wilkes and Kolmogorov-Smimov goodness of fit tests. Histograms of all data 
parameters, at all time-points were obtained to confirm normality of distribution.
Levens test of equality of variance checks were also carried out on all data. Where 
applicable, data transformations (for example log transformations) were performed to 
obliterate skewness. In instances where skewed interval or ratio level data could not be 
normalised using logarithmic or other transformation techniques, non-parametric tests 
were used. With the exceptions of peak power output, CD, RPE, CR-10, ABPI, patients 
self-reported walking ability, walking confidence, physical activity status, WIQ and 
EQ-5D questionnaire responses, all other variables were normally distributed. Peak 
power output and CD were normalised using logarithmic transformation before 
analysis. Parametric results are expressed as means ± SEM unless otherwise stated and 
non-parametric results are expressed as the median value, with ranges.
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A mixed design factorial ANOVA was used to test for changes in normally distributed 
variables over time within groups and for differences between groups at the same time- 
points. If sphericity could not be assumed the Greenhouse Geisser and Huyndt-Feldt 
assumptions were observed to check for time and time x group interactions. The 
ANOVA is a robust procedure, which can withstand minor violations. Where 
significance was indicated, the mixed factorial ANOVA analysis was followed up with 
one way ANOVA’s within and between groups and post hoc comparisons to determine 
where group and time-point differences occurred. Data, which could not be normalised 
using data transformation techniques were analysed using the Kruskall Wallace test, 
with group differences at each time-point being identified using the Mann-Whitney U 
test and changes over time within groups analysed using the Friedman and Wilcoxon 
signed ranks test.
The magnitude of the changes in walking performance (CD and MWD) between 
baseline and the 24-week intervention and the 48-week follow-up period were 
calculated using the mean percentage difference score. The percentage difference from 
baseline for each patient was obtained. The group mean of the individual percentage 
difference scores were calculated for each of the three study groups. Between group 
analysis was compared using one-way ANOVA.
The relationship between walking performance (MWD) as assessed using the 
incremental shuttle-walk test, and patients’ perceived walking ability as identified using 
the WIQ, was assessed using Pearson’s correlation coefficient. All statistical analyses 
were performed using SPSS for Windows (SPSS U.K. Ltd, Woking, U.K.), with 
significance indicated at the 0.05 level.
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Chapter 3 -  Intervention Study Results
3.1 Demographics, patient attendance and compliance
3.1.1 Demographics
A total of 104 patients (81 males, 23 females) were recruited for this study. The median 
age was 69 years (range 50- 85 years) and their mean BMI was 27.6. Thirty seven, 34 
and 33 patients were randomised to the lower- and upper-limb training and control 
groups, respectively. Demographic data (age, sex, resting ABPI, weight, height, current 
angina, previous MI and stroke, sleep duration, diabetic and smoking status) are shown 
in Table 8. The majority of patients (89%) claimed to eat a well-balanced diet, including 
fruit and vegetables, and to adhere to previous advice regarding the reduction of fat in 
their diet. Seventy-seven percent of patients reported a disturbed sleep pattern, 
awakening several times during the night, requiring the toilet.
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Table 8. Demographics of the entire patient group and those of the three study groups.
Variable
AH
Patients
N=104
Lower-
limb
Training
N=37
Upper-
limb
Training
N=34
Control
Group
N=33
Sig
Median age, years 
(range)
Sex
Male, %
Female, %
Duration of claudication, 
months
69
(50 to 85)
78%
22%
55
69
(50 to 85)
81 % 
19%
59
66
(54 to 84)
79%
21 %
50
12
(56 to 84)
73%
27%
55
JVS" 
1VS“ 
NS?
Resting ABPI 0.66 ± 0.02 0.64 ± 0.03 0.65 ± 0.03 0.69 ± 0.03 NS1"
Weight, kg 78.4 ±1.4 76.3 ± 2.2 80.8 ± 1.9 78.3 ±3.2 NS?
Height, m 1.68 ±0.01 1.69 ±0.01 1.68 ±0.01 1.67 ±0.01 NS?
Previous MI, % 8% 3% 9% 12% NS6
Previous stroke, % 17% 19% 18% 15% NS?
Current angina, % 18% 14% 18% 24% NS?
Diabetes mellitus, % 17% 8% 18% 27% P < 0.05
Duration of sleep, hr 7.3 7.3 7.1 7.4 NS1
Smoking status 
Current, % 
Previous, % 
Never smoked, %
32%
62%
6%
38%
54%
8%
24%
73%
3%
33 % 
61 % 
6%
NS?
ABPI data are presented for the most symptomatic limb. Patients with diabetes mellitus were 
taking oral hypoglycaemics or insulin. Unless otherwise stated, values are means ± S.E.M. NS 
indicates no significance between the three study groups: aANOVA, bChi Square test.
3.1.2 Medication history
Some patients in this study were taking prescribed cardiac medication, including p- 
blockers, ACE-inhibitors, Ca2+ channel blockers, nitrates, diuretics, statins and aspirin
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(Table 9). Patients were advised to continue on their drug regimen throughout the study 
period. Any changes to medication, including drug dosage, were recorded.
Table 9. Medication details of the entire patient group and of the three study groups.
AH
Patients
N=104
Lower-limb
Training
N=37
Upper-limb
Training
N=34
Control
Group
N=33
P-Blockers, % 26 19 24 36
ACE Inhibitors, % 15 14 18 15
Ca2+ Blockers, % 30 22 35 33
Nitrates, % 10 11 6 12
Diuretics, % 32 35 29 30
Digoxin, % 6 8 3 6
Warfarin, % 5 8 3 3
Statins, % 68 73 68 61
Aspirin, % 83 81 82 85
Data are represented as the percentage o f patients in each group on the specific cardiac
medication.
3.1.3 Patients time o f  day preferences to undertake exercise 
The majority of patients in this study (N=62, 60%) did not have a preference for the 
time of day in which to perform exercise, and indeed according to Home & Ostberg’s 
lark/owl questionnaire the majority of patients were classed as neither morning nor 
evening types of individuals (Figure 4). Seven (7%), 34 (32%) and one (1%) patient 
were classed as definite morning, moderate morning and moderate evening types of 
individual. All patients undertook all training and assessment sessions according to their 
individual classification and personal time of day preference.
87
Moderate evening (n=l, 1%) Definite morning (n=7, 7%)
Neither morning or evening (n=62, 60%) Moderate morning (n=34, 32%)
Figure 4. Patients time of day preferences to undertake exercise. Proportion of patients classed 
as definite morning, moderate morning, moderate evening, or neither morning or evening types 
of individuals.
3.1.4 Patient attendance and compliance
Of the 104 patients recruited, 94 patients completed the 24-week intervention period, 
with five, four and one patient withdrawing from the leg, arm and control groups, 
respectively. Patient drop-out rate during the intervention period was 9.6%.
Three patients withdrew between their initial assessment and their first 6-week re­
assessment. One was diagnosed with bowel cancer, another became a full-time carer for 
his wife who had sustained a stroke; both patients were from the leg-training group. A 
third, from the control group found the assessments too stressful.
Five patients withdrew between the 6th and 12th week of the intervention period. One 
was diagnosed with gout, one sustained a heart attack following a fishing expedition, 
another fell ill with pneumonia which resulted in death, and one withdrew without 
providing an explanation. All were in the arm-training group. One patient from the leg-
training group was known to suffer with manic depression and found the training 
sessions too stressful.
Two patients, both from the leg-training group, withdrew in between the 12th and 18th 
week of the intervention period due to medical reasons. One developed ulcers on his 
leg, another broke his foot. Both were unable to continue with the training sessions.
Of the 94 patients who completed the 24-week intervention study, compliance to the 
arm-cranking, leg-cranking, and walking assessments at the five time-points (94 x 5 x 3 
= 1,410 assessments in total) was 99.9%. Two of these 94 patients each failed to attend 
one assessment session (assessment 5). One because his daughter was killed in a hit and 
run accident, and another was diagnosed with bowel cancer prior to his last assessment. 
Compliance to the twice-weekly training sessions run over the 24-week intervention 
period was 99%.
3.2 Intervention study walking performance
3.2.1 Claudication distance
Claudication distance increased over time (P <0.01) in both training groups, but was 
unchanged from baseline in the control group over the 24-weeks of the study period 
(Table 10). The magnitude of improvement in CD, in both training groups, over the 
intervention period was comparable. There was no difference between groups in the 
pre-intervention CD. Data were not normally distributed and are presented as median, 
with range in parentheses.
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Table 10. CD at each assessment stage of the intervention period.
Intervention Lower-limb Upper-limb Control
Period Training Training Group
(weeks)
/£i
Baseline 73(20 - 568)
101 
(25 - 430)
94
(28 - 408)
s
oOda 6
113* 
(23 - 394)
120 
(38 - 480)
101 
(24 - 480)
5eo• m* 12
113** 
(20 - 692)
115** 
(39 - 430)
99
(30 - 463)
cz
aCZ
18 134** (26 - 465)
142** 
(29 - 438)
103 
(22 - 397)
U 24 143** (34 - 579)
152** 
(42 - 508)
113 
(25 - 333)
Data are presented as median value (with ranges). Statistical significance: * P < 0.05; ** P < 
0.01 indicate significantly higher than baseline.
Following the 24-week intervention period, CD improved in the lower- and upper-limb 
training groups by 65% and 56 %, respectively, compared with the control group of 
patients (P <0.01; Figure 5). There were no differences between the two training 
groups.
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80 i
Lower-limb Upper-limb Control
training training group
Figure 5. Changes in claudication distance upon completing the intervention period. Data are 
presented as means in relation to baseline measures, with error bars representing SEM. $ P < 
0.01 indicates significance between the lower- or upper-limb training groups and the control 
group of patients.
In the upper-limb training group a sharp improvement in CD was observed up to the 
12th week of training (i.e. assessment 3), the rate of improvement thereafter being 
progressively slower, possibly indicating a plateau effect. In the lower-limb training 
group, CD continued to progressively improve at each assessment stage (Table 11).
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Table 11. Mean percentage change in CD from baseline at each assessment stage of the
intervention period.
Intervention Lower-limb Upper-limb Control
Period training training group
(weeks)
6 + 28 t + 24 + 3
QU a>ca>v
C
*3VI 12 + 37 J + 41 { -2MCJucS• P4Q
BoA 18 + 54 J + 47 { + 3
0s
24 + 65 t + 56 J + 5
Data are presented as the mean % difference from baseline, f  P < 0.05; $ P < 0.01 indicates 
significance between the leg or arm-training group and the control group o f patients.
Heart rate, blood lactate, perceived exertion and perceived pain responses were assessed 
during the incremental walking test to assess the consistency of effort and level of pain 
experienced between walking assessments at the different time-points.
3.2.1.2 Heart rate at claudication distance
Despite increases in CD in both training groups, the heart rate at CD was unchanged in 
all groups throughout the intervention period. The only significant difference between 
groups was observed between the arm-training and control group following 12-weeks of 
the intervention period (Figure 6).
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6 120 18 24
Weeks o f  Training
Figure 6. Changes in heart rate at claudication distance. Data are presented as mean ± SEM at 
each assessment stage o f the intervention period, f  P < 0.05 indicates significance between the 
arm-training and control group of patients.
3.2.1.3 Perceived pain at claudication distance
The degree of pain experienced at CD in the main was “very weak” (i.e. 1 on the Borg 
CR-10 scale) and was consistent between groups throughout the intervention period. 
Interestingly, despite being able to walk further prior to the onset of pain, patients in the 
lower-limb training group also reported the pain to be less intense at CD following the 
24-week intervention period. These patients perceived their pain to be “extremely 
weak” (i.e. 0.5 on the Borg CR-10 scale) compared to “very weak” at baseline (P < 
0.01). This difference in pain perception was significant compared with both the arm- 
training and control group of patients (P < 0.05; Table 12).
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Table 12. Perceived pain (Borg CR-10 scale) at CD at each stage of the intervention 
period.
Intervention Lower-limb Upper-limb Control
Period training training group
(weeks)
Baseline 1.0 (0.3 - 3.0)
1.0 
(0.3 - 3.0)
1.8 
(0.5 - 3.0)
QU /r 1.0 1.0 1.0
Cl• PN « O (0.3 - 2.5) (0.3 - 3.0) (0.3-3.0)C5
Oh
o"cS
<u 12 0.5 1.0 1.0> • PNQ orH (0.3 - 5.0) (0.3-3.0) (0.3 - 7.0)Ou,a
Pm ubX) 18 1.0 1.0 1.0uo (0.3-3.0) (0.3 - 3.0) (0.3 - 7.0)
e
24 0.5**f 1.0 1.0(0.3 - 2.0) (0.3 - 3.0) (0.3 - 5.0)
Data are presented as median (range). ** P < 0.01 indicates significance from baseline, f  P < 
0.05 indicates significance between the leg-training group, compared with both the arm-training 
and control group of patients.
3.2.2 Maximum walking distance
The pattern of improvement in MWD (Figure 7) was similar to that observed for CD. 
Maximum walking distance increased by 35% and 30% in the lower- and upper-limb 
training groups respectively, compared with baseline measures (P <0.01; Table 13).
The differences in improvement between the two training groups were not significant. A 
trend indicating deterioration in MWD was observed in the control group of patients.
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Table 13. Mean percentage change in maximum walking distance (MWD) from
baseline at each assessment stage of the intervention period.
Intervention Lower-limb Upper-limb Control
Period training training group
(weeks)
6 +16 { +15 f -2
0  £  12 + 23 } + 22 t - 4• PM ^ T Vo jge j  03fl PQ u g5+h O
0s
18 + 28 J + 2 7 t  -5
24 + 35 { + 30 J -3
Data are presented as mean % difference from baseline. J P < 0.01 indicates significance 
between the leg or arm-training group and the control group of patients.
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Figure 7. Changes in maximum walking distance throughout the intervention period. Changes in MWD (left) at 6-weekly intervals and mean % difference in MWD 
(right) after the intervention period. Changes in MWD are presented as mean ± S.E.M. ** P < 0.01 indicates significance from baseline, f P < 0.05; %P < 0.01 
between leg- or arm exercise training and the control group of patients.
3.2.2.1 Peak heart rate at MWD
Improvements in MWD in both exercise training groups were accompanied by 
progressive increases in peak HR at MWD compared to baseline (106 ± 3 versus 120 ± 
4 and 110 ± 4 versus 116 ± 4 beats.min'1, following lower- and upper-limb exercise 
training, respectively; P < 0.05). HR at MWD in both training groups was higher than 
that observed for the control group at the 24-week time-point (.P <0.01; Figure 8), 
indicating that both exercise groups attained a higher level of cardiovascular stress at 
MWD following the intervention period. The differences in HR between the two 
training groups were not significant.
130 —□ — Leg
------- Arm
-  A -  Control
120 -
i arH
a
c / i  1 1 0  -
<D
100 -
246 12 180
Weeks o f  Training
Figure 8. Changes in heart rate at MWD during the intervention period. Data are presented as 
mean ± SEM at each assessment stage, during the intervention period. * P < 0.05; ** P < 0.01 
indicates significance compared to baseline, f P < 0.05; J P < 0.01 indicates significance 
between the leg- or arm-training group and the control group of patients.
3.2.2.2 Peak blood lactate at MWD
At the 12-, 18- and 24-week time-points, the concentration of blood lactate at MWD 
was higher in both exercise training groups compared to that observed in the control 
group of patients (P at least < 0.05). Following 6-, 12-, 18- and 24-weeks of the 
intervention period blood lactate concentration at MWD was increased from baseline in
97
the upper-limb exercise training group only (1.95 ± 0.14 vs. 2.40 ± 0.17 mM, pre- and 
post-intervention; P < 0.05; Figure 9). No changes in these parameters were observed in 
the control group of patients.
3.2.2.3 Peak blood lactate 5 min post MWD
Similarly, at the 6-, 12-, 18- and 24-week time-points, the concentration of lactate in 
blood taken 5-min post MWD was higher in both exercise training groups compared to 
that observed in the control group (P at least < 0.05). Following 12-, 18- and 24-weeks 
of the intervention period peak blood lactate concentration 5-min post MWD was 
increased from baseline in the upper-limb exercise training group only (2.00 ±0.13 vs. 
2.59 ±0.19 mM, pre- and post-intervention; P at least < 0.05; Figure 9). No changes in 
these parameters were observed in the control group of patients.
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3.2.2.4 Perceived exertion and perceived pain at MWD
The level of pain experienced in the baseline assessment of MWD was fairly consistent 
between groups, although an increase in the amount of pain experienced at MWD at the 
18- and 24-week time-points was observed in the upper-limb training group only (P < 
0.05; Table 14). This increase in perceived pain at these time-points was also associated 
with a higher level of perceived exertion (RPE) at MWD in the upper-limb exercise 
training group, compared to baseline (P at least < 0.05).
Table 14. Perceived pain (Borg CR-10 scale) and perceived exertion (Borg RPE scale)
at MWD at each assessment stage of the intervention period.
Intervention Lower-limb Upper-limb Control
Period training training group
(weeks)
Baseline 6.0 5.0 5.5(3.0-11.0) (2.5-11.0) (2.5-11.0)
a 7.0 7.0 6.0• pP
Pm
WIfl Q
6 (2.5-10.0) (1.5-11.0) (2.5-10.0)
'O
£
*«w
©
A
U
£
§
ca
12 7.0(2.0-11.0)
7.0
(1.0-11.0)
6.0
(3.0-10.0)
ipCJPm
bDu© 7.0 7.0* 6.5P5 l o (3.0-11.0) (2.5-11.0) (2.0-11.0)
'JA 7.0 7.0* 5.0(2.0-11.0) (2.5-11.0) (1.0-10.0)
Baseline 13.0 13.5 15.0(9.0 - 20.0) (7.0 - 20.0) (7.0-19.0)
c'O 15.0 13.5 14.5%-»u O (8.0 - 20.0) (6.0 - 20.0) (7.0-20.0)CJp ce Q
w H £ 15.0 15.0* 15.0
2 § l  z (9.0 - 20.0) (6.0-19.0) (11.0-19.0)
WDo(J u© 18 15.0 15.0* 13.0ua>PM CQ (11.0-20.0) (7.0 - 20.0) (7.0-19.0)
A 15.0 16.0** 14.024 (7.0-19.0) (6.0 - 20.0) (6.0 - 20.0)
Data are presented as median (range). * P < 0.05; ** P < 0.01 indicate significance compared 
to baseline.
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3.2.3 Patients se lf perceived walking ability
The majority of patients in both training groups stated that they had observed a 
noticeable improvement in their walking ability, both when walking up a hill, but 
particularly when walking on the flat (Table 15). This is in agreement with the 
improvement in walking ability observed in both the training groups.
Interestingly, almost half of the patients in the control group also perceived an 
improvement in walking ability, yet no actual improvement in walking ability was 
recorded in this group.
Table 15. Patients self perceived walking ability following the intervention period.
% Lower-limbtraining
Upper-limb
training
Control
group
Improvement 84 90 44
No Change 16 - 47
Deterioration - 10 9
Data are presented as the percentage of patients in each study group.
3.2.4 Confidence in walking
The improvement in walking ability observed in both training groups, was also 
associated with an improved confidence in walking upon completing the intervention 
period, compared to baseline measures (P < 0.01; Table 16). The increased confidence 
in walking, however, was not significant when compared with the control group.
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Table 16. Patients perceived confidence in walking.
Confidence in Walking
Pre-Intervention Post-Intervention
Lower-limb Training 5 g * *(2-10) (3 -10)
Upper-limb Training 5 9 * *(1 - 10) (1 -10)
Control Group 7 7.5(1 -10) (3 -10)
Data are presented as the median (range). ** P < 0.01 indicates significance from baseline.
Data are presented from 23, 20 and 22 patients from the lower-, upper-limb training and control 
groups, respectively, due to some patients withdrawing throughout the study period.
3.2.5 Changes in ABPI
Despite the improvements in walking ability, no changes in resting ABPI were observed 
at any assessment time-point during the intervention period, either between or within 
groups. A significant decrease in post shuttle-walk ABPI was observed at 24-weeks in 
both training groups compared to baseline (P < 0.01). This decrease was significantly 
different to the control group in the upper-limb training group only (P < 0.05; Table
17).
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Table 17. Resting, post shuttle-walk and mean individual difference in ABPI at each
assessment stage of the intervention period.
Intervention
Period
(weeks)
Lower-limb
Training
Upper-limb
Training
Control
Group
Baseline 0.65 (± 0.03) 0.66 (± 0.03) 0.69 (± 0.03)HHPhPQ 6 0.63 (± 0.03) 0.67 (± 0.04) 0.68 (± 0.03)<bx>a 12 0.64 (± 0.02) 0.65 (± 0.03) 0.66 (± 0.03)*•+-tj& 18 0.67 (± 0.03) 0.65 (± 0.04) 0.68 (± 0.04)
24 0.65 (± 0.02) 0.66 (± 0.04) 0.68 (± 0.03)
£ Baseline 0.46 (± 0.04) 0.43 (± 0.03) 0.48 (± 0.04)
&■ 6 0.40 (± 0.04) 0.40 (± 0.03) 0.46 (± 0.03)Q HH52 Phs  5 12 0.40 (± 0.04) 0.36 (± 0.03) 0.47 (± 0.04)js <3Cfl 18 0.39 (± 0.03) 0.38 (±0.04) 0.45 (± 0.04)OPk 24 0.37 (± 0.03)** 0.31 (± 0.02)**f 0.42 (± 0.04)
a Baseline -0.20 -0.24 -0.22
S  Ifa .S 6 -0.24 -0.28 -0.22
i s  S sa pq ^ 12 -0.24 - 0.30 f -0.19
S < ZS o 18 -0.28 -0.27 -0.23W Q.QJ «
§ 24 - 0.28 * - 0.35**f -0.26
Data are presented as mean ± SEM, at each assessment stage o f the intervention period. * P < 
0.05; **P  < 0.01 indicate significance from baseline, f  P < 0.05 indicates significance between 
the arm-training group and the control group of patients.
3.3 Walking Impairment Questionnaire Domains
3.3.1 Claudication pain severity, walking distance, walking speed and stair 
climbing ability
Further to the changes in walking ability, patients’ walking impairment, as defined 
using the walking impairment questionnaire (WIQ) was also altered during the course 
of the intervention period.
Following the 24-week intervention period an increase from baseline in walking 
distance, walking speed and stair climbing ability was observed in both exercise training 
groups (P <0.01; Table 18). An improvement in claudication pain severity was also
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observed in the upper-limb training group at the 24-week time-point (.P < 0.05; Table
18) compared to the control group of patients.
Table 18. Changes in WIQ domains throughout the intervention period.
Intervention Lower-limb Upper-limb Control
Period training training group
(weeks)
Baseline 50 (0-75) 50 (0-75) 50 (25-75)
co+* &S. 6 50 (0-75) 50 (25-75) t 50 (0-75)C5O•  m *nss
a>xn 12 50 (0-75) 50 (0-75) f 50 (25-75)
p ves
0
C•  P *cb
P h 18 50 (25-75) 50 (0-100) 50 (0-75)
24 50 (25-100) 63 (0-100) f 50 (0-75)
Baseline 27 (4-89) 23 (0-100) 22 (2-100)
bJDc a>w 6 28 (4-89) 36(1-100) 24(1-89)
g
CS
c 12 32 (7-83) 38(1-100)* 22 (2-89)£ s 18 33 (7-83) 45 (1-100)* 26(1-100)
24 45 (7-100)** 49 (1-100)** 28 (4-100)
Baseline 28 (0-89) 27 (0-93) 31 (3-89)
b£c
6 37 (3-89) 39 (0-93) 38 (0-100)g
cs
uO)C. 12 35 (10-72) 45 (0-93)** 32 (0-89)£ G0 18 39 (11-89) 50 (0-100)** 39(10-100)
24 43 (18-100)** 46 (7-93)** 38 (0-72)
b£
Baseline 42 (0-100) 40(4-100) 42 (0-100)
c3S0 £3
6
12
52 (0-100) 
67 (0-100)*
54 (4-100)* 
59 (0-100)
42 (4-100) 
40 (0-100)
*3
•+ *Xfl 18 67 (0-100)** 67 (4-100)*
42 (0-100)
24 67 (0-100)** 71 (0-100)** 42 (0-100)
Data are presented as median (range), at each assessment stage o f the intervention period. * P < 
0.05; ** P < 0.01 indicates significance from baseline, f  P < 0.05 indicates significance 
between the leg- or arm-training group and the control group.
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3.3.2 Correlation o f  WIQ indices with walking performance
All WIQ indices were positively correlated with MWD prior to the intervention (Table
19). In particular, correlation coefficients for walking distance and walking speed were 
highly correlated with MWD. Weaker relationships existed between patients’ perceived 
stair climbing ability and perceived pain severity due to walking.
Table 19. Relationship between walking performance (MWD) and WIQ scores for the 
entire patient group pre-intervention.
MWD Correlated with WIQ Indices of
Pain Walking Walking Stair Climbing
Severity Distance Speed Ability
Baseline 0.37** 0.71** 0.67** 0.56**
Data are presented as the Pearson Correlation Coefficient. * P < 0.05; ** P < 0.01 indicating a 
positive correlation with MWD.
Similar relationships were found for walking distance and walking speed throughout the 
course of the intervention period, in all three study groups, again with weaker 
relationships for stair climbing ability and perceived pain severity, particularly in the 
lower-limb training group of patients (Table 20).
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Table 20. Relationship between walking performance (MWD) and WIQ scores for the
three study groups at each assessment stage during the intervention period.
Intervention
Period
(weeks)
MWD Correlated with WIQ Indices of
Pain
Severity
Walking
Distance
Walking
Speed
Stair
Climbing
Ability
b£ Baseline 0.32 0.70** 0.66** 0.50**aS3•  m 4C3 6 0.27 0.62** 0.66** 0.55**
I nHXis 12 0.20 0.52** 0.48** 0.48**
sio>■ 18 0.21 0.60** 0.34 0.50**>oP 24 0.07 0.45* 0.45** 0.33
W) Baseline 0.34* 0.63** 0.62** 0.52**aa*S 6 0.28 0.68** 0.66** 0.43*
I nH
B 12 0.39* 0.77** 0.72** 0.38*
Iu«i 18 0.38* 0.66** 0.67** 0.54**CuaP 24 0.57** 0.80** 0.62** 0.47**
Baseline 0.52** 0.82** 0.75** 0.68**
a
o 6 0.43* 0.70** 0.61** 0.57**
O
o
I n
12 0.44* 0.76** 0.64** 0.64**
N-»S3oU 18 0.52** 0.73** 0.72** 0.64**
24 0.46** 0.73** 0.62** 0.66**
Data are presented as the Pearson Correlation Coefficient. * P < 0.05; ** P < 0.01 indicating a 
positive correlation with MWD.
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3.4 Physical activity
3.4.1 Incentive to perform physical activity
Ninety-one, and 93 % of patients in the lower- and upper-limb training groups, 
respectively, stated that the study had provided them with an incentive to increase their 
level of physical activity. Interestingly, 75% of patients in the control group also stated 
that the study had provided them with an incentive to exercise (Table 21).
Table 21. Patients self-assessed perception to perform physical activity.
% Lower-limb Upper-limb ControlTraining Training Group
Incentive 91 93 75
No Incentive 9 7 25
Data are presented as the percentage value within each group
3.4.2 Self perception o f  physical activity status
An increase in physical activity status from baseline was observed in all three study 
groups upon completing the 24-week intervention period (P < 0.01). The physical 
activity status of the exercise training groups was rated higher than that of the control 
group following the intervention period (P < 0.01; Table 22).
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Table 22. Patients self-assessed physical activity status.
Physical Activity Status
Pre-Intervention Post-Intervention
Lower-limb Training 2 10**1(0 -1 0 ) (10-10)
Upper-limb Training 6 10**1(0 -1 0 ) (8 -1 0 )
Control Group 6 6(0 -1 0 ) (0 -1 0 )
Data are presented as the median (range). ** P < 0.01 from baseline. $ P < 0.01 between the leg 
or arm-training group and the control group of patients.
3.4.3 Global PAD-PAR physical activity
The observed increases in walking ability in both exercise training groups were 
associated with an increase in global physical activity of approximately 11 MET-h.wk'1 
from baseline to the end of the 24-week intervention period (151 ± 8 vs. 162 dk 8 and 
158 ± 7 vs. 169 ± 7 MET-h.wk'1 for the lower and upper-limb exercise training groups, 
respectively, P < 0.01). There was no change in global physical activity status in the 
control group at any time-point (Figure 10).
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FigurelO. Changes in global physical activity during the intervention period. Changes in global 
PAD-PAR scores. Data are presented as mean ± SEM. ** P  < 0.01 indicates significance from 
baseline.
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3.4.3.1 PAD-PAR work, household and leisure-time physical activity 
The increases in global physical activity in the PAD-PAR in both training groups was 
attributed to an observed increase from baseline in the leisure-time physical activity 
domain of the questionnaire throughout the course of the intervention period in these 
patients (P < 0.01). This in the main was attributed to the twice weekly attendance to 
the supervised exercise classes. In the control patients, an increase (P < 0.05) in leisure 
time physical activity was also observed, but only for the first 12-weeks of the 
intervention period (Figure 11).
Despite the advancing years, some patients continued to undertake part or full-time 
employment (n=4, 5 and 7, for the lower-limb, upper-limb and control group, 
respectively). There was no difference between or within study groups in the level of 
work activities undertaken throughout the intervention period (Figure 11). Similarly, 
there was no significant difference between or within groups in the household activity 
domain of the PAD-PAR questionnaire throughout the study intervention period (Figure 
11). This is a typical observation of elderly patients in the main, who routinely perform 
household chores with little change in pattern observed over time.
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Figure 11. PAD-PAR questionnaire physical activity levels. Changes in PAD-PAR scores 
relating to work, household and leisure activities. Data are presented as mean ± SEM * P < 
0.05; ** P < 0.01 indicate significance from baseline.
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3.5 Quality of life -  SF-36 v2 questionnaire
3.5.1 The short-term influence o f  exercise on the dimensions ofphysicalfunction  
There were no differences in the pre-intervention responses of the three study groups. A 
significant mean improvement of 6 percentage points in the general health domain of 
the SF-36 v2 following 6-weeks of exercise training was only observed in the lower- 
limb training group of patients compared to baseline (53.7 ± 3.4 vs. 59.7 ± 3.7; P <
0.01; Figure 10). No significant differences in this domain were observed between study 
groups. Although trends were observed, no significance differences in the bodily pain, 
physical functioning or role limitation physical domains were found, either within or 
between the study groups (Figure 12).
3.5.2 The longer-term influence o f  exercise on the dimensions ofphysicalfunction  
The general health of patients who had undertaken exercise training was significantly 
improved upon completing the 24-week intervention period, compared to the control 
group of patients (53.7 ± 3.4 vs. 57.6 ± 3.5; P < 0.05 and 59.5 ± 3.4 vs. 60.5 ± 3.7; P < 
0.01, for lower- and upper-limb training, respectively). However, the improvements 
from baseline in these patients were not significant (Figure 12). A decline in general 
health over the course of the intervention period was observed in the control group of 
patients (49.9 ± 3.2 vs. 45.0 ± 3.5; P < 0.05).
In addition to the improvement in general health, an improvement in the physical 
functioning domain was observed in the upper-limb training group only, compared to 
baseline (47.5 ± 3.9 vs. 58.7 ± 3.9; P < 0.01), which was also improved compared to the 
control group of patients (P < 0.05; Figure 12). Bodily pain was also improved from 
baseline in this patient group (51.5 ± 3.7 vs. 62.8 ± 4.0; P < 0.01). No significant 
changes in the role limitation physical domain were observed either between or within 
study groups (Figure 12).
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3.5.3 The short-term influence o f  exercise on the domains o f  mental health
The pre-intervention responses of the three study groups were not different. Although 
trends were observed, there were no significant differences within or between the study 
groups, in the mental health, energy and vitality, social functioning or role limitation 
emotional domains following 6-weeks of exercise training (Figure 13).
3.5.4 The longer-term influence o f  exercise on the domains o f  mental health
Deterioration in the role limitation emotional domain was observed in the control group 
of patients upon competing the 24-week intervention period (77.0 ± 4.2 vs. 69.0 ± 4.5; P 
< 0.05; Figure 13). In contrast, in the upper-limb training group an improvement in 
energy and vitality (53.5 ± 2.9 vs. 57.1 ± 3.2) was observed compared with the control 
group of patients (P < 0.05; Figure 13). However, this improvement in these patients 
was not significant from baseline. There were no significant changes in the mental 
health or social functioning domains of the SF-36 v2, either within or between study 
groups.
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Figure 13. Changes in the Mental Health domains of the SF-36 v2 Quality of Life Questionnaire. Data are presented as mean ± SEM at baseline and following 6- 
24-weeks of the intervention period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; %P < 0.01 between the leg or arm-training group and the controls.
3.6 General health status identified using the EuroQol (EQ-5D) questionnaire
3.6.1 The short-term influence o f  exercise on EuroQol questionnaire domains 
General health was perceived to be better following 6-weeks of exercise training in the 
upper-limb training group compared to the control group (P < 0.05; Table 23). No 
changes in mobility, self care, patients’ ability to perform usual activities, general 
bodily pain and discomfort and anxiety were observed following 6-weeks of the 
intervention period either between or within study groups (Table 23).
3.6.2 The longer-term influence o f  exercise on EuroQol questionnaire domains 
General health was also improved following the 24-week intervention period in the 
upper-limb training group compared to the control group (P < 0.05; Table 23). In 
addition, an improvement from baseline in the degree of general bodily pain and 
discomfort in this patient group was observed following the intervention period (P < 
0.01). A decline in mobility status was observed in the control group of patients (P <
0.05) following the 24-week study period. There were no significant differences 
between or within groups in perceived self care, ability to perform usual activities or 
anxiety status following the intervention period.
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Table 23. EuroQol (EQ-5D) questionnaire domains throughout the intervention period.
Intervention
Period
(weeks)
Lower-Iimb
training
Upper-limb
training
Control
group
Xfl 70 73 603-4 ^ Baseline (40 - 95) (35 - 90) (40 - 95)
GC 70 70 f 60
-4 ^
o (30 - 95) (45 - 90) (30 - 95)CQ 70 70 t 60X 24 (40 - 100) (50- 100) (30 - 90)
. 70 75 73
£
Baseline (25 - 100) (30- 100) (35 - 100)
a 62.5 75 70*pfiO o (40 - 100) (25 - 100) (45 - 100)
*1/1 60 75 60*Z4 (40 - 100) (25 - 100) (40 - 100)
100 100 100
Ou Baseline (50- 100) (75 - 100) (30- 100)C3u c 100 100 100o (50- 100) (60 - 100) (35 - 100)
£ 100 100 10024 (50- 100) (70- 100) (40 - 100)
65 70 50
O) Baseline (20 - 100) (25 - 95) (25 - 100)
s  £ c 62.5 67.5 60CH .3P  ts o (30- 100) (30- 100) (25 - 100)< 72.5 77.5 5524 (25 - 100) (30- 100) (35 - 90)
65 70 65C3 '*-• .3 i- 3 . © Baseline (25 -  95) (5 - 95) (25 - 100)A .  «4H 60 70 70>> c 5 6 (25 - 85) (5 -1 0 0 ) (20 - 90)
°  s  tt Q 24 72.5 75** 73(25 - 90) (20 - 90) (25 - 90)
90 100 9073 £3s  1
Baseline (50- 100) (30- 100) (50- 100)
. Gn£  s 6 85 90 90•- fe. Vi (25 - 100) (35 - 100) (35 - 100)d 85 100 8824 (40 - 100) (50- 100) (50- 100)
Data are presented as median (range), at each assessment stage of the intervention period, where 
0% and 100% indicate severe difficulty and no difficulty, respectively. * P < 0.05; ** P < 0.01 
indicate significance from baseline, f  P < 0.05 indicates significance between the leg- or arm- 
training group and the control group of patients.
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3.7 Physical function as assessed during the incremental leg and arm-cranking 
assessments
3.7.1 Pre-intervention cardiorespiratory performance
The pre-intervention peak VO 2 , VCO2 , VE , VE/VO2 , Bf, Vt, RPP and blood lactate 
responses of the three study groups were not different, for either the leg-cranking (LCT) 
or arm-cranking assessment (ACT).
When the entire cohort of patients (N=104) were compared, peak VO2 for the ACT was 
92% of that measured for the LCT (1.01 ± 0.03 vs. 1.10 ± 0.03 Limn"1, respectively; P <
0.001), representing an absolute difference of less than 0.10 l.min'1 between upper- and 
lower-limb aerobic exercise capacity (Table 24). The initial maximum leg power (MLP) 
for the entire cohort of patients was 67 ± 2 W and maximum arm power (MAP) was 44 
± 1 W. Peak power output for the ACT was 66% of that achieved in the LCT (P < 
0.001).
Peak values for VCO2 (P < 0.01), Vt (P <0.01) were also lower for upper-limb exercise, 
but with no differences in the peak measures of RER, VE , Bf, HR, SBP, RPP or RPE 
between the ACT and LCT were observed. Patients experienced a higher level of leg 
pain during the LCT than arm pain during the ACT at maximum exercise tolerance 
("very strong" versus "moderate to strong"; P < 0.01), despite similar RPE and higher 
blood lactate levels during arm-cranking (P < 0.05; Table 24).
In a significant sub-group of patients (n=36; 35%; Table 24), peak VO2 for the ACT was 
equal to or exceeded that for the LCT, with mean values of 1.09 ± 0.04 and 0.95 ± 0.05
1.min'1, respectively (P < 0.001). In this sub-group, peak power output for the ACT was 
74% of that achieved in the LCT (P < 0.001). Other peak cardiorespiratory responses 
were also higher for the ACT in this patient sub-group, including HR (P < 0.001), RPP 
(P < 0.01), VE (P<  0.001) and Bf (P < 0.001). The discrepancy between arm and leg 
pain (7 vs. 4, respectively; P < 0.001) at maximum exercise tolerance was greater in this 
patient sub-group than in the remaining patients with higher leg aerobic exercise 
capacity (6 vs. 5, respectively; P < 0.001).
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Table 24. Cardiorespiratory, metabolic and perceptual responses at maximum exercise 
tolerance during the ACT and LCT for all patients and for the sub-group with higher 
arm aerobic exercise capacity.
Variable
All Patients (7V=104)
Sub-group with higher arm 
aerobic capacity (77=36)
ACT LCT ACT LCT
Power Output. W 4 7 .{. 1*** 73 ±2 50 ±2*** 68 ±4
VOi, l.min'1 1.01 ±0.03*** 1.10 ±0.03 1.09 ±0.04*** 0.95 ± 0.05
VCOi, l.min'1 0.99 ±0.03*** 1.07 ±0.03 1.02 ±0.04** 0.93 ± 0.05
RER, VCO2 /VO 2 0.99 ±0.01 0.99 ±0.01 0.96 ± 0.02 0.99 ± 0.02
VE , l.min'1 36.0 ± 1.1 37.5 ±1.1 39.4 ± 1.8*** 34.8 ± 1.8
V t,l 1.26 ±0.03*** 1.36 ±0.04 1.35 ±0.05 1.30 ±0.06
Bf, Br.min'1 30.2 ±0.6 29.6 ± 0.6 30.8 ± 1.1*** 28.8 ± 1.0
SBP, mmHg 195 ±3* 199 ±3 195 ±4 197 ±4
DBP, mmHg 92 ± 1* 90 ± 1 89 ±2 89 ±2
HR, beats.min'1 114 ± 2 113 ±2 116 ± 4*** 106 ±4
RPP 22471 ±593 22623 ± 608 22682 ±983** 20888 ±851
Blood lactate, mM 3.30± 0.11* 3.07 ±0.10 3.48 ±0.21*** 2.83 ±0.15
Perceived Exertion 17(10-20) 17(12-20) 17(12-20) 17(12-20)
Perceived Pain 4(0-11) *** 7(0-11) 4 (0-11) *** 7(3-11)
Values are means ± SEM. Perceived exertion and perceived pain responses were not normally 
distributed, and are presented as medians with range in parentheses. * P < 0.05; ** P < 0.01, 
*** p  < 0.001 between the ACT and LCT.
3.7.2 Physical function throughout the intervention period.
3.7.2.1 Peak power output
The improved walking performance in both exercise training groups following the 
intervention period was accompanied by an increase in peak power output at maximum 
exercise tolerance from baseline in the lower-limb training group during the LCT (67 
(38 -  126) to 96 (53 -  169 W); P < 0.01) and in the upper-limb training group during 
the ACT (38 (17 -  82) to 53 (24 -  118 W); P < 0.01), which were also higher than 
those of the control group of patients (P < 0.01). The differences between the two 
training groups were not significant at any assessment time-point. When compared, the 
training effect was most apparent for the specific training apparatus, with some cross-
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over improvement for the other exercise modality. Maximum power output during the 
LCT and ACT improved by 43% and 24%, and by 19% and 39% in the lower- and 
upper-limb training groups, respectively, indicating an improvement in peak power 
output for both trained and untrained skeletal muscle groups in exercising individuals 
(Table 25).
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Table 25. Peak power output at maximum exercise tolerance during the LCT and ACT
at each assessment stage of the intervention period.
Intervention
Period
(weeks)
Power Output (W)
LCT ACT
uO*oP
Baseline
6
12
18
24
67 46}
(38 - 126) (24 - 82)
82**1 53**}
(53 - 155) (24 - 82)
96**} 53**}
(53 - 155) (24 - 82)
96**} 53**}
(53 - 155) (24 - 82)
96**} 57**}
(53 - 169) (24 - 89)
75 38
(9 -140) (17-82)
82**| 53**}
(24- 155) (24-111)
82**} 57**}
(38 - 155) (24-111)
82**} 57**}
(38 - 155) (24-111)
89**} 53**}
(24- 155) (24-118)
67 38
(24 - 105) (17-60)
67 38
(24 - 96) (17-67)
67 38
(24 - 96) (17-67)
53 38
(9 - 96) (9 - 67)
60 38
(9 - 96) (9 - 67)
c
osu-W
S•  PMIuaao*P
Baseline
6
12
18
24
&aoutXj
©u-4-*cou
Baseline
6
12
18
24
Data are presented as median (range), at each assessment stage of the intervention period. ** P 
< 0.01 indicates significance from baseline, f  P < 0.05; % P < 0.01 indicate significance 
between the leg- or arm-training group and the control group of patients.
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3.7.2.2 Peak VOi
The observed improvement in walking performance in both training groups during the 
intervention period was associated with an improvement in peak VO2 at maximum 
exercise tolerance during both assessments. Patients assigned to exercise training 
showed an increase in peak VO2 of 17% and 19% during the LCT (1.12 ± 0.04 vs. 1.31 
± 0.06 and 1.12 ± 0.06 vs. 1.33 ± 0.09 l.min'1 following lower- and upper-limb training, 
respectively), at the 24-week time-point in relation to baseline measures (P at least < 
0.05; Figure 14) and control patients (P < 0.01). Peak VO2 during the ACT was greater 
in both training groups compared with the control group at the 6-, 12-, 18- and 24-week 
time-points (P at least < 0.05). However, an increase from baseline was only observed 
in the patients assigned to the upper-limb exercise training group (1.05 ± 0.05 vs. 1.19 ± 
0.07 l.min'1; P < 0.05; Figure 14).
3.7.23 Peak VCO2
Similarly, peak VCO2 responses were higher in both training groups following the 24- 
week intervention period, in both the LCT and ACT in relation to baseline measures (P 
at least < 0.05), and the control group (P < 0.01). The pattern of response resembled 
that of peak VO2 (Figure 15). In the LCT peak VCO2 increased by 22% and 21% (1.08 
± 0.05 vs. 1.32 ± 0.06 and 1.12 ± 0.06 vs. 1.36 ± 0.10 l.min"1) and in the ACT by 14% 
and 18% (0.96 ± 0.04 vs. 1.09 ± 0.05 and 1.05 ± 0.06 vs. 1.24 ± 0.07 l.min'1) following 
lower- and upper-limb training, respectively (P at least < 0.05; Figure 15).
3.7.2.4 Peak RER
There were no significant differences in peak RER within any of the study groups over 
the course of the intervention period. The only differences observed were between the 
lower- and upper-limb training groups, following 12-weeks and 24-weeks of the 
intervention period, respectively, compared to the control group of patients (P < 0.05; 
Figure 16).
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Figure 14. Changes in peak VO2 during the leg- and arm-cranking assessments during the intervention period. Data are presented as mean ± SEM at maximum 
exercise tolerance, at each assessment stage during the intervention period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; % P < 0.01 between the leg or 
arm-training group and the control group of patients.
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Figure 15. Changes in peak VCO2 during the leg- and arm-cranking assessments during the intervention period. Data are presented as mean ± SEM at maximum 
exercise tolerance, at each assessment stage during the intervention period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; J P < 0.01 between the leg- or 
arm-training group and the control group of patients.
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3.7.2.5Peak VE
The increases in peak VO2 were accompanied by increases in peak VE responses at 
maximum exercise tolerance in both training groups, at the 6-, 12-, 18- and 24-week 
time-points in both the LCT and ACT, in relation to baseline measures (.P < 0.01) and 
the control group (P < 0.01). The pattern of response resembled that of peak VO2 
(Figure 17). In the leg-cranking assessment, following the 24-week intervention period 
peak VE increased by 33% and 25% (39.0 ± 2.0 vs. 52.0 ± 2.6 and 39.5 ±1.9 vs. 49.3 ± 
2.9 l.min'1) and in the arm-cranking assessment by 20% and 26% (37.7 ± 2.0 vs. 45.2 ±
2.7 and 37.6 ± 2.0 vs. 47.3 ± 2.7 l.min'1) following lower- and upper-limb training, 
respectively (P <0.01; Figure 17).
3.7.2.6Peak VE/VO2
Peak values for the ventilatory equivalent for oxygen (VE/VO2) at maximum exercise 
tolerance were higher in both training groups in both the LCT and ACT, compared to 
the control group of patients (P at least < 0.05). The pattern of response at each time 
point resembled that of peak VO2 but with higher values attained in the lower-limb 
training group at each time point (Figure 18). In the leg-cranking assessment, following 
the 24-week intervention period peak FE/FChhad only significantly increased from 
baseline in the lower-limb training group (34.7 ±1.3 vs. 40.6 ± 1.8; an increase of 
17%). Whereas, in the arm-cranking assessment increases of 15 and 13 % (36.8 ±1.5 
vs. 42.5 ±2.1 and 35.9 ±1.2 vs. 40.5 ± 1.6) were observed following both lower- and 
upper-limb exercise training, respectively (P < 0.01).
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Figure 17. Changes in peak VE during the leg- and arm-cranking assessments during the intervention period. Data are presented as mean ± SEM at maximum 
exercise tolerance, at each assessment stage during the intervention period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; %P < 0.01 between the leg- or 
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3.7.2.7 Peak breath frequency (Bf)
Peak Bf responses at maximum exercise tolerance were also higher in both training 
groups, in both the LCT and ACT, compared to the control group of patients (P <
0.01), the pattern of response resembling that of peak VO2 . In the LCT peak Bf 
increased by 16% and 15% following the 24-week intervention period (29.7 ± 1.1 vs.
34.4 ±1.2 and 30.4 ±1.0 vs. 35.0 ±1.2 Br.min'1) and in the ACT by 15% and 10% 
(29.4 ±1.0 vs. 33.8 ±1.3 and 31.4 ± 0.9 vs. 34.6 ±1.0 Br.min'1) following lower- and 
upper-limb training, respectively (P <0.01; Figure 19).
3.7.2.8 Peak tidal volume (Vt)
Peak Vt responses at maximum exercise tolerance were higher during both assessments 
following lower-limb training, but only higher during the arm-cranking assessment 
following upper-limb training, compared to the control group (P < 0.01). Significant 
differences from baseline values were observed in the lower-limb training group during 
LCT (1.41 ± 0.06 vs. 1.55 ± 0.06 1) and in the upper-limb training group during the ACT 
(1.28 ± 0.08 vs. 1.42 ± 0.08 1; Figure 20) only.
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Figure 19. Changes in peak Breath Frequency during the leg- and arm-cranking assessments during the intervention period. Data are presented as mean ± SEM at 
maximum exercise tolerance, at each assessment stage during the intervention period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; $ P < 0.01 between 
the leg- or arm-training group and the control group of patients.
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Figure 20. Changes in peak Tidal Volume during the leg- and arm-cranking assessments during the intervention period. Data are presented as mean ± SEM at 
maximum exercise tolerance, at each assessment stage during the intervention period.. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; %P < 0.01 between 
the leg- or arm-training group and the control group of patients.
3.7.3 Peak cardiovascular responses throughout the intervention period
3.7.3.1 Peak systolic blood pressure (SBP)
There were no differences in SBP from baseline in any of the study groups during the 
course of the intervention period at any time-point, for either LCT or ACT. However, 
SBP was significantly greater in the upper-limb exercise training group at week 18 of 
the intervention period during the LCT and at week 6, 12 and 18 during the ACT, 
compared to the control group of patients (P at least < 0.05; Figure 21).
3.7.3.2 Peak diastolic blood pressure (DBP)
There were no differences in DBP between the study groups at any time-point during 
the intervention period, for either the LCT or ACT. A decrease in DBP from baseline 
was only observed during the ACT following 18-weeks of the intervention period in the 
upper-limb training group only (P < 0.05; Figure 22).
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Figure 21. Changes in peak Systolic Blood Pressure during the leg- and arm-cranking assessments during the intervention. Data are presented as mean ± SEM at 
maximum exercise tolerance, at each assessment stage during the intervention period . * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; % P < 0.01 between 
the leg- or arm-training group and the control group of patients.
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Figure 22. Changes in peak Diastolic Blood Pressure during the leg- and arm-cranking assessments during the intervention period. Data are presented as mean ± SEM 
at maximum exercise tolerance, at each assessment stage during the intervention period * P < 0.05; ** P < 0.01 compared to baseline.
3.7.3.3 Peak heart rate (HR)
The increase in peak VO2 in the lower-limb exercise training group at maximum 
exercise tolerance during the LCT was accompanied by an increase in HR compared to 
baseline measures (113 ± 4 vs. 123 ± 4 beats.min_1; P < 0.01; Figure 23). Higher HRs 
were observed in both training groups, in both the LCT and ACT at the 6-, 12-, 18- and 
24-week time-points compared to the control group of patients (P at least <0.01; Figure
23). A decrease in HR in the control group of patients was observed in the LCT and 
ACT following 12; and 18- and 24-weeks of the intervention period, respectively (P at 
least < 0.05). Pre-intervention peak HR responses at maximum exercise tolerance were 
not different between the three study groups for the LCT, but for the ACT there was a 
difference between the lower-limb exercise training and control group of patients (P < 
0.05).
3.7.3.4 Peak rate pressure product (RPP)
A similar pattern of response was observed in RPP, with values being higher in both 
training groups, in both the LCT and ACT compared to the control group of patients, 
following 6-, 12-, 18- and 24-weeks of the intervention period (P at least < 0.05; Figure
24). Similarly to HR, an increase in RPP from baseline (12 %) was only observed in the 
lower-limb training group during the LCT (22.3 x 103 ± 0.91 x 103 vs. 24.9 x 103 ± 0.97 
x 103 beats.min"1.mmHg), following the intervention period. Decreases in RPP in the 
control group in the LCT and ACT were observed following 12; and 12-, 18- and 24- 
weeks of the intervention period, respectively (P < 0.01).
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Figure 23. Changes in peak Heart Rate during the leg- and arm-cranking assessments during the intervention period. Data are presented as mean ± SEM at maximum 
exercise tolerance, at each assessment stage during the intervention period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; %P < 0.01 between the leg- or 
arm-training group and the control group of patients.
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Figure 24. Changes in peak Rate Pressure Product during the leg- and arm-cranking assessments during the intervention period. Data are presented as mean ±
SEM at maximum exercise tolerance, at each assessment stage during the intervention period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; %P < 0.01 
between the leg- or arm-training group and the control group of patients.
3.7.4 Peak blood lactate responses throughout the intervention period
Increases in peak HR were accompanied by comparable increases in peak blood lactate 
concentration in both training groups, in both the LCT and ACT compared to the 
control group of patients (P <0.01; Figure 25). Peak blood lactate increased from 3.34 
± 0.16 to 4.05 ± 0.22 mM and 3.21 ± 0.18 to 3.91 ± 0.20 mM during the LCT in the 
lower- and upper-limb training groups, respectively (.P < 0.01). During the ACT an 
increase in peak blood lactate was only observed in the upper-limb training group of 
patients (3.33 ± 0.21 to 4.42 ± 0.24 mM; P < 0.01). A significant decrease in peak 
blood lactate was observed in the control group of patients following 18-weeks of the 
intervention period (P < 0.05).
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Figure 25. Changes in peak Blood Lactate during the leg- and arm-cranking assessments during the intervention period. Data are presented as mean ± SEM at 
maximum exercise tolerance, at each assessment stage during the intervention period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; $ P < 0.01 between 
the leg- or arm-training group and the control group of patients.
3.7,5 Peak Psycho-Physiological responses throughout the intervention period
Peak RPE responses for the ACT and LCT did not increase throughout the 24-week 
intervention period in any of the groups (Table 26). Similarly, there was no difference 
in peak pain perception during the LCT. However, peak perceived pain did increase in 
the upper-limb training group at the 6-, 12-, 18- and 24-week time-points (P at least < 
0.05).
Table 26. Changes in perceived exertion and perceived pain at each assessment stage of
the intervention period.
Weeks
of
Leg-Cranking Assessment Arm-Cranking Assessment
Training LCT ACT Control LCT ACT Control
Baseline 18 17 17 17 16 173T (13-20) (12-20) (13-20) (13-20) (10-20) (13-20)
o
6 17 15** 17 17 16 17WPh/«> (13-20) (9-20) (12-20) (13-20) (8-20) (7-20)P5
12 17 16 17 17 15 18(13-20) (10-20) (10-20) (13-19) (13-20) (12-20)
b.VX 18 17 15 16 17 16 17(12-20) (9-20) (13-20) (13-20) (11-20) (11-20)
C3o£- 24 17(12-20)
17
(7-20)
15
(12-20)
17
(10-19)
17
(8-20)
17
(11-20)
Baseline 8 6 6 5 3f 5
IT (0-11) (3-11) (0-11) (0-10) (0-10) (0-11)”3tjcn 6 7 5 8 7 T 4* 6©r*H (3-10) (2-11) (2.5-11) (0-10) (0-10) (0-11)1pau
G
Ph
12 7 7 8 6 T 4*f 7(0-10) (1-11) (2.5-11) (0-11) (0-11) (0-11)
18 7 6 7 7 'T 5** 7p*es (0-11) (2-11) (3-10) (0-11) (0-11) (0-10)oc- 24 8(3-10)
7
(3-11)
7
(3-10)
7
(2-11)
5**
(0-11)
7
(0-10)
Data are presented as the median (ranges). * P < 0.05; ** P < 0.01 compared to baseline, f  P < 
0.05; $ P < 0.01 between the leg- or arm-training group and the control group of patients. *F?< 
0.05 between the leg- and arm-training group.
3.7.6 Changes in Haematocrit
Haematocrit was measured in 65 patients (N=23, 21 and 21 patients, from the leg- 
training, arm-training and control groups, respectively). No changes in haematocrit were
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observed either between or within groups, at any time-point throughout the intervention 
period (Figure 26).
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Figure 26. Changes in haematocrit during the intervention period. Data are presented as mean 
± SEM at each assessment stage during the intervention period.
3.7.7 Changes in BM I
No changes in BMI within any of the study groups were observed at any time- point 
during the intervention period (Figure 27). However, differences between the lower- 
and upper-limb training groups were observed following 18- (26.6 ± 0.6 vs.26.1 ± 0.6 
and 28.6 ± 0.7 vs. 29.2 ± 0.8) and 24-weeks of the intervention period (26.6 ± 0.6 vs.
26.1 ± 0.6 and 28.6 ± 0.7 vs. 29.3 ± 0.8), respectively (P < 0.05).
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Figure 27. Changes in BMI during the intervention period. Data are presented as mean ± SEM 
at each assessment stage during the intervention period. 'F < 0.05 between the lower- and upper- 
limb training groups of patients.
141
Chapter 4 -  Intervention Study Discussion
Overview
Most randomised controlled studies are limited by their small size and have not assessed 
mechanisms for improved claudication distances (Gardner et al. 2001). The primary 
aims of this study were to determine the relative efficacies of a 24-week programme of 
twice weekly upper- and lower-limb aerobic exercise training on CD and MWD in a 
large cohort of patients with stable intermittent claudication, and to investigate the 
mechanisms which could influence symptomatic improvement. The influence of 
changes in walking performance and physical activity status on patients’ quality of life, 
perceived walking impairment, pain tolerance and confidence in walking were also 
investigated.
This study indicates that upper- and lower-limb aerobic exercise training can induce a 
similar significant time-course of improvement in walking performance in patients with 
intermittent claudication, and that this improvement was associated with an improved 
confidence in walking. Improvements in MWD in both exercise training groups were 
accompanied by progressive increases in peak HR at MWD and a decrease in post 
shuttle-walk ABPI compared to baseline measures. The increase in peak HR suggests 
that either a greater exercise stimulus was required to elicit a claudication response or 
that patients were able to push themselves further beyond the 'pain barrier' after exercise 
training.
In the upper-limb training group, peak blood lactate concentration and perceived pain 
were higher at MWD compared to baseline measures, suggesting that an alteration in 
exercise pain tolerance accounted for more of the change in MWD than it did in the 
lower-limb exercise training group. In both exercise training groups, HR at CD 
remained unchanged, however perceived pain at CD was lower at the end of the 
intervention period in patients performing lower-limb exercise, possibly indicating an 
enhanced pain perception response in this group. Ninety-one and 93% of patients in the 
lower- and upper-limb training groups, respectively, stated that the study had provided 
them with an incentive to perform physical activity.
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Community based walking ability was assessed using the WIQ, a disease-specific 
quality of life questionnaire for patients with symptomatic PAD (Regensteiner et al 
1990; Hiatt et a l 1995a). Both modes of exercise training induced increases in the 
walking distance, walking speed and stair climbing ability domains of the WIQ, and 
patients in the upper-limb training group also perceived an improvement in the 
claudication pain severity dimension of the WIQ. In accordance with the observation 
that walking ability was unchanged in the control group of patients over the course of 
the 24-week intervention period, WIQ responses were also unchanged in all domains 
from baseline measures in this group.
A short-period of exercise training (6-weeks) improved the general health status of 
patients in the lower-limb training group only, in relation to baseline measures, as 
assessed using the SF-36 v2 questionnaire. Whereas 24-weeks of exercise training 
improved the general health status in both exercise training groups, in relation to the 
control group of patients. Physical function, bodily pain and energy and vitality were 
also improved in the upper-limb training group, whereas general health and role 
limitation emotional status had deteriorated in the control group following the 24-week 
intervention period. Upon comparing quality of life, as assessed using the EQ-5D 
questionnaire, general health status was perceived to be improved after 6- and 24-weeks 
in the upper-limb training group only. In addition, bodily pain was improved in the 
upper-limb training group, whereas mobility status had deteriorated in the control group 
following the 24-week intervention period. Differences in questionnaire design could 
account for the observed differences in response to the SF-36 v2 and EQ-5D 
questionnaires.
In order to further understand the effects of the two training regimens on upper- and 
lower-limb exercise tolerance, the physiological responses to incremental arm- and leg- 
cranking exercise were also studied. In both exercise training groups, improvements in 
lower-limb peak aerobic power, peak VO2 , VCO2 , VE , breath frequency and blood 
lactate concentration during the LCT accompanied the observed improvements in 
walking performance. The improvement of lower-limb peak VO2 in patients 
undertaking upper-limb exercise training was particularly interesting, indicating that 
upper-limb exercise can improve lower-limb function in patients with PAD. No changes 
in peak systolic or diastolic blood pressure, perceived exertion or perceived pain 
responses were observed in either group. Peak HR, RPP and VE/VO2 during the LCT
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were higher in the lower-limb training group in relation to baseline measures, and 
higher in both training groups in relation to control patients. Similarly, peak tidal 
volume was only increased in the lower-limb training group of patients.
At maximum exercise tolerance during the ACT, peak power output, VO2 , tidal volume 
and blood lactate were higher in the upper-limb training group of patients in relation to 
baseline measures, but higher values were observed in both training groups in relation 
to the control patients. Other peak respiratory values (V E , VE/VO2 , VCO2 and breath 
frequency) were higher in both exercise training groups at the end of the intervention 
period in relation to baseline measures. However, no changes in peak systolic or 
diastolic blood pressure, HR, RPP or perceived exertion responses were observed in 
either group. An increase in perceived pain was only observed in the upper-limb 
training group.
Outcome Measures -  Walking Performance
The primary outcome measure in this study was walking performance. In patients with 
PAD, changes in exercise performance using the graded treadmill test have been shown 
to correlate with improved outpatient ambulatory function (Hiatt et a l 1990; 
Regensteiner et al. 1993a). This association is important because it allows even small- 
percentage improvements in treadmill performance to be interpreted as being clinically 
relevant (Hiatt et a l 1995b). In the lower- and upper-limb training groups following the 
24-week intervention period, CD increased by 65% and 56% and MWD by 35% and 
30% respectively, based on mean individual percentage difference of actual walking 
distances. Typically, a 25% to 50% increase in treadmill performance is considered to 
be of clinical significance (Hiatt, 1999). The apparent clinical relevance of these 
changes were confirmed as the majority of patients in the exercise training groups 
perceived that their day-to-day walking ability had also improved as a direct result of 
the 24-week intervention period.
Previous reports have suggested that patients with disease confined to the superficial 
femoral/popliteal arteries benefit most from exercise training (Binnie et a l 1999). In 
two-thirds of the patients in this present study, claudication was due to superficial 
femoral artery disease as determined by angiogram, duplex scanning or examination of 
pulses. The remainder of patients had tibial vessel disease. These proportions were 
fairly well balanced across the three study groups. Further suggestions have also
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inferred that patients with an initial MWD of > 100m and those enrolled in a 
programme as a primary treatment rather than after failed intervention, also show a 
trend towards greater benefit (Binnie et al 1999). Again, all patients in all three study 
groups had an initial MWD of > 100m.
The increase in CD and MWD reported in this study were lower than some reported in 
the literature following randomised controlled walking exercise interventions, which 
were in the range of 28-134% and 51-210% for CD and MWD, respectively (Robeer et 
al. 1998; Gardner et al. 2001; Brandsma et al. 1998). In these studies most patients 
gained an improvement in walking ability during the last 2 months of a 6-month 
walking program (Andriessen et al 1989). Although the exercise stimulus in weight­
bearing walking exercise programmes might be greater than in weight-supported upper- 
and lower-limb exercise, the use of constant-pace treadmill testing to assess walking 
performance in previous studies (Gardner and Poehlman, 1995) may have also had 
some bearing on the magnitudes of improvement previously reported.
Constant-load protocols have several potential limitations, in that a single workload 
may not be appropriate for a heterogeneous population of patients with different 
walking abilities (Regensteiner and Hiatt, 1995). If the workload remains constant at a 
low level, some patients may be claudication-limited on entry to a programme, but 
never reach a maximal level of claudication pain after an intervention from which they 
experience a large improvement (Regensteiner and Hiatt, 1995). For a graded test, the 
coefficient of variation of MWD is 12-13% compared with 30-45% for a constant-load 
protocol (Clyne et a l 1979; Gardner et al 1991; Gardner et a l 1992b; Hiatt et al 
1988). In addition, constant-pace walking tests are considered less effective when 
compared to incremental assessments, as control patients who have multiple tests at the 
same constant workload can experience an increase in MWD (Porter et a l 1982; Clyne 
et al 1979).
The mechanism underlying this observation is unknown, but may represent a “learning 
effect” as patients repeat the test, a classic placebo effect, or it may be due to improved 
walking biomechanics as patients become familiar with the treadmill apparatus (Hiatt et 
al 1995b). In control patients the magnitude of improvement in walking distance from 
repetitive testing is typically 36% and 25% for CD and MWD respectively (Porter et al 
1982), but might be as great as 100% for MWD over a two week period (Skinner J.S.
145
and Strandness, 1967). In contrast, sequential testing of control patients with graded 
treadmill tests is not associated with temporal improvement in the initial or absolute 
CD’s or times (Hiatt et al. 1988; Gardner et al 1991).
In this study an incremental shuttle-walk test was used, which has good test-retest 
reproducibility (Zwierska et al. 2004). This test might better reflect changes in 
everyday walking ability compared to incline treadmill assessments (Zwierska et al. 
2004) which have been criticised for not reflecting the influence of claudication on 
everyday functional activities (Montgomery and Gardner, 1998). Nor do they measure 
the true functional capacity of patients walking on level ground (Coughlin et al. 2001). 
Repetitive testing over a short time period can produce confounding problems, in that 
multiple testing may induce an improved walking performance or placebo response 
(Regensteiner and Hiatt, 1995). Such placebo responses on tests of physiological 
function are usually due to a learning or order effect which result from increased 
familiarity with the testing procedures. In this study, control patients were only required 
to attend the Centre on a 6-weekly basis, and the order of assessments (LCT, ACT and 
walking assessment) were performed on a random basis during each visit.
A review of previous exercise intervention studies in this area (Hiatt et al. 1995b) have 
reported placebo responses of 25-36% when patients were assessed using constant-pace 
tests, whereas no placebo response was observed where incremental testing had been 
used. In this study, all patients were fully accustomed with the testing procedures before 
undertaking the first walking assessment and our previous research (Zwierska et al.
2004) showed that responses on this test are stable over time. The shuttle-walk test is 
incremental (graded) and may yield less variability of response than has previously been 
observed for constant-pace assessments.
Interestingly, although no placebo response was observed in the control patients in this 
study, a psychological perception of improved walking performance was observed, as 
almost half of the control patients perceived a noticeable improvement in their walking 
ability when asked at the end of the intervention period. This perception can only be 
attributed to the fact that these patients were receiving emotional support through 
weekly telephone contact, during which their level of self-reported physical activity was 
monitored via the PAD-PAR questionnaire. These patients appreciated someone taking
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an active interest in their walking ability and as a consequence believed their walking 
impairment was improving.
Mechanisms Underpinning Improved Walking Performance
Claudication occurs in muscles distal to arterial lesions at times when the metabolic 
demand of the active musculature exceeds the capacity of the peripheral circulation to 
deliver oxygen (Gardner et al. 2001). A better match between energy utilisation and 
energy delivery in the active leg musculature would delay the development of 
claudication pain and, as a consequence, increase the distance walked before intolerable 
pain ensued (Gardner et al. 2001). The mismatch between metabolic demand and the 
capacity of the peripheral circulation to deliver oxygen can be ameliorated either by 
decreasing metabolic demand, increasing oxygen delivery, or both (Gardner et al.
2001).
It is believed that an improved effect in walking performance is not based on one 
mechanism alone, but is induced by a combination of factors and mechanisms 
(Remijnse-Tamerius et al. 1999). Of the proposed mechanisms that could be involved 
in this beneficial effect, the most important include an adaptation or redistribution of the 
peripheral blood flow within the ischaemic tissues (collateral development), inhibition 
of the progression of the atherosclerotic disease (Remijnse-Tamerius et al. 1999), 
central cardiovascular adaptations (Walker et al. 2000; Hiatt et al. 1990; Brendle et al.
2001) and increases in muscle enzyme activity (Nehler and Hiatt, 1999b). It has been 
postulated that training enhances oxidative skeletal muscle metabolism in patients with 
PAD (Hiatt et al. 1996; Hiatt et al. 1992).
A decrease in blood viscosity has also been associated with increases in walking 
distance in these patients (Remijnse-Tamerius et al. 1999). Enzymatic changes 
including increases in the activity of cytochrome oxidase, citrate synthetase and 3- 
hydroxyacyl-CoA dehydrogenase, in conjunction with altered blood rheology (Whyman 
and Ruckley, 1998) have also been proposed. Furthermore, exercise-induced 
inflammation is ameliorated, cardiorespiratory function is improved and the oxygen cost 
of exercise decreases following exercise training (Tan et al. 2000b). It has been 
suggested that there are many interactions between the factors described above and most 
factors are not yet fully understood (Remijnse-Tamerius et al. 1999).
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There is no agreement on the results of studies on the effect of training on calf blood 
flow in patients with PAD (Alpert et al 1969; Johnson et al. 1989; Hiatt et al 1990). 
Some studies have reported an increases in leg blood flow after programmes of walking 
exercise rehabilitation (Alpert et al 1969; Hiatt et a l 1990; Gardner et al 2000; 
Brendle et a l 2001) and the increase in blood flow could reduce muscle ischaemia by 
increasing oxygen delivery (Remijnse-Tamerius et a l 1999). However, in only two 
studies was a correlation between the increased blood flow and improved walking 
performance observed, and this correlation was low to moderate (Alpert et al 1969; 
Gardner et a l 2000). Other studies have shown no changes in lower-limb blood flow 
following walking exercise rehabilitation, despite improvements in CD and MWD being 
observed (Larsen and Lassen, 1966; Johnson et al 1989; Blumchen et a l 1970; 
Mannarino et a l 1989; Tan et a l 2000a).
The inhibition of atherosclerotic disease progression can also be a factor in reducing the 
amount of muscle ischaemia (Remijnse-Tamerius et a l 1999). It has been hypothesised 
that a normalisation of nitric oxide release can reduce claudication by enhancing the 
induction of flow-dependent vasodilation, both mechanisms causing an increase in 
muscle oxygen delivery (Remijnse-Tamerius et al 1999). In this present study, 
localised metabolic adaptations within the lower-limb skeletal muscles could have 
contributed to the improvement in CD observed in the lower-limb exercise training 
group, which demonstrated progressive improvements in walking ability throughout the 
intervention period. However, it is not feasible that such a physiological adaptation 
accounted for the improvement in CD observed in the upper-limb exercise training 
group. The rate of improvement in CD in the upper-limb training group rose quite 
sharply up to the 12th week of training, followed by a progressively slower rate of 
improvement thereafter, thereby suggesting a possible plateau effect. This observed 
improvement in CD was more likely to be related to central and/or systemic 
cardiovascular adaptations than improved lower-limb perfusion during exercise.
An increase in cardiac stroke volume is known to account for most of the rapid 
improvement in cardiorespiratory capacity observed after short-term programmes of 
aerobic training in previously sedentary individuals (Saltin et a l 1968). Furthermore, 
the increase in stroke volume observed after a programme of exercise training in 
patients with chronic heart failure appears to be accompanied by a decrease in total 
peripheral resistance at rest and during exercise (Hambrecht et a l 2000; Gielen et al
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2002). An improvement in cardiac stroke volume, combined with a decrease in total 
peripheral resistance would facilitate improved blood flow to lower-limb skeletal 
muscle groups during walking and might explain the improvement in CD observed in 
the upper-limb training group. However, a number of other systemic adaptations, 
including improved endothelial vasoreactivity (Brendle et a l 2001), nitric oxide 
metabolism (Arosio et al 1999) and blood rheological adaptations (Ernst and Matrai, 
1987) cannot be dismissed on the basis of the evidence presented herein. In addition, it 
has previously been suggested that a decrease in blood viscosity could be associated 
with an increase in walking ability in patients with PAD (Remijnse-Tamerius et al 
1999). Although rheological changes were not studied as part of this present study, 
haematocrit was determined in approximately two thirds of the patients in all groups, no 
change in which was observed.
Although the CD in both training groups improved as a result of the intervention period, 
the HR at CD was unchanged throughout the study period. This suggests that although 
patients could walk further and at a faster pace (because the shuttle-walk was 
incremental in nature) before the onset of claudication pain at the end of the exercise 
training programme, patients experienced a comparable level of cardiovascular stress at 
CD both before and after the programme. In addition, given that CD reflects the first 
perception of claudication pain, the onset of pain at CD was perceived to be in the main 
‘very weak’ throughout the programme of exercise rehabilitation in both exercising 
groups, suggesting consistency of pain perception. However, despite being able to walk 
further prior to the onset of pain, patients in the lower-limb training group also reported 
the pain to be less intense at CD following the 24-week intervention period. These 
patients perceived their pain to be ‘extremely weak’ compared to ‘very weak’ at 
baseline.
This could suggest an enhanced pain perception in this lower-limb group, that is, these 
patients were possibly more aware of pain perception and the onset of claudication pain. 
The reason for this apparent difference in pain perception in the lower-limb training 
group is unknown. One explanation could be that these patients were being subjected to 
high levels of pain on a twice weekly basis during the supervised exercise training 
classes. The fact that these patients were experiencing the sensation of pain on such a 
frequent basis, in comparison to the upper-limb training group who were exercising 
relatively pain-free, and control patients who experienced claudication pain only during
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walking, could explain the difference in pain perception threshold in the lower-limb 
training group.
The improvement in CD following exercise training in both exercise training groups, 
coupled with the perception of pain in the main being ‘very weak’ would suggest that 
the exercise-induced ischaemic pain response was delayed at sub-maximal intensities of 
walking, even though there was no change in resting ABPI. Although there was no 
change in resting ABPI following exercise training in either group, this does not 
preclude an increased perfusion of the lower-limb skeletal muscles during sub-maximal 
walking exercise. Previous reports have shown that a number of medical treatments can 
significantly improve treadmill exercise performance and functional status without a 
change in ABPI or leg blood flow (Hiatt et a l 1990). Furthermore, resting ABPI has 
been reported to be unrelated to walking performance in a number of studies (Gardner et 
al 1992a; Hiatt et al 1992; Leder et a l 2002) and the substantial change in walking 
performance which can be evoked by exercise rehabilitation is not always accompanied 
by a change in resting ABPI (Perkins et a l 1996).
As a means to understanding changes in MWD following upper- and lower-limb 
exercise rehabilitation, HR, blood lactate, perceived exertion and the pain responses at 
MWD were measured during the shuttle-walk test to assess consistency of effort and 
exercise pain tolerance. Improvements in MWD in both training groups were 
accompanied by progressive increases in peak HR over the course of the exercise 
interventions, suggesting that either a greater exercise stimulus was required to elicit a 
claudication response, or that patients were able to push themselves further beyond the 
'pain barrier' after training.
The improvements in MWD were also accompanied by progressive increases in peak 
blood lactate concentration in both training groups of patients compared to the controls. 
However, increases from baseline were only observed in the upper-limb exercise 
training group. Blood lactate concentration reflects a balance between production within 
the working skeletal muscles and mechanisms of removal. This response may indicate 
an enhanced rate of lactic acid clearance from skeletal muscle after the programme of 
exercise training, perhaps associated with improved oxygen and substrate delivery, a 
mechanism which could help to control skeletal muscle acidosis.
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Changes in the psychological approach to exercise and adjustments in gait to 
compensate for pain (Whyman and Ruckley, 1998), and a change in pain perception 
through an improved tolerance of claudication pain (Remijnse-Tamerius et al. 1999; 
Ernst and Matrai, 1987; Alpert et al. 1969) could also account for improved walking 
performance in patients with PAD (Nehler and Hiatt, 1999b). It is also possible that 
patients with PAD develop an increased supply of endorphins with exercise training 
(Remijnse-Tamerius et al. 1999). Interestingly, a higher rating of perceived pain at 
MWD after 18- and 24-weeks of the intervention was only observed in the upper-limb 
training group of patients. This indicates that patients in this group could tolerate a 
higher amount of pain, pushing themselves further beyond the pain barrier after exercise 
training. An increase in exercise pain tolerance might therefore be a possible 
mechanism of adaptation, which could account for the improvement in MWD in this 
patient group. Furthermore, a significant decrease in post shuttle-walk ABPI was 
observed in this group of patients, in relation to the control group, thereby providing 
further evidence that these patients were pushing themselves further beyond the pain 
barrier after the programme of exercise rehabilitation.
A possible criticism of this theory is that the investigator might have encouraged these 
patients to a greater extent and that this could explain the fact that they were pushing 
themselves harder. Operator encouragement has been reported to have a positive effect 
on walking performance in previous walking protocols, such as the 6-minute walk test 
(Guyatt et al. 1984). The advantage of the incremental shuttle-walk test is that it is 
standardised, externally paced and thereby diminishes the effect of operator influence 
(Singh et al. 1992). Although a limitation of this study is that assessors were not 
blinded to training group assignment, consideration of the peak HR, RPE and pain 
responses suggests that patients in both exercise training groups were equally motivated 
to perform well on tests of physical function. Furthermore, tests were conducted in a 
standardised manner, with equal encouragement given to all patients, irrespective of 
training group assignment.
Patients in both exercise training groups expressed an improved confidence in walking 
following the 24-week intervention period, which accompanied the improvements 
observed in MWD. This was an interesting finding and a further possible explanation 
for the improved walking ability in these patients. It has been suggested that before 
training, patients are often afraid to walk because of a possible negative effect, whereas
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an increased confidence in walking ability after a training programme can stimulate 
patients to walk a greater distance (Remijnse-Tamerius et al. 1999).
Alternative lower-limb exercise rehabilitation strategies such as dynamic leg exercise 
(incorporating running, dancing and playing ball) (Dahllof et al. 1974; Lundgren et al. 
1989b; Lundgren et al. 1989a; Holm et al. 1973; Ekroth et al. 1978), repeated heel 
raising (Hedberg et al. 1988), functional exercises related to common activities of daily 
living (Sorlie and Myhre, 1978; Clifford et al. 1980), lower-limb cycle ergometry 
exercise (Zetterquist, 1970), lower-limb gymnastics exercise (Ericsson et al. 1970) and 
lower-limb strength training (Hiatt et al. 1994) have been investigated. These training 
modalities are well-tolerated by patients with claudication and all have been shown to 
have a positive impact on walking performance. Two of these studies reported an 
increase in maximum calf blood flow using venous occlusion plethysmography, 
following the rehabilitation programme (Lundgren et al. 1989a; Ericsson et al. 1970).
The limitation of previous studies that have measured leg blood flow after lower-limb 
exercise rehabilitation programmes are that blood flow has typically been measured at 
rest after an ischaemic or exercise challenge, and not during exercise. In addition, it is 
possible that improved tissue perfusion results from changes in the distribution of blood 
flow or capillary surface area (Regensteiner and Hiatt, 1995; Delp, 1998), rather than 
from changes in total blood flow to the lower extremities. Consequently in the absence 
of a formal exercise training regimen, a trend towards a decrease in MWD following the 
24-week intervention period was observed in the control group. This is consistent with 
expectations, since intermittent claudication is a leveraged disability i.e. pain increases 
with walking (Beebe, 2001). The degree of ischaemic pain evoked by walking might 
deter some patients from engaging in such exercise (McDermott et al. 2002a) and the 
muscle strength of patients with the condition erodes (Beebe, 2001). The reduced levels 
of physical activity could potentially contribute to subsequent disability (McDermott et 
al. 2002a), with walking capacity decreasing further over time (Beebe, 2001). Indeed, 
evidence suggests that self-reported walking ability declines at a rate of 9.2 yards per 
year (Aquino et al. 2001) in patients with intermittent claudication.
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Physiological responses to incremental upper- and lower-limb aerobic exercise in the 
whole cohort o f  patients
Tolerance to upper- and lower-limb aerobic exercise
In order to further understand the effects of upper- and lower-limb exercise on tolerance 
to upper- and lower-limb exercise and the mechanisms underpinning the improvement 
in walking performance, the physiological responses to incremental arm- and leg- 
cranking exercise were also studied during the intervention period.
At maximal exercise tolerance peak VO2 is consistently lower during arm-crank 
compared to cycle exercise in healthy individuals. Values in the range of 36% to 89 %, 
with a mean of 73 % have been reported (Astrand et al. 1965; Bergh et a l 1976; Davis 
et al 1976; Magel et a l 1978; Miles et a l 1983; Pollock et al 1974; Sawka et a l 
1982; Astrand et a l 1961; Reybrouck et al 1975; Stenberg et a l 1967; Sawka, 1986). 
Maximal power output during arm-crank exercise is also lower compared to cycle 
exercise (Sawka et a l 1982; Vokac et al 1975).
Peak VO2 values are dependent upon central (cardiac output) and peripheral (ability to 
extract and utilise oxygen) components (Sawka, 1986). Both upper- and lower-body 
exercise share the same control mechanisms to maintain cardiac output (Sawka, 1986). 
During maximal exercise, cardiac output values are lower for arm-crank compared to 
cycle exercise (Clausen, 1976), by approximately 30% (Reybrouck et a l 1975). This 
disparity in maximal cardiac output corresponds to the difference in peak VO2 between 
the two types of exercise (Sawka, 1986) in healthy individuals.
The relatively smaller skeletal muscle mass and thus, the exercise oxygen extraction 
capacity during upper-body exercise, further contributes to the reduced peak VO2 
values relative to lower-body exercise (Sawka, 1986) reported in the literature. 
Nevertheless, although both modes of ergometry employ different muscle groups 
(Sawka, 1986), strong correlation coefficients (r=0.70 to 0.94) have been reported for 
peak VO2 responses between upper- and lower-body exercise (Bar-Or and Zwiren,
1975; DeBusk et a l 1978; Falkel et a l 1986; Sawka et a l 1983a). Thus, it is believed 
that in arm exercise, neither oxygen transport nor oxygen extraction in the tissues can 
exceed that reached in maximal leg work due to the larger skeletal muscle mass in the 
latter (Stenberg et a l 1967). However, although upper-body muscle groups are
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relatively weaker than the lower-body muscle groups (Falkel et a l 1985), it has been 
suggested that, in theory, muscular strength could influence upper-body performance by 
enabling stronger individuals to achieve higher levels of cardiorespiratory stress prior to 
local fatigue and exercise termination (Sawka, 1986). Certainly, individuals who train 
their upper-body muscle groups can achieve arm-crank values approaching 90% of their 
cycle exercise peak VCh values (Cerretelli et al 1977; Seals and Mullin, 1982; Vrijens 
et a l 1975). Conversely, sedentary individuals may achieve approximately 60% of 
their cycle exercise peak VO2 values during arm-crank exercise (Sawka, 1986).
The findings of this current study have shown that when the entire cohort of patients 
was compared at baseline, peak VO2 during upper-limb aerobic exercise was 92% of 
that measured during lower-limb aerobic exercise, representing an absolute difference 
of less than 0.10 1 min'1 between upper- and lower-limb aerobic exercise capacity. This 
supports the findings of Fardy et al (Fardy et al 1977) who reported a similar aerobic 
exercise capacity between incremental arm-cranking exercise and treadmill walking in a 
single patient with intermittent claudication. The impaired blood flow through the 
peripheral arteries resulting from the condition (Bulmer and Coombes, 2004), 
undoubtedly accounts for this observation. Furthermore, in over one-third of our patient 
cohort (35%), peak upper-limb aerobic capacity was equal to or exceeded lower-limb 
aerobic capacity. This sub-group of patients exhibited a lower resting ABPI than the 
remaining patients with higher leg exercise tolerance (0.60 ± 0.03 vs. 0.69 ± 0.02, 
respectively; P < 0.05).
Other cardiovascular and metabolic stress responses such as HR (Pimental et al 1984), 
VE and blood lactate levels are also lower following upper-limb exertion than lower- 
limb exertion at maximum exercise tolerance in healthy individuals (Sawka et a l 1982; 
Sawka, 1986; Astrand et a l 1965; Bergh et a l 1976; Sawka et a l 1982). The 
difference in blood lactate concentration is probably explained by the amount of muscle 
mass involved during the two exercise types (Sawka, 1986), and the subjective feeling 
of strain during exercise is related to the metabolic rate per unit mass of contracting 
muscle (Astrand and Rodahl, 1970). The association between selected physiological 
responses and ratings of perceived exertion (RPE) may also be different between upper- 
and lower-body exercise (Sawka, 1986).
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In the present study, peak responses for VE , Bf, RER, HR, SBP, RPP and blood lactate 
following incremental upper- and lower-limb exercise were equivalent in our cohort of 
patients with PAD. This is unusual, since in healthy individuals all these responses are 
greater in LCT. These results reflect the impact of impaired perfusion and ischaemic 
pain on the ability to support moderate to high intensity leg exercise in this patient 
group (Fardy et al. 1977). Peak HR during treadmill walking has also been observed to 
be much lower in claudicants than healthy controls (Regensteiner et al. 1993b), thereby 
reflecting the fact that exercise performance and peak VO2 are limited primarily by 
peripheral, rather than central blood flow to working muscles (Askew et al. 2002).
The level of leg pain experienced at maximal exercise intensity in the leg-cranking 
assessment further reflects the inability of these patients to support high intensity leg 
exercise due to their lower-limb impaired perfusion. The level of peak pain during leg- 
cranking was greater than the level of arm pain experienced in the arm-cranking 
assessment, despite similar levels of perceived exertion and blood lactate levels being 
increased during the arm-cranking assessment. Patients typically experienced ischaemic 
pain in the calf and thigh regions of the lower extremity during the leg-cranking 
assessment, which was described as being similar to the pain experienced during 
walking. Given that upper extremity arterial disease is reported to be 20 times less 
frequent than lower extremity involvement, (Laroche et al. 1976; Welling et al. 1981), 
the pain experienced in the arms during the arm-cranking assessment was more likely 
attributable to the fatiguing effects of unaccustomed exercise in upper extremity muscle 
groups.
Perceived pain experienced during the assessment sessions in this present study was 
short-lived, since for both the upper- and lower-limb assessment an intermittent 
protocol was utilised, despite the fact that a continuous exercise protocol would have 
required less time to administer (Sawka, 1986). Intermittent arm-crank protocols have 
previously incorporated rest periods between exercise bouts ranging from 1 min 
(DeBusk et al. 1978; Washburn and Seals, 1983) to 20 min (Miles et al. 1984; Sawka 
et al. 1982). Two studies have examined whether the selection of a continuous or 
intermittent protocol alters the physiological responses to maximal effort arm-crank 
exercise (Sawka et al. 1983b; Washburn and Seals, 1983). Neither study found a 
difference in peak VO2 response, although Sawka et al (Sawka et al. 1983b) reported
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maximal power output to be greater during the intermittent than continuous arm-crank 
protocol. Arm-crank ergometry has been reported to be accurate and reproducible in 
eliciting physiological responses (Bar-Or and Zwiren, 1975; Davis et a l 1976; Lazarus 
et a l 1981). However, upper-limb exercise above the head level elicits greater 
physiological strain (compared to below the heart level) which results from increased 
sympathetic vasoconstrictor tone mediated by arm elevation as well as a contributing 
isometric exercise component (Sawka, 1986). The mid-point of the sprocket was set at 
shoulder height for all patients individually in the ACT for this reason.
It has been suggested that intermittent protocols have a particular application in arm- 
crank ergometry, in which exercise termination is frequently associated with local 
muscular fatigue (Sawka, 1986). It is believed that perceptual sensitivity to process 
physiological information may be enhanced during upper-body exercise (Sawka, 1986) 
as compared to exercise with large muscle groups (Gamberale, 1972). Such intermittent 
protocols may minimise the effects of accumulated localised fatigue and thus enable 
improved maximal performance during arm-crank exercise (Sawka, 1986). In this study, 
due to the severe pain encountered during lower-limb exercise in some patients, such an 
intermittent protocol at least in part alleviated pain and discomfort and allowed each 
patient to continue to maximum exercise tolerance during both exercise protocols.
Changes in upper- and lower-limb aerobic exercise capacity after upper- and lower- 
limb exercise training
It is well recognised that a decline in aerobic fitness contributes to decreased mobility 
(Buckwalter, 1997). Consequently an increase in aerobic fitness, as reflected by an 
increase in peak VOi can lead to an increase in mobility. It has even been suggested that 
in healthy elderly patients, potentially rigorous training can achieve levels comparable 
to those of younger individuals (Buckwalter, 1997). In healthy 60-70 year olds, VO2 
max can increase by 30% on average with 6-months of aerobic exercise (Seals et al 
1984).
In this study, peak VO2 increased by 17% and 19% in the lower- and upper-limb 
training groups during the LCT following the intervention period, respectively. In 
comparison, a programme of 45- min of walking, or running four days per week for 9-
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12-months increased mean aerobic capacity in patients with intermittent claudication by 
24% (Coggan et al. 1992). These findings further identify the impact of intermittent 
claudication on functional capacity. Although peak VO2 in this study was much lower 
than that observed with healthy individuals, it is important to note that even small 
improvements in peak VO2 can have considerable implications for patients walking 
performance, overall health and general well-being, all of which make a substantial 
difference to quality of life.
Some studies have reported that endurance training only affects the trained muscle 
groups (Bhambhani et al. 1991; Magel et al. 1978; McKenzie et al. 1978), whereas 
others have suggested that endurance training also increases the performance capacity 
of untrained muscles (Clausen et al. 1973; Lewis et al. 1980; Loftin et al. 1988). The 
observed improvement in walking performance in both exercise training groups in this 
study may in part be attributed to an increase in lower-limb peak power and peak VO2 
during the leg-cranking assessment, since peak responses for perceived exertion and 
pain were similar for both groups.
It can be argued that the higher peak HR for the lower-limb exercise training group and 
higher blood lactate response for both exercise groups during the LCT suggest that these 
patients became more motivated to perform well and pushed themselves harder after the 
period of supervised exercise training. The level of encouragement during all 
assessments was identical for all patients, regardless of grouping. Patients were actively 
encouraged to keep going as long as possible, taking into account all criteria, including 
verifying that blood pressure, HR and ECG rhythms were within acceptable limits. All 
groups were treated equally, since the investigators were aware of the fact that a bias for 
any group could hamper the validity of the findings.
The improvement in lower-limb peak VO2 in the upper-limb exercise training group in 
this study is of particular interest, since this indicates that such an exercise regimen can 
improve lower-limb function in patients with PAD. Specific and transfer effects have 
previously been observed between arm- and leg-training (Tordi et al. 2001), however 
not in patients with intermittent claudication. Furthermore, transfer effects of endurance 
training (i.e. increase of performance measured during exercise with untrained muscles) 
are more controversial (Franklin, 1989) than specific training effects (Tordi et al.
2001). It is believed that in healthy individuals the magnitude of specific effects
157
depends on the pre-training level of peak VO 2 of participants, and that this initial peak 
VO2 also indirectly influences the transfer effect (Tordi et a l  2001).
The occurrence of a transfer effect depends on the magnitude of the specific effect, with 
the transfer effect from legs to arms being more effective than transfer from arms to legs 
(Tordi et a l  2001) in healthy individuals. In arm training studies in which the peak 
VO2 improvement (measured in the arm test) is below 20%, no transfer effect has been 
reported (Bhambhani et a l  1991; Magel et a l  1978). Indeed, it has been suggested that 
an increase of more than 30% of peak VO2 is necessary to obtain a significant transfer 
effect (Lewis et a l  1980). In contrast, the findings in this present study suggest that a 
transfer effect from arms to legs had occurred in patients undertaking upper-limb 
exercise training, as indicated by the improvement in aerobic capacity and power output 
during the LCT.
The improvement in peak VO2 in these patients during the ACT (13%) was considerably 
less than that previously reported to generate a transfer effect. The patients in the 
present study were sedentary, elderly individuals. Perhaps, their low peak VO2 could 
account for the transfer effect of endurance training to untrained limbs, as previously 
suggested (Lewis et a l  1980; Loftin et a l  1988). These observations are consistent 
with the central circulatory changes observed after short periods of endurance training 
in individuals with low peak VO2 (Thompson et a l  1981), and may account for the 
observations in this study.
It has been suggested that when legs are trained, a 15% increase in VO2 (measured 
during the leg test) is generally sufficient to induce a significant transfer effect in the 
arms (Clausen et a l  1973; Lewis et a l  1980). In this study a 17% improvement in 
peak VO2 during the LCT by the lower-limb training group was observed, however no 
transfer effect, as suggested by an improved peak VO2 was observed by these patients in 
the ACT. Undoubtedly, due to the impairment in lower-limb perfusion in these patients, 
a greater increase in peak VO2 is required compared to those of healthy individuals. An 
increase in peak VO2 from baseline during the ACT was only observed in the upper- 
limb training group of patients, indicating the specificity of exercise training. The 
improvement in upper-limb peak VO2 following arm ergometer exercise is probably
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attributable to enhanced oxygen utilisation resulting from an expanded arterio-venous 
oxygen difference (Magel et a l 1978).
Aerobic training substantially changes the respiratory response to exercise, with the 
dramatic increase in ventilation at maximal power output being accomplished by an 
increase in both maximal respiratory rate and maximal tidal volume (Wilmore, 2003). In 
the present study, increases in peak VOi were associated with increases in peak VCO2 , 
VE and breath frequency in both training groups, during both the LCT and ACT 
assessments, with no changes in systolic or diastolic blood pressure or perceived 
exertion from baseline values being observed.
Functional Status Measures
In order to evaluate functional status in patients with PAD comprehensively, it is 
important not only to consider laboratory-based measures, but also to examine data on 
community-based walking ability obtained from questionnaire responses (Regensteiner 
and Hiatt, 1995; Regensteiner et a l 1997b). The questionnaire data in this study, as in 
previous studies (Izquierdo-Porrera et al 2005; Labs et a l 1999a) were collected as a 
secondary outcome measure, in order to further explore the effects of exercise 
rehabilitation on function in older patients with symptomatic PAD. Only relatively 
recently have questionnaires been used routinely in clinical trials in patients with PAD 
(Regensteiner et a l 1997b; Patterson et a l 1997; Whyman et a l 1997; Regensteiner 
et a l 1996; Hiatt et a l 1990), and therefore comparatively little is known about the 
effects of a treatment programme on community-based walking ability or quality of life 
(Regensteiner and Hiatt, 1995).
Physiological measures of PAD severity correlate with specific subscales (physical 
functioning) of the generic (SF-36 v2) measure and with the disease-specific measures 
(WIQ), suggesting that both generic and disease-specific questionnaires can provide 
insight into health related quality of life in patients with PAD (Izquierdo-Porrera et al
2005). Both questionnaires describe the impact of claudication and treatment thereof, 
and provide insight into disease-specific and more global aspects of function, which are 
essential measures of therapeutic outcome in PAD clinical trials (Hiatt et a l 1995b).
The information obtained from these questionnaires can provide a valuable adjunct to 
laboratory-based measures (Regensteiner and Hiatt, 1995). Furthermore, the European 
quality of life questionnaire (EQ-5D) has been specifically designed to complement
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other health related quality of life questionnaires (Krabbe and Weijnen, 2004) such as 
the SF-36.
In accordance with previous recommendations (Regensteiner et a l 1990), in the main 
all questionnaires were administered before undertaking the shuttle-walk test in order to 
minimise the potential for bias in the self evaluation of walking ability and functional 
status, and to prevent shuttle-walk performance from influencing questionnaire 
response. In addition, both interviewer and patient were blinded to previous 
questionnaire scores (Regensteiner et al. 1996) so that patients could not answer based 
on previous experience (Regensteiner et al. 1990).
Walking Impairment Questionnaire (WIQ)
The WIQ has been referred to as a disease-specific health related quality of life 
questionnaire (Izquierdo-Porrera et a l 2005). It has been widely used to examine the 
effect of exercise rehabilitation on patients functional status in the PAD population 
(Regensteiner et a l 1990; Regensteiner et al 1997b). Improvements in WIQ domains 
have been observed following supervised exercise (Regensteiner et a l 1997b) in the 
form of treadmill intervention (Hiatt et al 1990; Regensteiner et a l 1996) and strength 
training (Regensteiner et al 1996). In the WIQ, walking capabilities are quantified in 
terms of walking defined distances, speeds, stair climbing ability and severity of 
claudication pain during usual walking activities (Regensteiner et a l 1990). A score of 
0 to 100 is used to measure each domain, with a score of 0 representing inability to 
perform the task and 100 representing no difficulty performing the task (Izquierdo- 
Porrera et al 2005).
The WIQ has previously been used to detect changes in community based walking 
ability following two of the major intervention treatments used for patients with PAD 
(Regensteiner et a l 1990), namely exercise training (Hiatt et a l 1990) and peripheral 
bypass surgery (Regensteiner et al 1994; Regensteiner et a l 1993a; Regensteiner et 
al 1990). Changes in graded treadmill exercise performance (Regensteiner et al 
1990), the 6-minute and 4-m walk score all correlate with changes in questionnaire 
scores (McDermott et a l 1998a) and WIQ responses are stable when repeated over 
time in control patients (Hiatt et a l 1995b; Regensteiner and Hiatt, 1995). The findings 
of this present study also confirm that all WIQ domains correlate highly with MWD
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determined using the shuttle-walk protocol, with correlation coefficients of 0.71 and 
0.67 for walking distance and walking speed observed.
It has previously been argued that the WIQ should be able to measure walking 
impairment regardless of the type of intervention used or lack of intervention to 
improve walking ability (Regensteiner et a l 1996). Although the WIQ has been shown 
to accurately reflect treadmill performance, it does not duplicate it, since it asks 
questions about habitual walking patterns rather than walking performed in the 
laboratory setting (Regensteiner et al 1990). The corroboration of shuttle-walk results 
by questionnaire results assumes great importance in this present study.
In some patients the onset of claudication pain can occur with even low-intensity 
physical activity, severely restricting the patient’s ability to ambulate in the community 
setting (Nehler and Hiatt, 1999b). Upon commencing this present study all patients 
perceived a 50% degree of difficulty in walking, due to claudication severity, as 
assessed using the WIQ pain severity domain. This further confirms that patients are 
limited in their walking ability due to claudication, as opposed to angina or arthritis for 
example. Claudication severity may be regarded as a minor inconvenience, or 
alternatively, a significant handicap, imposing frustrating and sometimes distressing 
limitations on lifestyles (Binnie et al. 1999). Some patients with intermittent 
claudication experience a feeling of disability, due to having a moderate to severe 
impairment in walking ability that may limit their ability to meet the personal, social or 
occupational demands of daily living (Regensteiner et a l 1996; Regensteiner et al 
1990; Regensteiner, 1997).
Intermittent claudication causes both men and women to have poorer walking 
endurance and slower walking speeds (McDermott, 1998a; Hiatt et a l 1988). The WIQ 
includes questions specifically on both walking distance and walking speeds, since 
some patients may be limited selectively in either speed or distance, therefore the 
questionnaire is more applicable to a broad range of patients with PAD (Regensteiner et 
al 1990). Individual questions about each defined distance or speed allow a close 
examination of the limitations of walking ability (Regensteiner et a l 1990) in these 
patients. The integrated summary scores provide a single value which can be related to 
an entire component of self-reported walking ability (Regensteiner et al 1990).
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Upon commencing the present study patients displayed a characteristic pattern of 
response to the WIQ, in that walking ability was rated as becoming increasingly 
difficult at longer distances and faster speeds. These findings were similar to those 
reported previously (Regensteiner et al. 1990). WIQ scores in patients with PAD are 
lower than those reported in non-PAD patients (Gardner and Montgomery, 2001). In the 
present study the degree of difficulty associated with walking distance was 27, 23 and 
22% and walking speed was 28, 27, and 31% for the lower-, upper-limb and control 
groups, respectively, thereby indicating that patients perceived themselves as being 
functionally impaired (Izquierdo-Porrera et al. 2005). These scores are similar to those 
in previous reports (Regensteiner et al. 1990), but lower than those in others 
(McDermott et al. 1998a; Izquierdo-Porrera et al. 2005; Regensteiner et al. 1997b). 
Differences in patient numbers could account for the discrepancy in perceived abilities 
between studies.
No changes in the WIQ distance or speed domains were observed in either exercise 
training group following a 6-week period of exercise training. It is possible that 
perceived improvements in walking ability lag behind the physical improvements in 
ambulatory function achieved following 6-weeks of exercise training. It is equally 
possible that the WIQ is not sensitive to address small improvements in walking ability 
obtained through short-term exercise. A criticism of the WIQ has been that patient- 
specific factors such as depressed mood and perception of optimal walking speed and 
endurance are likely to affect the responses to the WIQ (McDermott et al. 1998a).
Following 12- and 18-weeks of exercise training, improvements in the WIQ distance 
and speed scores were observed in the upper-limb training group only. It is interesting 
that these improvements were not observed in the lower-limb training group of patients, 
since improvements in walking performance and functional capacity were observed in 
both exercise training groups at these time-points. It is possible that perceived 
improvements in walking ability in the lower-limb training group of patients in this 
present study continue to lag behind the physical improvements in ambulatory function 
induced in these patients. Conflicting findings in WIQ domains exist following short­
term exercise training, since improvements in all WIQ domains have been observed in 
some studies following a 12-week period of treadmill training (Regensteiner et al.
1997b; Tsai et al. 2002; Regensteiner et al. 1990), but not in others (Regensteiner et al.
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1996). Twelve weeks of strength training improved only walking speed and stair 
climbing ability, with no changes in other WIQ scores (Regensteiner et al 1996).
These perceived differences between groups in the present study following 12- and 18- 
weeks of exercise training might also be explained by a greater confidence in walking in 
the upper-limb training group of patients at these time-points. Perceived confidence in 
walking was improved in both exercise training groups following the 24-week 
intervention period, however it was not assessed at intermediate time-points throughout 
the study. Equally, it is possible that differences associated with adaptations which 
contributed to improved walking performance between the two exercise training 
regimens could have influenced the perception of improved walking ability (WIQ 
domains of speed and distance) in these patients at these time-points. A further 
possibility which cannot be excluded is the fact that patients in the upper-limb exercise 
training group were participating in relatively pain-free, twice-weekly exercise, 
compared to the lower-limb training group. The frequent sensation of pain experienced 
during the training sessions in the lower-limb training group could have masked their 
perception of an improvement in the walking distance and speed domains at the 12- and 
18-week time-points.
In contrast, stair climbing ability was improved following 12-weeks of exercise training 
only in the lower-limb exercise training group, whereas at the 18-week time-point an 
improvement in this domain was seen in both groups. It is possible that peripheral 
adaptations could account for the more rapid improvements observed in the lower-limb 
training group at the 12-week time point. The improvement in functional capacity 
through central/systemic cardiovascular function in the upper-limb training group could 
possibly account for the observed improvement in stair climbing ability following 18- 
weeks of exercise training.
At the end of the intervention period in this present study there was no change in the 
claudication pain severity domain of the WIQ from baseline measures in any group, 
indicating that perceived difficulty in walking due to calf pain was unchanged.
However, an improvement in this domain was observed in the upper-limb training 
group compared to the control group of patients. Similarly, 12-weeks of treadmill 
exercise intervention have not resulted in changes in this domain (Regensteiner et al 
1990), although improvements have been observed following 24-weeks of treadmill
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training (Regensteiner et a l 1996) and following surgical intervention (Regensteiner et 
al 1990).
It has been suggested that when patients exit an intervention study, they are able to 
perform at a higher level than on entry, so that many of them can reach the upper limit 
of the questionnaire’s distance scale (Regensteiner et a l 1990). In this present study 
and in parallel to the improvements in CD and MWD observed during the shuttle-walk 
assessment during standardised laboratory conditions, walking ability (distance, speed 
and stair-climbing ability) in the community setting was perceived to be improved 
following the intervention period in both exercise training groups, as determined by the 
WIQ. Furthermore, these patients also reported a self-observed noticeable improvement 
in walking ability in the community setting, stating that they could walk much further 
on the flat, but also up a hill following the intervention period.
Similarly, 24-weeks of treadmill training have also been associated with increases in the 
WIQ distance, speed and stair climbing scores (Regensteiner et a l 1996). However, the 
improvements in these domains were greater than those observed in the present study. 
The specificity of walking exercise might account for these findings. Although a 
proportion of the control group did perceive an improvement in their walking ability, no 
changes in WIQ domains were observed at any time-point throughout the intervention 
period. This further supports that WIQ responses are stable when repeated over time in 
control patients (Hiatt et al 1995b; Regensteiner and Hiatt, 1995).
The perceived improvement in both walking distance and speed in both exercise 
training groups could be associated with a number of factors including an improvement 
in confidence in walking, which was shown to improve from baseline in both exercise 
training groups. The improved confidence in walking could account for the fact that 
patients felt that they could push themselves further or indeed that they felt able to 
tolerate the pain more when they were walking and this in itself could account for the 
improvement in walking performance. Walking distance and speed were also highly 
correlated with the shuttle-walk test and this was the case at each assessment stage of 
the intervention period.
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Quality o f  L ife
Although health related quality of life is thought to be an important measure of 
disability in patients with PAD, the severity of functional impairment in these patients 
only partially determines this (Breek et al 2002), since PAD represents just one 
(peripheral) manifestation of a generalised atherosclerotic status (Labs et al. 1999a). 
Usually, affected patients have multiple morbidities, and the assessment of quality of 
life may give a more representative picture of the patients’ perception of health than the 
exclusive measurement of walking performance (Labs et al. 1999a). It might be 
expected that all claudication therapies would alleviate pain and improve walking 
capacity, however such an improvement could, but might not necessarily, lead to an 
improved quality of life (Hiatt, 1997b).
Health-related quality of life is reduced in older patients with PAD (Breek et a l 2001) 
(Izquierdo-Porrera et a l 2005), and this might be attributable to their ambulatory 
dysfunction (Feinglass et a l 1996), degree of bodily pain and reduction in physical 
function (Bartman et a l 1998). Several non-disease specific questionnaires have been 
used to measure health related quality of life in these patients (Izquierdo-Porrera et al 
2005). These have included amongst others the Medical Outcomes Study (MOS) Short 
Form 36 (SF-36) (Pell, 1995; Bosch and Hunink, 1996; Bartman et a l 1998) and the 
European Quality of Life Instrument (Chetter et a l 1997; Cook et a l 1997; De Vries 
etal. 1998).
Data from the SF-36 questionnaire (Izquierdo-Porrera et a l 2005) indicate that the self­
perceived physical performance such as physical functioning, role limitation due to 
physical health and bodily pain subscales in these patients is impaired, supporting 
previous findings (Gardner et al 2001). The present study also supports these findings. 
In addition, lower scores in energy and vitality were also observed. This is in agreement 
with previous studies, since when compared with national norms (Ware, 2004), patients 
with PAD not only scored lower in the subscales of vitality, but also in the subscales of 
mental health and social functioning (Izquierdo-Porrera et a l 2005).
The SF-36 and EQ-5D questionnaires
In contrast to the WIQ and PAD-PAR, which measure only walking ability and physical 
activity, respectively, the SF-36 assesses multiple functional domains (Hiatt, 1997b; 
Izquierdo-Porrera et a l 2005). The SF-36 is a reliable, valid, generic health related
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quality of life instrument (Ware and Sherboume, 1992). It measures eight health 
domains of physical function, social function, role limitations due to physical 
dysfunction, role limitations due to emotional problems, mental health, bodily pain, 
general health and vitality (Izquierdo-Porrera et al. 2005). For each subscale, several 
item scores are standardised into a scale from 0 to 100, with better health states 
resulting in higher scores (Izquierdo-Porrera et a l 2005). Another questionnaire which 
is being increasingly incorporated in randomised controlled trials as a secondary 
outcome measure is the European quality of life (EQ-5D) questionnaire (Krabbe and 
Weijnen, 2004). In the EQ-5D questionnaire, general health state, mobility, self-care, 
ability to perform usual activities, pain and discomfort, and anxiety and depression are 
assessed on a scale from 0 to 100, indicating worst imaginable and best imaginable 
states, respectively (Health Policy, 1990).
Short-term influence o f  exercise rehabilitation on Quality o f Life 
Therapeutic interventions which improve ambulatory function such as exercise 
rehabilitation, may improve quality of life (Izquierdo-Porrera et al. 2005). In this 
present study, 6-weeks of exercise training improved the general health status of 
patients in the lower-limb exercise training group only, despite improvements in 
walking ability and functional capacity in both exercise training groups during this 
period. It is possible that in the upper-limb training group, a patient’s perceived 
improvement in general health status might lag behind the physiological improvements 
in walking ability and functional capacity observed.
Equally, it is possible that patients in the upper-limb training group initially perceived 
their training intervention negatively. Upon commencing the exercise intervention the 
majority of patients undertaking upper-limb exercise training felt sceptical regarding the 
possible benefits which they might receive from such an intervention. Such negative 
feelings might have had an impact when answering the questions which contributed to 
the scoring of the general health domain in the SF-36 v2. These questions included ‘I 
expect my health to get worse’ and ‘my health is excellent’. It is possible that these 
patients did not perceive that an upper-limb training intervention could generate 
improvements and as such answered these questions accordingly, anticipating a decline 
in their general health. A further possibility is that a 6-week period of upper-limb 
exercise training is insufficient to generate feelings of improvement in general health 
status in these patients.
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Although trends were observed, there were no significant differences within or between 
the study groups, in the physical functioning, role limitation physical, bodily pain, 
mental health, energy and vitality, social functioning or role limitation emotional 
domains in either exercise training group. As a consequence, this study failed to support 
the findings of a preliminary 6-week study of both upper-and lower-limb exercise 
training which reported improvements in the physical functioning and role limitation 
physical domains of the SF-36 in both exercise training groups (Walker et al. 2000). 
Other studies have also reported improvements in these domains after exercise training 
in these patients (Regensteiner et a l 1996). There are several possible explanations 
which could possibly account for differences between studies.
Firstly, it is possible that the patients in this present study were more sedentary than 
those in previous studies, since physical activity status was not assessed in the Walker et 
al study (Walker et a l 2000). Thus, it is feasible that 6-weeks of exercise training 
might be insufficient to generate improvements in these domains if patients in this 
present study were more sedentary at baseline, since questions which contribute to the 
physical functioning domains included questions about performing vigorous activities 
and walking long distances. In addition, questions contributing to the role limitation 
physical domain, ask questions regarding the amount of time spent performing activities 
and the degree of difficulty in doing so.
Furthermore, it is possible that patients in the present study were severely affected by 
their claudication and thus a longer period of exercise training was required to generate 
any improvement in physical functioning domains. It is also feasible that differences in 
patient number between studies and patients age, and types of physical activities 
typically undertaken by patients could all account for the discrepancies between studies. 
In contrast to another study (Currie et al 1995), Walker et al (Walker et a l 2000) and 
the findings of this present study found no improvement in the bodily pain domain of 
the SF-36 v2 following 6-weeks of either upper- or lower-limb exercise training. One 
possibility for this might be that exercise delays the onset of, rather than eliminates 
claudication pain (Walker et a l 2000).
For comparison, in this study quality of life was also assessed using the EQ-5D 
questionnaire. Following 6-weeks of the intervention period no changes in any of the 
questionnaire domains were observed, however the general health of patients in the
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upper-limb training group was higher compared to the control group of patients. 
Differences in general health perception between the SF-36 v2 and EQ-5D 
questionnaire can be explained by differences in questionnaire design. The EQ-5D uses 
a scale, rather like a thermometer, on which best imaginable state is marked by 100 and 
worst imaginable marked by 0 (Health Policy, 1990). The SF-36 v2 on the other hand 
asks a series of specific questions, regarding a patient’s perceptions of health, asking 
them to compare themselves to other people. It might be that such differences between 
the SF-36 v2 and EQ-5D questionnaire could account for the discrepancies in perception 
of health status by both exercise training groups.
Long-term influence o f  exercise rehabilitation on Quality o f Life 
Intermittent claudication is associated with increased mortality as well as decreased 
functional status (Regensteiner, 2004) and a substantial limitation in the quality of life 
of patients is the reduction in walking ability (Remijnse-Tamerius et a l 1999). It is of 
interest therefore that the observed improvement in walking ability following exercise 
training in this present study, similarly to previous findings, coincided with an 
improvement in both the patients’ physical aspect and quality of life (Tan et al. 2000b).
In this present study, in agreement with previous findings (Clifford et a l 1980) the 
improved functional capacity and walking ability in both exercise training groups was 
associated with an improvement in perceived general health status of these patients 
following 24-weeks of the intervention period, compared with the control group of 
patients, whose general health deteriorated over the study period. The physical function 
aspects examined in an earlier version of the SF-36 have also been shown to improve 
with exercise training (Regensteiner et al 1996). Although patients who perform 
exercise training might not obtain the level of function of healthy aged-matched 
individuals, even small improvements in function may have practical relevance for 
patients with PAD (Regensteiner et al 1996). It is believed that patients feel much 
healthier following exercise training, having unduly restricted their activities before, 
fearing the onset of ischaemic leg pain, thereby suggesting that exercise training is 
simple and effective in treating intermittent claudication (Clifford et a l 1980).
Improvements in other physical functioning domains of the SF-36 v2 following 12- 
(Tsai et a l 2002; Regensteiner et a l 1997b) and 24-weeks of treadmill training 
(Regensteiner et a l 1996) have also been reported, thereby corroborating the treadmill
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findings observed in these studies. A 38% to 67% gain in the physical functioning 
domain have been reported in smaller samples of claudicants following exercise 
programmes (Regensteiner et a l 1996; Regensteiner et a l 1997b). However, one study 
(Gardner et al 2001) reported no change in the physical and mental health components 
of the SF-36 survey following exercise rehabilitation. Several factors may account for 
this discrepancy, including the fact that in the Garder et al study, the sample of patients 
was older and incorporated a higher percentage of patients with low socio-economic 
status (Gardner et a l 2001).
In this present study, further to the improvement in general health, improvements in the 
physical functioning and bodily pain domains of the SF-36 v2 were observed in the 
upper-limb training group of patients only, however no significant changes in the role 
limitation physical domain were observed either between or within study groups. The 
upper-limb training group also showed an improvement in the energy and vitality 
domains compared with the control group of patients. Why such an improvement in 
bodily pain, physical functioning and energy and vitality should be achieved in the 
upper-limb training group only and not both training groups could result from 
limitations of the SF-36 v2 questionnaire. Although the questionnaire is suitable in a 
broad field and extensively used in previous studies with patients with intermittent 
claudication, the SF-36 v2 could have drawbacks when upper- and lower-limb exercise 
training are directly compared.
In the SF-36 v2, questions that relate to the scoring of the physical functioning domain, 
incorporate questions regarding the ability to perform ‘vigorous activities such as lifting 
heavy objects’ and ‘moderate activities such as moving a table, vacuuming, bowling 
etc’, and the degree of difficulty involved with ‘lifting or carrying groceries’, and 
‘bathing or dressing’ oneself. Such activities predominantly involve the use of the 
upper-body. It could thus be argued that patients who performed upper-limb exercise 
training felt an improvement in their upper-body strength and function, and that this 
could account for differences in response and thereby perceived improvement in the 
physical functioning domain by this group of patients.
Furthermore, only two questions in the SF-36 v2 questionnaire contribute to the bodily 
pain domain (Ware et al 1993). One question asks the patient about ‘the intensity of 
bodily pain’ experienced in the last 4-weeks. It could be argued that the patients in the
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upper-limb training group experienced less pain on a twice weekly basis compared to 
the lower-limb training group of patients. The second question contributing to the 
bodily pain domain asks about ‘the extent pain interfered with their normal work’ 
(including both work outside the home and housework). Due to the structure and regular 
pattern which the exercise training classes established, incorporating group sessions and 
also the frequency of attendance involved at the Centre, the majority of patients classed 
their participation in the study on a similar par to their previous working experience. As 
such, it is possible that patients in the upper-limb training group answered the 
questionnaire perceiving that they had been subject to minimal bodily pain and that this 
minimally interfered with their normal work, i.e. attending the Centre. Consequently, 
the lower-limb training group was subjected to more pain than normal through attending 
the twice weekly training sessions and this could explain why there was no change in 
this domain from baseline measures.
Similarly questions in the SF-36 v2 which relate to the energy and vitality domain, 
specifically ask questions, if patients ‘feel worn out’, ‘have a lot of energy’ and if they 
‘feel tired’. It could also be argued that the patients in the lower-limb training groups 
were subject to higher intensity pain levels on a twice weekly basis and as such they 
could have perceived to be tired and worn out as a result of this. This might therefore 
explain why no improvements in the energy and vitality domain in this patient group 
were observed compared to the control group of patients.
It has previously been reported that improvements in the physical functioning domains 
are more pronounced than changes in the mental health component of the questionnaire 
(Tsai et al. 2002), with no changes in the social and role function domains reported 
following treadmill training in patients with PAD (Regensteiner et al. 1996). Longer 
exercise rehabilitation programmes of 3-6 months in duration, equally have found no 
change in the mental health domain in these patients (Menard et al. 2004; Patterson et 
al. 1997; Gardner et al. 2001). This present study agrees with these findings, since 
both lower- and upper-limb exercise training failed to alter a patient’s perception of 
mental health, social function and role limitation emotional status. Several factors may 
account for this. In chronically ill patients with PAD, ambulatory dysfunction may be 
the most important factor influencing self perceived health related quality of life (Tsai et 
al. 2002). It is also possible that the perceived improvements in the mental health
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component of quality of life may lag behind the improvements in ambulatory function 
(Tsai et a l 2002).
Therefore, in agreement with hospital-based treadmill training the primary effects of 
this present study have all been in physical functioning (Regensteiner et al. 1997b), 
suggesting that improved walking ability does not alter other domains of functional 
status (Regensteiner et a l 1996). This is not surprising since physical functioning 
domains enable patients to become more functionally independent (Tsai et a l 2002); 
after all PAD is a disease wherein the symptom of intermittent claudication limits 
walking ability. This is important, since unsupervised exercise programmes are unlikely 
to significantly improve patient’s quality of life (Currie et a l 1995).
The patients in the control group, were given general lifestyle advice and an in depth 
consultation regarding ways of increasing physical activity which were identical to 
those given to patients undertaking exercise training. Some of the patients in the control 
group who heeded this advice increased their level of physical activity. However, this 
was unstructured and short-lived, indicating a lack of motivation and did not result in an 
improvement in quality of life. It is noteworthy that many patients frequently 
commented that they felt that they were insufficiently motivated to perform exercise at 
home. Indeed, patients with PAD frequently associate specific barriers to exercise 
including; comorbidity, lack of specific advice and lack of supervision (Bartelink et al 
2004). Many patients do not feel safe or comfortable in undertaking unsupervised 
exercise. Hence, in the absence of increased physical activity the patients in the control 
group perceived that their general health status and role limitation emotional status had 
deteriorated following the 24-week intervention period. This is what one would expect, 
since intermittent claudication is a progressive deteriorative condition and general 
health status would be expected to progressively decline.
Similarly to the SF-36 v2 questionnaire, an improvement in the general bodily pain and 
discomfort domain of the EQ-5D was only observed in the upper-limb training group of 
patients, following the 24-week intervention period. However, an improvement in the 
general health domain of this questionnaire was only observed in the upper-limb 
training group of patients, compared to the control group, whereas improvements were 
observed in both exercise training groups in the SF-36 v2 questionnaire. Again, 
differences in questionnaire design could account for this observation. The SF-36 v2
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asks a series of specific questions, regarding patient’s perceptions of general health, 
asking them to compare themselves to other individuals, whereas the EQ-5D uses a 
scale, rather like a thermometer, on which best imaginable state is marked by 100 and 
worst imaginable marked by 0 (Health Policy, 1990). It is possible that the lower-limb 
training group could relate to specific questions on general health better using this style 
of response and that this could account for the differences between questionnaires 
following the 24-week intervention period.
As previously suggested, intermittent claudication typically affects the physical 
functioning domains of the SF-36 questionnaire, and it is therefore not surprising that 
no significant differences were observed either between or within groups in the domains 
of perceived self care, the ability to perform usual activities or in anxiety and depression 
status following the intervention period in the EQ-5D questionnaire. Equally, it is not 
surprising that in the absence of a structured exercise training programme, patients in 
the control group perceived a deterioration in mobility status in the EQ-5D. The 
extremely sedentary lifestyle of patients with intermittent claudication (Sieminski and 
Gardner, 1997) places them at high risk for subsequent decline in mobility and physical 
function (Visser et a l 2002), even if symptoms remain unchanged (Gardner et al. 
2004b). This was observed in these control patients since although they perceived a 
deterioration in mobility, their measured CD and MWD were unchanged. Decreased 
mobility undermines the capacity for activities of daily living such as the ability to feed 
and dress oneself and attend to personal hygiene (Buckwalter, 1997). However, despite 
their perception of decreased mobility, the overall self-care perception of these patients 
was unaffected.
Compliance to the assessments and exercise training sessions 
Compliance to an exercise intervention can be a problem for any patient (Buckwalter, 
1997). However, considering that intermittent claudication is a frequent complaint 
among the elderly (Perakyla et al. 1998), compliance can be particularly problematic 
for these older individuals who have been sedentary for decades (Buckwalter, 1997). 
Given the age of the patients in this study (median age 69 years, range 50-85 years), an 
excellent level of compliance to the assessment and twice-weekly training sessions 
(98.9 % and 99.9 %, respectively) was observed. Attendance to exercise rehabilitation 
studies of similar duration has been reported to be 75% of the possible exercise training 
classes (Gardner et al. 2004a), yet it can be as low as 45% (Creasy et a l 1990). High
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attendance nevertheless has been reported for a 24-week resistance training programme 
in these patients (90 ± 6%), but the high level of compliance was attributable to the 
transportation service that was provided to and from the training and evaluation sessions 
in that study (McGuigan et a l 2001). This present study was unable to offer such a 
service, and therefore patients had to utilise both public and private transport, in order to 
attend the Centre.
The level of compliance in this present study contrasts with those reported in previous 
exercise studies of 12-weeks to 6 months in duration which have reported compliance to 
range from 65% to 87% (Carter et a l 1989; Ekroth et a l 1978; Gardner et a l 2004a) 
(Gardner et a l 2001; Tsai et al 2002). However, shorter studies of 6-12 weeks in 
duration have reported high attendance and low patient dropout figures (Walker et al 
2000; Tsai et al 2002). Studies with fewer patients (61 to 64 patients) have reported 
patient dropout to be 17% (Gardner et a l 2001; Tsai et a l 2002). The patient dropout 
rate in this present study was also low (~ 9.6 %), with only 10 of the 104 patients 
recruited withdrawing within the course of the 24-week intervention period. As detailed 
in the Results section, these were primarily for medical reasons. Previous randomised 
controlled studies of similar magnitude to the present study have experienced a dropout 
rate in the region of 31%, with 29 out of 94 patients recruited dropping out (Andriessen 
etal. 1989).
The high compliance rates experienced in this present study can be attributed to the 
strong emphasis placed on providing good group training sessions, reinforced with 
social adhesion where possible. Previous recommendations have suggested that elderly 
patients should be urged to exercise with like-minded companions and be educated to 
obtain realistic expectations, as they will become discouraged and discontinue if 
anticipated swift and dramatic improvements are not forthcoming (Buckwalter, 1997). 
Assessing and accommodating a patient’s time of day preferences to undertake exercise 
was undoubtedly beneficial.
The high attendance rates in this present study can be attributed to the determination of 
the training/assessment session supervisor and the degree of flexibility applied in 
accommodating patients who were, for various reasons such as hospital, GP or dental 
appointments, unable to attend a pre-arranged meeting. A strong emphasis was always 
placed on such appointments being a priority. Patients unable to attend their particular
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group session, were always allocated a further similar time of day group session, 
without being made to feel that they were inconveniencing anyone, and thus eliminating 
any feelings of guilt which might otherwise have arisen. Patients were seen on an 
individual basis, if alternative group sessions were not possible.
The value of group sessions, can not be dismissed. The social success in this study, 
could be attributable to the fact that PAD is not widely known about among the general 
public, and the intermittent and largely hidden symptoms of claudicants are not easily 
understood by others, including their own families (Binnie et a l 1999). Thus patients 
during an exercise class often report that the opportunity to talk to fellow sufferers is 
helpful and reassuring (Binnie et a l 1999). Indeed, as in previous observations some 
patients may have undoubtably benefited more from its psychological dimension than 
from the exercise (Binnie et a l 1999). Recognizing the value of this aspect of an 
exercise class, the exercise supervisor consciously but unobtrusively promoted and 
facilitated it (Binnie et a l 1999).
Maintaining motivation, providing advice, encouragement and ensuring that each and 
every patient, regardless of grouping felt at ease with the investigator were undoubtedly 
the strongest factors which contributed to the high compliance figures observed for the 
assessment and exercise training sessions. Indeed, these proved to be essential in 
overcoming the barriers to exercise. Patients were actively encouraged to approach the 
investigator if they experienced any difficulty or concern or potential problem at any 
time-point during the intervention period of the study.
Additional factors, which could have contributed to the high compliance to the 
assessment and exercise training sessions, included the structure of the interval training 
regime. Interval training regimens enable a greater amount of higher-intensity work to 
be performed in a given time than could be achieved with continuous exercise of a 
similar nature and therefore optimise the stimulus for cardiovascular adaptations 
(Astrand and Rodhal, 1986). Thus, training regimens based on short, higher-intensity 
interval exercise which include interpolated rest intervals may be more effective at 
producing rapid, symptomatic improvement in patients with symptomatic PAD (Walker 
et a l 2000) and other cardiovascular conditions including chronic heart failure, than 
continuous exercise regimens.
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During the supervised exercise training sessions all patients were motivated to exercise 
to their optimum capability within the limits previously defined. However, the 2-min 
rest period which followed each 2-min exercise bout was sufficient to allow any pain or 
discomfort to pass. This was particularly important for patients in the lower-limb 
exercise training group, who experienced some instances of extreme pain in the buttock, 
thigh or calf regions, depending on the site of their atherosclerotic lesions. Patients were 
urged to express their feelings of exertion and pain as honestly as possible during all 
training sessions.
The initial consultation session in this present study, undoubtedly played a major role 
regarding this studies success. Though comprehensive, it was lengthy and time 
consuming, lasting on average approximately 1.5 hr per patient. However, it is believed 
that without such an investment of time during the initial visit, the patient dropout rate 
during this present study would have been considerably higher and similar to those 
observed in other studies. Similarities can be drawn here with physician counselling, in 
which positive instruction and encouragement can make the difference between 
progressive immobility and deterioration, and an active, rewarding old age (Buckwalter,
1997). The initial consultation session served primarily to inform and educate patients 
on realistic expectations, however a degree of trust and a rapport between patient and 
investigator was developed and also a feeling of ease in the new surroundings. The 
regular contact and excellent rapport between the patients undergoing exercise training 
and the investigator undoubtedly played a major role and was crucial to the success of 
this present study. Regular contact with the control group of patients was achieved via 
weekly telephone contact.
Patient attrition was also minimised in the control group of patients who were only 
required to attend the Centre at 6-weekly intervals for assessment purposes. All patients 
in the control group were actively encouraged to “keep walking and stop smoking” 
(Housley, 1988), as per the advice which they would have received in the hospital 
setting and initial consultation visit in the Centre. Weekly telephone calls with the 
control patients provided them with emotional support which was comparable to that 
being received by patients randomised to the supervised exercise training classes.
During the weekly phone calls, physical activity status was assessed via completion of 
the PAD-PAR questionnaire. Patients also had an opportunity to discuss anxieties 
concerning their walking impairment.
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Physical activity status between groups
This study indicates that increases in self-reported physical activity were well-balanced 
between both supervised exercise training groups, as assessed using the PAD-PAR 
questionnaire. Physical activity is an important variable to consider in these patients 
given its potential role in subsequent cardiovascular disease morbidity and mortality 
(Otis et al. 2000). Knowledge of physical activity levels and tight control of the 
exercise training stimulus allows more robust conclusions to be drawn about the relative 
efficacy of different exercise regimens, and the extent to which symptomatic 
improvement can be attributed to supervised exercise, as opposed to changes in home- 
based physical activity.
Despite their advancing years, some patients continued to be in full or part-time 
employment. Over the course of the intervention period there were no observed changes 
in either the work or household activity domains of the PAD-PAR questionnaire, further 
highlighting that in the main, elderly patients maintain regular routines with regards to 
shopping activities, gardening, cleaning and general household chores, with very little 
fluctuation observed in any of the study groups over time. In a previous study of 51 
patients with PAD, the PAD-PAR questionnaire indicated that approximately 94% of 
activities performed by PAD patients with intermittent claudication are either of low or 
very low intensity and less than 2% of activities are of high intensity (Otis et al 2000). 
This is in line with the findings of this present study, since patients with intermittent 
claudication initially felt reluctant to engage in high intensity exercise.
The overall amount of physical activity undertaken by patients in both training groups 
increased throughout the intervention period, as indicated by an increased score in the 
leisure time (recreational) domain of the PAD-PAR questionnaire. This amounted to 
around 11 MET-h.wk’1. Although increased scores in this domain of the PAD-PAR 
have been reported after 24-weeks of treadmill exercise training, following which scores 
increased by 39 MET-h.wk’1 (Regensteiner et a l 1996), no changes in PAR scores 
have been observed following 12-weeks of strength training (Regensteiner et al 1996). 
In the latter study (Regensteiner et al 1996), the improvement in peak walking time 
was 123% following 24-weeks of treadmill exercise training, as measured by a graded 
treadmill protocol. Increases in the overall amount of physical activity undertaken by 
patients in the exercise training groups in the present study might, in some way at least, 
explain the observed improvements in both CD and MWD.
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The values for self-reported physical activity levels presented in this study (151 ± 8 and 
158 ± 7 MET-h.wk'1 for the lower- and upper-limb exercise training groups, 
respectively) are in agreement with the values reported by Regensteiner et al (1996) 
(Regensteiner et a l 1996) for patients with PAD (155 ± 31 MET-h.wk"1), but 
considerably higher than those presented by other authors, who have reported PAD- 
PAR scores in the range of 109 -  119 MET-h.wk'1 (Otis et a l 2000; Gardner et al 
2001). One explanation for this discrepancy may be the fact that some activities may 
have gone unreported in some patients due to poor recall (Otis et a l 2000). By 
comparison, healthy older subjects from a previous population study (San Luis Valley 
Diabetes study) have been reported to have a PAR score of 268 ± 49 MET-h.wk'1 
(Regensteiner et a l 1991).
A further possible explanation for the discrepancy in physical activity between studies 
is that in this study during the initial consultation session, a patient’s current physical 
activity status and exercise habits (walking, utilising an exercise bike in the home 
setting, swimming, dancing, bowling etc) were thoroughly investigated. During the 
consultation session, and prior to study group randomisation, the general hospital advice 
of “stop smoking and keep walking” (Housley, 1988) was given to all patients, with the 
emphasis being placed on increasing patients level of physical activity. At this stage and 
throughout the study period all patients were treated equally with regards to the advice 
given to them. With each patient their interest in the various types of physical activity 
were more deeply explored. Suggestions were made to each patient for increasing their 
level of physical activity within safe limits of perceived exertion in the home setting. 
Some patients requested and were given copies of the Borg RPE scales, since some 
patients initially expressed an interest in increasing their level of physical activity, thus 
these scales could help patients gauge their intensity of physical activity in the home 
setting.
When questioned, three-quarters of the patients randomised to the control group felt that 
the study had provided them with an incentive to perform physical activity. This was 
probably due to the fact that patients had taken on board the “stop smoking and keep 
walking” recommendation (Housley, 1988) and heeded the encouragement which was 
given to all patients during the consultation session. This advice was re-enforced on a 
weekly basis through telephone contact with these control patients. These patients 
increased their leisure time physical activity level in the home environment through
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increased participation in community based physical activities such as walking, 
dancing, swimming, bowling and the use of personal exercise bikes.
Despite this encouragement, an increase in leisure time physical activity (as assessed by 
the PAD-PAR questionnaire) was only observed up to the 12 week of the intervention 
period in these control patients. This indicates that self motivation is short-lived. 
Furthermore, at the end of the 24-week intervention period these patients did not 
perceive any change in their physical activity status, despite increases in physical
iLactivity being observed up to the 12 week. An increase in self-reported physical 
activity is not necessarily reflected by an improvement in walking performance, since 
no difference in actual walking ability (CD or MWD) was observed in these patients at 
any assessment time-point. It therefore appears that the form of exercise which is 
undertaken has to be specific and at an appropriate intensity to generate any defined 
clinical improvement.
The PAD-PAR has been criticised as not being an accurate measurement of free-living 
daily physical activity when compared to energy expenditure using the criterion method 
of doubly labelled water, and the PAD-PAR questionnaire measures have been reported 
to correlate poorly with clinical measures of PAD severity (Otis et a l 2000). One 
plausible reason why PAD-PAR responses are poorly correlated with the energy 
expenditure of physical activity is that the majority of physical activity performed by 
patients with claudication is unstructured (walking in and around the home) and more 
difficult to accurately report than more structured types of activities (Otis et al. 2000).
It has also been suggested that the PAD-PAR responses are prone to over-reporting 
bias, resulting from an average of approximately 9 hr of self-reported physical activity 
per day (Otis et a l 2000). Indeed Otis et al (Otis et a l 2000) believe that the PAD- 
PAR questionnaire is not a clinically useful tool in determining the physical activity 
level of patients with intermittent claudication.
The main reason for using the PAD-PAR measure in this study was to ensure that self- 
reported physical activity was balanced between the two exercising groups, rather than 
being used to precisely quantify the level of physical activity performed by any one 
group. As it is likely that any reporting bias would be controlled for by randomisation, 
our results show that the increase in self-reported physical activity level was well- 
balanced across the supervised exercise training groups. In addition to the supervised
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exercise classes, a few patients undertook extra leisure time walks or other activities 
such as swimming or cycling on an exercise cycle in the home setting. This may raise 
the question whether changes in lifestyle, rather than the exercise regime itself 
influenced the results. Additional changes in lifestyle were only observed in the initial 
weeks of the intervention study. Patients reported that due to the time commitment 
involved in attending the Centre on a twice weekly basis for the supervised training 
sessions, they had difficulty in physically committing themselves to extra physical 
activity in the community setting. Furthermore, it is believed that the improvement in 
walking performance in both exercise training groups can be attributable to the 
supervised exercise classes and not to changes in lifestyle, since for reasons stated these 
were minimal in only a few patients.
The self-perception of physical activity status was increased in both exercise training 
groups, in relation to baseline and control patients following the 24-week intervention 
period. When questioned, the majority of patients (91% and 93% of patients in the 
lower- and upper-limb training groups, respectively) stated that the study had provided 
them with an incentive to perform physical activity. These patients thus suggested that 
they were more inclined to continue keeping active in the home environment and 
community-setting through physical activities such as walking, dancing, swimming, 
bowling and the use of personal exercise bikes. These patients expressed an interest in 
pursuing such activities following the 24-week intervention period.
The use of the penultimate power output achieved in the respective arm- or leg-cranking 
assessments enabled exercise training intensity, used in the supervised training sessions 
to be balanced between the groups, equating to 85-90% of the respective limb specific 
peak VOi, ensuring a similar cardiovascular stimulus between training modalities. In 
addition to peak power output, monitoring of HR, perceived exertion and perceived pain 
ensured that the correct training intensities were used in the supervised exercise 
sessions. The reassessment of patients at 6-weekly intervals ensured that the exercise 
stimulus was maintained at this level throughout the intervention period and the interval 
style training regimen enabled exercise of this intensity to be well tolerated by the 
patients.
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Chapter 5 - Intervention Study Conclusions
This is the first study to comprehensively examine the influence of upper- and lower- 
limb aerobic exercise training on walking performance in patients with PAD and the 
effects that these have on functional capacity, community-based walking ability, pain 
tolerance, confidence in walking, quality of life and physical activity status. Knowledge 
of physical activity levels and tight control of the exercise training stimulus allow more 
robust conclusions to be drawn about the relative efficacy of both exercise regimens. 
Furthermore increases in self-perceived physical activity status as observed in this 
study, might be associated with patients being more physically independent (Gardner et 
al. 2001).
The findings of this randomised controlled trial indicate that the time course of 
improvement in walking performance following both exercise training regimens were 
similar throughout the 24-week intervention period. These results confirm earlier 
preliminary findings (Walker et al. 2000) that both upper- and lower-limb weight 
supported aerobic exercise training provide an adequate stimulus for evoking 
improvements in walking performance in patients with PAD. In this present study 
improved walking performance was associated with an improvement in a patient’s 
general health status, self-perceived walking ability, with perceived improvements in 
walking distance, speed and stair climbing ability. This study also suggests that the 
improvements in walking performance following upper-limb training are due to a 
combination of central cardiovascular and/or systemic mechanisms, in addition to an 
improvement in walking confidence and an adaptation in exercise pain threshold, which 
might enable patients to walk further beyond the ‘pain barrier’. Such an adaptation in 
pain threshold might also explain the perceived improvement in bodily pain, physical 
functioning and energy and vitality domains of quality of life observed in these patients.
These findings demonstrate the effectiveness of alternative aerobic exercise 
interventions for patients with PAD. Arm-cranking was very well tolerated by our 
patient cohorts, who were able to exercise at high exercise intensities using the interval 
training regimen. At this point in time, we do not envisage that arm-crank training 
would ever be used in isolation from leg-crank training, nor be considered the 
preferential treatment of choice. Rather, that arm-crank training might be used in
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conjuction with a program of other alternative exercise training modalities such as leg- 
cranking, or that a staged rehabilitation approach might be taken. Arm-crank training 
could be a very useful strategy for improving cardiovascular function and exercise pain 
tolerance in patients that have become physically inactive due to the discomfort that 
they encounter during walking, and may be particularly beneficial during the early 
stages of a rehabilitation program.
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Chapter 6 -  Follow-Up Study Results
6.1 Patient attendance and compliance to the follow-up assessment sessions
Of the 94 patients (32, 30 and 32 from the lower-, upper-limb and control groups, 
respectively) who completed the 24-week intervention period, compliance to the 6-, 12-, 
24- and 48-week follow-up assessments was high (Table 27), since only 16% of patients 
were unable to attend the 48-week follow-up time-point, primarily for medical reasons.
Table 27. Number of patients attending at each follow-up assessment time-point.
Follow-up
assessment
Lower-limb
training
Upper-limb
training
Control
group
6 weeks 28 30 28
12 weeks 29 30 28
24 weeks 29 26 28
48 weeks 27 25 27
Four patients from the lower-limb training group were unable to attend at the 6-week 
follow-up stage. One sustained a stroke, one developed bowel cancer, one underwent 
knee replacement surgery and one went on holiday to Australia. At the 12-week time- 
point, the patient who had gone on holiday to Australia had returned and was re­
assessed. Two patients had sustained an M.I. prior to the 48-week follow-up 
assessment.
All patients that had completed the intervention in the upper-limb training group were 
able to attend the 6- and 12-week follow-up assessments. However, four patients were 
unable to attend at the 24-week time-point. One patient developed a back problem, due 
to a slipped disc, one had sustained an M.I., one developed bowel cancer and a further 
patient developed lung cancer. Prior to the 48-week-time point a further patient 
underwent surgery for a ruptured aortic aneurysm.
Four patients from the control group were unable to attend at 6-week's follow-up. One 
had sustained a stroke, one an M.I., one received surgery for an aortic aneurysm repair 
and one was too ill, due to flu. At the 12- and 24-week follow-up time-points the patient 
who was ill with flu at 6-weeks attended, however a further patient sustained a stroke. 
Prior to the 48-week follow-up session a further patient developed bowel cancer.
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6.2 Post-intervention study walking performance
6.2.1 Claudication distance
The CD of patients assigned to the lower- and upper-limb exercise training programme 
remained increased up to the 24- and 48-week follow-up assessment time-points, 
respectively, in relation to baseline measures (.P at least < 0.05). However these 
observed increases were not significantly different from the patients assigned to the 
control group (Table 28). Data were not normally distributed and are presented as 
median, with range in parentheses. Statistical analyses were performed on log 
transformed data.
Table 28. Claudication distance data at each assessment stage of the follow-up period.
Post-
intervention
follow-up
period
Lower-limb
training
Upper-limb
training
Control
group
Baseline 67 104 94e\/—S Data (20 - 274) (25 - 430) (28 - 408)B
« 6 106** 164** 94Wect weeks post (26-312) (53 - 402) (23 - 503)-+-*GC /oT5 bX)e 12 104** 159** 96
S3o csu weeks post (27 - 287) (34 - 425) (37 - 438)
a 24 95** 149** 100
53CQ
weeks post (35-317) (58-513) (17-396)
u 48 80 151* 106
weeks post (31-301) (33 - 455) (20 - 350)
Data are presented as median value (with ranges). Statistical significance: * P < 0.05; ** P < 
0.01 indicate significantly higher than baseline.
Considering the mean individual percentage difference data, compared to baseline, at 
the 48-week follow-up time-point, CD in the lower- and upper-limb exercise trained 
groups remained improved by 48% and 39%, respectively (P < 0.05; Figure 28). The 
difference between the two exercise trained groups was not significant.
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Lower-limb Upper-limb Control
training training group
Figure 28. Claudication Distance at 48-weeks follow-up. Data are presented as the mean % 
difference at the 48-week follow-up time-point, in relation to baseline measures, ± SEM. f P < 
0.05 indicates significance between the lower- or upper-limb exercise trained groups and the 
control group of patients.
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Up to 12-weeks following the 24-week intervention period, CD remained improved to a 
greater extent in the group of patients who had undertaken lower-limb exercise training, 
compared to baseline values (Table 29).
Table 29. Mean percentage change in CD from baseline at each assessment stage of the 
follow-up period.
Post­
intervention Lower-limb Upper-limb Controlfollow-up
period training training group
(weeks)
B 6 + 57**} + 43*} -2
JsoV o 12 + 61**} + 39**} 2a•  P P a
f \ 'qwc«u
£ 24
+ 46**| + 45*f 1
4m
s
0s 48 + 48*f + 39*f - 1
Data are presented as the mean % difference from baseline. * P < 0.05; ** P < 0.05 indicate 
significance from baseline, f P < 0.05; } P < 0.01 indicates significance between the leg- or 
arm-training group and the control group of patients.
Heart rate, blood lactate, perceived exertion and perceived pain responses were assessed 
during the incremental walking test to assess the consistency of effort and level of pain 
experienced between walking assessments at the different time-points during the 
follow-up period.
6.2.1.1 Heart rate at claudication distance during the follow-up period
HR at CD was unchanged in all groups at each assessment time-point during the follow-
up period (Figure 29).
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Figure 29. HR at claudication during the follow-up period. Data are presented at mean ± SEM 
at each assessment time-point during the follow-up period.
6.2.1.2 Perceived pain at claudication distance during the follow-up assessments 
The degree of pain experienced at CD in the main was rated to be between ‘extremely’ 
and ‘very weak’ (i.e. 0.5 and 1 on the Borg CR-10 scale) and was consistent between 
groups, at the 6- and 12-week follow-up assessments. Interestingly, at the 24-week 
time-point, pain was rated to be less intense by both groups who had undertaken 
exercise training during the intervention period, compared to the control group of 
patients (P at least < 0.05). Furthermore, the observation in the lower-limb training 
group that pain was rated as less intense at CD upon completing the 24-week 
intervention study, in relation to baseline measures, was also observed at each follow-up 
assessment time-point. These patients perceived their pain to be “extremely weak” (i.e. 
0.5 on the Borg CR-10 scale) compared to “very weak” at baseline (P < 0.05). A similar 
observation was also observed in the upper-limb training group up to the 24-week 
follow-up assessment time-point (P < 0.05; Table 30).
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Table 30. Perceived pain (Borg CR-10 scale) at CD, at each stage of the follow-up
period.
Post­
intervention 
follow-up 
period 
(weeks)
Lower-limb
training
Upper-limb
training
Control
group
QU
-+Me*
*3 /aTOh
73Q V I£ ©*0> rHou ciaCm uuoPQ
Baseline 1.0 (0.3 - 3.0)
1.0 
(0.5-3.0)
2.0 
(0.5 - 3.0)
6 0.5** (0.3-3.0)
1.0* 
(0.3 - 2.0)
0.8 
(0.3 - 3.0)
12 0.5* (0.3 - 3.0)
0.5* 
(0.3-3.0)
0.8 
(0.3 - 4.0)
24 0 5**f(0.3 - 2.0)
0.5* f 
(0.3 - 2.0)
1.0 
(0.3 - 3.0)
48 0.5** (0.3 - 2.0)
1.0 
(0.3 - 4.0)
1.0 
(0.3 - 4.0)
Data are presented as median (range). * P < 0.05; ** P < 0.01 indicates significance from 
baseline measures, f  P < 0.05 indicates significance between the leg- or arm-training group, 
compared with the control group of patients.
6.2.2 Maximum walking distance during the follow-up assessments
The pattern of sustained improvement in MWD at each follow-up assessment (Figure 
30) was similar to that observed for CD. At the 48-week follow-up time-point, MWD 
remained improved by 26% and 18% in the patients who had undertook lower- and 
upper-limb exercise training, respectively, compared with baseline measures (P at least 
< 0.05; Table 31) and control patients (P at least < 0.05; Table 31). A trend indicating 
deterioration in MWD was observed in the control group of patients at each assessment 
time-point.
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Table 31. Mean percentage change in MWD from baseline at each assessment stage of
the follow-up period.
Post-
intervention
follow-up
period
Lower-limb
training
Upper-limb
training
Control
group
oosou
c«
So*+4
weeks post 
12
weeks post 
24
weeks post 
48
weeks post
+ 33**1
+ 29**J 
+ 27**{ 
+ 26**J
+ 23**J 
+ 25**J 
+ 22**{ 
+ 18*t
-6
-4
-2
-2
Data are presented as mean % difference from baseline. * P < 0.05; ** P < 0.01 indicates 
significance from baseline measures, f P < 0.05; $ P < 0.01 indicate significance between the 
leg- or arm-training group and the control group of patients.
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6.2.2.1 Peak heart rate at MWD
The sustained improvements in MWD in both groups of patients who had undertaken 
exercise training were associated with HR at MWD being greater compared to the 
control group of patients at each follow-up assessment time-point (P at least < 0.05; 
Figure 31). However compared to baseline measures, HR at MWD only remained 
increased in the group who had undertaken lower-limb exercise training (109 ± 4 vs. 
121 ± 5 beats.min'1; comparing pre-intervention and data at the 48-week follow-up 
time-point), indicating these patients were continuing to attain a higher level of 
cardiovascular stress at MWD up to 48-weeks follow-up. The differences in HR 
between the two training groups were not significant.
140 -I 
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Figure 31. HR at MWD during the follow-up period. Data are presented as mean ± SEM at 
each assessment stage, during the follow-up period. * P < 0.05; ** P < 0.01 indicates 
significance compared to baseline, f  P < 0.05; $ P < 0.01 indicates significance between the 
leg- or arm-training group and the control group of patients.
-O—  Leg-training group 
Arm-training group 
A- • • Control group * * J * t
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6.2.2.2 Peak blood lactate at MWD
At the 12-week follow-up assessment time-point, blood lactate concentration at MWD 
was higher in both groups who had undertaken exercise training, compared to the 
control group of patients {P at least < 0.05). At the 24-week follow-up time-point, blood 
lactate was only higher in the patients who had undertaken upper-limb exercise training, 
in relation to control patients (P < 0.05), whereas at the 48-week follow-up time-point 
the concentration of blood lactate at MWD was only higher in the patients who had 
undertaken lower-limb exercise training compared to the control group of patients (P < 
0.05; Figure 32). No changes in these parameters were observed in the control group of 
patients.
6.2.2.3 Peak blood lactate 5-min post MWD
At the 6- and 12-week follow-up time-points, the concentration of blood lactate taken 5- 
min post MWD was higher in the group of patients who had undertaken lower-limb 
exercise training only, in relation to baseline measures (P at least < 0.01) and control 
patients (P < 0.05). At the 24- and 48-week follow-up time-points blood lactate 5-min 
post MWD remained increased in these patients, in relation to baseline measures only 
( P < 0  .05). In the group of patients who had undertaken upper-limb exercise training, 
differences were only observed at the 12- and 24-week follow-up time-points, in 
relation to the control group (P < 0.05). No changes in these parameters were observed 
in the control group of patients (Figure 32).
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Figure 32. Blood lactate concentration at MWD and 5-min post MWD during the follow-up period. Data are presented as mean ± SEM, at each assessment stage 
during the follow-up period. * P < 0.05; ** P < 0.01 indicates significance from baseline, f P < 0.05; $ P < 0.01 indicates significance between the leg-or arm- 
training group and the control group of patients.
6.2.2.4 Perceived exertion and perceived pain at MWD
At the 12-week follow-up time-point an increase in the amount of pain experienced at 
MWD was observed in both groups who had undertaken exercise training, compared to 
the control group of patients (P < 0.05). An increase in RPE was associated with this 
increase in perceived pain at this time-point, in patients who had undertaken lower-limb 
exercise training, compared to the upper-limb training and control group of patients (P 
< 0.05). However compared to baseline measures, at each follow-up time-point 
perceived pain at MWD only remained increased in the group who had undertaken 
upper-limb exercise training (P at least <0.05; Table 32).
Table 32. Perceived pain (Borg CR-10 scale) and perceived exertion (Borg RPE scale)
at M W D at each assessment stage of the follow-up period.
Follow-Up Lower-limb Upper-limb Control
period training training group
(weeks)
Baseline 7.0 5.0 6.0(3.0-11.0) (3.0-11.0) (3.0-11.0)
jy 7.0 7.0* 5.0PP • PpC3Oh
vZo
Q
0 (2.5-11.0) (1.0-11.0) (2.0-10.0)
*0<u
©▼H1 £ 7.0f 7 0 * * f 5.0> • pP«fj V S-«-»
12 (3.0-11.0) (3.0-11.0) (1.0-10.0)
ua> 60U
C3
1  A 7.0 9.0* 6.0o
M 24 (3.0-11.0) (2.0-11.0) (2.5-11.0)
A O 7.0 7.0* 5.04o (3.0-11.0) (3.0-11.0) (2.0-10.0)
Baseline 13.0 15 15.0(11.0-20.0) (7.0 - 20.0) (7.0-19.0)
a£ 'aT r 15.0 15.0 15’•*35- w o (11.0-20.0) (6.0 - 20.0) (9.0 - 20.0)QJX 03 QW (3 £ ■t i 17.0 f'F 14.0 14.5T3
> E £
12 (12.0 - 20.0) (6.0 - 20.0) (7.0-19.0)
’«v
W)u© a 24 16.0 15.0 15.0uu t t (13.0-19.0) (6.0 - 20.0) (11.0-19.0)
A O 16.0 15.0 14.54o (12.0 - 20.0) (6.0 - 20.0) (8.0 - 20.0)
Data are presented as median (range). * P < 0.05; ** P < O.Olindicate significance compared to 
baseline, f  P < 0.05 indicates significance between the leg- or arm-training group and the 
control group of patients. ¥  indicate significance between the leg- and arm-training group of 
patients.
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6.2.3 Confidence in w alking during the fo llow -up  period
The retained improvement in walking ability observed in both patient groups that had 
undertaken exercise training was also associated with a continued improved confidence 
in walking at all follow-up assessment time-points compared to baseline measures (P < 
0.01). However, the increased confidence in walking was not significant when 
compared with the control group of patients. Furthermore, walking confidence was also 
improved in the control group of patients at 6-, 12- and 24-week follow-up time-points 
(P < 0.05; Table 33), but not at the 48-week follow-up time-point.
Table 33. Patients perceived confidence in walking at each assessment stage of the 
follow-up period.
Post­
intervention 
Follow-Up 
period 
(weeks)
Lower-limb
training
Upper-limb
training
Control
group
6X)
S33
*
S3a>«S3QJ*0
S3oU
Baseline
6
12
24
48
5.0 5.0 8.0
(2.0-10.0) (2.0-10.0) (1.0-10.0)
9.0** 9.0** 9.0*
(4.0-10.0) (1.0-10.0) (3.0-10.0)
9.0** 10.0** 9.0*
(4.0-10.0) (5.0-10.0) (3.0-10.0)
9.0** 10.0** 9.0*
(4.0-10.0) (5.0-10.0) (3.0-10.0)
9.0** 10.0** 9.0
(3.0-10.0) (3.0-10.0) (3.0-10.0)
Data are presented as the median (range). * P < 0.05; ** P < 0.01 indicates significance from 
baseline. Data are presented from 19, 15 and 17 patients from the lower-, upper-limb training 
and control groups, respectively.
6.2.4 Changes in A B P I  during the fo llow -up period
Although walking ability remained improved over baseline measures in the patients 
who had undertaken exercise training, resting ABPI was unchanged at each assessment 
time-point throughout the post-intervention follow-up period in all study groups. A 
significant decrease in post shuttle-walk ABPI was observed 6- and 12-weeks post­
intervention in both groups that had undertaken exercise training (P at least < 0.05), and
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at 24-weeks follow-up in the group that had undertaken upper-limb exercise training, 
compared to baseline measures (P < 0.05; Table 34). These data again suggest that 
these patients were pushing themselves further beyond the pain barrier at these time- 
points.
Table 34. Resting, post shuttle-walk and mean individual difference in ABPI at each 
assessment stage of the follow-up period.
Post-
Intervention
Follow-Up
Period
(weeks)
Lower-limb
training
Upper-limb
training
Control
group
Baseline 0.67 (± 0.03) 0.66 (± 0.03) 0.72 (± 0.04)
WD 6 0.65 (± 0.03) 0.66 (± 0.03) 0.69 (± 0.04)a• PN HHOhM 12 0.64 (± 0.03) 0.64 (± 0.03) 0.67 (± 0.03)CJ& < 24 0.65 (± 0.03) 0.65 (± 0.04) 0.68 (± 0.04)
48 0.65 (± 0.03) 0.62 (± 0.04) 0.62 (± 0.04)
Baseline 0.45 (± 0.04) 0.42 (± 0.03) 0.50 (± 0.05)
*i 6 0.34 (± 0.03)** 0.32 (± 0.02)**t 0.45 (± 0.05)HH-+■» P-l 12 0.34 (± 0.03)**f 0.34 (± 0.03)*f 0.47 (± 0.04)<in-*■»cn 24 0.36 (± 0.04) 0.32 (± 0.03)*f 0.45 (± 0.04)OOh 48 0.36 (± 0.04) 0.36 (± 0.04) 0.42 (± 0.04)
Baseline - 0.22 (± 0.03) - 0.26 (± 0.03) - 0.23 (± 0.03)V /S5VG G• PN 6 -0.32 (±0.02)** - 0.34 (± 0.03)f - 0.24 (± 0.03)
£ E O£ 12 -0.31 (±0.03)**f - 0.30 (± 0.03) -0.21 (±0.03)
S  ^ icaQi
VIO
&
24 - 0.29 (± 0.03) - 0.34 (± 0.03)*f - 0.23 (± 0.02)
s 48 - 0.29 (± 0.04) - 0.26 (± 0.03) -0.21 (±0.03)
Data are presented as mean ± S.E.M, at each assessment stage of the post-intervention period. 
* P < 0.05; ** P < 0.01 indicate significance from baseline, f  P < 0.05 indicates significance 
between the leg or arm-training group and the control group of patients.
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6.3 Walking Impairment Questionnaire domains
6.3.1 Claudication pa in  severity, walking distance, walking speed and  stair 
clim bing ability during the fo llow -up period
Claudication pain severity remained unchanged in all groups throughout the follow-up 
period. Both groups who had undertaken exercise training continued to perceive an 
improvement in walking distance throughout the follow-up period, compared to 
baseline measures (P at least < 0.05). Compared to the control group, a retained 
improvement in walking distance was perceived up to the 24- and 48-week follow-up 
time-points in the lower- and upper-limb exercise training groups, respectively (P < 
0.05). Both groups who had undertaken exercise training perceived a retained 
improvement in walking speed at 12- and 24-week follow-up time-points, in relation to 
control patients (P at least < 0.01). However, compared to baseline measures this 
improvement was only significant in patients who had undertaken upper-limb exercise 
training (P < 0.01). Stair climbing ability also continued to be improved in both groups 
who had undertaken exercise training up to the 24-week follow-up time-point, in 
relation to baseline measures (P at least < 0.05). This perceived improvement was only 
significant at the 24-week and at the 12-, 24- and 48-week time-points in patients who 
had undertaken lower- and upper-limb exercise training, respectively (P  < 0.05; Table 
35).
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Table 35. Changes in WIQ domains at each assessment stage of the follow-up period.
Post­
intervention Lower-limb Upper-limb Control
period training training group
(weeks)
Baseline 50 (25-75) 50 (0-75) 50 (25-75)
G'O*-£2 &  • miu 6 50 (25-75) 50 (0-75) 50(25-100)a
' O
3
0>Xfl
mi
12 50 (25-75) 50 (25-75) 50 (25-75)
C3
□
• mia
O h 24 50 (25-75) 50 (0-75) 50 (25-75)
48 50 (25-75) 50 (0-100) 50 (25-75)
Baseline 26 (4-89) 27 (0-100) 18 (2-89)
fcDg j
«(j 6 44 (7-89)*f 51 (2-100)*t 21 (2-89)
g
CS
GG 12 54 (10-83)*t 51 (l-100)*f 24 (3-83)
5 24 40 (9-83)*f 55 (2-100)* 15(2-100)
48 34 (5-89)* 62 (5-100)**t 18(3-100)
Baseline 28 (0-89) 28 (0-93) 28 (3-89)
b £ 6 50(15-89) 50 (0-89) 29(10-89)G nsg
CS
wQia 12 39 (25-78)f 50 (3-93)**J 26 (0-83)
£ cn 24 43 (22-89)t 50 (0-100)**t 32 (0-83)
48 36 (7-89) 50 (0-100) 33 (3-89)
t J jG• mipfis
c
Baseline 42 (8-88) 42 (8-100) 30 (0-100)
&• pN
• pNSi
6
12
67 (8-100)** 
67 (8-100)*
67 (8-100) 
79 (4-100)**f
33 (0-100) 
33 (0-100)
<
CZ5
24 67 (13-100)*f 67 (0-100)*t 42 (0-100)
48 50 (8-100) 79 (0-100)f 38 (0-100)
Data are presented as median (range), at each assessment stage o f the intervention period. * P < 
0.05; ** P < 0.01 indicates significance from baseline, f  P < 0.05; $ P < 0.01 indicate 
significance between the leg- or arm-training group and the control group of patients.
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6.4 Physical activity
6.4.1 Selfpercep tion  o fphysica l activity status during the fo llow -up  period  
An increase in physical activity status was observed in all three study groups at 6-, 12- 
and 24-week follow-up time-points, relative to baseline measures (P < 0.01). However, 
at the 48-week follow-up time-point physical activity status remained increased in both 
groups that had undertaken exercise training, relative to baseline measures (P< 0.01; 
Table 36).
Table 36. Patients self-assessed physical activity status.
Post-
Intervention Lower-limb Upper-limb ControlFollow-Up training training groupPeriod
(weeks)
•I—I
Pm <
ViacsC/5
Baseline
12
24
48
2.0 6.0 6.0
(0-10) (0- 10) (0- 10)
6.0** 6.0** 6.0**
(2- 10) (2- 10) (0-10)
6.0** 6.0** 6.0**
(2-10) (2- 10) (0- 10)
6.0** 6.0** 6.0**
(2- 10) (2- 10) (0- 10)
6.0** 6.0** 6.0
(2- 10) (0- 10) (0-10)
Data are presented as the median (range). ** P < 0.01 from baseline measures.
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6.4.2 Global PA D -PA R physical activity during the fo llow -up  period
There was no change in global physical activity status, either within or between study 
groups at any time-point throughout the follow-up period (Figure 33).
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48
Figure33. PAD-PAR Global Physical Activity during the follow-up period. Data are presented 
as mean ± SEM.
6.4.2.1 PAD-PAR work, household and leisure-time physical activity 
There was no difference between or within study groups in the level of work activities 
or in the household chores domain of the PAD-PAR questionnaire throughout the 
follow-up period (Figure 34). An increase in the leisure-time domain of the PAD-PAR 
questionnaire at the 24-week follow-up time-point relative to baseline measures was 
only observed in patients who had undertaken upper-limb exercise training (64 ± 5 vs. 
69 ± 5 MET-h.wk"1; P < 0.05; Figure 34).
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Figure 34. PAD-PAR scores relating to work, household and leisure activities during the 
follow-up period. Data are presented as mean ± SEM. * P < 0.05 indicates significance from 
baseline.
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6.5 Quality of life -  SF-36 v2 questionnaire
6.5.1 The influence o f  exercise on the domains ofphysical function during the 
follow-up period
The general health of patients in the upper-limb exercise training group continued to be 
perceived to be better than that in the control group at 12- and 48-week follow-up time- 
points {P < 0.05). However, a persistent improvement in this domain was not observed 
throughout the follow-up period. The degree of bodily pain experienced by patients 
following the intervention period was no different to that present at baseline, although 
compared to the control patients, an improvement at the 12-week follow-up time-point 
was perceived in the group of patients who had undertaken upper-limb exercise training 
only (P < 0.05). No difference in the physical function and the role limitation physical 
domains of the SF-36 v2 were observed either between or within study groups at any 
follow-up assessment time-point (Figure 35).
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6.5.2 The in fluence o f  exercise on the domains o f  m ental health during the fo llow - 
up period
Energy and vitality remained improved at 12-, 24- and 48-week follow-up time-points 
in patients who had undertaken upper-limb exercise training as compared to the control 
group of patients (P < 0.05; Figure 36). However, although improved, these changes 
were not of statistical significance when comparisons were made with the baseline 
measures. There was no significant difference in the mental health, social functioning or 
role limitation emotional domains of the SF-36 v2 during the follow-up period, either 
within or between the study groups (Figure 36).
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6.6 General Health Status - EuroQol (EQ-5D) Questionnaire
The general health of patients who had undertaken lower-limb exercise training was 
perceived to be better at 6-, 12- and 24-week follow-up time-points, compared to 
baseline measures (P at least < 0.05) and up to the 12-week follow-up time-point in 
relation to control patients (P < 0.05; Table 37). Patients who had undertaken upper- 
limb exercise training perceived an improvement in general health and ability to 
perform usual activities at the 12-week follow-up time-point, compared to control 
patients (P at least < 0.05; Table 37). However, the difference from baseline measures 
in these domains, in these patients, was not significant. No changes in the domains of 
mobility, self care, bodily pain and discomfort, and anxiety and depression were 
observed at any follow-up assessment time-point, either between or within study groups 
(Table 37).
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Table 37. EuroQol (EQ-5D) questionnaire domains throughout the follow-up period.
Follow- Up 
Period 
(weeks)
Lower-limb
Training
Upper-Iimb
Training
Control
Group
Baseline 65 (40-95) 70 (35 -  90) 60 (40-95)
w 6 70 (45 -  95) **f 7 0 (4 5 -9 0 ) 55 (25-90)
§ 3 12
24
70(40-100) *t 
70 (38 -  100) *
75 (50 — 90) J 
8 0 (4 0 -9 0 )
60 (40-95) 
60 (4 0 -9 5 )
48 75 (35-95) 70 (3 0 -9 4 ) 58 (40-94)
Baseline 65 (2 5 - 100) 75 (5 0 -  100) 73 (3 5 - 100)
£ 6 60 (3 5 - 100) 75 (50 -9 0 ) 70 (5 0 - 100)
X!o 12 70 (45-100) 80 (5 0 -9 0 ) 63 (50-95)
% 24 70(4 0 -9 5 ) 80(40-100) 70 (35-90)
48 70 (30-95) 7 0 (4 0 -9 0 ) 70(40-100)
Baseline 100 (70-100) 100 (7 5 -  100) 100 (30-100)
.. . Ci 6 100 (60-100) 98 (75-100) 100 (60-100)SS u « eg GC 0 12 100 (60-100) 98 (7 0 -  100) 99 (50-100)
24 100 (60-100) 95 (50-100) 93 (50-100)
48 100(10-100) 95 (7 0 -  100) 94 (70-100)
Baseline 70 (25 -  100) 70 (25 -  95) 50 (30-100)
cw— .« 6 70 (25-100) 70 (25 -100) 59 (25 -  95)5 •- ^ > 12 70 (25 -100) 80 (2 5 -  100) f 60 (28 -  90)
< 24 7 5 (2 5 - 100) 70 (3 0 -9 0 ) 75 (30-100)
48 60 (30-95) 75 (1 0 -9 5 ) 50(1 0 -9 0 )
ari i » Baseline 65 (25 -  90) 70 (5 -9 5 ) 58 (25-100).3 ucS ar\ ,7  «  a*  a §to rj
6
12
75 (2 5 -  100) 
75 (30-100)
75 (25 -  95) 
75 (25 -  90)
70 (20 -95 ) 
60 (25 -  80)
*a %
& s 24 65 (25-95) 75 (3 0 -9 5 ) 70 (25 -90 )48 70 (25-95) 75 (20 -  90) 69 (20 -90 )
Baseline 80 (5 0 - 100) 95 (3 0 -  100) 90 (5 0 -  100)c&  .2.2 'O « H cs «S « fc
6
12
80(40-100) 
82 (3 0 -  100)
90 (50-100) 
92 (50-100)
93 (75-100) 
90 (25 -100)
«Q 24 85 (6 0 - 100) 90 (60-100) 90 (70-100)
48 80 (40-100) 95 (55-100) 90 (60-100)
Data are presented as median (range), at each assessment stage of the follow-up period, where 0% and 
100% indicate severe difficulty and no difficulty, respectively. * P < 0.05; ** P < 0.01 indicate 
significance from baseline, f P < 0.05; %P < 0.01 indicate significance between the leg- or arm- 
training group and the control group of patients.
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6.7 Cardiorespiratory function throughout the follow-up period as assessed 
during the leg-and arm-cranking assessments
6.7,1 Peak power output
The retained improvement in walking performance observed during the follow-up 
period in both exercise groups was accompanied by a continued increase in peak power 
output at maximum exercise tolerance during the LCT up to the 48-week follow-up 
time-point, compared to baseline measures (.P <0.01) and control patients (P <0.01; 
Table 38). Similarly, peak power output during the ACT also remained increased in 
both exercise groups at each follow-up time-point, compared to baseline measures (.P < 
0.01) and control patients (P < 0.01; Table 38).
The training effect continued to be most apparent for the specific training apparatus, 
although there was some cross over improvement with respect to the alternative exercise 
modality. As compared to baseline, maximum power output during the LCT and ACT 
remained increased by 21% and 14%, and by 15% and 30 % in the lower- and upper- 
limb training groups, respectively. These findings indicated that the improvement in 
peak power output for both trained and untrained skeletal muscle groups, in trained 
patients persisted.
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Table 38. Peak power output at maximum exercise tolerance during the LCT and ACT
at each assessment stage of the follow-up period.
Follow-Up
Period
Power Output (W)
(weeks) LCT ACT
Baseline 67 46
b£ (38-96) (31 -67)#C*8a5-i
6 81**} (53 -  139)
53**}
(31 -74 )
H.a8»N 12
96**} 
(53 -  139)
53**}
(31 -81 )1u
*o 24
81**} 
(53 -124)
53**}
(31-81)
48 81**} (53 -124)
53**}
(24 -74)
Baseline
6
71 46
t J jea•p*au
(9 -140)
81**} 
(3 8 -  153)
(17 -82)
60**}
(31-103)
H
s
12 96**} (3 8 - 153)
53**}
(24-110)
a>
a
&
L 5
24
96**} 
(3 8 - 139)
60**}
(31-103)
48 81**}(24-139)
60**}
(31-110)
Baseline 67 38(24-105) (17 -60 )
Q  , ( i 53 35
0o ♦ .
o (9 -110) (17 -67)
M
o 12 53 35o5--*-* (9 -110) (17 -67)ao
U 24 67 38(9-110) (17 -67 )
48 53(9-110)
38
(9 -7 4 )
Data are presented as median (range), at each assessment stage of the follow-up period. ** P < 
0.01 indicates significance from baseline, f  P < 0.05; } P < 0.01 indicate significance between 
the leg- or arm-training group and the control group of patients.
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6.7 ,2P eak VO2
During the LCT peak VO2 at maximum exercise tolerance remained improved in both 
exercise trained groups at the 6-week follow-up time-point, compared to baseline (P < 
0.05) and control patients (P at least < 0.05), but at 48-weeks follow-up peak VO2 was 
unchanged from baseline measures in all study groups. Throughout the follow-up 
period, during the ACT peak VO2 was unchanged from baseline measures in both 
exercise trained groups. However, compared to control patients, peak VO2 remained 
improved in the upper-limb exercise trained patients up to 48-weeks follow-up during 
both the LCT and ACT (P < 0.01). Peak VO2 remained unchanged in the control group 
of patients, during both the LCT and ACT throughout the follow-up period (Figure 37).
6.7 .3Peak VCO2
The pattern of peak VCO2 responses was similar to those of peak VO2 . At maximum 
exercise tolerance during both the LCT and ACT peak VCO2 remained increased in 
both exercise trained patients at the 6-week follow-up time-point compared to baseline 
(P at least < 0.05), but at 48-weeks follow-up peak VCO2 was unchanged from baseline 
measures in all study groups. Compared to control patients peak VCO2 remained 
increased in both exercise trained patients during the LCT at 6-weeks follow-up (P < 
0.05). At 48-weeks follow-up during both the LCT and ACT an increase was only 
observed in the upper-limb trained patients, compared to the control patients (P < 0.01). 
Peak VCO2 remained unchanged during both the LCT and ACT in the control group of 
patients throughout the follow-up period (Figure 38).
6.7.4 P eak R E R
No significant differences were observed in peak RER during the LCT, within any of 
the study groups over the course of the follow-up period (Figure 39). During the ACT, 
peak RER was higher at the 48-week follow-up time-point, compared to the control 
group of patients (P < 0.01). No other differences between or within groups were 
observed during the ACT (Figure 39).
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Figure 38 Changes in peak VCO2 during the leg-and arm-cranking assessments during the follow-up period. Data are presented as mean ± SEM at maximum exercise 
tolerance, at each assessment stage during the follow-up period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; %P < 0.01 between the leg- or arm-training 
group and the control group of patients.
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Figure 39. Changes in peak RER during the leg- and arm-cranking assessments during the follow-up period. Data are presented as mean ± SEM at maximum exercise 
tolerance, at each assessment stage during the follow-up period. % P < 0.01 between the leg- or arm-training group and the control group of patients.
6.7.5Peak VE
At maximum exercise tolerance during both the LCT and ACT, at 6-weeks follow-up 
peak VE remained increased in both exercise trained groups of patients, compared to 
baseline (P at least < 0.05). At 48-weeks follow-up an increase compared to baseline 
was only observed during the LCT in the group of patients who had undertaken lower- 
limb exercise training (38.1 ± 2.3 vs. 43.1 ± 2.7 l.min'1; P < 0.05; Figure 40). Compared 
to control patients peak VE remained increased upto 48-weeks follow-up in both 
exercise trained groups, during both the LCT and ACT (P at least < 0.05). No change in 
peak VE was observed in the control group of patients during the LCT or ACT 
throughout the follow-up period (Figure 40).
6.7.6Peak VE/VOi
Peak values for the ventilatory equivalent for oxygen (VE/VO2 ) during the LCT at 
maximum exercise tolerance at 6-weeks follow-up remained increased in the lower-limb 
trained group of patients only, compared to baseline (P < 0.05) and control patients (P 
< 0.05). At the 48-week follow-up time-point peak VE/VO2 was unchanged from 
baseline measures in these patients (Figure 41). During the ACT peak VE/VO2 
remained increased at 6-weeks follow-up in patients who had undertaken upper-limb 
exercise training only, compared to baseline (P < 0.05) and control patients (P < 0.05),. 
However at 48-weeks follow-up this retained increase was only significant compared to 
the control group of patients (P < 0.05). No change in peak VEIVO2 was observed in 
the control group of patients during the LCT or ACT throughout the follow-up period 
(Figure 41).
213
LCT ACT
ACA A
.f. 
t. 
A A
**
<H
<H
OO"d-'3-CN<N'OI<uc/3cdm
C/3<DCD"T3.2CDPP&£OOPP
om
m,d-
o
inm
I- uiurj
oCO
mCN
OO
<H
CNCN
O£0U1<3
mm
om
in
o
UIUI'T 
I- * 
1
mm
om
C/3
MCDCDT3•SCDPP£aoPh
Figure 40. Changes in peak VE during the leg- and arm-cranking assessments during the follow-up period. Data are presented as mean ± SEM at maximum exercise 
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Figure 41. Changes in peak VElVOi during the leg- and arm-cranking assessments during the follow-up period. Data are presented as mean ± S.E.M at maximum 
exercise tolerance, at each assessment stage during the follow-up period. * P < 0.05 compared to baseline, f P < 0.05 between the leg- or arm-training group and the 
control group of patients.
6.7.7 Peak breath frequency (Bf)
Peak breath frequency at maximum exercise tolerance remained higher during both the 
LCT and ACT in both exercise groups at 6-weeks follow-up, compared to baseline 
measures (P at least < 0.05), but was unchanged at the 48-week follow-up time-point. 
No change in peak breath frequency was observed in the control group throughout the 
follow-up period (Figure 42).
6.7.8 Peak tidal volume (Vt)
At 6-weeks follow-up peak tidal volume during the LCT remained higher compared to 
baseline measures in patients who were lower-limb trained (P < 0.01), but at the 48- 
week follow-up time-point no change from baseline was observed (Figure 43). 
Compared to baseline measures peak tidal volume was unchanged in both exercise 
trained groups during the ACT throughout the follow-up period. However at 6-weeks 
follow-up, tidal volume was greater in patients who who had undertaken upper-limb 
exercise training, compared to control patients (P < 0.01), and greater in both exercise 
groups at 48-weeks follow-up, compared to control patients (P at least < 0.05). Peak 
tidal volume was unchaged in the control patients during both the LCT and ACT 
throughout the follow-up period (Figure 43).
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Figure 42. Changes in Peak Breath Frequency during the leg- and arm-cranking assessments during the follow-up period. Data are presented as mean ± SEM at 
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Figure 43. Changes in Peak Tidal Volume during the leg and arm cranking assessments during the follow-up period. Data are presented as mean ± SEM at maximum 
exercise tolerance, at each assessment stage during the follow-up period.. ** P < 0.01 compared to baseline, f P < 0.05; $ P < 0.01 between the leg or arm-training 
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6.8 Peak cardiovascular responses throughout the follow-up period
6.8.1 Peak systolic blood pressure (SBP)
Peak SBP during both the LCT and ACT assessment remained unchanged from baseline 
in both groups of exercise trained patients, throughout the course of the follow-up 
period. However, compared to control patients, at the 6-weeks follow-up time-point 
SBP was greater in the upper-limb trained group during the LCT (P < 0.05; Figure 44). 
During the ACT, at all follow-up time-points SBP was higher in the group of patients 
who had performed upper-limb exercise training, compared to control patients (P at 
least < 0.05). At all follow-up assessment time-points, peak SBP during the ACT was 
significantly lower in the control group of patients, as compared to baseline (P <0.01; 
Figure 44).
6.8.2 Peak diastolic blood pressure (DBP)
Peak DBP during the LCT remained unchanged from baseline in both groups of 
exercise trained patients, throughout the course of the follow-up period. At the 6-week 
follow-up time-point, peak DBP during the LCT was lower than that at baseline in the 
control group of patients (P < 0.05) and was also lower than baseline during the ACT at 
all follow-up assessment time-points (P < 0.01). Similarly, peak DBP during the ACT 
was lower than that at baseline at 12-, 24- and 48-weeks follow-up in patients who had 
undertaken lower-limb exercise training (P at least < 0.05; Figure 45).
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Figure 44. Changes in Peak Systolic Blood Pressure during the leg- and arm-cranking assessments throughout the follow-up period. Data are presented as 
mean ± SEM at maximum exercise tolerance, at each assessment stage during the follow-up period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 
0.05; $ P < 0.01 between the leg- or arm-training group and the control group of patients.
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Figure 45. Changes in Peak Diastolic Blood Pressure during the leg- and arm-cranking assessments throughout the follow-up period. Data are presented 
as mean ± SEM at maximum exercise tolerance, at each assessment stage during the follow-up period * P < 0.05; ** P < 0.01 compared to baseline.
6.8.3 Peak h eart rate (HR)
Peak HR during the LCT and ACT remained unchanged from baseline in both groups of 
exercise trained patients, throughout the follow-up period. However, higher HR’s 
during LCT and ACT were observed in these patients, as compared to the control group, 
during all follow-up time-points (.P at least < 0.05). During the ACT, lower peak HR’s 
were observed in the control group of patients at the 6- and 12-week follow-up time- 
points (P at least < 0.01; Figure 46).
6.8.4 P eak rate pressure product (RPP)
A similar pattern of response was observed in peak RPP. During the LCT and ACT 
peak RPP remained unchanged from baseline in both groups of exercise trained 
patients, throughout the follow-up period. However, compared to the control group, at 
the 6- and 12-week follow-up time-points RPP remained increased in both exercise 
trained patient groups during the LCT (P <0.01) and at all follow-up time-points during 
the ACT (P at least < 0.05). During the LCT, at 48-weeks follow-up RPP remained 
increased in the upper-limb trained group of patients only, compared to the control 
group (P < 0.01). Lower RPP during the ACT was observed throughout the follow-up 
period in the control patients (P <0.01; Figure 47).
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Figure 46. Changes in Peak Heart Rate during the leg- and arm-cranking assessments throughout the follow-up period. Data are presented as mean ± SEM at 
maximum exercise tolerance, at each assessment stage during the follow-up period. * P < 0.05; ** P < 0.01 compared to baseline, f P < 0.05; %P < 0.01 
between the leg- or arm-training group and the control group of patients.
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Figure 47. Changes in Peak Rate Pressure Product during the leg- and arm-cranking assessments throughout the follow-up period. Data are presented as mean ± 
SEM at maximum exercise tolerance, at each assessment stage during the follow-up period. * P < 0.05; ** P < 0.01 compared to baseline. f P< 0.05; % P < 0.01 
between the leg or arm-training group and the control group of patients.
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6.8.5 Peak blood lactate responses throughout the follow-up period
The higher peak HR’s observed during the LCT and ACT in both exercise trained 
groups were accompanied by higher peak blood lactate measures at each assessment 
time-point of the follow-up period, as compared to the control group of patients (P at 
least < 0.05). These increases in blood lactate concentration during the LCT over 
baseline were only of statistical significance at the 6-weeks follow-up time-point in 
patients who were upper-limb trained, and at the 12-weeks follow-up time-point in 
patients who were lower-limb trained (P at least < 0.05; Figure 48).
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6.9 Peak psycho-physiological responses throughout the follow-up period
Peak RPE responses during both the LCT and ACT were unchanged throughout the 
course of the follow-up period, in all study groups (Table 39). Similarly there was no 
difference in peak pain perception during the LCT either between or within study 
groups. However, an increase in peak perceived pain perception during the ACT 
compared to baseline measures was observed at each follow-up assessment time-point 
in the patients who had undertaken upper-limb exercise training (P <0.01; Table 39).
Table 39. Changes in perceived exertion and perceived pain at each assessment stage of 
the follow-up period.
Follow-
Up Leg-Cranking Assessment Arm-Cranking Assessment
Period
(Weeks)
Lower-
Limb
Training
Upper-
Limb
Training
Control
Group
Lower-
Limb
Training
Upper-
Limb
Training
Control
Group
o Baseline 18 17 16 18 16 18
C«o (13-20) (13-20) (13-20) (13-20) (10-20) (13-20)Ifl
Ph
6 17 15 17 17 17 17(13-20) (11-20) (12-20) (13-20) (12-20) (13-20)
HH
S3 12 17 16 17 17 17 17
.2 (13-20) (11-20) (6-20) (13-20) (13-20) (11-20)
•—oX 24 17 16 16 17 17 17
W (13-20) (12-20) (13-20) (13-20) (11-20) (13-20)mm
o 48 17 17 17 17 17 17P h (13-20) (12-20) (12-20) (14-20) (13-20) (13-20)
Baseline 8 7 5 5 4 5
C3 (5-11) (3-11) (0-11) (0-10) (0-10) (0-11)CJin 6 8 7 7 7 y * * 7© (4-11) (2-11) (2-11) (2-10) (0-11) (0-10)
ckr j 12 9 7 7 7 7W
c
Ph
fm*
(4-11) (0-11) (0-10) (2-11) (0-11) (0-11)
24 8 7 7 7 y * * 7(4-11) (3-11) (2-10) (0-11) (0-11) (0-11)
WoPh 48 9(3-11)
9
(5-11)
7
(4-10)
7
(3-11)
y % sH 
(0-11)
6
(0-10)
Data are presented as the median (ranges). * P < 0.05; ** P < 0.01 compared to baseline.
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6.10 Changes in Haematocrit
No changes in haematocrit were observed either between or within groups, at any time- 
point throughout the follow-up period (Figure 49).
48 -I 
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Figure 49. Changes in haematocrit during the follow-up period. Data are presented as mean ± 
SEM at each assessment stage during the follow-up period.
6.11 Changes in BMI
No changes in BMI within any of the study groups were observed at any time-point 
during the follow-up period (Figure 50).
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Figure 50. Changes in BMI during the follow-up period. Data are presented as mean ± SEM at 
each assessment stage during the follow-up period.
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Chapter 7 -  Follow-Up Study Discussion
Overview
Although the long-term success of an exercise programme has been defined as the 
ability to continue walking, with good functional status in the community setting and a 
maintained improvement of claudication symptoms (Menard et a l 2004), few studies 
have monitored the long-term benefits of exercise training following the cessation of the 
supervised classes and the long-term durability of results has not been fully established 
(Cheetham et al. 2004; Menard et al 2004; Patterson et a l 1997). The logistics of 
keeping in touch and retaining patients following an exercise intervention can be 
problematic, and advancing years and a further deterioration in health can also 
contribute to a patient’s unwillingness to attend. This study also monitored the 
persistence of any beneficial effects elicited by a 24-week programme of twice weekly 
upper- and lower-limb aerobic exercise training over a subsequent 48-week period. A 
great deal of effort was made to schedule return visits for the follow-up assessments for 
every patient who completed the 24-week intervention period.
All appointments were made in advance upon completing the intervention period. One 
week prior to the 6- and 12-week follow-up assessment sessions, patients were 
contacted to remind them of their appointment. Availability was also confirmed the day 
before the scheduled visit. Patients unable to attend were offered a similar day of day 
appointment on a mutually convenient day. Prior to the 24- and 48-week follow-up 
assessments, all patients were contacted approximately a fortnight in advance. This was 
important, since due to the advancing years and other medical complaints which these 
patients have, and considering that personal situations could change, patients might be 
unable to attend. Similarly, at these time-points patients were also contacted the day 
before the scheduled visit to confirm attendance. Out of the 94 patients who completed 
the 24-week intervention period, only 16% were unable to attend at the 48-week follow- 
up time-point. Inabilities to attend the follow-up assessments were primarily due to 
medical reasons, which included sustained M.I, stroke and, in some instances, death.
During the follow-up study the degree of retention of improvement in both CD and 
MWD over a period of 48-weeks was assessed. Changes in walking confidence, pain 
tolerance, functional capacity, physical activity status and quality of life were also 
investigated during this period. The follow-up analysis indicates that improvements in
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walking performance persisted up to 48-weeks post-intervention, with MWD remaining 
improved by 26% and 18% in patients who had undertaken upper- and lower-limb 
aerobic exercise training, respectively. The persisting improvement in walking 
performance in these patients was associated with a continued improvement in walking 
confidence.
In both the groups of patients who had performed exercise training during the 
intervention period, HR at CD remained unchanged at each follow-up assessment time- 
point. Perceived pain at CD was lower in the group of patients who had undertaken 
lower-limb exercise training up to 48-weeks post-intervention, compared to baseline 
measures, a finding that was similar to that observed during the 24-week intervention 
period. This further suggests that an enhanced pain perception response was retained in 
this group of patients at least up to the 48-week follow-up time-point.
At the 48-week follow-up time-point, peak blood lactate concentration at MWD was 
higher in the group of patients who had undertaken lower-limb exercise training, in 
relation to the control group of patients. This suggests a possible alteration in exercise 
tolerance in these patients which continued after supervised exercise training. However, 
this observation was not apparent at all follow-up time-points. Peak HR at MWD was 
higher in both groups of patients who had performed exercise training relative to the 
control group, but was only higher in the group of patients who had performed lower- 
limb exercise training relative to baseline measures. This retained increase in peak HR 
suggests that these patients continued to push themselves further beyond the ‘pain 
barrier’ up to 48-weeks after undertaking the 24-week programme of exercise training.
Alternatively, the need for a greater exercise stimulus to elicit a claudication response 
could equally account for this observation. Peak perceived pain was higher at MWD at 
48-weeks follow-up in the group of patients who had undertaken upper-limb exercise 
training, in relation to baseline measures, suggesting that an alteration in exercise pain 
tolerance accounted for more of the change in MWD than it did in patients who had 
undertaken lower-limb exercise training. In all study groups, resting ABPI was 
unchanged throughout the follow-up period. The lack of change in ABPI is supported 
by previous studies (Gardner et al. 2004b; McLafferty et al. 1997), and indicates that 
PAD, as defined by ABPI, did not worsen in any group during the follow-up study.
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In both exercise training groups, improvements in community based walking distance 
remained improved up to 48-weeks follow-up, as compared to baseline. This finding is 
consistent with the persisting improvement in both CD and MWD in these patients. Up 
to the 24-week follow-up time point, walking speed and stair climbing ability were also 
perceived to be improved in both exercise training groups, as compared with the control 
group. Patients who had undertaken upper-limb exercise training perceived that their 
stair-climbing ability was improved up to the 48-week follow-up time-point, in relation 
to the control group of patients. All WIQ domains were unchanged in the control group 
of patients at all follow-up assessment time-points, in relation to baseline measures.
Disappointingly, global physical activity was unchanged at each follow-up assessment 
time-point in relation to baseline measures in patients who had undertaken exercise 
training. Nevertheless, trends indicating an increase in physical activity were observed 
up to the 24-week follow-up time point in both exercise groups. An increase in the 
leisure-time domain of the PAD-PAR questionnaire was only observed at the 24-week 
follow-up time-point in patients who had undertaken upper-limb exercise training. This 
suggests that patients with intermittent claudication need motivation, encouragement 
and perhaps supervision in order to routinely participate in exercise and to increase their 
physical activity status. There was no difference in the level of work activities or in the 
household chores domain of the PAD-PAR questionnaire throughout the post­
intervention period in any of the study groups. These observations are typical of elderly 
patients who, in the main, routinely perform household work with little change in 
pattern observed over time.
Although a perceived improvement in general health in patients who had undertaken 
exercise training was not persistent during the follow-up period, the upper-limb exercise 
trained group did perceive their general health, as assessed using the SF-36 v2 
questionnaire to be better at the 12- and 48-week follow-up time-points, in relation to 
the control group of patients. Energy and vitality remained improved up to the 48-week 
follow-up time-point in these patients. The degree of bodily pain experienced by 
patients following the intervention period was no different to that present at baseline, 
although compared to the control patients, an improvement at the 12-week follow-up 
time-point was perceived in the upper-limb exercise training group only. There was no 
difference in any of the study groups, in the physical function, role limitation physical,
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mental health, social functioning or role limitation emotional domains of the SF-36 v2, 
during the follow-up period.
Upon comparing quality of life using the EQ-5D questionnaire, general health remained 
improved up to the 24-week follow-up time-point in patients who had undertaken 
lower-limb exercise training, in relation to baseline measures. Patients who had 
undertaken upper-limb exercise training also perceived an improvement in general 
health and ability to perform usual activities at the 12-week follow-up time-point, 
compared to control patients. However, the difference from baseline measures in these 
domains, in these patients, was not significant. No changes in the domains of mobility, 
self care, bodily pain and discomfort, and anxiety and depression were observed at any 
follow-up assessment time-point, in any study group.
In order to further understand the effect of the two training regimens on upper- and 
lower-limb exercise tolerance, the physiological responses to incremental arm- and leg- 
cranking exercise were also studied following the intervention period. Peak power 
output remained improved up to the 48-week follow-up time-point for both the trained 
and untrained skeletal muscle groups in patients who had undertaken exercise training 
during the 24-week intervention period. The post-intervention training effect continued 
to be most apparent for the specific training apparatus, with some cross over 
improvement for the other exercise modality.
In both the groups who had undertaken exercise training, the retained improvement in 
walking performance was accompanied by the sustained increase in lower-limb peak 
aerobic power and blood lactate concentration during the LCT, compared to baseline 
measures and control patients, respectively. At the 6-week follow-up time-point peak 
VO2 remained increased in both exercise trained groups, compared to baseline 
measures, but was unchanged at 48-week's follow-up. However, compared to control, 
peak VO2 remained improved in the upper-limb training group of patients only at this 
time-point. At the 6- and 12-week follow-ups, peak lactate concentration, HR and RPP 
were higher during the LCT in both exercise groups of patients, in relation to baseline 
measures. At 48-weeks, these variables were higher in both exercise groups of patients, 
compared to the control group of patients, however higher values were not persistent 
throughout the follow-up period. RPE and perceived pain were unchanged in all groups 
throughout the follow-up period during the LCT.
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During the ACT at maximum exercise tolerance, peak power output was higher in both 
groups who had undertaken exercise training, in relation to baseline measures. Peak 
blood lactate concentration, HR and RPP were all higher in these patients' at all follow- 
up assessment time-points, in relation to the control group of patients. Peak VO2 was 
unchanged from baseline measures in patients who had undertaken exercise training, 
however compared to control patients' peak VO2 remained improved in the upper-limb 
training group of patients throughout the follow-up period. RPE was unchanged in all 
groups, however perceived pain was higher in the group of patients who had undertaken 
upper-limb exercise training at all follow-up assessment time-points compared to 
baseline measures. In the control group of patients, during the ACT lower peak SBP, 
DBP and RPP values were observed at all follow-up assessment time-points.
Outcome Measures - Walking Performance
The benefits of supervised exercise are recognised and well documented. A structured, 
supervised exercise programme is more effective at improving CD compared to a less 
formal home-based exercise programme (Savage et a l 2001), and provides superior 
increased walking ability (Patterson et a l 1997). However, it is equally important to 
observe for how long such improvements can be retained. This study aimed to observe 
patients walking ability up to 48-weeks following the 24-week intervention period. The 
follow-up period in this present study was considered lengthy, however it was not as 
comprehensive as other studies (Menard et a l 2004; Perkins et a l 1996) which have 
assessed patients at up to approximately 6 years follow-up.
An improvement in walking performance following a short 12-week exercise 
programme has been sustained for a subsequent 24-weeks in patients with intermittent 
claudication (Savage et a l 2001; Patterson et a l 1997). Walking performance has also 
been shown to be improved 9- and 12-months following the cessation of a 6-month 
supervised exercise and motivation class involving exercise three times per week 
(Cheetham et a l 2004). However, the improvements in walking performance and 
walking economy were sustained for such a long period in this latter study due to the 
fact that patients undertook a less frequent exercise maintenance programme involving 
twice weekly exercise during the follow-up period (Cheetham et a l 2004). Patients 
who continue to exercise can potentially maintain the benefits obtained through 
supervised exercise rehabilitation (Menard et a l 2004). Similarly a 12-week home 
exercise programme, incorporating weekly lectures and exercise instruction can also
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sustain improvements in walking performance for up to 6-months after its conclusion 
(Patterson et al. 1997).
In contrast, a study of the long-term effects of exercise training has found that the initial 
improvements in walking performance are not sustained, since the majority of patients 
do not continue to take regular exercise (Perkins et al. 1996). This present study has 
found that improved walking ability obtained as a direct result of exercise rehabilitation 
can be sustained for up to 48-weeks following the cessation of supervised exercise, 
although this is much reduced compared to that observed immediately following the 24- 
week intervention period. Furthermore, a gradual reduction in improved walking 
performance was observed at each follow-up time-point. Although the sustained 
improvements in walking performance demonstrated in the present study were lower 
than those reported by others (Gardner et al. 2002), the less frequent formal 
maintenance programme might account for these differences. Although increases in CD 
and MWD over baseline measures induced by an exercise rehabilitation programme can 
be maintained for up to 80-months in patients who continue exercising for a minimum 
of 60 min.wk'1, both CD and MWD return to baseline values over such a time period in 
patients who do not continue with exercise (Menard et al. 2004).
For many patients even a small actual improvement in walking ability obtained during 
the intervention period could make a considerable difference to what they can cope with 
in everyday life and also to their attitude to their disability (Binnie et al. 1999). 
Therefore, an exercise rehabilitation programme which can sustain walking 
performance for a considerable time following exercise attendance might be considered 
to be of value to these patients. Some patients also learn to accept their disability, to live 
within its limits and to feel less fearful about their symptoms (Binnie et al. 1999).
An 18-month follow-up study observing the natural history of physical function in older 
men with intermittent claudication reported CD and MWD to decrease by 22% and 9%, 
respectively in these patients (Gardner et al. 2004b). A non-statistically significant 
trend towards a decline in walking performance was observed in the control group of 
patients at each follow-up assessment time-point in this present study. The method used 
to assess walking performance might explain these observed differences, since the 
Gardner et al. (2004) study used the 6-minute walk test to assess walking ability. Other 
studies using the 6-minute walk test from the same investigator have also indicated that
235
there is little change in CD in a non-exercise control group over an 18-month period 
(Gardner et a l 2002). Differences in these findings could be due to differences in the 
patient selection process (Gardner et al 2004b).
A longer follow-up period (mean 45-months) of patients with intermittent claudication 
has indicated that walking distance in patients with intermittent claudication does 
decline at an average of 9.2 yards per year, with an average rate of ABPI decline of
0.014 per year (Aquino et a l 2001). It is thus believed that incorporating appropriate 
regular exercise into the lives of patients in a way that is sustainable indefinitely will 
improve long-term results (Binnie et al 1999).
Physical A ctivity S ta tus Following Exercise Rehabilitation
Having built up patients’ confidence during the supervised exercise intervention period, 
it was essential to advise patients of the importance of continuity to exercise in the 
home setting. Finding realistic, practical strategies for participating in physical activity 
was necessary in the hope that it would be perceived as an enjoyable, long-term element 
of their lives (Binnie et a l 1999). Upon completing the 24-week intervention period, 
each patient who had undertaken supervised exercise was informed of the necessity of 
continuing exercising, in the hope of retaining the improvement in walking ability as a 
result of the study. Those patients assigned to the control group, were equally provided 
with identical physical activity advice.
Indeed the final assessment session upon completing the 24-week intervention period 
also focused on a consultation theme, feeding back to the patient on an individual basis 
their reported walking ability in terms of both CD and MWD which they had achieved 
as a result of the 24-week intervention period, compared to baseline values in terms of 
actual walking distance and percentage improvement. This information was provided on 
an individual basis for each patient. This provided a dual focus. In the majority of 
individuals, this feedback provided the patient with the satisfaction that their hard work 
had paid off. Secondly, it provided further motivation that patients need to continue 
with physical activity to sustain improvements. It can be argued that regular follow-up 
assessments can provide an important motivating function, since seeing a formal record 
of their improving walking performance reassures many patients that their efforts to 
exercise are worthwhile and encourages them to persevere (Binnie et a l 1999). It has 
been suggested that experience and skills in counselling and the use of the therapeutic
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relationship (Binnie et al. 1999) can be particularly beneficial in motivating patients to 
continue exercising.
Some patients established that they enjoyed the exercise routine and they felt confident 
about maintaining an exercise programme following the intervention period. Indeed, the 
need for structure and routine for elderly patients is important, since regarding work or 
household chore activities, no difference between or within study groups was observed 
throughout the follow-up period. These observations are typical of elderly patients who 
routinely perform household chores with little change in pattern observed over time. 
Advice which was given to the patients regarding the continuation of exercise in the 
home setting included the advice of taking regular walks. A ‘keep walking’ regime of 
combined community-based intervention of cessation of smoking and increased 
physical activity has been shown to improve MWD attributed to increased physical 
activity through recreation walking (Fowler et al. 2002).
Patients were informed that going for a walk, ideally every day, but at least three or four 
times per week would be a key element to keeping active (Binnie et al. 1999). The 
advice that was given regarding walking included encouraging the use of local 
landmarks, in order for patients to mark stopping points and then to try to increase the 
distance between stops, since such an incremental approach further builds the patients 
confidence (Binnie et al. 1999). However, similar problems with encouraging patients 
to take up this advice to those experienced at the beginning of the intervention period 
were encountered, as much resistance and many anxieties have to be overcome before 
patients will adopt it, including the fear of pain, as patients fear that walking with pain 
will do some damage to the affected artery (Binnie et al. 1999). Patients were also 
encouraged to consider sports and hobbies of potential therapeutic value, including golf 
and dancing (Binnie et al. 1999). Attending a local gym was a further option 
considered for those patients requiring the need for structure and discipline.
A small proportion of patients heeded the advice to keep active. Patients who had 
undertaken lower-limb exercise training quickly associated the feasibility of continuing 
exercising from a practical perspective. Some patients already had exercise bikes in the 
home setting, although these had not been used for some time. Some patients purchased 
an exercise bike or other suitable aerobic equipment (arm crankers, and rowing 
machines in a few cases) upon completing the intervention study. These patients
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continued the regimen that they were prescribed during the 24-week intervention period, 
with advice provided to exercise within safe limits in the home setting, with RPE and 
CR-10 scales provided for self-evaluation of exertion and pain. Patients who had 
undertaken upper-limb exercise initially reported a feeling of reluctance associated with 
other forms of exercise such as cycle exercise, since by comparison these patients had 
been exercising relatively pain-free during the 24-week intervention period. Some 
patients did indicate that they would consider purchasing arm-cranking equipment.
Disappointingly however, despite the in depth advice and encouragement given to 
patients upon completing the intervention study, the global physical activity status of 
patients who had undertaken exercise training during the intervention period was 
unchanged throughout the follow-up period. Nevertheless, trends indicating an increase 
in physical activity were observed up to the 24-week follow-up time-point in both 
exercise groups, and this most likely resulted from the fact that some patients heeded 
the keep active advice during the 6-, 12- and 24-week follow-up assessments. 
Orthopaedic and arthritic complaints, as well as general health concerns have been 
stated as being primary reasons for patients to discontinue with exercise (Menard et al 
2004). Also, the advice ‘to take more exercise’ is rarely an adequate or effective means 
of helping patients with intermittent claudication (Binnie et al 1999). Ultimately, it 
would be beneficial to identify characteristics of patients with PAD who are likely to 
continue with an exercise programme (Menard et al 2004).
In this study, the reluctance of patients to continue exercising might possibility result 
from the fact that a large proportion of patients were satisfied with their walking ability 
following the intervention period, as observed in previous studies (Andriessen et al 
1989). As a result they thought it unnecessary to engage in further exercise, believing it 
to be surplus and needless. Patients believed that improving walking ability was 
sufficient and that this would be endlessly retained, despite being informed that the 
retention of improved walking ability required continued exercise. Certainly, up to 12- 
weeks post-intervention leisure-time physical activity status was unchanged in all of the 
study groups, in relation to baseline measures.
A decrease in monitored physical activity in a previous 18-month follow-up study has 
suggested that this was related to a decline in walking performance in these patients 
(Gardner et a l 2004b). In the present study walking performance in patients who had
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undertaken exercise training remained improved during the follow-up assessments 
compared to baseline measures in the absence of increased physical activity status, 
although it did decline. The retained confidence in walking in patients who were 
exercise trained could possibly contribute to the feeling that these patients were able to 
push themselves further when walking, and this in itself could help in part to account 
for the retained walking performance observed throughout the follow-up period. 
Nevertheless, this study also observed a progressive dwindling of enthusiasm for 
exercise in the home setting throughout the follow-up period.
Patients who initially felt enthusiastic about exercising in the home setting upon 
completing the intervention study soon lost interest, indicating that exercise in the home 
setting for patients with intermittent claudication is short-lived, since patients lacked 
motivation. A lack of motivation has previously been stated as a reason for 
discontinuation with exercise (Menard et a l 2004). It has been suggested that follow- 
up assessments provide the opportunity to discuss difficulties, to revise exercise 
strategies or to set new targets at follow-up visits, since these can revive waning 
enthusiasm (Binnie et a l 1999). In the present study, motivational advice was given to 
all patients at each follow-up assessment time-point. It has been suggested that a great 
deal of patient listening and careful exploration of sensitive issues is required to identify 
the right motivational triggers or to expose the real stumbling blocks (Binnie et al 
1999). During the follow-up assessments patients frequently commented on the need to 
attend and exercise in a group setting. Others felt less comfortable to exercise due to the 
safety issue and reluctant in the event of experiencing difficulty. The supervised 
intervention programme provides motivation, encouragement and feedback as well as 
instruction and supervision (Binnie et al 1999).
A lack of enthusiasm could account for the differences in leisure-time physical activity 
at the 24-week follow-up time-point between both groups who had undertaken exercise 
training during the intervention period. It is possible that after the 12-week follow-up 
time-point, patients who had undertaken upper-limb exercise training heeded the advice 
regarding keeping active. Some of these patients reported that they enjoyed bowling and 
as such undertook this as a pastime. This could account for the overall increase in this 
domain of the PAD-PAR questionnaire in this patient group. Patients commented that 
the improved upper-body strength obtained during the intervention period resulted in an 
improvement in their bowling performance. It is also possible that these patients took
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extra leisure-time walks, and that a mixture of activities cumulatively resulted in an 
increase in leisure-time physical activity at 24-week's follow-up. However, whatever the 
reason, the increase in physical activity was short-lived since leisure-time physical 
activity was unchanged from baseline measures in all groups at the 48-week follow-up 
time-point.
It has also been suggested that if patients are screened properly and simply receive 
advice and instruction, then a home-based programme can be a safe, low-cost 
alternative to a supervised exercise programme, providing similar long term (24-weeks) 
exercise benefits in MWD (Savage et al. 2001). The findings of the present study do 
not support this. At 48-weeks post-intervention, the physical activity status of all 
patients was unchanged from baseline measures. The long duration from the 24-week 
follow-up assessment to the 48-week follow-up assessment involved no patient- 
investigator contact, apart from the fact that each patient received a phone call 
approximately 2 weeks and the day before the 48-week assessment session to confirm 
attendance. Had weekly or fortnightly phone calls been maintained, then perhaps this 
could have motivated patients sufficiently to continue exercising in the home setting. 
Future studies should take this into account.
F unctional S tatus M easures Following Exercise Rehabilitation
As in previous studies, the WIQ was administered in order to assess the functional 
status of the population (Menard et a l 2004). The findings of this study indicate that 
claudication pain severity was unchanged during the follow-up period. However, 
community-based walking distance, as assessed using the WIQ, continued to be 
perceived to be improved up to 48-weeks after the intervention in exercise trained 
patients. This is consistent with the retained improvement in walking performance 
which was observed throughout the follow-up period, as assessed using the incremental 
shuttle-walk test. However, an improvement in walking speed and stair-climbing ability 
was only perceived in both exercise trained groups of patients up to the 24-week follow- 
up time-point. The absence of sustained improvement in these WIQ domains at the 48- 
week follow-up time-point in both exercise groups could be explained by the fact that 
the retained improvement in walking performance at this time-point was less than that at 
24-weeks follow-up. Differences between measured walking performance and WIQ 
perception might also account for the observed differences, since the WIQ is a 
subjective instrument to assess claudication pain, and therefore may be less sensitive to
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detect change in claudication pain than the more objective measure of walking ability 
(Gardner et a l 2004b), as assessed using the incremental shuttle-walk test. 
Furthermore, the lack of continuation of exercise undoubtedly is a contributory factor, 
since higher WIQ distance, speed and stair climbing ability scores have been reported 
by patients who continue to exercise after exercise rehabilitation programmes (Menard 
et a l 2004).
By comparison, studies which have included a follow-up period of 18-months duration 
have found no significant change in self-reported ability to ambulate at various 
distances, speeds or stair climbing ability, as assessed using the WIQ (Gardner et al 
2004b). This indicates that if exercise is not maintained, patients perceived ability to 
ambulate in the community setting returns to baseline measures. Similarly, no changes 
at the end of the 48-week follow-up period were observed in the control group of 
patients in this present study. The lack of change in perceived claudication symptoms 
and walking distance, speed and stair-climbing ability, as measured by the WIQ, in the 
control group of patients supports previous investigations that report stabilisation in 
symptoms over time (Gardner et al 2004b; Jelnes et a l 1986; Imparato et a l 1975; 
Bloor, 1961).
The psychological and quality of life improvement from participation in an exercise 
programme cannot be underestimated, nor can the contribution of this to the overall 
well-being of patients with intermittent claudication, who have to cope with chronic, 
handicapping symptoms (Binnie et a l 1999). Regarding quality of life, a persistent 
improvement in general health was not observed in either group of patients who had 
undertaken exercise training during the intervention period. Again, the lack of 
continuation of exercise undoubtedly contributed to this observation. Patients who 
continue to exercise for 60 min.wk"1 following rehabilitation programmes will 
potentially experience improved health-related quality of life compared to patients who 
cease exercising after a period of supervised exercise (Menard et a l 2004). Such 
improvements have been reported to be in the domains of physical function, role- 
limitation physical function and bodily pain, yet no differences in general health, energy 
and vitality, social function, role-limitation emotional and mental health have been 
observed between patients who do and do not continue to exercise following a 
programme of supervised exercise (Menard et al 2004). However, it is equally
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important to note that general medical concerns and co-morbid disease can also limit 
functional status (Menard et a l 2004).
In the present study, patients who had undertaken upper-limb exercise training during 
the intervention period perceived their general health, as assessed using the SF-36 v2 
questionnaire to be better at the 12- and 48-week follow-up time-point, in relation to the 
control group of patients. The degree of bodily pain was improved at the 12-week 
follow-up time-point, in these patients compared to the control group. However, the 
differences were not significant compared to baseline measures. Energy and vitality 
remained improved up to the 48-week follow-up time-points in these patients. The 
design of the SF-36 v2 questionnaire and types of questions, which relate to each 
domain could possibly account for the fact why patients who had undertaken lower- 
limb exercise training did not report an improvement in this domain throughout the 
follow-up period. No difference in the physical function, role limitation physical, 
mental health, social functioning or role limitation emotional domains of the SF-36 v2 
were observed in any study group throughout the follow-up period.
When comparing quality of life using the EQ-5D questionnaire, the general health of 
patients who had undertaken lower-limb exercise training continued to be improved up 
to the 24-week follow-up time-point, in relation to baseline measures. This indicates 
that lower-limb exercise training had a greater long-term impact following the cessation 
of supervised exercise rehabilitation, as compared to upper-limb exercise training. 
Equally, the withdrawal of the supervised exercise classes could have had a greater 
impact on patients who were upper-limb exercise trained, which was apparent 6-weeks 
after the intervention. Nevertheless, this finding again highlights the fact that 
improvements in general health are not retained indefinitely after undertaking such a 
programme, since at the 48-week follow-up time-point the general health of patients 
who were lower-limb trained also returned to baseline levels. The long-duration 
between the 24- and 48-week follow-up assessments, during which the contact with the 
investigator was minimal, could also of been a contributory factor, since at each follow- 
up assessment time-point general health concerns were also discussed with all patients, 
regardless of grouping.
An improvement in both general health and ability to perform usual activities at the 12- 
week follow-up time-point was observed in the patients who had undertaken upper-limb
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exercise training, compared to control patients. It could be that a small, yet statistically 
insignificant increase in physical activity following the 6-week follow-up time-point 
contributed to this observation. However, the difference in both these domains was not 
significant from baseline measures in these patients. No changes in the domains of 
mobility, self care, bodily pain and discomfort, and anxiety and depression were 
observed at any follow-up assessment time-point, either between or within study 
groups.
Exercise Tolerance Follow ing Exercise Rehabilitation
Regarding aerobic exercise capacity, the determination of peak VO2 is considered to be 
important for assessing a patient’s functional capacity (Womack et a l 1998). Patients 
limited by intermittent claudication have previously been shown to experience a decline 
in physical function during 18-months of follow-up despite there being no change in 
ABPI (Gardner et al. 2004b). At the 6-week follow-up time-point, peak VO2 remained 
increased during the LCT in both groups of trained patients. However, a gradual decline 
in peak VO2 during the LCT was observed in both trained groups, which was unchanged 
from baseline measures at the 48-week follow-up time-point.
Peak VO2 during the ACT remained increased compared to control patients up to the 
48-week follow-up time-point in the group of patients that were upper-limb trained. 
However, compared to baseline, at the 6- and 48-week follow-ups, peak VO2 during the 
ACT was unchanged in both exercise groups. The decline in physical activity during the 
follow-up study are more plausible explanations for the decline in physical function 
(Gardner et al. 2004b) and aerobic exercise capacity during the LCT and ACT 
throughout the follow-up period. Patients advancing years and general frailty also meant 
that patients were unlikely to increase their exercise tolerance further (Binnie et al. 
1999). The eldest patient recruited onto this study was 85 years of age. The lack of 
change in ABPI during this study suggests that progression of disease is an unlikely 
explanation for the observed decline in physical function, as suggested in previous 
studies (Gardner et al. 2004b).
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Chapter 8 -  Follow-Up Study Conclusions
The main findings of the follow-up study indicates that although walking performance 
remained improved in both exercise trained patients at 48-week's follow-up, as 
compared to baseline measures, a progressive dwindling of improvement was observed 
over this time period. Reluctance for the continuation of exercise in the home-setting 
was observed. This study supports previous findings, which have indicated that patients 
with intermittent claudication need to continue with an exercise programme, either 
supervised or at home, and that this is necessary for the maintenance of the positive 
effects obtained from a supervised exercise programme (Menard et a l 2004). The need 
for continued motivation to exercise was also highlighted in this study.
If obstacles to continued exercise, such as lack of motivation were overcome, perhaps 
more patients would benefit (Menard et al 2004) and this could have a direct impact on 
the retention of improved walking ability. Indeed, it has been estimated that in spite of 
the relatively high level of supervisor support, the cost of putting a patient through the 
first year of a conservative therapy programme is less than a quarter of the cost of an 
angiogram followed by angioplasty (Binnie et a l 1999). The referral of older patients 
with intermittent claudication to established physiotherapy programmes in the 
community can increase their levels of physical activity and thereby reduce disability 
related to PAD (Fowler et al 2002). Perhaps a less frequent exercise maintenance 
programme during the follow-up period could have sustained the benefits that were 
induced during the intervention period, as has been observed in previous studies which 
have continued with such a strategy after exercise rehabilitation (Gardner et al 2002).
Study L im itations and  Strengths
Randomised controlled trials of supervised exercise therapy for the treatment of 
claudication have relatively small study populations and limited follow-up (Nehler and 
Hiatt, 1999a). This study included a large cohort of patients, with by comparison, a 
lengthy intervention and follow-up period. The 24-week intervention period consisted 
of 6-weekly assessments throughout this period, and the follow-up assessments 
comprised of four time-points at which both short and longer-term effects of the 
cessation of such a programme on patients walking performance, as well as other 
parameters of interest were observed. The excellent attendance and compliance during
244
this study undoubtedly allows detailed conclusions to be drawn regarding not only 
upper- and lower-limb exercise rehabilitation programmes, but also the duration in 
terms of improvement and patient’s general health and well-being following such an 
intervention, in a large cohort of patients with intermittent claudication.
The major strength of this study is the integrated examination of the effects of exercise 
rehabilitation across the domains of walking performance, functional capacity, physical 
activity status and quality of life in a large well characterised cohort of older patients 
with a well-described stage of intermittent claudication. The intermittent protocol 
utilised in this study allowed such collection of detailed data. Furthermore, such a 
protocol also minimised the effects of accumulated localised fatigue and thus enabled 
improved maximal performance to be achieved especially during arm-crank exercise 
(Sawka, 1986). However, one drawback of such a protocol was the substantial length of 
time that each assessment took to administer.
A further limitation of this randomised controlled trial was that the main investigator 
was not blinded to training group assignment due to the volume of assessment sessions 
which had to be undertaken during the 24-week intervention period (1,410 
assessments). A further 1,128 assessments were undertaken during the 48-week follow- 
up period. This could be interpreted as a study weakness, not only from the point of 
view of study duration, but also it could be suggested that those patients in the exercise 
training groups were provided with extra motivation to perform well during the training 
and assessment sessions. However, this was not the case, as all patients were provided 
with an equal level of encouragement and were pushed to their maximum exercise 
tolerance regardless of their grouping. Furthermore, consideration of the peak HR, RPE 
and CR-10 responses during the assessment sessions suggest that patients in both 
exercise groups were equally motivated to perform well on tests of physical function.
Although, physical activity levels were well balanced across both exercise training 
cohorts during the 24-week intervention period, it is conceivable that additional 
physical activity may have consisted primarily of unstructured types of activity, such as 
walking in and around the home, which is difficult to discern using standardised 
physical activity questionnaires because they focus more on structured activities 
(Gardner et a l 2001). As in previous studies (Gardner et a l 2001; Gardner et al 
2004a), a further limitation of this study was the select nature of the participants and the
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high percentage of men enrolled despite extensive efforts to recruit women. This has 
also been found to be a weakness in previous studies and suggests that the natural 
history of female patients with claudication might be different from that of male patients 
(Aquino et a l 2001).
A further limitation is one which has previously been encountered in exercise 
rehabilitation studies i.e. that patients who participated in this study were volunteers and 
therefore that they might represent patients who were more interested in exercise, who 
had better access to transportation to the programme, and who were in relatively better 
health than patients with PAD who did not volunteer (Gardner et a l 2004a).
Future Research
We have shown that upper-limb aerobic exercise is as effective as lower-limb exercise 
in improving walking ability in patients with intermittent claudication. Individuals with 
increased disease severity might derive more benefit from an upper-limb exercise 
strategy compared to lower-limb exercise rehabilitation, especially in the early stages of 
an exercise regimen. It would be interesting to undertake a study in which patients 
undertake upper-limb exercise in the early stages and progress to lower-limb exercise 
(either cycle or walking) in order to observe whether such a programme further 
enhances walking ability in these patients. Such a programme could have direct clinical 
implications and the effectiveness of this pragmatic approach could be evaluated using 
intention to treat analysis. Furthermore, on the basis of the follow-up findings of this 
study, in order to sustain improvements achieved following exercise rehabilitation, 
regular motivational advice at least should be included in all future studies following the 
cessation of formal exercise classes. Also, the use of pole-striding as an alternative form 
of upper-limb exercise needs further evaluation.
Blood samples were taken at each assessment time-point throughout this study. It is 
proposed to study cardiovascular risk markers following upper- and lower-limb aerobic 
exercise training in this patient group as very little work has been reported in this area. 
Furthermore, some studies have found changes in blood rheology through training 
whereas others have not. Analysis for plasma viscosity and packed cell volume could 
also be performed, since it has been hypothesised that a decrease in PCV can lead to a 
reduction of blood viscosity, and consequently an improvement in blood flow in these 
patients (Tan et a l 2000a).
246
It would also be interesting to provide further insight into the mechanisms which 
contribute to improved walking performance and lower-limb circulatory function as a 
consequence of upper-limb aerobic exercise training. In particular, the cross-transfer 
effects of upper-limb aerobic exercise training on lower-limb circulatory function in 
patients with PAD should be investigated in more detail. This could be achieved by 
undertaking a shorter programme of upper-limb aerobic exercise training, for example 
of 12-weeks duration. In order to assess the effect of aerobic upper-limb exercise, 
techniques such as near-infrared sprectroscopy (NIRS) could be used to look at muscle 
oxygenation during exercise. This technique is non-invasive and completely painless 
and harmless to the patient, and has for many years been used in the clinical setting. The 
use of oxygen uptake kinetics in these patients could also provide further insight.
Patients in whom PAD progresses develop rest pain which leads to chronic critical limb 
ischaemia. These patients are severely disabled and have extremely low levels of 
physical activity. The usefulness of this type of exercise modality has yet to be 
established in this patient group. A possibility could be to take arm-ergometers to these 
patients and to supervise exercise in the home setting. Such a strategy might improve 
cardiovascular function in these patients. The influence of exercise in these patients 
could be observed using both generic (SF-36 v2 and EQ-5D) and disease specific (WIQ) 
questionnaires in these patients.
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Appendix 2
Letter sent to patients
Sheffield Teaching Hospitals
NHS Foundation Trust !>
Sheffield Hallam University
Dear
We are undertaking a British Heart Foundation sponsored study, to 
compare the effects of a 26-week training programme of both arm- and leg- 
exercise on the symptoms of claudication.
We have recently shown that a 6-week programme of either arm- or leg- 
exercise can improve walking distances in claudicant patients. We now 
need to show which is the more efficient way of exercising and whether 
there are long-term benefits over a home-based programme of walking.
You may have been selected as being a suitable patient from attending the 
Vascular Clinic or because you have been involved in a previous study.
Please find enclosed a patient information sheet, which describes the study 
in detail and answers the most frequently asked questions.
One of my staff (Miss Irena Zwierska), will be phoning you shortly to see 
if you would be interested in participating in this study and will gladly 
answer any further questions you may have. It is important to note that 
there is no pressure to participate in this study and if you do not wish to be 
contacted please phone 0114 225 5690 before (insert date).
Yours sincerely,
Professor R. F. M. W ood, M .D., F.R.C.S.
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Appendix 3
Patient Information Sheet
TH E SH E F F IE L D  C L A U D IC A T IO N  ST U D Y
PATIENT INFORM ATION SHEET
University of Sheffield Sheffield Hallam University
This study is sponsored by the B ritish  H eart Foundation  
and the Sheffield  V ascu lar Institu te
Q: W hy has my doctor asked me to take part in this study?
A: We are currently proposing to undertake a study, in order to compare the effects of 
a 26-week training programme of both arm- and leg-exercise on the symptoms of 
claudication. You may have been selected as being a suitable patient from your 
medical notes or because you have been involved in a previous study.
Exercising the legs can improve your walking distance, however this can be 
painful. We have recently shown that a 6-week programme of arm-exercise 
improved walking distances in claudicant patients. The improvements were 
equivalent to those in patients undertaking leg-exercise. However, the main 
advantage of undertaking arm-exercise is that patients are able to exercise without 
experiencing the pain associated with leg-exercise.
Q: W hat will I have to do?
A: All patients entering the study will have a medical examination and will be 
randomly allocated to one of three groups. Two groups will be required to 
undertake either an arm-exercise programme or a leg-exercise programme at the 
Centre fo r  Sport and Exercise Science, of Sheffield Hallam University, Collegiate 
Hall, Collegiate Crescent (off Ecclesall Road). The third group will not be required 
to undertake formal exercise training, but will be actively encouraged to exercise, 
with monitoring of physical activity using an activity diary.
Q: How long will the study last?
A: The programme will last for a total of 26-weeks. We will monitor everyone's
progress with assessments at 6-week intervals and also at 6-, 12-, 24- and 48-weeks 
after the programme period has ended.
Q: How long will I have to exercise for?
A: If allocated to one of the exercise groups you will be required to exercise twice per 
week, for a total of 20 minutes during a 40-minute training session -  i.e. 2 minutes 
exercise, 2 minutes rest, 2 minutes exercise, 2 minutes rest etc. All exercise will be 
carefully supervised and you will be shown how to use the equipment.
Q: Are there side-effects?
A: No side effects have been observed in our previous study and therefore none are
expected.
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Q: W hat will the assessm ent visits entail?
A: During the assessment visits we will:-
1. ask you to perform both arm- and leg-exercise (on two separate days).
During these sessions we will monitor your heart rate and take your blood 
pressure. We will also take a small fmger-prick blood sample and measure 
your oxygen consumption whilst you are exercising.
2. assess the distance that you can walk and take your blood pressure and a
small finger-prick blood sample before and after walking.
3. take a small blood sample from you.
You will also be asked to complete a brief questionnaire at the start of the study, at 
the end of the training period and again when the study has ended. Two additional 
brief questionnaires will be completed during the training period and also during 
the assessment sessions.
Q: W hat if  I do not wish to take part?
A: This will in no way affect your treatment.
Q: W hat if  I change my mind during the study?
A: You are free to withdraw from the study at any time without affecting your
treatment.
Q: W hat will happen to the inform ation from the study?
A: The overall conclusions of the study will be available to you, however it will not
be possible to produce an individualised report of your performance.
Q: W hat if I have further questions?
A: If you have any further questions with regards to this study you may phone:-
Participating in this 
study 
or
the arrangements for 
the training and 
assessment sessions, 
at the:- 
CENTRE FOR SPORT & 
EXERCISE SCIENCE
Miss IRENA 
ZWIERSKA
OR
DR JOHN 
SAXTON
CENTRE 
FOR SPORT 
&
EXERCISE
SCIENCE
(SHEFFIELD
HALLAM
UNIVERSITY)
0114 225 5690 
(DIRECT LINE)
0114 225 4414 
(DIRECT LINE)
Participating in this 
study DR GRAHAM POCKLEY NORTHERNGENERAL
HOSPITAL
0114 271 4450 
(DIRECT LINE)
Your health 
(i.e. medically related) MR SOHAIL CHOKSY
0114 271 4914 
(DIRECT LINE)
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Appendix 4
PATIENT CONSENT FORM
To be completed by the patient:
Have you read the information sheet about this study? 
YES/NO
Have you been able to ask questions about this study? 
YES/NO
Have you received answers to all your questions? 
YES/NO
Have you received enough information about this study? 
YES/NO
Who have you spoken to about this study?
Do you understand that you are free to withdraw from this study 
at any time?
YES/NO
Without giving a reason for withdrawing 
YES/NO
Without affecting your future medical care 
YES/NO
Do you agree to take part in this study? 
YES/NO
Signed:
Name (Block Letters): 
Date:
Witness:
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A ppen d ix  5 
The PAR-Q Form
Physical Activity Readiness™ pam PAR - Q  & YOU
(A Q u e s t io n n a i r e  fo r  P e o p le  A g e d  15  to  6 9 )
Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day. Being more 
active is very safe for most people. However, some people should check with their doctor before they start becoming much more 
physically active.
If you are planning to become much more physically active than you are now, start by answering the seven questions in the box below. If 
you are between the ages of 15 and 69, the PAR-Q will tell you if you should check with your doctor before you start If you are over 69 years 
of age, and you are not used to being very active, check with your doctor.
Common sense is your best guide when you answer these questions. Please read the questions carefully and answer each one honestly: 
check YES or NO.
YES NO
□ □ 1. Has you doctor ever said that you have a heart condition and that you should only do physical activity recommended by a doctor?
□ □ 2. Do you feel pain in your chest when you do physical activity?
□ □ 3. In the past month, have you had chest pain when you were not doing physical activity?
□ □ 4. Do you lose your balance because of dizziness or do you ever lose consciousness?
□ □ 5. Do you have a  bone or joint problem that could be made worse by a  change in your physical activity?
□ □ 6. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart condition?
□ □ 7. Do vou know of anv other reason whv you should not do Dhvsical activitv?
YES to one or more questions
If
you
answered
Talk with your doctor by phone or in person BEFORE you start becoming much more physically active or BEFORE you have a 
fitness appraisal. Tell your doctor about the PAR-Q and which questions you answered YES.
• You may be able to do any activity you want—as long as you start slowly and build up gradually. Or, you may need to restrict 
your activities to those which are safe for you. Talk with your doctor about the kinds of activities you wish to participate in 
and follow his/her advice.
• Find out which community programs are safe and helpful for you.
NO to all questions
If you answered NO honestly to all PAR-Q questions, you can be 
reasonably sure that you can:
• start becoming much more physically active—begin slowly and build 
up gradually. This is the safest and easiest way to go.
• take part in a  fitness appraisal—this is an excellent way to determine 
your basic fitness so that you can plan the best way for you to live 
actively. ____________ ___________
DELAY BECOMING MUCH MORE ACTIVE:
• if you are not feeling well because of a  temporary illness such 
as a  cold or a  fever—wait until you (eel better, or
• if you are or may be pregnant—talk to your doctor before you 
start becoming more active.
Please note: ff your health changes so that you then answer YES to 
any of the above questions, tell your fitness or health professional. 
Ask whether you should change your physical activity plan.
Informed U se of the PAR-Q-. The C anadian Society for E xercise Physiology. H ealth C anada, and their a gents assum e no  Sab wry for pe rsons w ho undertake physical activity, and 
if in doubt after completing this questionnaire, consult your doctor prior to physical activity.
You are encouraged to copy the PAR-Q but only If you use the entire form
NOTE: If  the PAR-Q is being given to a person before he of she participates in a  physical activity program o r a fitness appraisal, this section may be used for legal or 
administrative purposes.
I have read, understood and  com pleted this questionnaire. Any questions I had were answ ered  to my full satisfaction.
NAME____________________________________________________________________________________
SIGNATURE OF PARENT__________________________________________________________________  W
or GUARDIAN (for participants under the a ge  of majority)
©  Canadian Society for Exercise Physiology Supported by:
Societecanadiennedephysioiogiede I’exercice B ^ l  Canada C anada
FIGURE 2-1 . PAR-Q form. (Reprinted with permission from the Canadian Society for 
Exercise Physiology, Inc., 1994.)
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Appendix 6
The Borg RPE scale
6 No exertion at all
7
8 Extremely light
9 Very light
10
11 Light
12
13 Somewhat hard
14
15 Hard (heavy)
16
17 Very hard
18
19 Extremely hard
20 Maximal exertion
Appendix 6. The Borg RPE (15-graded) scale (Gunnar Borg, 1998).
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Appendix 7
The Borg CR10 scale
0 Nothing at all “No P”
0.3
0.5 Extremely weak Just noticeable
1 Very weak
1.5
2 Weak Light
2.5
3 Moderate
4
5 Strong Heavy
6
7 Very strong
8
10 Extremely strong “Max P"
11
# Absolute maximum Highest possible
Appendix 7. The Borg CR10 scale (Gunnar Borg, 1998).
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Appendix 8
Borg’s RPE scale instructions
While exercising I want you to rate your perception of exertion, i.e., how heavy and 
strenuous the exercise feels to you. The perception of exertion depends mainly on the 
strain and fatigue in your muscles and on your feeling of breathlessness or aches in the 
chest. Look at this rating scale; I want you to use this scale from 6 to 20, where
6 means “no exertion at all”
9 corresponds to “very light” exercise.
For a normal, healthy person it is like walking slowly at his or her own pace for 
some minutes.
13 on the scale is “somewhat hard” exercise, but it still feels OK to continue.
17 “very hard” is very strenuous.
A healthy person can still go on, but he or she really has to push him or herself.
It feels very hard and the person is very tired.
19 on the scale is an “extremely strenuous” exercise level.
For most people this is the most strenuous exercise they have ever experienced.
20 means “maximal exertion”.
Try to appraise your feeling of exertion as honestly as possible, without thinking about 
what the actual physical load is. Don’t underestimate it, but don’t overestimate it 
either. It’s your own feeling of effort and exertion that’s important, not how it 
compares to other people’s. What other people think is not important either. Look at the 
scale and the expressions when performing exercise and then give a number.
Scaling perceived exertion
We want you to rate your perceived (P) exertion, that is, how heavy and strenuous the 
exercise feels to you. This depends mainly on the strain and fatigue in your muscles and 
on your feeling of breathlessness or aches in the chest. But you must only attend to your 
subjective feelings and not to the physiological cues or what the actual physical load is.
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Appendix 9
Borg’s CR-10 scale instructions
Basic instruction : 10, “Extremely strong -  Max P”, is the main anchor. It is the 
strongest perception (P) you have ever experienced. It may be possible, however, to 
experience or to imagine something even stronger. Therefore, “Absolute maximum” is 
placed somewhat further down the scale without a fixed number and marked with a dot 
If you perceive an intensity stronger than 10, you may use a higher number.
Start with a verbal expression and then choose a number. If your perception is “Very 
weak”, say 1; if “Moderate”, say 3; and so on. You are welcome to use half values (such 
as 1.5, or 3.5 or decimals, for example, 0.3, 0.8, or 2.3). It is very important that you 
answer whatyow perceive and not what you believe you ought to answer. Be as honest 
as possible and try not to overestimate or underestimate the intensities.
Scaling pain
What are your worst experiences of pain? If you use 10 as the strongest exertion you 
have ever experienced or can think of, how strong would you say that your three worst 
pain experiences have been?
10 “Extremely strong -  Max P” is your main point of reference. It is anchored in
your previously experienced worst pain, which you just described, the “Max P”.
• Your worst pain experienced, the “Max P” may not be the highest possible level. 
There may be pain that is still worst. If that feeling is somewhat stronger, you 
will say 11 or 12. If it is much stronger, 1.5 times “Max P”, you will say 15.
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Appendix 10 - Modified Horne & Ostberg’s (1976) Lark/Owl Questionnaire
Questionnaire Relating to an Individuals Time Preference to Perform Physical Activity
1. Please read each question very carefully before answering.
2. Answer ALL questions.
3. Answer questions in numerical order.
4. Each question should be answered independently of others. DO NOT go back and check your answers.
5. All questions have a selection of answers. For each question place a circle around ONE answer only. Some 
questions have a scale instead of a selection of answers. Place a cross at the appropriate point along the 
scale.
6. Please answer each question as honestly as possible. Both your answers and your results will be kept, in 
strict confidence.
7. Please feel free to make any comments in the section provided below each question.
The Questionnaire, with scores for each choice.
1. Considering only your own “feeling best” rhythm, at what time would you get up if you were 
entirely free to plan your day?
2. Considering only your own “feeling good” rhythm, at what time would you go to bed if you 
were entirely free to plan your evening?
PM 8 9 10 11 12 AM 1 2 3
<— 5  *<—4------ ► M------------  3 ------------► <-------- 2—► * ---------- 1---------- ►
3. If there is a specific time at which you have to get up in the morning, to what extent are you 
dependent on being woken up by an alarm clock?
Not at all dependent... 
Slightly dependent... 
Fairly dependent... 
Very dependent...
4. Assuming adequate environmental conditions, how easy do you find getting up in the mornings?
Not at all easy ... 
Not very easy... 
Fairly easy... 
Very easy ...
5. How alert do you feel during the first half hour after having woken in the mornings?
Not at all alert... 
Slightly alert... 
Fairly alert... 
Very alert...
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6. How is your appetite during the first half-hour after having woken in the mornings?
Very poor... 
Fairly poor... 
Fairly good... 
Very good...
7. During the first half-hour after having woken in the morning, how tired do you feel?
Very tired... 
Fairly tired... 
Fairly refreshed... 
Very refreshed...
8. When you have no commitments the next day, at what time do you go to bed compared to your 
usual bedtime?
Seldom or never later... 
Less than 1 hour later... 
1-2 hours later...
More than 2 hours later...
9. You have decided to engage in some physical activity. A friend suggests that you do this 1 hour 
twice a week and the best time for him/her is between 7-8 AM. Bearing in mind nothing else but 
your own “feeling best” rhythm, how do you think you would perform?
Would be on good form... 
Would be on reasonable form... 
Would find it difficult...
Would find it very difficult...
10. At what time in the evening do you feel tired and as a result in need of sleep?
-LI L
PM 12 AM 
 ► <- 2- ►  <4- 1-
3
11. You wish to be at your peak performance for a test which you know is going to be mentally 
exhausting and lasting for two hours. You are entirely free to plan your day and considering 
only your own “feeling best” rhythm, which ONE of the four testing times would you choose?
8.00 - 10.00 AM...
11.00 AM -1.00 PM...
3.00 PM -5.00 PM...
7.00 PM - 9.00 PM...
12. If you went to bed at 11.00 PM, at what level of tiredness would you be?
Not at all tired... 
A little tired... 
Fairly tired... 
Very tired...
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13. For some reason you have gone to bed several hours later than usual, but there is no need to get 
up at any particular time the next morning. Which ONE of the following events are you most 
likely to experience?
16.
Will wake up at usual time and will NOT fall asleep... 
Will wake up at usual time and WILL dose thereafter... 
Will wake up at usual time but will fall asleep again... 
Will NOT wake up until later than usual...
14. One night you have to remain awake between 4.00 - 6.00 AM in order to carry out a night 
watch. You have no commitments the next day. Which ONE of the following alternatives will 
suit you best?
Would NOT go to bed until watch was over... 
Would take a nap before and sleep after...
Would take a good sleep before and a nap after... 
Would take ALL sleep before watch...
15. You have to do two hours of hard physical work. You are entirely free to plan your day and 
considering only your own “feeling best” rhythm, which ONE of the following times would you 
choose?
8.00- 10.00 AM...
11.00-1.00 PM...
3.00-5.00 PM...
7.00- 9.00 PM...
You have decided to engage in hard physical exercise. A friend suggests that you do this for one 
hour twice a week and the best time for him/her is between 10.00 - 11.00 PM. Bearing in mind 
nothing else but your own “feeling best” rhythm, how well do you think you would perform?
Would be on good form... 
Would be on reasonable form... 
Would find it difficult...
Would find it very difficult...
17. Suppose that you can choose your own work hours. Assume that you worked a FIVE-hour day 
(including breaks) and that your job was interesting and paid by results. Which FIVE 
CONSECUTIVE HOURS would you select ?
12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 
MIDNIGHT NOON MIDNIGHT-X -X- -X- L
18. At what time of the day do you think that you reach your “feeling best” peak?
12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12
MIDNIGHT NOON MIDNIGHT
A   1  X   5 -► < 4—4  X -----------------------------2---------------------X -------------------------- 2-----------► <*—  1— ►
19. One hears about “morning” and “evening” types of people. Which ONE of these types do you 
consider yourself to be ?
Definitely a “morning” type...
Rather more a “morning” than an “evening” type...
Rather more an “evening” than a “morning” type...
Definitely an “evening” type...
6
4
2
0
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Appendix 11
Demographics
Name:
Address:
Tel.
Hospital No.
D.O.B Age: Male/Female
INCLUSION CRITERIA
Symptoms >12 months
Able to undertake exercise
No Interventional Procedure 
within the last 12 months
No Exercise limiting angina
No Shortness of breath
No Severe Arthritis
Past Medical History
Heart Attack
Stroke
Hypertension
Diabetes
High Cholesterol 
Dyspnoea
Alcohol
Angina
Chronic Airways Disease
Smoker
Ex-Smoker
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Presenting Complaint
Claudication Distance (m): Maximum Walking Distance (m):
Operations
Date: Operation:
Date: Operation:
Date: Operation:
Current Medication
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Examination
Pulse Popliteal
Blood Pressure
Ankle/Brachial 
Pressure Index
Femoral
Posterior Tibial
Dorsalis Pedis
ECG
Angiogram
Duplex
Any additional relevant information
Date o f  examination 
Signed..............................
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A p p e n d i x  1 2  
Letter sent to GP
Sheffield Teaching Hospitals
NHS Foundation Trust
Sheffield Hallam University
Dear Dr
A comparison of upper- and lower-limb exercise training in patients with 
intermittent claudication
Re:
Your above named patient has consented to participate in a British Heart Foundation 
supported study, to determine the relative efficacy of a 6-month programme of upper- 
limb or lower-limb exercise training on walking distances in patients with intermittent 
claudication. The study, devised by the Sheffield Vascular Institute, will help to 
establish the mechanisms underlying exercise-induced symptomatic improvements with 
the aim of developing more effective strategies for the treatment of patients with 
peripheral vascular disease.
This is a controlled study and all participating patients will be randomised into one of 
three groups;- supervised upper-limb training, supervised lower-limb training or no­
training (control) groups. Prior to entering this study all patients will have a full 
medical assessment at the Northern General Hospital.
Those patients randomised to the training groups will undertake 20 minutes of 
supervised exercise, twice a week for a period of 6 months. The study will be 
performed at the Centre fo r  Sport and Exercise Science, of Sheffield Hallam 
University (off Ecclesall Road). The control group will not be required to undertake 
formal exercise training, but will be actively encouraged to exercise and their physical 
activity will be monitored using an activity diary.
Every 6 weeks during the 6-month training period, all three patient groups will undergo 
walking distance assessments and incremental arm- and leg-ergometer assessments. 
During these assessment sessions blood pressure, blood lactate and peak oxygen 
consumption (peak VO2) will be measured. A small blood sample will also be taken to 
measure systemic inflammatory responses to the exercise. Quality of life will be 
assessed by means of a questionnaire. Patients will also be assessed 6-, 12-, 24- and 48- 
weeks after the cessation of the 6-month training programme. The control group will be 
assessed at similar time points.
If you have any concerns or questions regarding your patient participating in this study 
please do not hesitate to contact me, my direct line telephone number is 0114 225 5690.
Yours sincerely,
Miss Irena Zwierska, BSc, MSc,
Research Assistant, BHF Project
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Appendix 13
Medical Outcomes Study SF-36 v2 Questionnaire
Your Health and W ell-Being 3. The following questions are about activities you might do during a typical day. Does your health now limit you in these activities? If so, how much?
This survey asks for your views about your health. This information will help 
keep track of how you feel and how well you are able to do your usual 
activities. Thank you for completing this survey!
For each of the following questions, please m ark an 0  in the one box that best 
describes your answer.
1. In general, would you say your health is:
Excellent Very good Good Fair Poor
▼ ▼ ▼ ▼ ▼Q □ - D D D
2. Compared to one year ago, how would you rate your health in general 
now?
Much better Somewhat About the Somewhat Much worse
now than one better now same as one worse now now than one
year ago than one year 
ago
year ago than one year 
ago
year ago
▼ ▼ ▼ ▼ ▼Q D Q Q D
Yes, Yes, No, not
limited limited limited
a lot a little at all
▼ ▼ ▼
. Vigorous activities, such as running, lifting 
heavy objects, participating in strenuous 
s p o r ts  „...............................     _............................... ............................ —r~li
,  Moderate activities, such as moving a table, 
pushing a vacuum cleaner, bowling, or 
playing g o lf ........    o
, Lifting or carrying groceries    .........
j Climbing several flights o f  stairs —----  D
. Climbing one flight o f  stairs ........     o
r Bending, kneeling, or stooping.........  .......................o
,  Walking more than a m ile    ............   Q
h Walking several hundred yards ...... - ..................[ 3
i Walking one hundred yards  ............- ....... D
j Bathing or dressing yourself .....  - ....... - .........• ••□ .
Q  -D
.......
Q   ...
Q   —Q
D -»...  Q
a .........D.
a ............q
D .........D
D   O
a ...........13
SF»36vTn*H«iHh Swvey© 1996,2000 byQuuhlyMdm-Tt>«.u»pu» JedmlMevbcjJ OJwxncNTr»»d_ AlIRnfbb*Roaved. 
SF-36£iaa Kgidovd fraJaaok of Medical Oufcoma That 
(SF-36v2 Sandud. US Venioo 2.0)
SF-36\I™Haallh Swvey® 1996. 2000 hyQuahtyMcfru-Incutr** Jed  md Medical OJcumoTmvl. All Removal 
SF-36X) is a PCjBsfcred avkmark of Medical Outturns Trust.
(SF-36v2 Saodud. US Vcoiun 2.0)
4. During the past 4 weeks, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of your physical health?
All o f Most o f  Some o f A little None of
the time the time the time o f the 
time
the time
▼ ▼ ▼ ▼ ▼
Cut down on the amount o f  time vou spent 
on work or other activities.-...... ........ .....................13... .....n~. ...13--...13......n<
Accomplished less than vou would l ik e____ .... .....13.....n<
Were limited in the kind o f  work or other 
activities.-................ ...................- ....... - _______ -..13.....13... ,...Q..._...D
Had difficulty performing the work or other 
activities (for example, it took extra e ffo rt)___ ._n- ~n.......13...
6. During the past 4 weeks, to what extent has your physical health or 
emotional problems interfered with your normal social activities with 
family, friends, neighbors, or groups?
| Not at all Slightly Moderately Quite a bit Extremely | 
▼ ▼ ▼ ▼ ▼Q  D  D  O  D
7. How much bodily pain have you had during the past 4 weeks?
None Very mild Mild Moderate Severe Very Severe
▼ ▼ ▼ ▼  . ▼ ▼
Q D D D D D
5. During the past 4 weeks, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a 
result of any emotional problems (such as feeling depressed or anxious)?
All o f  Most o f  Some o f  A little None o f 
the time the time the time o f  the the time 
time
8. During the past 4 weeks, how much did pain interfere with your normal 
work (including both work outside the home and housework)?
j Not at all A little bit Moderately Quite a bit Extremely |
▼ ▼ ▼ ▼ ▼O  D  D  D  D
.  Cut down on the amount o f  time you spent 
on work or other activities  .............. ............  D  D ..... D  D
 D D.... D—□»
, Did work or other activities less carefully 
than usual ..............   - ................. Q . -O O O-
SF'3fivI™H«ilth Savey © 19%, 2000 hy C^uJilyMetncInuffpurJed rod Medical Oak-umesTnLd. All Rights Resffvol 
SF-36& is a rcpslefed tnalenurii urMcdkaJ Oakums* Tmd.(SF-36v2 Standard. US V a n n  2.0)
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SF-Mv?™ Hodtfi S« vey © 1996,2000 by Qni)ityMe*ii> Incut]** Jed  m l Medkal Otfu 
SF-36& iv a retosieved frokvniol ufMecbwd Oakume* Trad.
(SF-36v2 Standard. US Venioo 2.0)
9. These questions are about how you feel and how things have been with you 
during the past 4 weeks. For each question, please give the one answer that 
comes closest to the way you have been feeling. How much of the time 
during the past 4 weeks...
All o f M ost o f Some o f A little None of
the time the time the time o f the the time
time
▼ ▼ ▼ ▼ ▼
Did you feel full o f life? .................... ........ .. . . . O - . . . a
Have you been very nervous? ....... ........ ........ . . . o ~ - O — .. .D - • O
Have you felt so down in the dumps
that nothing could cheer you u p ?_______ __ . . . . . Q . . . . . . o _ . . . o
Have you felt calm and peaceful?.......... _...... - - O — . . . a . . . D
Did you have a lot o fenergy?____ ....... ...... . — □*... - □ * .. O
Have you felt downhearted and
depressed?..... ........ ........................... ................. - - O . . . Q - . . . D ... . . .D . . . . o
Did you feel worn o u t? ___. . . . . ..... ........ ........ . . . D - - . - D .. . . . .D - O
Have you been happy?______ _________ ___ .. o ~ - D .. . . . O . . . . . o
Did you feel tired?_______ _________ ______ . . . .a , . . . n . . . . . . D - — . . . a . . . o
10. During the past 4 weeks, how much of the time has your physical health 
or emotional problems interfered with your social activities (like visiting 
friends, relatives, etc.)?
All o f  the Most o f  the Some o f  the A  little o f  the None o f  the
time time time time time
▼ ▼ ▼ ▼ ▼D D Q D o
11. How TRUE o r FALSE is each o f the following statem ents for you?
Definitely
true
Mostly
true
Don't
know
Mostly
false
Definitely
false
▼ ▼ ▼ ▼ ▼
I seem to get siclc a little easier 
than other people_______ ___ _____ ... Q . . .~ .....o .. . .~ . ......... Q ... ........D
I am as healthy as anybody I know.,.......□ .......... .....Q ....~ . . . . a . . . . . . . D - . ........D
1 expect my health to get worse ...... ....... .. a . . . . . . . .........Q .. . - .....O
My health is ex cellen t....... ............... . . ... D .. . . .. a . . . . . . . . . o „ .. a . . . - .....D
T H A N K  Y O U  F O R  C O M P L E T I N G  T H E S E  Q U E S T IO N S I
SF-3AV2™ Hoilth Swvey © 1996,2000 by QualrtyMefricTnturputrfedandMeilKalOiduKnesTneJ. All Rn(htsRe>avaL 
SF-36® is a legi stated fradcmufc of Medial Oufcoma ‘Dust 
(SF-36*2 S t n M .  US Version 2.0)
SF-3ftv?T2<Haifth Stsvey © 1996,2000hy QttJilvMetnc1najfruridfldaxlMedK.il] OnlwnnesTnisl. AJIfogtibRemoval 
SF-36& is i  R ^S ecd  k s k s a i i  of Medial Oufcana  D is t 
(SF-36v2 Sendnd. US V m kn 2J))
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Appendix 14
EuroQ oL EQ-5D
To help people say how good or bad a health state is, we 
have drawn a scale (rather like a thermometer) on which 
the best state you can imagine is marked 100 and the 
worst state you can imagine is marked 0.
We would like you to indicate on this scale how good 
or bad your own health is today, in your opinion. 
Please do this by drawing a line from the box below to 
whichever point on the scale indicates how good or bad 
your health state is today.
Your own 
health state 
today
Best 
imaginable 
health state
100
0
Worst 
imaginable 
health state
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Mobility SelfCare
No problems with No problems with self
mobility care
too. .too.
-9 0 - - 9 0 -
Now could you mark the scales on this 
and the next page 
to show how you 
would rate your 
current state for 
each of the specific 
areas shown.
Some examples 
have been put on 
the scales to help 
you to identify 
where your own 
state should be but 
you are free to mark 
any point on the 
scale!
- 8 0 -
-4 0 -
- 3 0 -
- 20-
- 10-
Minor 
limitations, 
e.g. unable 
to climb 
ladders
j  so-
Moderate 
limitation, e.g. unable to walk up hill or climb 
stairs unaided
Severe
restriction, e.g. 
■needs walking 
frame or 
wheelchair.
— 70—
- 6 0 -
- 4 0 -
- 3 0 -
- 20-
- 10-
-  0 -
Minor 
limitations, 
e.g. tying up 
shoe laces etc.
Needs some help with washing ■and dressing but 
not with personal tasks
Needs some help 
with personal 
■activities, using 
toilet, personal 
hygeine etc.
Completely immobile bed bound
Totally dependent upon 
others for care
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Usual
Activities
Pain/Discomfort Anxiety/Depression
No problems with 
usual activities
No pain or discomfort No anxiety or 
depression
100.
-9 0 -
-  80—
-7 0 -
-60^
-4 0 -
- 10-
-  0
Minor
limitations not 
interfering with 
job or main 
activities
100.
-'90-
-  80-
Moderate
limitations requiring 
■some change in 
work pattern or 
leisure activities
-7 0 -
-6 0 .
-50'.
-4 0 -
Severe restriction 
which make usual 
■job or leisure 
activities 
impossible
- 10-
100.
-90 -
:80i
Occasional 
mild pain or 
discomfort
-70L
Having 
constant mild 
pain or 
occasional 
moderate pains
-50-
Having 
constant 
moderate pain 
or ocassional 
extreme pains
- 10-
Occasional 
episodes of 
mild anxiety 
or depression
Frequent mild 
anxiety or 
■ depression or 
occasional more 
severe episodes
Frequent 
episodes of 
moderately 
severe anxiety or 
depression
Unable to carry out any 
work or usual activities Constant extreme pain Constant severe anxiety or depression
Walking Impairment Questionnaire (WIQ)
1. Walking impairment. These questions ask about the reasons why you had difficulty walking. We 
would like to know how much difficulty you had walking because of each of these problems during 
the last week. By difficulty, we mean how hard it was or how much physical effort it took to walk 
because of each of these problems.
A. PAD-Specific Questions Leg Degree of Difficulty Score
R i g h t
L e f t
B o t h
None Slight Some Much Very
1. Pain, aching or cramps in your calves (or buttocks) 
% Score = (Individual Score/4) x 100 4 3 2 1 0
B. Differential Diagnosis Degree of Difficulty Score
None Slight Some Much Very
1. Pain, stiffness, or aching in your joints 
(ankles, knees, or hips)? 4 3 2 1 0
2. Weakness in one or both your legs? 4 3 2 1 0
3. Pain or discomfort in your chest? 4 3 2 1 0
4. Shortness of breath? 4 3 2 1 0
5. Heart palpitations? 4 3 2 1 0
6. Other problems? (Please list) 4 3 2 1 0
2. Walking distance: Report the degree of physical difficulty that best describes how hard it was for you 
to walk on level ground without stopping to rest for each of the following distances during the last 
week:
Distance___________________________________Degree of Difficulty___________ Weight Score
None Slight Some Much Unable Feet
1. Walking indoors such as around 
your home? 4 3 2 1 0 x 20 =
2. Walking 50 feet? 4 3 2 1 0 x 50 =
3. Walking 150 feet QA block)? 4 3 2 1 0 x 150 =
4. Walking 300 feet (1 block)? 4 3 2 1 0 x 300 =
5. Walking 600 feet (2 blocks)? 4 3 2 1 0 x 600 =
6. Walking 900 feet (3 blocks)? x 900 =
7. Walking 1500 feet (5 blocks)? 4 3 2 1 0 xl500=
%  S c o r e  =  ( S u m  I n d i v i d u a l  S c o r e / 1 4 0 8 0 )  x  1 0 0 -
3. Walking speed: Report the degree of physical difficulty that best describes how hard it was for you to 
walk one city block (300 feet) on level ground at each of these speeds without stopping to rest during 
the last week:
Speed Degree of Difficulty Weight Score
None Slight Some Much Unable Mph
1. Walking 1 block slowly? 4 3 2 1 0 x 1.5 =
2. Walking 1 block at an average 
speed? 4 3 2 1 0 x 2.0 =
3. Walking 1 block quickly? 4 3 2 1 0 x 3.0 =
6. Running or jogging 1 block? 4 3 2 1 0 x 5.0
%  S c o r e  =  ( S u m  I n d i v i d u a l  S c o r e /  4 6 )  x  1 0 0
4. Stair climbing: For each of these questions, report the degree of physical difficulty that best describes 
how hard it was for you to climb stairs without stopping to rest during the past week:
Stairs Degree of Difficulty Weight Score
None Slight Some Much Unable
1. Climbing 1 flight of stairs? 4 3 2 1 0 x 12 =
2. Climbing 2 flights of stairs? 4 3 2 1 0 x 24 =
3. Climbing 3 flights of stairs? 4 3 2 1 0 x 36 =
% S c o r e  =  ( S u m  I n d i v i d u a l  S c o r e /  2 8 8 )  x  1 0 0
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Appendix 16
Selfperceived walking ability
As a result of the 24-week intervention period, do you feel that your walking ability has 
changed?
Please answer this question as honestly as possible, giving one response only, by 
circling the correct response.
Do you feel that your walking ability has now:-
Improved Remains Unchanged Deteriorated
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Appendix 18
Peripheral Arterial Disease Physical Activity Recall
(PAD-PAR)
Patient ID No...........................
Week No..................................
Date..........................................
1. How many hours do you sleep a night, on average?
Hours x 7 =
Sleep hours per week =
2. Explain to patient that you are going to ask about typical work activities performed 
during the past week (includes work for pay or regular volunteer activities).
If patient is not employed, go to question 3.
How many total hours did you work per week on average?
Work hours per week?
Here is a listing of typical work activities (show participant CARD A).
Activities are classified as heavy, moderate, light and very light, depending on their 
average energy demands.
With your job, time may be spent in more than one category of activity. Let’s start 
with heavy activities and then go on to moderate, light and then very light activities.
a) Please tell me the average number of days during the last week you 
performed heavy activities at work
b) Please tell me the average length of time you performed heavy activities in a 
day.
Then, repeat above directions for all intensities of activity.
Intensity of 
Activity
Days per 
Week 
(0.5 to 7.0)
Hours per Day 
(nearest 0.5 h) Hours per 
Week
MET Hours 
per Week
Heavy (5.1 - 7.0 
METs)
Moderate (3.1 - 5.0 
METs)
Light (2.1 - 3.0
METs)
Very Light (0.9 - 
2.0 METs)
TOTAL
273
3. Did you perform household chores or yard work around the home during the 
past week? (Follow instructions given above, except refer to CARD B). If yes, 
how many total hours did you spend in household chores?
Household or yard hours per week =
Intensity of 
Activity
Days per 
Week 
(0.5 to 7.0)
Hours per 
Day 
(nearest 0.5 h) Hours per 
Week
MET Hours 
per Week
Heavy (5.1 - 7.0 
METs)
Moderate (3.1 - 5.0 
METs)
Light (2.1 - 3.0
METs)
Very Light (0.9 - 
2.0 METs)
TOTAL
4. Did you perform recreational or leisure-time activities during the past week (Refer 
to CARD C). If yes, how many total hours did you spend in leisure activities?
Recreation or leisure hours per week =
Intensity of 
Activity
Days per 
Week 
(0.5 to 7.0)
Hours per 
Day 
(nearest 0.5 h) Hours per 
Week
MET Hours 
per Week
Heavy (5.1 - 7.0 
METs)
Moderate (3.1 - 5.0 
METs)
Light (2.1 - 3.0
METs)
Very Light (0.9 - 
2.0 METs)
TOTAL
274
Appendix 19
A Range o f Physical Activities
Selected list of activities with MET Values (in Parentheses)*
Card A Physical Activities at Wok
Heavy Moderate Light Very Light
Heavy power tools Locksmith Cashier Sitting
(6.0) (3.5) (2.5) (1.5)
Coal mining Carrying < 20 lbs Light assembly Standing
(7.0) (5.0) (2.5) (2.0)
Loading truck Farming Physician Typing
(6.5) (4.5) (2.5) (1.5)
Shovelling Machine tooling Teacher Computer work
(7.0) (4.0) (2.5) (1.5)
Heavy carpentry Forestry, chain saw Tailoring, machine Receptionist
(7.0) (4.5) (2.5) (1.5)
Card B Household Chores and Yard Work
Heavy Moderate Light Very Light
Roofing Food shopping Preparing meals Sitting
(6.0) (3.5) (2.5) (1.5)
Digging Heavy cleaning Sweeping Standing/laundry
(5.0) (4.5) (2.5) (1.5)
Chopping wood Laying carpet Making bed Fold, hang clothes
(6.0) (4.5) (2.5) (1.5)
Shoveling snow Weeding Fertilising Sewing
(6.0) (4.5) (2.5) (1.5)
Manual lawn mowing Power lawn mowing Ironing
(6.0) (4.5) (2.3)
Card C Recreational Activities
Heavy Moderate Light Very Light
Walking/hiking uphill Walking, level Walking (< 3 mph) Playing flute
(6.0) (4.0) (2.5) (2.0)
Moderate canoeing Easy bicycling Bowling, billiards Playing cards
(7.0) (5.0) (2.5) (1.5)
Bicycling 10-12 mph Frisbee, ultimate Walking down stairs Television/radio
(6.0) (3.5) (3.0) (1.0)
Light stationary cycle Ping pong Modem jazz Reading
(5.5) (4.0) (3.0) (1.0)
Aerobic dance Weight lifting Croquet Music listening
(7.0) (3.5) (2.5) (1.0)
Leisurely swimming Light rowing Golf with cart Socialising
(6.0) (3.5) (2.5) (2.0)
*MET values for many activities can be obtained from Ainsworth BE, et al. 
Compendium of physical activities: classification of energy costs of human physical 
activities. Med Sci Sports Exerc. 1993; 25: 71-80.
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Appendix 20
Selfperception o f changes in physical activity status
Please circle the number on the ladder that best describes your level of physical 
activity.
Please answer this question as honestly as you can.
*Regular exercise =
three or more times per 
week for 20 minutes or 
longer of moderate 
exercise e.g. walking 
briskly or cycling, 
swimming.
}
try
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I  exercise regularly* and 
have done so for longer 
than 6 months.
I  exercise regularly* but 
have done so for less than 
6 months.
I  currently exercise 
some, but not regularly*
I  have exercised in the 
past 6 months but have 
not done so recently
I  currently don't exercise 
but I  am thinking about 
starting in the  next 
6 months
I  currently don't exercise 
and I  do not intend to s ta r t  
in the  next 6 months
276
Appendix 21
Incentive to perform physical activity
Do you feel that the 24-week intervention period has provided you with an incentive to 
perform physical activity? Please answer this question as honestly as possible, by 
circling the correct response.
Do you feel that this study has provided you with an incentive to perform 
physical activity?
Incentive No Incentive
277
Appendix 22 
RISK ASSESSMENT PROFORMA
SHEFFIELD HALLAM UNIVERSITY 
SCHOOL OF SPORT LEISURE AND MANAGEMENT
PROCEDURE: British Heart Foundation Funded Study: A comparison of upper- and 
lower-limb exercise training in patients with intermittent claudication. 
ASSESSMENT No:- IZ/BHF/Out-line 
DATE ASSESSED:- 23rd March 2001
ASSESSED BY:- Mr Graham Jarman and Dr John M. Saxton 
SIGNED:- POSITION:-
HAZARDS RISKS AND SPECIFIC CONTROL 
MEASURES
1. Cardio-vascular complications Medium (C3xL2=R6). All patients to 
have a full clinical assessment prior to 
enrolment onto the study. Vascular 
Surgeon to be present at initial assessment 
session.
2. Venepuncture Medium (C3xLl=R4). Reference should 
be made to CSES/SLM specific risk 
assessment.
3. Capillary blood sampling Low (C2xLl=R2). Reference should be 
made to CSES/SLM specific risk 
assessment.
4. Use of ergometers Medium (C3xL2=R6). Reference should 
be made to CSES/SLM assessment on 
maximal oxygen consumption on a friction 
braked ergometer.
RISK EVALUATION (OVERALL): MEDIUM
278
GENERAL CONTROL MEASURES
Medical pre-screening must be carried out on all patients prior to enrolment onto the 
study. Medical supervision should be arranged for each initial assessment session. In 
addition, at least one first aider should be present at each assessment and each training 
session. When there is in attendance a qualified medical practitioner or person trained in 
advanced life support, an automated external defibrillator should be available. All of the 
risk assessments referred to above must be adhered to.
EMERGENCY PROCEDURES
Initiate first aid response in accordance with training and agreed CSES procedures.
MONITORING PROCEDURES
All safety procedures to be monitored throughout the assessment and training sessions.
REVIEW PERIOD
Annually.
REVIEWED BY:
Mr Graham Jarman / Dr John M. Saxton Date: 23 March 2001
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